Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
GRCh38/hg38 10q24.31-26.3(chr10:100194215-132432797)x3	LOC126861079|LOC126861080|LOC126861081|LOC126861082|LOC126861083|LOC126861084|LOC126861085|LOC126861086|LOC126861087|LOC126861088|LOC126861089|LOC126861090|LOC126861091|LOC126861092|LOC126861093|LOC126861094|LOC126861095|LOC126861096|LOC126861097|LOC126861098|LOC126861099|LOC126861100|LOC128598885|LOC128772341|LOC129390223|LOC129390224|LOC129390225|LOC129390226|LOC129390227|LOC129390228|LOC129390229|LOC129390230|LOC129390231|LOC129390232|LOC129390233|LOC129390234|LOC129390235|LOC129390236|LOC129390237|LOC129390238|LOC129390239|LOC129390240|LOC130004523|LOC130004524|LOC130004525|LOC130004526|LOC130004527|LOC130004528|LOC130004529|LOC130004530|LOC130004531|LOC130004532|LOC130004533|LOC130004534|LOC130004535|LOC130004536|LOC130004537|LOC130004538|LOC130004539|LOC130004540|LOC130004541|LOC130004542|LOC130004543|LOC130004544|LOC130004545|LOC130004546|LOC130004547|LOC130004548|LOC130004549|LOC130004550|LOC130004551|LOC130004552|LOC130004553|LOC130004554|LOC130004555|LOC130004556|LOC130004557|LOC130004558|LOC130004559|LOC130004560|LOC130004561|LOC130004562|LOC130004563|LOC130004564|LOC130004565|LOC130004566|LOC130004567|LOC130004568|LOC130004569|LOC130004570|LOC130004571|LOC130004572|LOC130004573|LOC130004574|LOC130004575|LOC130004576|LOC130004577|LOC130004578|LOC130004579|LOC130004580|LOC130004581|LOC130004582|LOC130004583|LOC130004584|LOC130004585|LOC130004586|LOC130004587|LOC130004588|LOC130004589|LOC130004590|LOC130004591|LOC130004592|LOC130004593|LOC130004594|LOC130004595|LOC130004596|LOC130004597|LOC130004598|LOC130004599|LOC130004600|LOC130004601|LOC130004602|LOC130004603|LOC130004604|LOC130004605|LOC130004606|LOC130004607|LOC130004608|LOC130004609|LOC130004610|LOC130004611|LOC130004612|LOC130004613|LOC130004614|LOC130004615|LOC130004616|LOC130004617|LOC130004618|LOC130004619|LOC130004620|LOC130004621|LOC130004622|LOC130004623|LOC130004624|LOC130004625|LOC130004626|LOC130004627|LOC130004628|LOC130004629|LOC130004630|LOC130004631|LOC130004632|LOC130004633|LOC130004634|LOC130004635|LOC130004636|LOC130004637|LOC130004638|LOC130004639|LOC130004640|LOC130004641|LOC130004642|LOC130004643|LOC130004644|LOC130004645|LOC130004646|LOC130004647|LOC130004648|LOC130004649|LOC130004650|LOC130004651|LOC130004652|LOC130004653|LOC130004654|LOC130004655|LOC130004656|LOC130004657|LOC130004658|LOC130004659|LOC130004660|LOC130004661|LOC130004662|LOC130004663|LOC130004664|LOC130004665|LOC130004666|LOC130004667|LOC130004668|LOC130004669|LOC130004670|LOC130004671|LOC130004672|LOC130004673|LOC130004674|LOC130004675|LOC130004676|LOC130004677|LOC130004678|LOC130004679|LOC130004680|LOC130004681|LOC130004682|LOC130004683|LOC130004684|LOC130004685|LOC130004686|LOC130004687|LOC130004688|LOC130004689|LOC130004690|LOC130004691|LOC130004692|LOC130004693|LOC130004694|LOC130004695|LOC130004696|LOC130004697|LOC130004698|LOC130004699|LOC130004700|LOC130004701|LOC130004702|LOC130004703|LOC130004704|LOC130004705|LOC130004706|LOC130004707|LOC130004708|LOC130004709|LOC130004710|LOC130004711|LOC130004712|LOC130004713|LOC130004714|LOC130004715|LOC130004716|LOC130004717|LOC130004718|LOC130004719|LOC130004720|LOC130004721|LOC130004722|LOC130004723|LOC130004724|LOC130004725|LOC130004726|LOC130004727|LOC130004728|LOC130004729|LOC130004730|LOC130004731|LOC130004732|LOC130004733|LOC130004734|LOC130004735|LOC130004736|LOC130004737|LOC130004738|LOC130004739|LOC130004740|LOC130004741|LOC130004742|LOC130004743|LOC130004744|LOC130004745|LOC130004746|LOC130004747|LOC130004748|LOC130004749|LOC130004750|LOC130004751|LOC130004752|LOC130004753|LOC130004754|LOC130004755|LOC130004756|LOC130004757|LOC130004758|LOC130004759|LOC130004760|LOC130004761|LOC130004762|LOC130004763|LOC130004764|LOC130004765|LOC130004766|LOC130004767|LOC130004768|LOC130004769|LOC130004770|LOC130004771|LOC130004772|LOC130004773|LOC130004774|LOC130004775|LOC130004776|LOC130004777|LOC130004778|LOC130004779|LOC130004780|LOC130004781|LOC130004782|LOC130004783|LOC130004784|LOC130004785|LOC130004786|LOC130004787|LOC130004788|LOC130004789|LOC130004790|LOC130004791|LOC130004792|LOC130004793|LOC130004794|LOC130004795|LOC130004796|LOC130004797|LOC130004798|LOC130004799|LOC130004800|LOC130004801|LOC130004802|LOC130004803|LOC130004804|LOC130004805|LOC130004806|LOC130004807|LOC130004808|LOC130004809|LOC130004810|LOC130004811|LOC130004812|LOC130004813|LOC130004814|LOC130004815|LOC130004816|LOC130004817|LOC130004818|LOC130004819|LOC130004820|LOC130004821|LOC130004822|LOC130004823|LOC130004824|LOC130004825|LOC130004826|LOC130004827|LOC130004828|LOC130004829|LOC130004830|LOC130004831|LOC130004832|LOC130004833|LOC130004834|LOC130004835|LOC130004836|LOC130004837|LOC130004838|LOC130004839|LOC130004840|LOC130004841|LOC130004842|LOC130004843|LOC130004844|LOC130004845|LOC130004846|LOC130004847|LOC130004848|LOC130004849|LOC130004850|LOC130004851|LOC130004852|LOC130004853|LOC130004854|LOC130004855|LOC130004856|LOC130004857|LOC130004858|LOC130004859|LOC130004860|LOC130004861|LOC130004862|LOC130004863|LOC130004864|LOC130004865|LOC130004866|LOC130004867|LOC130004868|LOC130004869|LOC130004870|LOC130004871|LOC130004872|LOC130004873|LOC130004874|LOC130004875|LOC130004876|LOC130004877|LOC130004878|LOC130004879|LOC130004880|LOC130004881|LOC130004882|LOC130004883|LOC130004884|LOC130004885|LOC130004886|LOC130004887|LOC130004888|LOC130004889|LOC130004890|LOC130004891|LOC130004892|LOC130004893|LOC130004894|LOC130004895|LOC130004896|LOC130004897|LOC130004898|LOC130004899|LOC130004900|LOC130004901|LOC130004902|LOC130004903|LOC130004904|LOC130004905|LOC130004906|LOC130004907|LOC130004908|LOC130004909|LOC130004910|LOC130004911|LOC130004912|LOC130004913|LOC130004914|LOC130004915|LOC130004916|LOC130004917|LOC130004918|LOC130004919|LOC130004920|LOC130004921|LOC130004922|LOC130004923|LOC130004924|LOC130004925|LOC130004926|LOC130004927|LOC130004928|LOC130004929|LOC130004930|LOC130004931|LOC130004932|LOC130004933|LOC130004934|LOC130004935|LOC130004936|LOC130004937|LOC130004938|LOC130004939|LOC130004940|LOC130004941|LOC130004942|LOC130004943|LOC130004944|LOC130004945|LOC130004946|LOC130004947|LOC130004948|LOC130004949|LOC130004950|LOC130004951|LOC130004952|LOC130004953|LOC130004954|LOC130004955|LOC130004956|LOC130004957|LOC130004958|LOC130004959|LOC130004960|LOC130004961|LOC130004962|LOC130004963|LOC130004964|LOC130004965|LOC130004966|LOC130004967|LOC130004968|LOC130004969|LOC130004970|LOC130004971|LOC130004972|LOC130004973|LOC130004974|LOC130004975|LOC130004976|LOC130004977|LOC130004978|LOC130004979|LOC130004980|LOC130004981|LOC130004982|LOC130004983|LOC130004984|LOC130004985|LOC130004986|LOC130004987|LOC130004988|LOC130004989|LOC130004990|LOC130004991|LOC130004992|LOC130004993|LOC130004994|LOC132089741|LOC132089742|LOC132089743|LOC132089744|LOC132089745|LOC132089746|LOC132089747|LOC132089748|LOC132089749|LOC132089750|LOC132089751|LOC132089752|LOC132089753|LOC132089754|LOC132089755|LOC132089756|LOC132089757|LOC132089758|LOC132089759|LOC132089760|LOC132089761|LOC132089879|LOC132089880|LOC132089881|LOC132089882|LOC132089883|LOC132089884|LOC132090825|LOC132090826|LOC132090827|LOC132090828|LOC132090829|LOC132090830|LOC132211103|LOC132211104|LOC283038|LOC728158|LRRC27|LZTS2|MCMBP|MFSD13A|MGMT|MIR1307|MIR146B|MIR2110|MIR3158-1|MIR3158-2|MIR3663|MIR3663HG|MIR378C|MIR3941|MIR4295|MIR4296|MIR4297|MIR4482|MIR4483|MIR4484|MIR4680|MIR4681|MIR4682|MIR548E|MIR608|MIR609|MIR6715A|MIR6715B|MIR936|MIR9851|MKI67|MMP21|MRPL43|MXI1|NANOS1|NDUFB8|NEURL1|NEURL1-AS1|NFKB2|NHLRC2|NKX1-2|NOLC1|NPM3|NPS|NRAP|NSMCE4A|NT5C2|OAT|OGA|OLMALINC|PAX2|PCGF6|PDCD11|PDCD4|PDCD4-AS1|PDZD7|PDZD8|PITX3|PKD2L1|PLEKHA1|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|POLL|PPP2R2D|PPRC1|PRDX3|PRLHR|PSD|PSTK|PTPRE|PWWP2B|RAB11FIP2|RBM20|RGS10|RPEL1|SCD|SEC23IP|SEC31B|SEMA4G|SFR1|SFXN2|SFXN3|SFXN4|SH3PXD2A|SH3PXD2A-AS1|SHOC2|SHTN1|SLC18A2|SLC18A2-AS1|SLF2|SLK|SMC3|SMNDC1|SNORA12|SNORA19|SNORA87|SNORD158|SORCS1|SORCS3|SORCS3-AS1|SPADH|SPMIP5|STK32C|STN1|SUFU|TACC2|TAF5|TCERG1L|TCERG1L-AS1|TCF7L2|TDRD1|TECTB|TEX36|TEX36-AS1|TIAL1|TLX1|TLX1NB|TRIM8|TRIM8-DT|TRUB1|TWNK|UROS|VAX1|VTI1A|VWA2|WBP1L|WDR11|WDR11-DT|WNT8B|XPNPEP1|ZDHHC6|ZRANB1|ABLIM1|ABRAXAS2|ACADSB|ACSL5|ACTR1A|ADAM12|ADD3|ADD3-AS1|ADRA2A|ADRB1|AFAP1L2|ARL3|ARMH3|ARMS2|AS-PTPRE|AS3MT|ATE1|ATE1-AS1|ATP5MK|ATRNL1|BAG3|BBIP1|BCCIP|BLOC1S2|BNIP3|BORCS7|BORCS7-ASMT|BTBD16|BTRC|BUB3|C10orf120|C10orf143|C10orf88|C10orf90|C10orf95|C10orf95-AS1|CACUL1|CALHM1|CALHM2|CALHM3|CASC2|CASP7|CCDC172|CCDC186|CFAP43|CFAP58|CFAP58-DT|CHST15|CHUK|CHUK-DT|CLRN3|CNNM2|COL17A1|CPXM2|CTBP2|CUEDC2|CUZD1|CWF19L1|CYP17A1|CYP17A1-AS1|DCLRE1A|DENND10|DHX32|DMBT1|DOCK1|DPCD|DPYSL4|DUSP5|DUSP5-DT|EBF3|EDRF1|EDRF1-AS1|EDRF1-DT|EEF1AKMT2|EIF3A|ELOVL3|EMX2|EMX2OS|ENO4|FAM204A|FAM24A|FAM24B|FAM24B-CUZD1|FAM53B|FAM53B-AS1|FANK1|FANK1-AS1|FBXL15|FBXW4|FGF8|FGFR2|FHIP2A|FOXI2|FRA10B|GBF1|GFRA1|GLRX3|GPAM|GPR26|GRK5|GRK5-AS1|GRK5-IT1|GSTO1|GSTO2|HABP2|HEAT2|HIF1AN|HMX2|HMX3|HPS6|HSPA12A|HSPA12A-AS1|HTRA1|IKZF5|INA|INPP5F|INSYN2A|ITPRIP|ITPRIP-AS1|JAKMIP3|JAKMIP3-AS1|KAZALD1|KCNIP2|KCNIP2-AS1|KCNK18|LBX1|LBX1-AS1|LDB1|LHPP|LINC00601|LINC00867|LINC01153|LINC01163|LINC01164|LINC01435|LINC01514|LINC01561|LINC02620|LINC02624|LINC02626|LINC02627|LINC02641|LINC02661|LINC02667|LINC02674|LINC02681|LINC03036|LINC03046|LINC03068|LOC101927692|LOC102724883|LOC103344931|LOC105378479|LOC105378482|LOC105378552|LOC107984265|LOC107984281|LOC109136576|LOC110120845|LOC110120846|LOC110120850|LOC110120851|LOC110120852|LOC110120886|LOC110120892|LOC110120898|LOC110120916|LOC110120919|LOC110120924|LOC110120928|LOC110120938|LOC110120952|LOC110121311|LOC110121334|LOC110121344|LOC110121396|LOC110121472|LOC110408762|LOC111501773|LOC111818958|LOC111818962|LOC111818963|LOC111875816|LOC111875817|LOC111875818|LOC111875819|LOC111875820|LOC111875821|LOC111875822|LOC111875823|LOC111875824|LOC111875825|LOC111875826|LOC111875827|LOC111875828|LOC111875829|LOC111875830|LOC111875831|LOC111875832|LOC111875833|LOC111875834|LOC111875835|LOC113939913|LOC113939914|LOC113939915|LOC116216120|LOC116216121|LOC116216122|LOC116216123|LOC121366077|LOC121366078|LOC121366079|LOC121366080|LOC121366081|LOC121366082|LOC121366083|LOC121366084|LOC121366085|LOC121366086|LOC121366087|LOC121366088|LOC121366089|LOC121366090|LOC121366091|LOC121366092|LOC121366093|LOC121815961|LOC121815962|LOC121815963|LOC121815964|LOC121815965|LOC121815966|LOC121815967|LOC121815968|LOC121815969|LOC121815970|LOC121815971|LOC121815972|LOC121815973|LOC121815974|LOC121815975|LOC121815976|LOC121815977|LOC124416890|LOC124416891|LOC124416892|LOC124416893|LOC124416894|LOC124416895|LOC124416896|LOC124416897|LOC124416898|LOC124416899|LOC124416900|LOC124416901|LOC124416902|LOC124416903|LOC124416904|LOC124416905|LOC124416906|LOC124416907|LOC124416908|LOC124416909|LOC124416910|LOC124416911|LOC124416912|LOC124416913|LOC124416914|LOC124416915|LOC124416916|LOC124416917|LOC124416918|LOC124416919|LOC124416920|LOC124416921|LOC124416922|LOC124416923|LOC124416924|LOC124416925|LOC124416926|LOC124416927|LOC124416928|LOC124416929|LOC124416930|LOC124416931|LOC124416932|LOC124416933|LOC124416934|LOC124416935|LOC126861016|LOC126861017|LOC126861018|LOC126861019|LOC126861020|LOC126861021|LOC126861022|LOC126861023|LOC126861024|LOC126861025|LOC126861026|LOC126861027|LOC126861028|LOC126861029|LOC126861030|LOC126861031|LOC126861032|LOC126861033|LOC126861034|LOC126861035|LOC126861036|LOC126861037|LOC126861038|LOC126861039|LOC126861040|LOC126861041|LOC126861042|LOC126861043|LOC126861044|LOC126861045|LOC126861046|LOC126861047|LOC126861048|LOC126861049|LOC126861050|LOC126861051|LOC126861052|LOC126861053|LOC126861054|LOC126861055|LOC126861056|LOC126861057|LOC126861058|LOC126861059|LOC126861060|LOC126861061|LOC126861062|LOC126861063|LOC126861064|LOC126861065|LOC126861066|LOC126861067|LOC126861068|LOC126861069|LOC126861070|LOC126861071|LOC126861072|LOC126861073|LOC126861074|LOC126861075|LOC126861076|LOC126861077|LOC126861078		See cases	VCV000059707	10	101953972 - 134246301	10	100194215 - 132432797	59707	74302			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 10q24.31-26.3(chr10:100600492-133622588)x3	ABLIM1|ABRAXAS2|ACADSB|ACSL5|ACTR1A|ADAM12|ADAM8|ADD3|ADD3-AS1|ADGRA1|ADGRA1-AS1|ADRA2A|ADRB1|AFAP1L2|ARL3|ARMH3|ARMS2|AS-PTPRE|AS3MT|ATE1|ATE1-AS1|ATP5MK|ATRNL1|BAG3|BBIP1|BCCIP|BNIP3|BORCS7|BORCS7-ASMT|BTBD16|BTRC|BUB3|C10orf120|C10orf143|C10orf88|C10orf90|C10orf95|C10orf95-AS1|CACUL1|CALHM1|CALHM2|CALHM3|CALY|CASC2|CASP7|CCDC172|CCDC186|CFAP43|CFAP46|CFAP58|CFAP58-DT|CHST15|CLRN3|CNNM2|COL17A1|CPXM2|CTBP2|CUEDC2|CUZD1|CYP17A1|CYP17A1-AS1|CYP2E1|DCLRE1A|DENND10|DHX32|DMBT1|DOCK1|DPCD|DPYSL4|DUSP5|DUSP5-DT|EBF3|ECHS1|EDRF1|EDRF1-AS1|EDRF1-DT|EEF1AKMT2|EIF3A|ELOVL3|EMX2|EMX2OS|ENO4|FAM204A|FAM24A|FAM24B|FAM24B-CUZD1|FAM53B|FAM53B-AS1|FANK1|FANK1-AS1|FBXL15|FBXW4|FGF8|FGFR2|FHIP2A|FOXI2|FRA10B|FUOM|GBF1|GFRA1|GLRX3|GPAM|GPR26|GRK5|GRK5-AS1|GRK5-IT1|GSTO1|GSTO2|HABP2|HEAT2|HMX2|HMX3|HPS6|HSPA12A|HSPA12A-AS1|HTRA1|IKZF5|INA|INPP5A|INPP5F|INSYN2A|ITPRIP|ITPRIP-AS1|JAKMIP3|JAKMIP3-AS1|KAZALD1|KCNIP2|KCNIP2-AS1|KCNK18|KNDC1|LBX1|LBX1-AS1|LDB1|LHPP|LINC00601|LINC00867|LINC01153|LINC01163|LINC01164|LINC01165|LINC01166|LINC01167|LINC01168|LINC01435|LINC01514|LINC01561|LINC02620|LINC02624|LINC02626|LINC02627|LINC02641|LINC02661|LINC02667|LINC02674|LINC02681|LINC02870|LINC03036|LINC03046|LINC03068|LOC101927692|LOC102724883|LOC103344931|LOC105378479|LOC105378482|LOC105378552|LOC107984265|LOC107984281|LOC107984282|LOC109136576|LOC110120845|LOC110120846|LOC110120850|LOC110120851|LOC110120852|LOC110120886|LOC110120892|LOC110120898|LOC110120916|LOC110120919|LOC110120924|LOC110120928|LOC110120938|LOC110120952|LOC110121334|LOC110121344|LOC110121396|LOC110121444|LOC110121472|LOC110408762|LOC110599579|LOC110599585|LOC111501773|LOC111818958|LOC111818962|LOC111818963|LOC111875816|LOC111875817|LOC111875818|LOC111875819|LOC111875820|LOC111875821|LOC111875822|LOC111875823|LOC111875824|LOC111875825|LOC111875826|LOC111875827|LOC111875828|LOC111875829|LOC111875830|LOC111875831|LOC111875832|LOC111875833|LOC111875834|LOC111875835|LOC111946221|LOC113939913|LOC113939914|LOC113939915|LOC116216120|LOC116216121|LOC116216122|LOC116216123|LOC121366077|LOC121366078|LOC121366079|LOC121366080|LOC121366081|LOC121366082|LOC121366083|LOC121366084|LOC121366085|LOC121366086|LOC121366087|LOC121366088|LOC121366089|LOC121366090|LOC121366091|LOC121366092|LOC121366093|LOC121815962|LOC121815963|LOC121815964|LOC121815965|LOC121815966|LOC121815967|LOC121815968|LOC121815969|LOC121815970|LOC121815971|LOC121815972|LOC121815973|LOC121815974|LOC121815975|LOC121815976|LOC121815977|LOC124416890|LOC124416891|LOC124416892|LOC124416893|LOC124416894|LOC124416895|LOC124416896|LOC124416897|LOC124416898|LOC124416899|LOC124416900|LOC124416901|LOC124416902|LOC124416903|LOC124416904|LOC124416905|LOC124416906|LOC124416907|LOC124416908|LOC124416909|LOC124416910|LOC124416911|LOC124416912|LOC124416913|LOC124416914|LOC124416915|LOC124416916|LOC124416917|LOC124416918|LOC124416919|LOC124416920|LOC124416921|LOC124416922|LOC124416923|LOC124416924|LOC124416925|LOC124416926|LOC124416927|LOC124416928|LOC124416929|LOC124416930|LOC124416931|LOC124416932|LOC130004922|LOC130004923|LOC130004924|LOC130004925|LOC130004926|LOC130004927|LOC130004928|LOC130004929|LOC130004930|LOC130004931|LOC130004932|LOC130004933|LOC130004934|LOC130004935|LOC130004936|LOC130004937|LOC130004938|LOC130004939|LOC130004940|LOC130004941|LOC130004942|LOC130004943|LOC130004944|LOC130004945|LOC130004946|LOC130004947|LOC130004948|LOC130004949|LOC130004950|LOC130004951|LOC130004952|LOC130004953|LOC130004954|LOC130004955|LOC130004956|LOC130004957|LOC130004958|LOC130004959|LOC130004960|LOC130004961|LOC130004962|LOC130004963|LOC130004964|LOC130004965|LOC130004966|LOC130004967|LOC130004968|LOC130004969|LOC130004970|LOC130004971|LOC130004972|LOC130004973|LOC130004974|LOC130004975|LOC130004976|LOC130004977|LOC130004978|LOC130004979|LOC130004980|LOC130004981|LOC130004982|LOC130004983|LOC130004984|LOC130004985|LOC130004986|LOC130004987|LOC130004988|LOC130004989|LOC130004990|LOC130004991|LOC130004992|LOC130004993|LOC130004994|LOC130004995|LOC130004996|LOC130004997|LOC130004998|LOC130004999|LOC130005000|LOC130005001|LOC130005002|LOC130005003|LOC130005004|LOC130005005|LOC130005006|LOC130005007|LOC130005008|LOC130005009|LOC130005010|LOC130005011|LOC130005012|LOC130005013|LOC130005014|LOC130005015|LOC130005016|LOC130005017|LOC130005018|LOC130005019|LOC130005020|LOC130005021|LOC130005022|LOC130005023|LOC130005024|LOC130005025|LOC130005026|LOC130005027|LOC130005028|LOC130005029|LOC130005030|LOC130005031|LOC130005032|LOC130005033|LOC130005034|LOC130005035|LOC130005036|LOC132089741|LOC132089742|LOC132089743|LOC132089744|LOC132089745|LOC132089746|LOC132089747|LOC132089748|LOC132089749|LOC132089750|LOC132089751|LOC132089752|LOC132089753|LOC132089754|LOC132089755|LOC132089756|LOC132089757|LOC132089758|LOC132089759|LOC132089760|LOC132089761|LOC132089879|LOC132089880|LOC132089881|LOC132089882|LOC132089883|LOC132089884|LOC132090825|LOC132090826|LOC132090827|LOC132090828|LOC132090829|LOC132090830|LOC132211103|LOC132211104|LOC283038|LOC728158|LRRC27|LZTS2|MCMBP|MFSD13A|MGMT|MIR1307|MIR146B|MIR202|MIR202HG|MIR2110|MIR3158-1|MIR3158-2|MIR3663|MIR3663HG|MIR378C|MIR3941|MIR3944|MIR4295|MIR4296|MIR4297|MIR4482|MIR4483|MIR4484|MIR4680|MIR4681|MIR4682|MIR548E|MIR608|MIR609|MIR6715A|MIR6715B|MIR936|MIR9851|MKI67|MMP21|MRPL43|MTG1|MXI1|NANOS1|NEURL1|NEURL1-AS1|NFKB2|NHLRC2|NKX1-2|NKX6-2|NOLC1|NPM3|NPS|NRAP|NSMCE4A|NT5C2|OAT|OGA|PAOX|PAX2|PCGF6|PDCD11|PDCD4|PDCD4-AS1|PDZD7|PDZD8|PITX3|PLEKHA1|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PSD|POLL|PPP2R2D|PPRC1|PRAP1|PRDX3|PRLHR|PSTK|PTPRE|PWWP2B|RAB11FIP2|RBM20|RGS10|RPEL1|SCART1|SEC23IP|SEMA4G|SFR1|SFXN2|SFXN3|SFXN4|SH3PXD2A|SH3PXD2A-AS1|SHOC2|SHTN1|SLC18A2|SLC18A2-AS1|SLF2|SLK|SMC3|SMNDC1|SNORA19|SNORA87|SNORD158|SORCS1|SORCS3|SORCS3-AS1|SPADH|SPMIP5|SPRN|STK32C|STN1|SUFU|SYCE1|TACC2|TAF5|TCERG1L|TCERG1L-AS1|TCF7L2|TDRD1|TECTB|TEX36|TEX36-AS1|TIAL1|TLX1|TLX1NB|TRIM8|TRIM8-DT|TRUB1|TUBGCP2|TWNK|UROS|UTF1|VAX1|VENTX|VTI1A|VWA2|WBP1L|WDR11|WDR11-DT|XPNPEP1|ZDHHC6|ZNF511|ZNF511-PRAP1|ZRANB1|LOC124416933|LOC124416934|LOC124416935|LOC124416936|LOC126861016|LOC126861017|LOC126861018|LOC126861019|LOC126861020|LOC126861021|LOC126861022|LOC126861023|LOC126861024|LOC126861025|LOC126861026|LOC126861027|LOC126861028|LOC126861029|LOC126861030|LOC126861031|LOC126861032|LOC126861033|LOC126861034|LOC126861035|LOC126861036|LOC126861037|LOC126861038|LOC126861039|LOC126861040|LOC126861041|LOC126861042|LOC126861043|LOC126861044|LOC126861045|LOC126861046|LOC126861047|LOC126861048|LOC126861049|LOC126861050|LOC126861051|LOC126861052|LOC126861053|LOC126861054|LOC126861055|LOC126861056|LOC126861057|LOC126861058|LOC126861059|LOC126861060|LOC126861061|LOC126861062|LOC126861063|LOC126861064|LOC126861065|LOC126861066|LOC126861067|LOC126861068|LOC126861069|LOC126861070|LOC126861071|LOC126861072|LOC126861073|LOC126861074|LOC126861075|LOC126861076|LOC126861077|LOC126861078|LOC126861079|LOC126861080|LOC126861081|LOC126861082|LOC126861083|LOC126861084|LOC126861085|LOC126861086|LOC126861087|LOC126861088|LOC126861089|LOC126861090|LOC126861091|LOC126861092|LOC126861093|LOC126861094|LOC126861095|LOC126861096|LOC126861097|LOC126861098|LOC126861099|LOC126861100|LOC126861101|LOC126861102|LOC126861103|LOC126861104|LOC126861105|LOC126861106|LOC126861107|LOC128598885|LOC128772341|LOC129390224|LOC129390225|LOC129390226|LOC129390227|LOC129390228|LOC129390229|LOC129390230|LOC129390231|LOC129390232|LOC129390233|LOC129390234|LOC129390235|LOC129390236|LOC129390237|LOC129390238|LOC129390239|LOC129390240|LOC129390241|LOC129390242|LOC130004534|LOC130004535|LOC130004536|LOC130004537|LOC130004538|LOC130004539|LOC130004540|LOC130004541|LOC130004542|LOC130004543|LOC130004544|LOC130004545|LOC130004546|LOC130004547|LOC130004548|LOC130004549|LOC130004550|LOC130004551|LOC130004552|LOC130004553|LOC130004554|LOC130004555|LOC130004556|LOC130004557|LOC130004558|LOC130004559|LOC130004560|LOC130004561|LOC130004562|LOC130004563|LOC130004564|LOC130004565|LOC130004566|LOC130004567|LOC130004568|LOC130004569|LOC130004570|LOC130004571|LOC130004572|LOC130004573|LOC130004574|LOC130004575|LOC130004576|LOC130004577|LOC130004578|LOC130004579|LOC130004580|LOC130004581|LOC130004582|LOC130004583|LOC130004584|LOC130004585|LOC130004586|LOC130004587|LOC130004588|LOC130004589|LOC130004590|LOC130004591|LOC130004592|LOC130004593|LOC130004594|LOC130004595|LOC130004596|LOC130004597|LOC130004598|LOC130004599|LOC130004600|LOC130004601|LOC130004602|LOC130004603|LOC130004604|LOC130004605|LOC130004606|LOC130004607|LOC130004608|LOC130004609|LOC130004610|LOC130004611|LOC130004612|LOC130004613|LOC130004614|LOC130004615|LOC130004616|LOC130004617|LOC130004618|LOC130004619|LOC130004620|LOC130004621|LOC130004622|LOC130004623|LOC130004624|LOC130004625|LOC130004626|LOC130004627|LOC130004628|LOC130004629|LOC130004630|LOC130004631|LOC130004632|LOC130004633|LOC130004634|LOC130004635|LOC130004636|LOC130004637|LOC130004638|LOC130004639|LOC130004640|LOC130004641|LOC130004642|LOC130004643|LOC130004644|LOC130004645|LOC130004646|LOC130004647|LOC130004648|LOC130004649|LOC130004650|LOC130004651|LOC130004652|LOC130004653|LOC130004654|LOC130004655|LOC130004656|LOC130004657|LOC130004658|LOC130004659|LOC130004660|LOC130004661|LOC130004662|LOC130004663|LOC130004664|LOC130004665|LOC130004666|LOC130004667|LOC130004668|LOC130004669|LOC130004670|LOC130004671|LOC130004672|LOC130004673|LOC130004674|LOC130004675|LOC130004676|LOC130004677|LOC130004678|LOC130004679|LOC130004680|LOC130004681|LOC130004682|LOC130004683|LOC130004684|LOC130004685|LOC130004686|LOC130004687|LOC130004688|LOC130004689|LOC130004690|LOC130004691|LOC130004692|LOC130004693|LOC130004694|LOC130004695|LOC130004696|LOC130004697|LOC130004698|LOC130004699|LOC130004700|LOC130004701|LOC130004702|LOC130004703|LOC130004704|LOC130004705|LOC130004706|LOC130004707|LOC130004708|LOC130004709|LOC130004710|LOC130004711|LOC130004712|LOC130004713|LOC130004714|LOC130004715|LOC130004716|LOC130004717|LOC130004718|LOC130004719|LOC130004720|LOC130004721|LOC130004722|LOC130004723|LOC130004724|LOC130004725|LOC130004726|LOC130004727|LOC130004728|LOC130004729|LOC130004730|LOC130004731|LOC130004732|LOC130004733|LOC130004734|LOC130004735|LOC130004736|LOC130004737|LOC130004738|LOC130004739|LOC130004740|LOC130004741|LOC130004742|LOC130004743|LOC130004744|LOC130004745|LOC130004746|LOC130004747|LOC130004748|LOC130004749|LOC130004750|LOC130004751|LOC130004752|LOC130004753|LOC130004754|LOC130004755|LOC130004756|LOC130004757|LOC130004758|LOC130004759|LOC130004760|LOC130004761|LOC130004762|LOC130004763|LOC130004764|LOC130004765|LOC130004766|LOC130004767|LOC130004768|LOC130004769|LOC130004770|LOC130004771|LOC130004772|LOC130004773|LOC130004774|LOC130004775|LOC130004776|LOC130004777|LOC130004778|LOC130004779|LOC130004780|LOC130004781|LOC130004782|LOC130004783|LOC130004784|LOC130004785|LOC130004786|LOC130004787|LOC130004788|LOC130004789|LOC130004790|LOC130004791|LOC130004792|LOC130004793|LOC130004794|LOC130004795|LOC130004796|LOC130004797|LOC130004798|LOC130004799|LOC130004800|LOC130004801|LOC130004802|LOC130004803|LOC130004804|LOC130004805|LOC130004806|LOC130004807|LOC130004808|LOC130004809|LOC130004810|LOC130004811|LOC130004812|LOC130004813|LOC130004814|LOC130004815|LOC130004816|LOC130004817|LOC130004818|LOC130004819|LOC130004820|LOC130004821|LOC130004822|LOC130004823|LOC130004824|LOC130004825|LOC130004826|LOC130004827|LOC130004828|LOC130004829|LOC130004830|LOC130004831|LOC130004832|LOC130004833|LOC130004834|LOC130004835|LOC130004836|LOC130004837|LOC130004838|LOC130004839|LOC130004840|LOC130004841|LOC130004842|LOC130004843|LOC130004844|LOC130004845|LOC130004846|LOC130004847|LOC130004848|LOC130004849|LOC130004850|LOC130004851|LOC130004852|LOC130004853|LOC130004854|LOC130004855|LOC130004856|LOC130004857|LOC130004858|LOC130004859|LOC130004860|LOC130004861|LOC130004862|LOC130004863|LOC130004864|LOC130004865|LOC130004866|LOC130004867|LOC130004868|LOC130004869|LOC130004870|LOC130004871|LOC130004872|LOC130004873|LOC130004874|LOC130004875|LOC130004876|LOC130004877|LOC130004878|LOC130004879|LOC130004880|LOC130004881|LOC130004882|LOC130004883|LOC130004884|LOC130004885|LOC130004886|LOC130004887|LOC130004888|LOC130004889|LOC130004890|LOC130004891|LOC130004892|LOC130004893|LOC130004894|LOC130004895|LOC130004896|LOC130004897|LOC130004898|LOC130004899|LOC130004900|LOC130004901|LOC130004902|LOC130004903|LOC130004904|LOC130004905|LOC130004906|LOC130004907|LOC130004908|LOC130004909|LOC130004910|LOC130004911|LOC130004912|LOC130004913|LOC130004914|LOC130004915|LOC130004916|LOC130004917|LOC130004918|LOC130004919|LOC130004920|LOC130004921		See cases	VCV000148679	10	102360249 - 135436092	10	100600492 - 133622588	148679	158430			copy number gain		Pathogenic	Sep 12, 2011	no assertion criteria provided							
GRCh38/hg38 10q25.1-26.3(chr10:108102587-133620674)x3	ABLIM1|ABRAXAS2|ACADSB|ACSL5|ADAM12|ADAM8|ADD3|ADD3-AS1|ADGRA1|ADGRA1-AS1|ADRA2A|ADRB1|AFAP1L2|ARMS2|AS-PTPRE|ATE1|ATE1-AS1|ATRNL1|BAG3|BBIP1|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf143|C10orf88|C10orf90|CACUL1|CALY|CASC2|CASP7|CCDC172|CCDC186|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DCLRE1A|DENND10|DHX32|DMBT1|DOCK1|DPYSL4|DUSP5|DUSP5-DT|EBF3|ECHS1|EDRF1|EDRF1-AS1|EDRF1-DT|EEF1AKMT2|EIF3A|EMX2|EMX2OS|ENO4|FAM204A|LOC130004946|LOC130004947|LOC130004948|LOC130004949|LOC130004950|LOC130004951|LOC130004952|LOC130004953|LOC130004954|LOC130004955|LOC130004956|LOC130004957|LOC130004958|LOC130004959|LOC130004960|LOC130004961|LOC130004962|LOC130004963|LOC130004964|LOC130004965|LOC130004966|LOC130004967|LOC130004968|LOC130004969|LOC130004970|LOC130004971|LOC130004972|LOC130004973|LOC130004974|LOC130004975|LOC130004976|LOC130004977|LOC130004978|LOC130004979|LOC130004980|LOC130004981|LOC130004982|LOC130004983|LOC130004984|LOC130004985|LOC130004986|LOC130004987|LOC130004988|LOC130004989|LOC130004990|LOC130004991|LOC130004992|LOC130004993|LOC130004994|LOC130004995|LOC130004996|LOC130004997|LOC130004998|LOC130004999|LOC130005000|LOC130005001|LOC130005002|LOC130005003|LOC130005004|LOC130005005|LOC130005006|LOC130005007|LOC130005008|LOC130005009|LOC130005010|LOC130005011|LOC130005012|LOC130005013|LOC130005014|LOC130005015|LOC130005016|LOC130005017|LOC130005018|LOC130005019|LOC130005020|LOC130005021|LOC130005022|LOC130005023|LOC130005024|LOC130005025|LOC130005026|LOC130005027|LOC130005028|LOC130005029|LOC130005030|LOC130005031|LOC130005032|LOC130005033|LOC130005034|LOC130005035|LOC130005036|LOC132089741|LOC132089742|LOC132089743|LOC132089744|LOC132089745|LOC132089746|LOC132089747|LOC132089748|LOC132089749|LOC132089750|LOC132089751|LOC132089752|LOC132089753|LOC132089754|LOC132089755|LOC132089756|LOC132089757|LOC132089758|LOC132089759|LOC132089760|LOC132089761|LOC132089879|LOC132089880|LOC132089881|LOC132089882|LOC132089883|LOC132089884|LOC132090825|LOC132090826|LOC132090827|LOC132090828|LOC132090829|LOC132090830|LOC132211103|LOC132211104|LOC283038|LOC728158|LRRC27|MCMBP|MGMT|MIR202|MIR202HG|MIR2110|MIR3663|MIR3663HG|MIR378C|MIR3941|MIR3944|MIR4295|MIR4296|MIR4297|MIR4483|MIR4484|MIR4680|MIR4681|MIR4682|MIR548E|MIR6715A|MIR6715B|MIR9851|MKI67|MMP21|MTG1|MXI1|NANOS1|NHLRC2|NKX1-2|NKX6-2|NPS|NRAP|NSMCE4A|OAT|PAOX|PDCD4|PDCD4-AS1|PDZD8|PLEKHA1|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PPP2R2D|PRAP1|PRDX3|PRLHR|PSTK|PTPRE|PWWP2B|RAB11FIP2|RBM20|RGS10|SCART1|SEC23IP|SFXN4|SHOC2|SHTN1|SLC18A2|SLC18A2-AS1|SMC3|SMNDC1|SNORA19|SNORA87|SNORD158|SPADH|SPMIP5|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TCF7L2|TDRD1|TECTB|TEX36|TEX36-AS1|TIAL1|TRUB1|TUBGCP2|UROS|UTF1|VAX1|VENTX|VTI1A|VWA2|WDR11|WDR11-DT|XPNPEP1|ZDHHC6|ZNF511|ZNF511-PRAP1|ZRANB1|FAM53B|FAM24A|FAM24B|FAM24B-CUZD1|FAM53B-AS1|FANK1|FANK1-AS1|FGFR2|FHIP2A|FOXI2|FRA10B|FUOM|GFRA1|GLRX3|GPAM|GPR26|GRK5|GRK5-AS1|GRK5-IT1|HABP2|HEAT2|HMX2|HMX3|HSPA12A|HSPA12A-AS1|HTRA1|IKZF5|INPP5A|INPP5F|INSYN2A|JAKMIP3|JAKMIP3-AS1|KCNK18|KNDC1|LHPP|LINC00601|LINC00867|LINC01153|LINC01163|LINC01164|LINC01165|LINC01166|LINC01167|LINC01168|LINC01561|LINC02626|LINC02641|LINC02661|LINC02667|LINC02674|LINC02870|LINC03036|LINC03068|LOC101927692|LOC102724883|LOC103344931|LOC105378479|LOC105378482|LOC105378552|LOC107984281|LOC107984282|LOC110120846|LOC110120851|LOC110120852|LOC110120892|LOC110120898|LOC110120916|LOC110120919|LOC110120924|LOC110120928|LOC110120938|LOC110120952|LOC110121334|LOC110121344|LOC110121396|LOC110121444|LOC110121472|LOC110599579|LOC110599585|LOC111818958|LOC111818962|LOC111818963|LOC111875823|LOC111875824|LOC111875825|LOC111875826|LOC111875827|LOC111875828|LOC111875829|LOC111875830|LOC111875831|LOC111875832|LOC111875833|LOC111875834|LOC111875835|LOC111946221|LOC113939914|LOC113939915|LOC116216121|LOC116216122|LOC116216123|LOC121366081|LOC121366082|LOC121366083|LOC121366084|LOC121366085|LOC121366086|LOC121366087|LOC121366088|LOC121366089|LOC121366090|LOC121366091|LOC121366092|LOC121366093|LOC121815968|LOC121815969|LOC121815970|LOC121815971|LOC121815972|LOC121815973|LOC121815974|LOC121815975|LOC121815976|LOC121815977|LOC124416900|LOC124416901|LOC124416902|LOC124416903|LOC124416904|LOC124416905|LOC124416906|LOC124416907|LOC124416908|LOC124416909|LOC124416910|LOC124416911|LOC124416912|LOC124416913|LOC124416914|LOC124416915|LOC124416916|LOC124416917|LOC124416918|LOC124416919|LOC124416920|LOC124416921|LOC124416922|LOC124416923|LOC124416924|LOC124416925|LOC124416926|LOC124416927|LOC124416928|LOC124416929|LOC124416930|LOC124416931|LOC124416932|LOC124416933|LOC124416934|LOC124416935|LOC124416936|LOC126861034|LOC126861035|LOC126861036|LOC126861037|LOC126861038|LOC126861039|LOC126861040|LOC126861041|LOC126861042|LOC126861043|LOC126861044|LOC126861045|LOC126861046|LOC126861047|LOC126861048|LOC126861049|LOC126861050|LOC126861051|LOC126861052|LOC126861053|LOC126861054|LOC126861055|LOC126861056|LOC126861057|LOC126861058|LOC126861059|LOC126861060|LOC126861061|LOC126861062|LOC126861063|LOC126861064|LOC126861065|LOC126861066|LOC126861067|LOC126861068|LOC126861069|LOC126861070|LOC126861071|LOC126861072|LOC126861073|LOC126861074|LOC126861075|LOC126861076|LOC126861077|LOC126861078|LOC126861079|LOC126861080|LOC126861081|LOC126861082|LOC126861083|LOC126861084|LOC126861085|LOC126861086|LOC126861087|LOC126861088|LOC126861089|LOC126861090|LOC126861091|LOC126861092|LOC126861093|LOC126861094|LOC126861095|LOC126861096|LOC126861097|LOC126861098|LOC126861099|LOC126861100|LOC126861101|LOC126861102|LOC126861103|LOC126861104|LOC126861105|LOC126861106|LOC126861107|LOC128598885|LOC129390227|LOC129390228|LOC129390229|LOC129390230|LOC129390231|LOC129390232|LOC129390233|LOC129390234|LOC129390235|LOC129390236|LOC129390237|LOC129390238|LOC129390239|LOC129390240|LOC129390241|LOC129390242|LOC130004678|LOC130004679|LOC130004680|LOC130004681|LOC130004682|LOC130004683|LOC130004684|LOC130004685|LOC130004686|LOC130004687|LOC130004688|LOC130004689|LOC130004690|LOC130004691|LOC130004692|LOC130004693|LOC130004694|LOC130004695|LOC130004696|LOC130004697|LOC130004698|LOC130004699|LOC130004700|LOC130004701|LOC130004702|LOC130004703|LOC130004704|LOC130004705|LOC130004706|LOC130004707|LOC130004708|LOC130004709|LOC130004710|LOC130004711|LOC130004712|LOC130004713|LOC130004714|LOC130004715|LOC130004716|LOC130004717|LOC130004718|LOC130004719|LOC130004720|LOC130004721|LOC130004722|LOC130004723|LOC130004724|LOC130004725|LOC130004726|LOC130004727|LOC130004728|LOC130004729|LOC130004730|LOC130004731|LOC130004732|LOC130004733|LOC130004734|LOC130004735|LOC130004736|LOC130004737|LOC130004738|LOC130004739|LOC130004740|LOC130004741|LOC130004742|LOC130004743|LOC130004744|LOC130004745|LOC130004746|LOC130004747|LOC130004748|LOC130004749|LOC130004750|LOC130004751|LOC130004752|LOC130004753|LOC130004754|LOC130004755|LOC130004756|LOC130004757|LOC130004758|LOC130004759|LOC130004760|LOC130004761|LOC130004762|LOC130004763|LOC130004764|LOC130004765|LOC130004766|LOC130004767|LOC130004768|LOC130004769|LOC130004770|LOC130004771|LOC130004772|LOC130004773|LOC130004774|LOC130004775|LOC130004776|LOC130004777|LOC130004778|LOC130004779|LOC130004780|LOC130004781|LOC130004782|LOC130004783|LOC130004784|LOC130004785|LOC130004786|LOC130004787|LOC130004788|LOC130004789|LOC130004790|LOC130004791|LOC130004792|LOC130004793|LOC130004794|LOC130004795|LOC130004796|LOC130004797|LOC130004798|LOC130004799|LOC130004800|LOC130004801|LOC130004802|LOC130004803|LOC130004804|LOC130004805|LOC130004806|LOC130004807|LOC130004808|LOC130004809|LOC130004810|LOC130004811|LOC130004812|LOC130004813|LOC130004814|LOC130004815|LOC130004816|LOC130004817|LOC130004818|LOC130004819|LOC130004820|LOC130004821|LOC130004822|LOC130004823|LOC130004824|LOC130004825|LOC130004826|LOC130004827|LOC130004828|LOC130004829|LOC130004830|LOC130004831|LOC130004832|LOC130004833|LOC130004834|LOC130004835|LOC130004836|LOC130004837|LOC130004838|LOC130004839|LOC130004840|LOC130004841|LOC130004842|LOC130004843|LOC130004844|LOC130004845|LOC130004846|LOC130004847|LOC130004848|LOC130004849|LOC130004850|LOC130004851|LOC130004852|LOC130004853|LOC130004854|LOC130004855|LOC130004856|LOC130004857|LOC130004858|LOC130004859|LOC130004860|LOC130004861|LOC130004862|LOC130004863|LOC130004864|LOC130004865|LOC130004866|LOC130004867|LOC130004868|LOC130004869|LOC130004870|LOC130004871|LOC130004872|LOC130004873|LOC130004874|LOC130004875|LOC130004876|LOC130004877|LOC130004878|LOC130004879|LOC130004880|LOC130004881|LOC130004882|LOC130004883|LOC130004884|LOC130004885|LOC130004886|LOC130004887|LOC130004888|LOC130004889|LOC130004890|LOC130004891|LOC130004892|LOC130004893|LOC130004894|LOC130004895|LOC130004896|LOC130004897|LOC130004898|LOC130004899|LOC130004900|LOC130004901|LOC130004902|LOC130004903|LOC130004904|LOC130004905|LOC130004906|LOC130004907|LOC130004908|LOC130004909|LOC130004910|LOC130004911|LOC130004912|LOC130004913|LOC130004914|LOC130004915|LOC130004916|LOC130004917|LOC130004918|LOC130004919|LOC130004920|LOC130004921|LOC130004922|LOC130004923|LOC130004924|LOC130004925|LOC130004926|LOC130004927|LOC130004928|LOC130004929|LOC130004930|LOC130004931|LOC130004932|LOC130004933|LOC130004934|LOC130004935|LOC130004936|LOC130004937|LOC130004938|LOC130004939|LOC130004940|LOC130004941|LOC130004942|LOC130004943|LOC130004944|LOC130004945		See cases	VCV000144206	10	109862345 - 135434178	10	108102587 - 133620674	144206	153957			copy number gain		Pathogenic	May 27, 2010	no assertion criteria provided							
GRCh38/hg38 10q25.2-26.3(chr10:111313099-133620674)x3	ADAM8|ATRNL1|BAG3|C10orf143|C10orf88|CCDC186|DENND10|DHX32|FAM204A|FAM24A|FGFR2|FHIP2A|GPR26|GRK5|HSPA12A|INSYN2A|LINC01163|LINC02626|LINC03068|LOC101927692|LOC110120852|LOC110120892|LOC110120898|LOC110121444|LOC110121472|LOC111875826|FAM24B|LOC111946221|LOC113939914|FOXI2|LOC121366084|LOC121366085|LOC121366086|LOC121366087|LOC121366088|LOC121366089|LOC121366090|GRK5-AS1|ABLIM1|LOC121815973|LOC121815974|ADGRA1|ADGRA1-AS1|HSPA12A-AS1|BCCIP|BNIP3|LOC124416909|LOC124416910|LOC124416911|LOC124416912|LOC124416913|LOC124416914|LOC124416915|C10orf90|JAKMIP3|JAKMIP3-AS1|CFAP46|CHST15|LOC124416925|LOC124416926|LOC124416927|DMBT1|LOC124416936|LOC126861042|LOC126861043|LOC126861044|LOC126861045|LOC126861052|LOC126861053|LOC126861054|ABRAXAS2|ACADSB|ADRB1|AFAP1L2|BTBD16|CACUL1|CLRN3|CPXM2|CTBP2|DOCK1|DPYSL4|FAM24B-CUZD1|FAM53B|FUOM|GFRA1|GRK5-IT1|HTRA1|KCNK18|LINC01164|LINC01165|LINC02641|LINC02667|LOC102724883|LOC103344931|LOC110120916|LOC110120919|LOC110120924|LOC110599579|LOC110599585|LOC111875827|LOC111875828|LOC111875829|LOC111875830|LOC113939915|LOC121366091|LOC121366092|LOC121815975|LOC121815976|LOC121815977|LOC124416916|LOC124416917|LOC124416918|LOC124416928|LOC124416929|LOC124416930|LOC126861046|LOC126861047|LOC126861055|LOC126861056|LOC126861060|LOC126861061|LOC126861062|LOC126861066|LOC126861067|LOC126861074|LOC126861075|LOC126861078|LOC126861079|LOC126861080|LOC126861086|LOC126861087|LOC126861094|LOC126861095|LOC126861096|LOC126861101|LOC126861102|LOC126861103|LOC126861107|LOC128598885|LOC129390227|LOC129390232|LOC129390233|LOC129390239|LOC129390240|LOC129390241|LOC130004763|LOC130004764|LOC130004765|LOC130004770|LOC130004771|LOC130004772|LOC130004777|LOC130004778|LOC130004779|LOC130004785|LOC130004786|LOC130004787|LOC130004792|LOC130004799|LOC130004800|LOC130004801|LOC130004807|LOC130004810|LOC130004811|LOC130004812|LOC130004813|LOC130004819|LOC130004824|LOC130004825|LOC130004829|LOC130004830|LOC130004836|LOC130004837|LOC130004838|LOC130004846|LOC130004847|LOC130004848|LOC130004853|LOC130004854|LOC130004828|LOC130004831|LOC130004832|LOC130004833|LOC130004834|LOC130004835|LOC130004839|LOC130004840|LOC130004841|LOC130004842|LOC130004843|LOC130004844|LOC130004845|LOC130004849|LOC130004850|LOC130004851|LOC130004852|LOC130004802|LOC130004803|LOC130004804|LOC130004805|LOC130004806|LOC130004855|LOC130004856|LOC130004857|LOC130004808|LOC130004809|LOC130004814|LOC130004815|LOC130004816|LOC130004817|LOC130004818|LOC130004766|LOC130004767|LOC130004768|LOC130004769|LOC130004820|LOC130004821|LOC130004773|LOC130004774|LOC130004775|LOC130004776|LOC130004822|LOC130004823|LOC130004780|LOC130004781|LOC130004782|LOC130004783|LOC130004784|LOC130004788|LOC130004789|LOC126861097|LOC126861098|LOC126861099|LOC126861100|LOC130004790|LOC130004791|LOC126861104|LOC126861105|LOC126861106|LOC130004826|LOC130004827|LOC129390228|LOC129390229|LOC129390230|LOC129390231|LOC130004793|LOC130004794|LOC130004795|LOC129390234|LOC129390235|LOC126861063|LOC126861064|LOC126861065|LOC129390236|LOC129390237|LOC129390238|LOC126861068|LOC126861069|LOC126861070|LOC126861071|LOC126861072|LOC126861073|LOC130004796|LOC130004797|LOC130004798|LOC126861076|LOC126861048|LOC126861049|LOC126861050|LOC126861051|LOC126861077|LOC129390242|LOC130004758|LOC130004759|LOC124416923|LOC124416924|LOC124416919|LOC124416920|LOC124416921|LOC124416922|LOC126861081|LOC126861082|LOC126861083|LOC124416907|LOC124416908|LOC121366093|LOC121815969|LOC121815970|LOC126861084|LOC126861085|LOC116216122|LOC116216123|LOC124416904|LOC124416905|LOC124416906|LOC124416931|LOC124416932|LOC124416933|LOC124416934|LOC124416935|LOC130004760|LOC130004761|LOC130004762|LOC111875833|LOC111875834|LOC111875835|LOC126861088|LOC126861089|LOC126861090|LOC126861091|LOC126861092|LOC126861093|LOC110120928|LOC110120938|LOC110120952|LOC110121334|LOC121366081|LOC121366082|LOC121366083|LOC107984282|LOC110120846|LOC110120851|LOC111818958|LOC111818962|LOC126861057|LOC126861058|LOC110121344|LOC110121396|LINC00601|LINC00867|LINC01153|KNDC1|LHPP|LOC111875831|LOC111875832|LOC121815971|LOC121815972|LINC01166|LINC01167|HMX3|LINC01168|LINC01561|LOC126861059|FAM53B-AS1|FANK1|LINC02674|GLRX3|FANK1-AS1|INPP5F|HABP2|HMX2|LOC111818963|LOC111875824|LOC111875825|CYP2E1|DCLRE1A|CALY|CASC2|GPAM|CUZD1|LINC02870|LINC03036|C10orf120|IKZF5|INPP5A|EIF3A|EMX2|EMX2OS|ENO4|ACSL5|ADAM12|CASP7|CCDC172|ARMS2|AS-PTPRE|LOC105378552|LOC107984281|BUB3|ATE1|ATE1-AS1|EBF3|ECHS1|EDRF1|EDRF1-AS1|EDRF1-DT|EEF1AKMT2|LOC130004858|LOC130004859|LOC130004860|LOC130004861|LOC130004862|LOC130004863|LOC130004864|LOC130004865|LOC130004866|LOC130004867|LOC130004868|LOC130004869|LOC130004870|LOC130004871|LOC130004872|LOC130004873|LOC130004874|LOC130004875|LOC130004876|LOC130004877|LOC130004878|LOC130004879|LOC130004880|LOC130004881|LOC130004882|LOC130004883|LOC130004884|LOC130004885|LOC130004886|LOC130004887|LOC130004888|LOC130004889|LOC130004890|LOC130004891|LOC130004892|LOC130004893|LOC130004894|LOC130004895|LOC130004896|LOC130004897|LOC130004898|LOC130004899|LOC130004900|LOC130004901|LOC130004902|LOC130004903|LOC130004904|LOC130004905|LOC130004906|LOC130004907|LOC130004908|LOC130004909|LOC130004910|LOC130004911|LOC130004912|LOC130004913|LOC130004914|LOC130004915|LOC130004916|LOC130004917|LOC130004918|LOC130004919|LOC130004920|LOC130004921|LOC130004922|LOC130004923|LOC130004924|LOC130004925|LOC130004926|LOC130004927|LOC130004928|LOC130004929|LOC130004930|LOC130004931|LOC130004932|LOC130004933|LOC130004934|LOC130004935|LOC130004936|LOC130004937|LOC130004938|LOC130004939|LOC130004940|LOC130004941|LOC130004942|LOC130004943|LOC130004944|LOC130004945|LOC130004946|LOC130004947|LOC130004948|LOC130004949|LOC130004950|LOC130004951|LOC130004952|LOC130004953|LOC130004954|LOC130004955|LOC130004956|LOC130004957|LOC130004958|LOC130004959|LOC130004960|LOC130004961|LOC130004962|LOC130004963|LOC130004964|LOC130004965|LOC130004966|LOC130004967|LOC130004968|LOC130004969|LOC130004970|LOC130004971|LOC130004972|LOC130004973|LOC130004974|LOC130004975|LOC130004976|LOC130004977|LOC130004978|LOC130004979|LOC130004980|LOC130004981|LOC130004982|LOC130004983|LOC130004984|LOC130004985|LOC130004986|LOC130004987|LOC130004988|LOC130004989|LOC130004990|LOC130004991|LOC130004992|LOC130004993|LOC130004994|LOC130004995|LOC130004996|LOC130004997|LOC130004998|LOC130004999|LOC130005000|LOC130005001|LOC130005002|LOC130005003|LOC130005004|LOC130005005|LOC130005006|LOC130005007|LOC130005008|LOC130005009|LOC130005010|LOC130005011|LOC130005012|LOC130005013|LOC130005014|LOC130005015|LOC130005016|LOC130005017|LOC130005018|LOC130005019|LOC130005020|LOC130005021|LOC130005022|LOC130005023|LOC130005024|LOC130005025|LOC130005026|LOC130005027|LOC130005028|LOC130005029|LOC130005030|LOC130005031|LOC130005032|LOC130005033|LOC130005034|LOC130005035|LOC130005036|LOC132089741|LOC132089742|LOC132089743|LOC132089744|LOC132089745|LOC132089746|LOC132089747|LOC132089748|LOC132089749|LOC132089750|LOC132089751|LOC132089752|LOC132089753|LOC132089754|LOC132089755|LOC132089756|LOC132089757|LOC132089758|LOC132089759|LOC132089760|LOC132089761|LOC132090826|LOC132090827|LOC132090828|LOC132090829|LOC132090830|LOC132211103|LOC132211104|LOC283038|LOC728158|LRRC27|MCMBP|MGMT|MIR202|MIR202HG|MIR2110|MIR3663|MIR3663HG|MIR378C|MIR3941|MIR3944|MIR4295|MIR4296|MIR4297|MIR4483|MIR4484|MIR4681|MIR4682|MIR6715A|MIR6715B|MIR9851|MKI67|MMP21|MTG1|NANOS1|NHLRC2|NKX1-2|NKX6-2|NPS|NRAP|NSMCE4A|OAT|PAOX|PDZD8|PLEKHA1|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PPP2R2D|PRAP1|PRDX3|PRLHR|PSTK|PTPRE|PWWP2B|RAB11FIP2|RGS10|SCART1|SEC23IP|SFXN4|SHTN1|SLC18A2|SLC18A2-AS1|SNORA19|SNORA87|SNORD158|SPADH|SPMIP5|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TCF7L2|TDRD1|TECTB|TEX36|TEX36-AS1|TIAL1|TRUB1|TUBGCP2|UROS|UTF1|VAX1|VENTX|VTI1A|VWA2|WDR11|WDR11-DT|ZDHHC6|ZNF511|ZNF511-PRAP1|ZRANB1		See cases	VCV000057507	10	113072857 - 135434178	10	111313099 - 133620674	57507	72102			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 10q26.11-26.3(chr10:117866565-133554210)x3	LOC130004957|LOC130004958|LOC130004959|LOC130004960|LOC130004961|LOC130004962|LOC130004963|LOC130004964|LOC130004965|LOC130004966|LOC130004967|LOC130004968|LOC130004969|LOC130004970|LOC130004971|LOC130004972|LOC130004973|LOC130004974|LOC130004975|LOC130004976|LOC130004977|LOC130004978|LOC130004979|LOC130004980|LOC130004981|LOC130004982|LOC130004983|LOC130004984|LOC130004985|LOC130004986|LOC130004987|LOC130004988|LOC130004989|LOC130004990|LOC130004991|LOC130004992|LOC130004993|LOC130004994|LOC130004995|LOC130004996|LOC130004997|LOC130004998|LOC130004999|LOC130005000|LOC130005001|LOC130005002|LOC130005003|LOC130005004|LOC130005005|LOC130005006|LOC130005007|LOC130005008|LOC130005009|LOC130005010|LOC130005011|LOC130005012|LOC130005013|LOC130005014|LOC130005015|LOC130005016|LOC130005017|LOC130005018|LOC130005019|LOC130005020|LOC130005021|LOC130005022|LOC130005023|LOC130005024|LOC130005025|LOC130005026|LOC130005027|LOC130005028|LOC130005029|LOC130005030|LOC130005031|LOC130005032|LOC130005033|LOC130005034|LOC130005035|LOC130005036|LOC132089741|LOC132089742|LOC132089743|LOC132089744|LOC132089745|LOC132089746|LOC132089747|LOC132089748|LOC132089749|LOC132089750|LOC132089751|LOC132089752|LOC132089753|LOC132089754|LOC132089755|LOC132089756|LOC132089757|LOC132089758|LOC132089759|LOC132089760|LOC132089761|LOC132090826|LOC132090827|LOC132090828|LOC132090829|LOC132090830|LOC132211103|LOC132211104|LOC283038|LOC728158|LRRC27|MCMBP|MGMT|MIR202|MIR202HG|MIR378C|MIR3941|MIR3944|MIR4296|MIR4297|MIR4484|MIR4681|MIR4682|MKI67|MMP21|MTG1|NANOS1|NKX1-2|NKX6-2|NPS|NSMCE4A|OAT|PAOX|PLEKHA1|PLPP4|PPP2R2D|PRAP1|PRDX3|PRLHR|PSTK|PTPRE|PWWP2B|RAB11FIP2|RGS10|SCART1|SEC23IP|SFXN4|SNORA19|SPADH|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TEX36|TEX36-AS1|TIAL1|TUBGCP2|UROS|UTF1|VENTX|WDR11|WDR11-DT|ZNF511|ZNF511-PRAP1|ZRANB1|ABRAXAS2|ACADSB|ADAM12|ADAM8|ADGRA1|ADGRA1-AS1|ARMS2|AS-PTPRE|ATE1|ATE1-AS1|BAG3|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf143|C10orf88|C10orf90|CACUL1|CALY|CASC2|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DENND10|DHX32|DMBT1|DOCK1|DPYSL4|EBF3|ECHS1|EDRF1|EDRF1-AS1|EDRF1-DT|EEF1AKMT2|EIF3A|FAM204A|FAM24A|FAM24B|FAM24B-CUZD1|FAM53B|FAM53B-AS1|FANK1|FANK1-AS1|FGFR2|FOXI2|FUOM|GLRX3|GPR26|GRK5|GRK5-AS1|GRK5-IT1|HMX2|HMX3|HTRA1|IKZF5|INPP5A|INPP5F|INSYN2A|JAKMIP3|JAKMIP3-AS1|KNDC1|LHPP|LINC00601|LINC00867|LINC01153|LINC01163|LINC01164|LINC01165|LINC01166|LINC01167|LINC01168|LINC01561|LINC02641|LINC02667|LINC02870|LINC03036|LINC03068|LOC102724883|LOC105378552|LOC107984281|LOC107984282|LOC110120846|LOC110120851|LOC110120852|LOC110120892|LOC110120898|LOC110120916|LOC110120919|LOC110120924|LOC110120928|LOC110121344|LOC110121396|LOC110121444|LOC110599579|LOC110599585|LOC111818958|LOC111818962|LOC111818963|LOC111875828|LOC111875829|LOC111875830|LOC111875831|LOC111875832|LOC111875833|LOC111875834|LOC111875835|LOC111946221|LOC113939915|LOC121366084|LOC121366085|LOC121366086|LOC121366087|LOC121366088|LOC121366089|LOC121366090|LOC121366091|LOC121366092|LOC121366093|LOC121815970|LOC121815971|LOC121815972|LOC121815973|LOC121815974|LOC121815975|LOC121815976|LOC121815977|LOC124416919|LOC124416920|LOC124416921|LOC124416922|LOC124416923|LOC124416924|LOC124416925|LOC124416926|LOC124416927|LOC124416928|LOC124416929|LOC124416930|LOC124416931|LOC124416932|LOC124416933|LOC124416934|LOC124416935|LOC124416936|LOC126861057|LOC126861058|LOC126861059|LOC126861060|LOC126861061|LOC126861062|LOC126861063|LOC126861064|LOC126861065|LOC126861066|LOC126861067|LOC126861068|LOC126861069|LOC126861070|LOC126861071|LOC126861072|LOC126861073|LOC126861074|LOC126861075|LOC126861076|LOC126861077|LOC126861078|LOC126861079|LOC126861080|LOC126861081|LOC126861082|LOC126861083|LOC126861084|LOC126861085|LOC126861086|LOC126861087|LOC126861088|LOC126861089|LOC126861090|LOC126861091|LOC126861092|LOC126861093|LOC126861094|LOC126861095|LOC126861096|LOC126861097|LOC126861098|LOC126861099|LOC126861100|LOC126861101|LOC126861102|LOC126861103|LOC126861104|LOC126861105|LOC126861106|LOC126861107|LOC128598885|LOC129390233|LOC129390234|LOC129390235|LOC129390236|LOC129390237|LOC129390238|LOC129390239|LOC129390240|LOC129390241|LOC129390242|LOC130004819|LOC130004820|LOC130004821|LOC130004822|LOC130004823|LOC130004824|LOC130004825|LOC130004826|LOC130004827|LOC130004828|LOC130004829|LOC130004830|LOC130004831|LOC130004832|LOC130004833|LOC130004834|LOC130004835|LOC130004836|LOC130004837|LOC130004838|LOC130004839|LOC130004840|LOC130004841|LOC130004842|LOC130004843|LOC130004844|LOC130004845|LOC130004846|LOC130004847|LOC130004848|LOC130004849|LOC130004850|LOC130004851|LOC130004852|LOC130004853|LOC130004854|LOC130004855|LOC130004856|LOC130004857|LOC130004858|LOC130004859|LOC130004860|LOC130004861|LOC130004862|LOC130004863|LOC130004864|LOC130004865|LOC130004866|LOC130004867|LOC130004868|LOC130004869|LOC130004870|LOC130004871|LOC130004872|LOC130004873|LOC130004874|LOC130004875|LOC130004876|LOC130004877|LOC130004878|LOC130004879|LOC130004880|LOC130004881|LOC130004882|LOC130004883|LOC130004884|LOC130004885|LOC130004886|LOC130004887|LOC130004888|LOC130004889|LOC130004890|LOC130004891|LOC130004892|LOC130004893|LOC130004894|LOC130004895|LOC130004896|LOC130004897|LOC130004898|LOC130004899|LOC130004900|LOC130004901|LOC130004902|LOC130004903|LOC130004904|LOC130004905|LOC130004906|LOC130004907|LOC130004908|LOC130004909|LOC130004910|LOC130004911|LOC130004912|LOC130004913|LOC130004914|LOC130004915|LOC130004916|LOC130004917|LOC130004918|LOC130004919|LOC130004920|LOC130004921|LOC130004922|LOC130004923|LOC130004924|LOC130004925|LOC130004926|LOC130004927|LOC130004928|LOC130004929|LOC130004930|LOC130004931|LOC130004932|LOC130004933|LOC130004934|LOC130004935|LOC130004936|LOC130004937|LOC130004938|LOC130004939|LOC130004940|LOC130004941|LOC130004942|LOC130004943|LOC130004944|LOC130004945|LOC130004946|LOC130004947|LOC130004948|LOC130004949|LOC130004950|LOC130004951|LOC130004952|LOC130004953|LOC130004954|LOC130004955|LOC130004956		See cases	VCV000059728	10	119626076 - 135367714	10	117866565 - 133554210	59728	74323			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 10q26.11-26.13(chr10:119273012-123117390)x3	ACADSB|ARMS2|ATE1|ATE1-AS1|LINC01561|LOC121366091|LOC121366092|LOC124416919|LOC126861064|LOC129390235|LOC129390236|LOC129390237|LOC130004837|LOC130004848|LOC130004849|LOC130004850|LOC130004851|LOC130004862|LOC130004863|LOC130004872|LOC130004873|LOC130004874|LOC132089747|LOC132089748|LOC132089749|NSMCE4A|PLEKHA1|WDR11|WDR11-DT|LOC130004864|LOC130004865|LOC130004875|LOC130004876|LOC132089742|LOC110120851|LOC110121344|LOC111818958|LOC124416920|LOC124416921|LOC124416922|LOC132089750|LOC132090826|LOC132090827|LOC126861065|LOC126861066|LOC126861067|FAM24A|FAM24B|FAM24B-CUZD1|LOC130004838|LOC130004839|PLPP4|PSTK|LOC130004852|FGFR2|LOC111818962|LOC111875830|LOC111875831|LOC124416923|LOC124416924|LOC126861060|LOC126861068|LOC130004840|LOC130004841|LOC130004842|LOC130004853|LOC130004854|LOC130004855|LOC130004856|LOC130004866|LOC130004867|LOC132089743|LOC132089744|LOC132090828|RGS10|SPADH|TACC2|TIAL1|SEC23IP|LOC132089746|LOC130004857|LOC130004858|LOC130004868|LOC130004869|MIR4681|MIR4682|LOC130004843|LOC130004844|LOC132089745|LOC130004870|LOC130004871|LOC129390233|LOC129390234|MCMBP|MIR3941|LOC113939915|LOC121366087|LOC121366088|LOC121366089|LOC121366090|LOC126861061|IKZF5|INPP5F|LINC01153|LOC130004845|LOC130004846|LOC130004847|LOC126861069|LOC126861062|LOC126861063|LOC130004859|LOC130004860|LOC130004861|GRK5|GRK5-AS1|HTRA1|BAG3|BTBD16|C10orf120|C10orf88|CUZD1|DMBT1		See cases	VCV000057088	10	121032524 - 124876906	10	119273012 - 123117390	57088	71683			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 10q26.11-26.3(chr10:119707856-133613639)x3	LOC130004884|LOC130004885|LOC130004886|LOC130004887|LOC130004888|LOC130004889|LOC130004890|LOC130004891|LOC130004892|LOC130004893|LOC130004894|LOC130004895|LOC130004896|LOC130004897|LOC130004898|LOC130004899|LOC130004900|LOC130004901|LOC130004902|LOC130004903|LOC130004904|LOC130004905|LOC130004906|LOC130004907|LOC130004908|LOC130004909|LOC130004910|LOC130004911|LOC130004912|LOC130004913|LOC130004914|LOC130004915|LOC130004916|LOC130004917|LOC130004918|LOC130004919|LOC130004920|LOC130004921|LOC130004922|LOC130004923|LOC130004924|LOC130004925|LOC130004926|LOC130004927|LOC130004928|LOC130004929|LOC130004930|LOC130004931|LOC130004932|LOC130004933|LOC130004934|LOC130004935|LOC130004936|LOC130004937|LOC130004938|LOC130004939|LOC130004940|LOC130004941|LOC130004942|LOC130004943|LOC130004944|LOC130004945|LOC130004946|LOC130004947|LOC130004948|LOC130004949|LOC130004950|LOC130004951|LOC130004952|LOC130004953|LOC130004954|LOC130004955|LOC130004956|LOC130004957|LOC130004958|LOC130004959|LOC130004960|LOC130004961|LOC130004962|LOC130004963|LOC130004964|LOC130004965|LOC130004966|LOC130004967|LOC130004968|LOC130004969|LOC130004970|LOC130004971|LOC130004972|LOC130004973|LOC130004974|LOC130004975|LOC130004976|LOC130004977|LOC130004978|LOC130004979|LOC130004980|LOC130004981|LOC130004982|LOC130004983|LOC130004984|LOC130004985|LOC130004986|LOC130004987|LOC130004988|LOC130004989|LOC130004990|LOC130004991|LOC130004992|LOC130004993|LOC130004994|LOC130004995|LOC130004996|LOC130004997|LOC130004998|LOC130004999|LOC130005000|LOC130005001|LOC130005002|LOC130005003|LOC130005004|LOC130005005|LOC130005006|LOC130005007|LOC130005008|LOC130005009|LOC130005010|LOC130005011|LOC130005012|LOC130005013|LOC130005014|LOC130005015|LOC130005016|LOC130005017|LOC130005018|LOC130005019|LOC130005020|LOC130005021|LOC130005022|LOC130005023|LOC130005024|LOC130005025|LOC130005026|LOC130005027|LOC130005028|LOC130005029|LOC130005030|LOC130005031|LOC130005032|LOC130005033|LOC130005034|LOC130005035|LOC130005036|LOC132089742|LOC132089743|LOC132089744|LOC132089745|LOC132089746|LOC132089747|LOC132089748|LOC132089749|LOC132089750|LOC132089751|LOC132089752|LOC132089753|LOC132089754|LOC132089755|LOC132089756|LOC132089757|LOC132089758|LOC132089759|LOC132089760|LOC132089761|LOC132090827|LOC132090828|LOC132090829|LOC132090830|LOC132211103|LOC132211104|LOC283038|LOC728158|LRRC27|MCMBP|MGMT|MIR202|MIR202HG|MIR378C|MIR3941|MIR3944|MIR4296|MIR4297|MIR4484|MIR4682|MKI67|MMP21|MTG1|NKX1-2|NKX6-2|NPS|NSMCE4A|OAT|PAOX|PLEKHA1|PLPP4|PPP2R2D|PRAP1|PSTK|PTPRE|PWWP2B|SCART1|SEC23IP|SPADH|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TEX36|TEX36-AS1|TUBGCP2|UROS|UTF1|VENTX|WDR11|WDR11-DT|ZNF511|ZNF511-PRAP1|ZRANB1|ABRAXAS2|ACADSB|ADAM12|ADAM8|ADGRA1|ADGRA1-AS1|ARMS2|AS-PTPRE|ATE1|ATE1-AS1|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf143|C10orf88|C10orf90|CALY|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DHX32|DMBT1|DOCK1|DPYSL4|EBF3|ECHS1|EDRF1|EDRF1-AS1|EDRF1-DT|EEF1AKMT2|FAM24A|FAM24B|FAM24B-CUZD1|FAM53B|FAM53B-AS1|FANK1|FANK1-AS1|FGFR2|FOXI2|FUOM|GLRX3|GPR26|HMX2|HMX3|HTRA1|IKZF5|INPP5A|INPP5F|INSYN2A|JAKMIP3|JAKMIP3-AS1|KNDC1|LHPP|LINC00601|LINC01153|LINC01163|LINC01164|LINC01165|LINC01166|LINC01167|LINC01168|LINC01561|LINC02641|LINC02667|LINC02870|LINC03068|LOC102724883|LOC105378552|LOC107984281|LOC107984282|LOC110120846|LOC110120851|LOC110120852|LOC110120892|LOC110120898|LOC110120916|LOC110120924|LOC110120928|LOC110121344|LOC110121444|LOC110599579|LOC110599585|LOC111818958|LOC111818962|LOC111818963|LOC111875831|LOC111875832|LOC111875833|LOC111875834|LOC111875835|LOC111946221|LOC113939915|LOC121366088|LOC121366089|LOC121366090|LOC121366091|LOC121366092|LOC121366093|LOC121815973|LOC121815974|LOC121815975|LOC121815976|LOC121815977|LOC124416919|LOC124416920|LOC124416921|LOC124416922|LOC124416923|LOC124416924|LOC124416925|LOC124416926|LOC124416927|LOC124416928|LOC124416929|LOC124416930|LOC124416931|LOC124416932|LOC124416933|LOC124416934|LOC124416935|LOC124416936|LOC126861061|LOC126861062|LOC126861063|LOC126861064|LOC126861065|LOC126861066|LOC126861067|LOC126861068|LOC126861069|LOC126861070|LOC126861071|LOC126861072|LOC126861073|LOC126861074|LOC126861075|LOC126861076|LOC126861077|LOC126861078|LOC126861079|LOC126861080|LOC126861081|LOC126861082|LOC126861083|LOC126861084|LOC126861085|LOC126861086|LOC126861087|LOC126861088|LOC126861089|LOC126861090|LOC126861091|LOC126861092|LOC126861093|LOC126861094|LOC126861095|LOC126861096|LOC126861097|LOC126861098|LOC126861099|LOC126861100|LOC126861101|LOC126861102|LOC126861103|LOC126861104|LOC126861105|LOC126861106|LOC126861107|LOC128598885|LOC129390234|LOC129390235|LOC129390236|LOC129390237|LOC129390238|LOC129390239|LOC129390240|LOC129390241|LOC129390242|LOC130004857|LOC130004858|LOC130004859|LOC130004860|LOC130004861|LOC130004862|LOC130004863|LOC130004864|LOC130004865|LOC130004866|LOC130004867|LOC130004868|LOC130004869|LOC130004870|LOC130004871|LOC130004872|LOC130004873|LOC130004874|LOC130004875|LOC130004876|LOC130004877|LOC130004878|LOC130004879|LOC130004880|LOC130004881|LOC130004882|LOC130004883		See cases	VCV000153718	10	121467368 - 135427143	10	119707856 - 133613639	153718	163469			copy number gain		Pathogenic	Aug 19, 2013	no assertion criteria provided							
GRCh38/hg38 10q26.12-26.3(chr10:120454430-133620674)x1	LOC130004881|LOC130004882|LOC130004883|LOC130004884|LOC130004885|LOC130004886|LOC130004887|LOC130004888|LOC130004889|LOC130004890|LOC130004891|LOC130004892|LOC130004893|LOC130004894|LOC130004895|LOC130004896|LOC130004897|LOC130004898|LOC130004899|LOC130004900|LOC130004901|LOC130004902|LOC130004903|LOC130004904|LOC130004905|LOC130004906|LOC130004907|LOC130004908|LOC130004909|LOC130004910|LOC130004911|LOC130004912|LOC130004913|LOC130004914|LOC130004915|LOC130004916|LOC130004917|LOC130004918|LOC130004919|LOC130004920|LOC130004921|LOC130004922|LOC130004923|LOC130004924|LOC130004925|LOC130004926|LOC130004927|LOC130004928|LOC130004929|LOC130004930|LOC130004931|LOC130004932|LOC130004933|LOC130004934|LOC130004935|LOC130004936|LOC130004937|LOC130004938|LOC130004939|LOC130004940|LOC130004941|LOC130004942|LOC130004943|LOC130004944|LOC130004945|LOC130004946|LOC130004947|LOC130004948|LOC130004949|LOC130004950|LOC130004951|LOC130004952|LOC130004953|LOC130004954|LOC130004955|LOC130004956|LOC130004957|LOC130004958|LOC130004959|LOC130004960|LOC130004961|LOC130004962|LOC130004963|LOC130004964|LOC130004965|LOC130004966|LOC130004967|LOC130004968|LOC130004969|LOC130004970|LOC130004971|LOC130004972|LOC130004973|LOC130004974|LOC130004975|LOC130004976|LOC130004977|LOC130004978|LOC130004979|LOC130004980|LOC130004981|LOC130004982|LOC130004983|LOC130004984|LOC130004985|LOC130004986|LOC130004987|LOC130004988|LOC130004989|LOC130004990|LOC130004991|LOC130004992|LOC130004993|LOC130004994|LOC130004995|LOC130004996|LOC130004997|LOC130004998|LOC130004999|LOC130005000|LOC130005001|LOC130005002|LOC130005003|LOC130005004|LOC130005005|LOC130005006|LOC130005007|LOC130005008|LOC130005009|LOC130005010|LOC130005011|LOC130005012|LOC130005013|LOC130005014|LOC130005015|LOC130005016|LOC130005017|LOC130005018|LOC130005019|LOC130005020|LOC130005021|LOC130005022|LOC130005023|LOC130005024|LOC130005025|LOC130005026|LOC130005027|LOC130005028|LOC130005029|LOC130005030|LOC130005031|LOC130005032|LOC130005033|LOC130005034|LOC130005035|LOC130005036|LOC132089750|LOC132089751|LOC132089752|LOC132089753|LOC132089754|LOC132089755|LOC132089756|LOC132089757|LOC132089758|LOC132089759|LOC132089760|LOC132089761|LOC132090827|LOC132090828|LOC132090829|LOC132090830|LOC132211103|LOC132211104|LOC283038|LOC728158|LRRC27|MGMT|MIR202|MIR202HG|MIR378C|MIR3941|MIR3944|MIR4296|MIR4297|MIR4484|MKI67|MMP21|MTG1|NKX1-2|NKX6-2|NPS|NSMCE4A|OAT|PAOX|PLEKHA1|PLPP4|PPP2R2D|PRAP1|PSTK|PTPRE|PWWP2B|SCART1|SPADH|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TEX36|TEX36-AS1|TUBGCP2|UROS|UTF1|VENTX|WDR11|WDR11-DT|ZNF511|ZNF511-PRAP1|ZRANB1|ABRAXAS2|ACADSB|ADAM12|ADAM8|ADGRA1|ADGRA1-AS1|ARMS2|AS-PTPRE|ATE1|ATE1-AS1|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf143|C10orf88|C10orf90|CALY|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DHX32|DMBT1|DOCK1|DPYSL4|EBF3|ECHS1|EDRF1|EDRF1-AS1|EDRF1-DT|EEF1AKMT2|FAM24A|FAM24B|FAM24B-CUZD1|FAM53B|FAM53B-AS1|FANK1|FANK1-AS1|FGFR2|FOXI2|FUOM|GLRX3|GPR26|HMX2|HMX3|HTRA1|IKZF5|INPP5A|INSYN2A|JAKMIP3|JAKMIP3-AS1|KNDC1|LHPP|LINC00601|LINC01153|LINC01163|LINC01164|LINC01165|LINC01166|LINC01167|LINC01168|LINC01561|LINC02641|LINC02667|LINC02870|LINC03068|LOC102724883|LOC105378552|LOC107984281|LOC107984282|LOC110120846|LOC110120851|LOC110120852|LOC110120892|LOC110120898|LOC110120916|LOC110120924|LOC110120928|LOC110121344|LOC110121444|LOC110599579|LOC110599585|LOC111818958|LOC111818962|LOC111818963|LOC111875831|LOC111875832|LOC111875833|LOC111875834|LOC111875835|LOC111946221|LOC113939915|LOC121366088|LOC121366089|LOC121366090|LOC121366091|LOC121366092|LOC121366093|LOC121815973|LOC121815974|LOC121815975|LOC121815976|LOC121815977|LOC124416921|LOC124416922|LOC124416923|LOC124416924|LOC124416925|LOC124416926|LOC124416927|LOC124416928|LOC124416929|LOC124416930|LOC124416931|LOC124416932|LOC124416933|LOC124416934|LOC124416935|LOC124416936|LOC126861061|LOC126861062|LOC126861063|LOC126861064|LOC126861065|LOC126861066|LOC126861067|LOC126861068|LOC126861069|LOC126861070|LOC126861071|LOC126861072|LOC126861073|LOC126861074|LOC126861075|LOC126861076|LOC126861077|LOC126861078|LOC126861079|LOC126861080|LOC126861081|LOC126861082|LOC126861083|LOC126861084|LOC126861085|LOC126861086|LOC126861087|LOC126861088|LOC126861089|LOC126861090|LOC126861091|LOC126861092|LOC126861093|LOC126861094|LOC126861095|LOC126861096|LOC126861097|LOC126861098|LOC126861099|LOC126861100|LOC126861101|LOC126861102|LOC126861103|LOC126861104|LOC126861105|LOC126861106|LOC126861107|LOC128598885|LOC129390234|LOC129390235|LOC129390236|LOC129390237|LOC129390238|LOC129390239|LOC129390240|LOC129390241|LOC129390242|LOC130004863|LOC130004864|LOC130004865|LOC130004866|LOC130004867|LOC130004868|LOC130004869|LOC130004870|LOC130004871|LOC130004872|LOC130004873|LOC130004874|LOC130004875|LOC130004876|LOC130004877|LOC130004878|LOC130004879|LOC130004880		See cases	VCV000057403	10	122213942 - 135434178	10	120454430 - 133620674	57403	71998			copy number loss		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 10q26.12-26.3(chr10:120970558-133622588)x1	LOC130005014|LOC130005015|LOC130005016|LOC130005017|LOC130005018|LOC130005019|LOC130005020|LOC130005021|LOC130005022|LOC130005023|LOC130005024|LOC130005025|LOC130005026|LOC130005027|LOC130005028|LOC130005029|LOC130005030|LOC130005031|LOC130005032|LOC130005033|LOC130005034|LOC130005035|LOC130005036|LOC132089750|LOC132089751|LOC132089752|LOC132089753|LOC132089754|LOC132089755|LOC132089756|LOC132089757|LOC132089758|LOC132089759|LOC132089760|LOC132089761|LOC132090828|LOC132090829|LOC132090830|LOC132211103|LOC132211104|LOC283038|LOC728158|LRRC27|MGMT|MIR202|MIR202HG|MIR378C|MIR3941|MIR3944|MIR4296|MIR4297|MIR4484|MKI67|MMP21|MTG1|NKX1-2|NKX6-2|NPS|NSMCE4A|OAT|PAOX|PLEKHA1|PPP2R2D|PRAP1|PSTK|PTPRE|PWWP2B|SCART1|SPADH|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TEX36|TEX36-AS1|TUBGCP2|UROS|UTF1|VENTX|ZNF511|ZNF511-PRAP1|ZRANB1|ABRAXAS2|ACADSB|ADAM12|ADAM8|ADGRA1|ADGRA1-AS1|ARMS2|AS-PTPRE|ATE1|ATE1-AS1|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf143|C10orf88|C10orf90|CALY|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DHX32|DMBT1|DOCK1|DPYSL4|EBF3|ECHS1|EDRF1|EDRF1-AS1|EDRF1-DT|EEF1AKMT2|FAM24A|FAM24B|FAM24B-CUZD1|FAM53B|FAM53B-AS1|FANK1|FANK1-AS1|FGFR2|FOXI2|FUOM|GLRX3|GPR26|HMX2|HMX3|HTRA1|IKZF5|INPP5A|INSYN2A|JAKMIP3|JAKMIP3-AS1|KNDC1|LHPP|LINC00601|LINC01153|LINC01163|LINC01164|LINC01165|LINC01166|LINC01167|LINC01168|LINC02641|LINC02667|LINC02870|LINC03068|LOC102724883|LOC105378552|LOC107984281|LOC107984282|LOC110120846|LOC110120851|LOC110120852|LOC110120892|LOC110120898|LOC110120916|LOC110120924|LOC110120928|LOC110121344|LOC110121444|LOC110599579|LOC110599585|LOC111818958|LOC111818962|LOC111818963|LOC111875832|LOC111875833|LOC111875834|LOC111875835|LOC111946221|LOC113939915|LOC121366088|LOC121366089|LOC121366090|LOC121366091|LOC121366092|LOC121366093|LOC121815973|LOC121815974|LOC121815975|LOC121815976|LOC121815977|LOC124416921|LOC124416922|LOC124416923|LOC124416924|LOC124416925|LOC124416926|LOC124416927|LOC124416928|LOC124416929|LOC124416930|LOC124416931|LOC124416932|LOC124416933|LOC124416934|LOC124416935|LOC124416936|LOC126861063|LOC126861064|LOC126861065|LOC126861066|LOC126861067|LOC126861068|LOC126861069|LOC126861070|LOC126861071|LOC126861072|LOC126861073|LOC126861074|LOC126861075|LOC126861076|LOC126861077|LOC126861078|LOC126861079|LOC126861080|LOC126861081|LOC126861082|LOC126861083|LOC126861084|LOC126861085|LOC126861086|LOC126861087|LOC126861088|LOC126861089|LOC126861090|LOC126861091|LOC126861092|LOC126861093|LOC126861094|LOC126861095|LOC126861096|LOC126861097|LOC126861098|LOC126861099|LOC126861100|LOC126861101|LOC126861102|LOC126861103|LOC126861104|LOC126861105|LOC126861106|LOC126861107|LOC128598885|LOC129390234|LOC129390235|LOC129390236|LOC129390237|LOC129390238|LOC129390239|LOC129390240|LOC129390241|LOC129390242|LOC130004864|LOC130004865|LOC130004866|LOC130004867|LOC130004868|LOC130004869|LOC130004870|LOC130004871|LOC130004872|LOC130004873|LOC130004874|LOC130004875|LOC130004876|LOC130004877|LOC130004878|LOC130004879|LOC130004880|LOC130004881|LOC130004882|LOC130004883|LOC130004884|LOC130004885|LOC130004886|LOC130004887|LOC130004888|LOC130004889|LOC130004890|LOC130004891|LOC130004892|LOC130004893|LOC130004894|LOC130004895|LOC130004896|LOC130004897|LOC130004898|LOC130004899|LOC130004900|LOC130004901|LOC130004902|LOC130004903|LOC130004904|LOC130004905|LOC130004906|LOC130004907|LOC130004908|LOC130004909|LOC130004910|LOC130004911|LOC130004912|LOC130004913|LOC130004914|LOC130004915|LOC130004916|LOC130004917|LOC130004918|LOC130004919|LOC130004920|LOC130004921|LOC130004922|LOC130004923|LOC130004924|LOC130004925|LOC130004926|LOC130004927|LOC130004928|LOC130004929|LOC130004930|LOC130004931|LOC130004932|LOC130004933|LOC130004934|LOC130004935|LOC130004936|LOC130004937|LOC130004938|LOC130004939|LOC130004940|LOC130004941|LOC130004942|LOC130004943|LOC130004944|LOC130004945|LOC130004946|LOC130004947|LOC130004948|LOC130004949|LOC130004950|LOC130004951|LOC130004952|LOC130004953|LOC130004954|LOC130004955|LOC130004956|LOC130004957|LOC130004958|LOC130004959|LOC130004960|LOC130004961|LOC130004962|LOC130004963|LOC130004964|LOC130004965|LOC130004966|LOC130004967|LOC130004968|LOC130004969|LOC130004970|LOC130004971|LOC130004972|LOC130004973|LOC130004974|LOC130004975|LOC130004976|LOC130004977|LOC130004978|LOC130004979|LOC130004980|LOC130004981|LOC130004982|LOC130004983|LOC130004984|LOC130004985|LOC130004986|LOC130004987|LOC130004988|LOC130004989|LOC130004990|LOC130004991|LOC130004992|LOC130004993|LOC130004994|LOC130004995|LOC130004996|LOC130004997|LOC130004998|LOC130004999|LOC130005000|LOC130005001|LOC130005002|LOC130005003|LOC130005004|LOC130005005|LOC130005006|LOC130005007|LOC130005008|LOC130005009|LOC130005010|LOC130005011|LOC130005012|LOC130005013		See cases	VCV000150499	10	122730071 - 135436092	10	120970558 - 133622588	150499	160250			copy number loss		Pathogenic	Aug 27, 2012	no assertion criteria provided							
NM_000141.4(FGFR2):c.*1539C>A	FGFR2		Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Saethre-Chotzen syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome	VCV000878309	10	123237832	10	121478318	878309	868451	rs1194799333	NC_000010.11:121478317:G:T	single nucleotide variant		Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*1498_*1502del	FGFR2		Pfeiffer syndrome|Levy-Hollister syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Crouzon syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome|Acrocephalosyndactyly type I|Jackson-Weiss syndrome	VCV000298974	10	123237869 - 123237873	10	121478355 - 121478359	298974	309577	rs566259479	NC_000010.11:121478354:TTTATTTT:TTT	Deletion	3 prime UTR variant|non-coding transcript variant	Likely benign	Jun 14, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*1489C>T	FGFR2		Craniosynostosis syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Isolated Coronal Synostosis	VCV000298975	10	123237882	10	121478368	298975	320436	rs886046757	NC_000010.11:121478367:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*1402T>C	FGFR2		Craniosynostosis syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Isolated Coronal Synostosis	VCV000298976	10	123237969	10	121478455	298976	309579	rs886046758	NC_000010.11:121478454:A:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*1369C>T	FGFR2		Saethre-Chotzen syndrome|Craniosynostosis syndrome|Pfeiffer syndrome|Acrocephalosyndactyly type I|Bent bone dysplasia syndrome 1|Beare-Stevenson cutis gyrata syndrome|Jackson-Weiss syndrome|Levy-Hollister syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Gastric cancer|Familial scaphocephaly syndrome, McGillivray type|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Isolated Coronal Synostosis	VCV000298977	10	123238002	10	121478488	298977	309582	rs886046759	NC_000010.11:121478487:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.*1319A>G	FGFR2		Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Crouzon syndrome|Isolated Coronal Synostosis	VCV000298978	10	123238052	10	121478538	298978	320439	rs3135830	NC_000010.11:121478537:T:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign/Likely benign	Jan 12, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*1301C>T	FGFR2		Craniosynostosis syndrome|Saethre-Chotzen syndrome|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis	VCV000298979	10	123238070	10	121478556	298979	314366	rs71640261	NC_000010.11:121478555:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign/Likely benign	Jan 12, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*1287A>C	FGFR2		Crouzon syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome	VCV000298980	10	123238084	10	121478570	298980	320865	rs886046760	NC_000010.11:121478569:T:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*1283C>G	FGFR2		Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Saethre-Chotzen syndrome|Crouzon syndrome	VCV000878944	10	123238088	10	121478574	878944	865489	rs1844298421	NC_000010.11:121478573:G:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*1240A>C	FGFR2		Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Crouzon syndrome|Saethre-Chotzen syndrome	VCV000878945	10	123238131	10	121478617	878945	865490	rs1403038230	NC_000010.11:121478616:T:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*1126T>C	FGFR2		Craniosynostosis syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Isolated Coronal Synostosis	VCV000298981	10	123238245	10	121478731	298981	314367	rs370106008	NC_000010.11:121478730:A:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*1070T>C	FGFR2		Craniosynostosis syndrome|Saethre-Chotzen syndrome|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis	VCV000298982	10	123238301	10	121478787	298982	320874	rs886046761	NC_000010.11:121478786:A:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*921G>A	FGFR2		Crouzon syndrome|Saethre-Chotzen syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome	VCV000298983	10	123238450	10	121478936	298983	314377	rs185617859	NC_000010.11:121478935:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*874A>G	FGFR2		Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Saethre-Chotzen syndrome|Crouzon syndrome	VCV000878403	10	123238497	10	121478983	878403	865491	rs55723405	NC_000010.11:121478982:T:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*736dup	FGFR2		Craniosynostosis syndrome|Jackson-Weiss syndrome|Pfeiffer syndrome|Levy-Hollister syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Crouzon syndrome|Isolated Coronal Synostosis|Acrocephalosyndactyly type I	VCV000298984	10	123238634 - 123238635	10	121479120 - 121479121	298984	314378	rs886046762	NC_000010.11:121479120:T:TT	Duplication	3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*730G>C	FGFR2		Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Crouzon syndrome|Saethre-Chotzen syndrome	VCV000878994	10	123238641	10	121479127	878994	865492	rs549293047	NC_000010.11:121479126:C:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*674G>T	FGFR2		Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome|not provided	VCV000298985	10	123238697	10	121479183	298985	320440	rs566155088	NC_000010.11:121479182:C:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 1, 2022	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.*641_*644del	FGFR2		Saethre-Chotzen syndrome|Acrocephalosyndactyly type I|Pfeiffer syndrome|Jackson-Weiss syndrome|Crouzon syndrome|Levy-Hollister syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome	VCV000298986	10	123238727 - 123238730	10	121479213 - 121479216	298986	314379	rs548465887	NC_000010.11:121479212:ATTAATT:ATT	Deletion	3 prime UTR variant|non-coding transcript variant	Likely benign	Jun 14, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*497T>C	FGFR2		Craniosynostosis syndrome|Crouzon syndrome|Saethre-Chotzen syndrome|Isolated Coronal Synostosis|Beare-Stevenson cutis gyrata syndrome	VCV000298987	10	123238874	10	121479360	298987	320447	rs3135827	NC_000010.11:121479359:A:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*469G>A	FGFR2		Craniosynostosis syndrome|Saethre-Chotzen syndrome|not provided|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Isolated Coronal Synostosis	VCV000298988	10	123238902	10	121479388	298988	309583	rs41294351	NC_000010.11:121479387:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jun 30, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.*463A>G	FGFR2		Craniosynostosis syndrome|Isolated Coronal Synostosis|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Saethre-Chotzen syndrome	VCV000877435	10	123238908	10	121479394	877435	865493	rs373313930	NC_000010.11:121479393:T:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 27, 2017	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*403A>G	FGFR2		Saethre-Chotzen syndrome|Craniosynostosis syndrome|not provided|Crouzon syndrome|Isolated Coronal Synostosis|Beare-Stevenson cutis gyrata syndrome	VCV000298989	10	123238968	10	121479454	298989	320875	rs3135826	NC_000010.11:121479453:T:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign/Likely benign	Jul 15, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.*324A>G	FGFR2		Crouzon syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome|not provided	VCV000298990	10	123239047	10	121479533	298990	320448	rs150519853	NC_000010.11:121479532:T:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign/Likely benign	Jan 13, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.*282A>G	FGFR2		FGFR2-related disorder	VCV003058285	10	123239089	10	121479575	3058285	3217498		NC_000010.11:121479574:T:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Likely benign	Apr 1, 2019	no assertion criteria provided							
NM_000141.5(FGFR2):c.*259C>T	FGFR2		not provided|Craniosynostosis syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Crouzon syndrome|not specified	VCV000298991	10	123239112	10	121479598	298991	309584	rs1047057	NC_000010.11:121479597:G:A	single nucleotide variant	3 prime UTR variant|synonymous variant|non-coding transcript variant	Benign	May 9, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.*256G>A	FGFR2	V702I	Craniosynostosis syndrome|Isolated Coronal Synostosis|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome	VCV000880262	10	123239115	10	121479601	880262	865494	rs763095219	NC_000010.11:121479600:C:T	single nucleotide variant	3 prime UTR variant|missense variant|non-coding transcript variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*255C>T	FGFR2		FGFR2-related disorder	VCV003054639	10	123239116	10	121479602	3054639	3219300		NC_000010.11:121479601:G:A	single nucleotide variant	3 prime UTR variant|synonymous variant|non-coding transcript variant	Likely benign	Apr 7, 2020	no assertion criteria provided							
NM_000141.5(FGFR2):c.*197del	FGFR2	K682fs	Pfeiffer syndrome|Crouzon syndrome|not provided|Levy-Hollister syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|FGFR2-related disorder|Isolated Coronal Synostosis|Craniosynostosis syndrome|Acrocephalosyndactyly type I|Jackson-Weiss syndrome	VCV000298992	10	123239174	10	121479660	298992	320877	rs748777325	NC_000010.11:121479659:TT:T	Deletion	3 prime UTR variant|frameshift variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 2, 2024	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.*184C>T	FGFR2		Crouzon syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome	VCV000298993	10	123239187	10	121479673	298993	314389	rs4647917	NC_000010.11:121479672:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.*111G>A	FGFR2		Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|not provided|Saethre-Chotzen syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome	VCV000298994	10	123239260	10	121479746	298994	309585	rs574474794	NC_000010.11:121479745:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Aug 1, 2022	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.*1A>G	FGFR2		not specified	VCV001337798	10	123239370	10	121479856	1337798	1328807	rs547079762	NC_000010.11:121479855:T:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 28, 2020	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2448C>T (p.Asn816=)	FGFR2		FGFR2-related craniosynostosis	VCV001538969	10	123239389	10	121479875	1538969	1597850	rs774232306	NC_000010.11:121479874:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Mar 8, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2444_2445del (p.Ile815fs)	FGFR2	I587fs, I698fs, I699fs, I700fs, I703fs, I726fs, I813fs, I815fs, I816fs	FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Saethre-Chotzen syndrome|Levy-Hollister syndrome|Gastric cancer|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Jackson-Weiss syndrome|Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	VCV001062590	10	123239392 - 123239393	10	121479878 - 121479879	1062590	1046458	rs771208561	NC_000010.11:121479877:TAT:T	Deletion	frameshift variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 5, 2021	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2431C>A (p.Gln811Lys)	FGFR2	Q811K, Q583K, Q694K, Q699K, Q812K, Q695K, Q809K, Q696K, Q722K	FGFR2-related craniosynostosis	VCV002849050	10	123239406	10	121479892	2849050	3012694		NC_000010.11:121479891:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 17, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2426T>C (p.Leu809Pro)	FGFR2	L581P, L694P, L810P, L692P, L693P, L697P, L807P, L720P, L809P	FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Levy-Hollister syndrome|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Gastric cancer|Jackson-Weiss syndrome|Acrocephalosyndactyly type I|Saethre-Chotzen syndrome	VCV001415015	10	123239411	10	121479897	1415015	1474628	rs368003279	NC_000010.11:121479896:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Sep 21, 2023	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.2424C>T (p.Cys808=)	FGFR2		FGFR2-related craniosynostosis	VCV001115603	10	123239413	10	121479899	1115603	1098592	rs759496942	NC_000010.11:121479898:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Jul 13, 2020	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2424C>G (p.Cys808Trp)	FGFR2	C580W, C691W, C692W, C693W, C696W, C719W, C806W, C808W, C809W	FGFR2-related craniosynostosis	VCV001054430	10	123239413	10	121479899	1054430	1046459	rs759496942	NC_000010.11:121479898:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 13, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2421A>G (p.Pro807=)	FGFR2		FGFR2-related craniosynostosis	VCV001970360	10	123239416	10	121479902	1970360	2029073		NC_000010.11:121479901:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Apr 4, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2416G>A (p.Glu806Lys)	FGFR2	E806K, E807K, E694K, E578K, E691K, E717K, E689K, E804K, E690K	not provided|Crouzon syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome|FGFR2-related craniosynostosis	VCV000298995	10	123239421	10	121479907	298995	320883	rs764959117	NC_000010.11:121479906:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	May 16, 2023	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.2414dup (p.Tyr805Ter)	FGFR2	Y577*, Y688*, Y689*, Y690*, Y693*, Y716*, Y803*, Y805*, Y806*	not provided	VCV003379995	10	123239422 - 123239423	10	121479908 - 121479909	3379995	3539171		NC_000010.11:121479908:T:TT	Duplication	nonsense|non-coding transcript variant|intron variant	Uncertain significance	Aug 14, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2415C>A (p.Tyr805Ter)	FGFR2	Y577*, Y688*, Y689*, Y690*, Y693*, Y716*, Y803*, Y805*, Y806*	FGFR2-related disorder	VCV002631649	10	123239422	10	121479908	2631649	2801183		NC_000010.11:121479907:G:T	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Uncertain significance	Aug 1, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2415C>T (p.Tyr805=)	FGFR2		not provided|Saethre-Chotzen syndrome|Crouzon syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome|FGFR2-related craniosynostosis	VCV000298996	10	123239422	10	121479908	298996	314395	rs558460047	NC_000010.11:121479907:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Aug 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2411C>T (p.Pro804Leu)	FGFR2	P576L, P689L, P692L, P802L, P715L, P804L, P687L, P688L, P805L	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590734	10	123239426	10	121479912	3590734	3728024		NC_000010.11:121479911:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 27, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2410C>T (p.Pro804Ser)	FGFR2	P687S, P689S, P688S, P692S, P804S, P802S, P576S, P715S, P805S	FGFR2-related craniosynostosis|not provided	VCV001045256	10	123239427	10	121479913	1045256	1029468	rs575812178	NC_000010.11:121479912:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 31, 2021	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2399C>T (p.Pro800Leu)	FGFR2	P572L, P684L, P800L, P683L, P685L, P798L, P688L, P711L, P801L	FGFR2-related craniosynostosis	VCV002066127	10	123239438	10	121479924	2066127	2128812		NC_000010.11:121479923:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 20, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2398C>T (p.Pro800Ser)	FGFR2	P711S, P684S, P688S, P801S, P683S, P798S, P572S, P685S, P800S	FGFR2-related craniosynostosis	VCV002698801	10	123239439	10	121479925	2698801	2855092		NC_000010.11:121479924:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 24, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2395dup (p.Ser799fs)	FGFR2	S571fs, S682fs, S683fs, S684fs, S687fs, S710fs, S797fs, S799fs, S800fs	FGFR2-related craniosynostosis	VCV001051971	10	123239441 - 123239442	10	121479927 - 121479928	1051971	1046460	rs2133681563	NC_000010.11:121479927:AAAAAA:AAAAAAA	Duplication	frameshift variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 28, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2389G>T (p.Val797Phe)	FGFR2	V680F, V682F, V797F, V681F, V685F, V798F, V569F, V708F, V795F	Inborn genetic diseases	VCV002469981	10	123239448	10	121479934	2469981	2448749		NC_000010.11:121479933:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 26, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2368T>C (p.Cys790Arg)	FGFR2	C562R, C673R, C674R, C675R, C678R, C701R, C788R, C790R, C791R	not provided	VCV001315789	10	123239469	10	121479955	1315789	1306047	rs2133682792	NC_000010.11:121479954:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 27, 2020	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2351C>T (p.Pro784Leu)	FGFR2	P556L, P667L, P668L, P669L, P672L, P695L, P782L, P784L, P785L	not provided	VCV003372373	10	123239486	10	121479972	3372373	3531563		NC_000010.11:121479971:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 19, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2350C>T (p.Pro784Ser)	FGFR2	P667S, P782S, P784S, P556S, P669S, P668S, P695S, P672S, P785S	FGFR2-related craniosynostosis	VCV002917167	10	123239487	10	121479973	2917167	3077229		NC_000010.11:121479972:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 25, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2342C>G (p.Pro781Arg)	FGFR2	P553R, P664R, P665R, P666R, P669R, P692R, P779R, P781R, P782R	not provided	VCV003368991	10	123239495	10	121479981	3368991	3528183		NC_000010.11:121479980:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 13, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2340A>G (p.Ser780=)	FGFR2		FGFR2-related craniosynostosis	VCV002115186	10	123239497	10	121479983	2115186	2161422		NC_000010.11:121479982:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Mar 20, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2329G>T (p.Glu777Ter)	FGFR2	E549*, E775*, E660*, E688*, E661*, E662*, E665*, E777*, E778*	Neoplasm	VCV003257945	10	123239508	10	121479994	3257945	3416704		NC_000010.11:121479993:C:A	single nucleotide variant	nonsense|non-coding transcript variant|intron variant							Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	
NM_000141.5(FGFR2):c.2329G>A (p.Glu777Lys)	FGFR2	E777K, E778K, E661K, E688K, E660K, E662K, E665K, E549K, E775K	FGFR2-related craniosynostosis	VCV000134391	10	123239508	10	121479994	134391	138130	rs374993905	NC_000010.11:121479993:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 24, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2328C>T (p.Leu776=)	FGFR2		not provided|FGFR2-related craniosynostosis	VCV001168728	10	123239509	10	121479995	1168728	1156374	rs148478597	NC_000010.11:121479994:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2323C>T (p.Pro775Ser)	FGFR2	P547S, P658S, P659S, P660S, P663S, P686S, P773S, P775S, P776S	not provided	VCV003370876	10	123239514	10	121480000	3370876	3530066		NC_000010.11:121479999:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 10, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2311G>A (p.Asp771Asn)	FGFR2	D543N, D659N, D771N, D682N, D769N, D772N, D654N, D656N, D655N	FGFR2-related craniosynostosis	VCV001414370	10	123239526	10	121480012	1414370	1358393	rs765174665	NC_000010.11:121480011:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 10, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2302-4T>C	FGFR2		FGFR2-related craniosynostosis	VCV003604563	10	123239539	10	121480025	3604563	3743314		NC_000010.11:121480024:A:G	single nucleotide variant	intron variant	Uncertain significance	Apr 5, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2302-15C>T	FGFR2		FGFR2-related craniosynostosis	VCV002868406	10	123239550	10	121480036	2868406	3020719		NC_000010.11:121480035:G:A	single nucleotide variant	intron variant	Likely benign	Jul 21, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2302-17C>T	FGFR2		FGFR2-related craniosynostosis	VCV002026094	10	123239552	10	121480038	2026094	2077585		NC_000010.11:121480037:G:A	single nucleotide variant	intron variant	Likely benign	Aug 31, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2302-219C>A	FGFR2		not provided	VCV001187706	10	123239754	10	121480240	1187706	1177259	rs3135823	NC_000010.11:121480239:G:T	single nucleotide variant	intron variant	Likely benign	Oct 21, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2302-895del	FGFR2		not provided	VCV002640884	10	123240430	10	121480916	2640884	2809670		NC_000010.11:121480915:AAAAAAAAAA:AAAAAAAAA	Deletion	intron variant	Benign	Apr 1, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2302-1025T>G	FGFR2		not provided	VCV002640885	10	123240560	10	121481046	2640885	2809671		NC_000010.11:121481045:A:C	single nucleotide variant	intron variant	Likely benign	Aug 1, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2302-1589C>T	FGFR2		not provided	VCV001879147	10	123241124	10	121481610	1879147	1935994		NC_000010.11:121481609:G:A	single nucleotide variant	intron variant	Benign	Oct 1, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2302-1734A>G	FGFR2		not provided	VCV002640886	10	123241269	10	121481755	2640886	2809672		NC_000010.11:121481754:T:C	single nucleotide variant	intron variant	Likely benign	Feb 1, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2302-1807_2302-1806insAAAAAAA	FGFR2		not provided	VCV002640887	10	123241341 - 123241342	10	121481827 - 121481828	2640887	2809673		NC_000010.11:121481827:TTTTTT:TTTTTTTTTTTTT	Insertion	3 prime UTR variant|intron variant	Likely benign	Nov 1, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2302-1811_2302-1807dup	FGFR2		not provided	VCV001701150	10	123241341 - 123241342	10	121481827 - 121481828	1701150	1693542	rs1172844728	NC_000010.11:121481827:TTTTTT:TTTTTTTTTTT	Duplication	3 prime UTR variant|intron variant	Likely benign	Nov 1, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2302-1819T>A	FGFR2		not provided	VCV001275991	10	123241354	10	121481840	1275991	1268620	rs1799603	NC_000010.11:121481839:A:T	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Aug 8, 2019	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2302-1820A>T	FGFR2		not provided	VCV001289123	10	123241355	10	121481841	1289123	1278954	rs11598152	NC_000010.11:121481840:T:A	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Aug 8, 2019	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2302-1826A>T	FGFR2		not provided	VCV001279390	10	123241361	10	121481847	1279390	1269423	rs11598153	NC_000010.11:121481846:T:A	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Aug 6, 2019	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2302-1838G>A	FGFR2		not provided	VCV000667903	10	123241373	10	121481859	667903	664070	rs3135817	NC_000010.11:121481858:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2301+1829G>A	FGFR2		not provided	VCV000670716	10	123241383	10	121481869	670716	664618	rs1649166	NC_000010.11:121481868:C:T	single nucleotide variant	intron variant|3 prime UTR variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2301+1823G>A	FGFR2		not provided	VCV001281127	10	123241389	10	121481875	1281127	1271845	rs57571942	NC_000010.11:121481874:C:T	single nucleotide variant	intron variant|3 prime UTR variant	Benign	Jun 30, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2301+1756G>A	FGFR2		not provided	VCV002640888	10	123241456	10	121481942	2640888	2809674		NC_000010.11:121481941:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Apr 1, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2301+1716A>G	FGFR2		not provided	VCV000667902	10	123241496	10	121481982	667902	664912	rs1649167	NC_000010.11:121481981:T:C	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2301+1596C>T	FGFR2		not provided	VCV001235867	10	123241616	10	121482102	1235867	1224987	rs3135816	NC_000010.11:121482101:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Aug 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2301+1526A>G	FGFR2		not specified	VCV000134389	10	123241686	10	121482172	134389	138128	rs189179463	NC_000010.11:121482171:T:C	single nucleotide variant	stop lost|intron variant	not provided	Sep 19, 2013	no classification provided							
NM_000141.5(FGFR2):c.2301+1512dup	FGFR2		FGFR2-related disorder	VCV003047978	10	123241699 - 123241700	10	121482185 - 121482186	3047978	3209548		NC_000010.11:121482185:AAAAAAA:AAAAAAAA	Duplication	intron variant	Likely benign	Dec 16, 2019	no assertion criteria provided							
NM_000141.5(FGFR2):c.2301+1418G>A	FGFR2		not provided	VCV001263215	10	123241794	10	121482280	1263215	1251833	rs2556537	NC_000010.11:121482279:C:T	single nucleotide variant	intron variant	Benign	Jun 25, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2301+1405G>A	FGFR2		not provided	VCV002640889	10	123241807	10	121482293	2640889	2809675		NC_000010.11:121482292:C:T	single nucleotide variant	intron variant	Benign	Nov 1, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2301+1319C>T	FGFR2		not provided	VCV002640890	10	123241893	10	121482379	2640890	2809676		NC_000010.11:121482378:G:A	single nucleotide variant	intron variant	Likely benign	Sep 1, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2301+1196G>A	FGFR2		not provided	VCV001711267	10	123242016	10	121482502	1711267	1709683		NC_000010.11:121482501:C:T	single nucleotide variant	intron variant	Benign	Apr 1, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2301+1186A>G	FGFR2		not provided	VCV000667901	10	123242026	10	121482512	667901	664913	rs3135814	NC_000010.11:121482511:T:C	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2301+494C>T	FGFR2		not provided	VCV002640891	10	123242718	10	121483204	2640891	2809677		NC_000010.11:121483203:G:A	single nucleotide variant	intron variant	Likely benign	Oct 1, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2301+15C>T	FGFR2		Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|FGFR2-related craniosynostosis|not provided|Isolated Coronal Synostosis|Craniosynostosis syndrome|not specified|Saethre-Chotzen syndrome	VCV000255317	10	123243197	10	121483683	255317	253699	rs2278202	NC_000010.11:121483682:G:A	single nucleotide variant	intron variant	Benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2290A>G (p.Thr764Ala)	FGFR2	T649A, T675A, T676A, T652A, T536A, T648A, T762A, T764A, T647A, T765A	Inborn genetic diseases	VCV002387023	10	123243223	10	121483709	2387023	2380431		NC_000010.11:121483708:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 16, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2283C>T (p.Leu761=)	FGFR2		not provided	VCV000513800	10	123243230	10	121483716	513800	503584	rs753103160	NC_000010.11:121483715:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 23, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2276G>A (p.Arg759Gln)	FGFR2	R531Q, R643Q, R644Q, R647Q, R670Q, R759Q, R642Q, R671Q, R757Q, R760Q	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590737	10	123243237	10	121483723	3590737	3728029		NC_000010.11:121483722:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 12, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2260G>A (p.Val754Ile)	FGFR2	V637I, V665I, V754I, V642I, V752I, V526I, V666I, V638I, V639I, V755I	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590741	10	123243253	10	121483739	3590741	3728035		NC_000010.11:121483738:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 11, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2256G>A (p.Gln752=)	FGFR2		FGFR2-related craniosynostosis	VCV002712352	10	123243257	10	121483743	2712352	2868192		NC_000010.11:121483742:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 1, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2251A>C (p.Lys751Gln)	FGFR2	K634Q, K662Q, K639Q, K751Q, K752Q, K523Q, K636Q, K635Q, K663Q, K749Q	not provided|FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Beare-Stevenson cutis gyrata syndrome|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Gastric cancer|LADD syndrome 1|Jackson-Weiss syndrome|Acrocephalosyndactyly type I|Saethre-Chotzen syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	VCV002728040	10	123243262	10	121483748	2728040	2889378		NC_000010.11:121483747:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2247G>A (p.Thr749=)	FGFR2		not provided	VCV000762985	10	123243266	10	121483752	762985	767655	rs1246437941	NC_000010.11:121483751:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 16, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2246C>T (p.Thr749Met)	FGFR2	T521M, T750M, T661M, T749M, T632M, T637M, T747M, T633M, T634M, T660M	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590748	10	123243267	10	121483753	3590748	3728043		NC_000010.11:121483752:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 24, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2245A>G (p.Thr749Ala)	FGFR2	T521A, T632A, T633A, T634A, T637A, T660A, T661A, T747A, T749A, T750A	not provided	VCV000993605	10	123243268	10	121483754	993605	981685	rs754928713	NC_000010.11:121483753:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 27, 2020	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2240G>T (p.Arg747Ile)	FGFR2	R631I, R635I, R745I, R630I, R747I, R519I, R632I, R658I, R659I, R748I	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590752	10	123243273	10	121483759	3590752	3728048		NC_000010.11:121483758:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 7, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2232C>T (p.Pro744=)	FGFR2		FGFR2-related craniosynostosis|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Levy-Hollister syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Bent bone dysplasia syndrome 1|not provided	VCV000720445	10	123243281	10	121483767	720445	723815	rs142639988	NC_000010.11:121483766:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Oct 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2231C>T (p.Pro744Leu)	FGFR2	P628L, P629L, P516L, P655L, P745L, P632L, P656L, P742L, P627L, P744L	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590754	10	123243282	10	121483768	3590754	3728055		NC_000010.11:121483767:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 25, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2230C>T (p.Pro744Ser)	FGFR2	P516S, P629S, P628S, P627S, P632S, P656S, P742S, P744S, P745S, P655S	FGFR2-related craniosynostosis|not provided	VCV001380817	10	123243283	10	121483769	1380817	1499660	rs747941020	NC_000010.11:121483768:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2223T>C (p.His741=)	FGFR2		FGFR2-related craniosynostosis	VCV002148608	10	123243290	10	121483776	2148608	1880936		NC_000010.11:121483775:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 25, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2210G>C (p.Arg737Thr)	FGFR2	R509T, R620T, R621T, R622T, R625T, R648T, R649T, R735T, R737T, R738T	not provided	VCV001710624	10	123243303	10	121483789	1710624	1709035		NC_000010.11:121483788:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 11, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2205G>A (p.Met735Ile)	FGFR2	M733I, M507I, M620I, M623I, M646I, M647I, M618I, M619I, M735I, M736I	FGFR2-related craniosynostosis	VCV002897848	10	123243308	10	121483794	2897848	3067229		NC_000010.11:121483793:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 30, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2205G>C (p.Met735Ile)	FGFR2	M620I, M735I, M733I, M507I, M619I, M646I, M618I, M623I, M647I, M736I	Inborn genetic diseases	VCV002229712	10	123243308	10	121483794	2229712	2213129		NC_000010.11:121483793:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 26, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2200A>T (p.Met734Leu)	FGFR2	M506L, M617L, M618L, M619L, M622L, M645L, M646L, M732L, M734L, M735L	not provided	VCV001722843	10	123243313	10	121483799	1722843	1780346		NC_000010.11:121483798:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 2, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2196G>T (p.Leu732=)	FGFR2		FGFR2-related craniosynostosis	VCV002768526	10	123243317	10	121483803	2768526	2926677		NC_000010.11:121483802:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Oct 14, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2196-5C>T	FGFR2		FGFR2-related craniosynostosis	VCV001950269	10	123243322	10	121483808	1950269	2000096		NC_000010.11:121483807:G:A	single nucleotide variant	intron variant	Likely benign	Apr 7, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2196-11A>G	FGFR2		FGFR2-related craniosynostosis	VCV002823600	10	123243328	10	121483814	2823600	2985965		NC_000010.11:121483813:T:C	single nucleotide variant	intron variant	Likely benign	Nov 13, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2196-19G>A	FGFR2		FGFR2-related craniosynostosis	VCV002781731	10	123243336	10	121483822	2781731	2947628		NC_000010.11:121483821:C:T	single nucleotide variant	intron variant	Likely benign	May 1, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2196-346dup	FGFR2		not provided	VCV001282228	10	123243662 - 123243663	10	121484148 - 121484149	1282228	1272082	rs4647920	NC_000010.11:121484148:T:TT	Duplication	intron variant	Benign	Sep 18, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2196-350G>A	FGFR2		not provided	VCV001246674	10	123243667	10	121484153	1246674	1236625	rs4647919	NC_000010.11:121484152:C:T	single nucleotide variant	intron variant	Benign	Jul 24, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2195+232G>A	FGFR2		not provided	VCV001220738	10	123244677	10	121485163	1220738	1212425	rs3135807	NC_000010.11:121485162:C:T	single nucleotide variant	intron variant	Benign	Jul 24, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2195+75G>A	FGFR2		not provided	VCV001222606	10	123244834	10	121485320	1222606	1213004	rs1613776	NC_000010.11:121485319:C:T	single nucleotide variant	intron variant	Benign	Jul 24, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2195+7G>A	FGFR2		FGFR2-related craniosynostosis|not specified	VCV001552360	10	123244902	10	121485388	1552360	1586439	rs377397478	NC_000010.11:121485387:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 23, 2023	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.2194C>A (p.Leu732Met)	FGFR2	L504M, L615M, L616M, L617M, L620M, L643M, L644M, L730M, L732M, L733M	not provided	VCV001701678	10	123244910	10	121485396	1701678	1694068	rs2133793332	NC_000010.11:121485395:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 8, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2191G>A (p.Glu731Lys)	FGFR2	E503K, E614K, E643K, E731K, E732K, E616K, E642K, E729K, E615K, E619K	FGFR2-related craniosynostosis	VCV002735491	10	123244913	10	121485399	2735491	2901514		NC_000010.11:121485398:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 17, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2190C>T (p.Asn730=)	FGFR2		Isolated Coronal Synostosis|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|FGFR2-related craniosynostosis|Craniosynostosis syndrome|not provided	VCV000514067	10	123244914	10	121485400	514067	503156	rs55637244	NC_000010.11:121485399:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 13, 2023	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.2189A>G (p.Asn730Ser)	FGFR2	N502S, N613S, N614S, N615S, N618S, N641S, N642S, N728S, N730S, N731S	not provided|FGFR2-related craniosynostosis	VCV001317423	10	123244915	10	121485401	1317423	1306367	rs200453002	NC_000010.11:121485400:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2177C>G (p.Ala726Gly)	FGFR2	A638G, A726G, A727G, A609G, A610G, A637G, A724G, A498G, A614G, A611G	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	VCV000931843	10	123244927	10	121485413	931843	919259	rs1458081920	NC_000010.11:121485412:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2152G>C (p.Glu718Gln)	FGFR2	E601Q, E602Q, E603Q, E716Q, E718Q, E719Q, E490Q, E629Q, E630Q, E606Q	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	VCV000931219	10	123244952	10	121485438	931219	919260	rs1589713974	NC_000010.11:121485437:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 28, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2152G>A (p.Glu718Lys)	FGFR2	E601K, E718K, E719K, E490K, E602K, E603K, E629K, E606K, E630K, E716K	FGFR2-related craniosynostosis	VCV000649790	10	123244952	10	121485438	649790	638760	rs1589713974	NC_000010.11:121485437:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 25, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2124C>T (p.Pro708=)	FGFR2		not provided|FGFR2-related craniosynostosis	VCV000501920	10	123244980	10	121485466	501920	493344	rs140813163	NC_000010.11:121485465:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 16, 2022	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.2123C>T (p.Pro708Leu)	FGFR2	P480L, P591L, P592L, P593L, P596L, P619L, P620L, P706L, P708L, P709L	not provided	VCV003337108	10	123244981	10	121485467	3337108	3495770		NC_000010.11:121485466:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 27, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2122C>A (p.Pro708Thr)	FGFR2	P480T, P591T, P592T, P593T, P596T, P619T, P620T, P706T, P708T, P709T	LADD syndrome 1	VCV003066137	10	123244982	10	121485468	3066137	3226150		NC_000010.11:121485467:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 18, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2108C>T (p.Pro703Leu)	FGFR2	P475L, P703L, P588L, P591L, P614L, P615L, P586L, P587L, P701L, P704L	Inborn genetic diseases	VCV002291686	10	123244996	10	121485482	2291686	2286239		NC_000010.11:121485481:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 27, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2106G>A (p.Ser702=)	FGFR2		not provided	VCV000194591	10	123244998	10	121485484	194591	191754	rs794727163	NC_000010.11:121485483:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 5, 2018	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.2101G>T (p.Gly701Cys)	FGFR2	G473C, G584C, G585C, G586C, G589C, G612C, G613C, G699C, G701C, G702C	not provided	VCV003252545	10	123245003	10	121485489	3252545	3411340		NC_000010.11:121485488:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 12, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2096T>C (p.Leu699Ser)	FGFR2	L471S, L582S, L583S, L584S, L587S, L610S, L611S, L697S, L699S, L700S	Pfeiffer syndrome	VCV003064462	10	123245008	10	121485494	3064462	3224667		NC_000010.11:121485493:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Mar 25, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2091C>T (p.Phe697=)	FGFR2		FGFR2-related craniosynostosis	VCV002957683	10	123245013	10	121485499	2957683	3118895		NC_000010.11:121485498:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 17, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2078T>C (p.Met693Thr)	FGFR2	M577T, M604T, M694T, M576T, M605T, M578T, M581T, M693T, M465T, M691T	FGFR2-related craniosynostosis	VCV002065795	10	123245026	10	121485512	2065795	2118483		NC_000010.11:121485511:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 13, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2077A>G (p.Met693Val)	FGFR2	M465V, M576V, M577V, M578V, M581V, M604V, M605V, M691V, M693V, M694V	not provided|Bent bone dysplasia syndrome 1|Pfeiffer syndrome|Levy-Hollister syndrome|Beare-Stevenson cutis gyrata syndrome|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Saethre-Chotzen syndrome|Jackson-Weiss syndrome	VCV001317030	10	123245027	10	121485513	1317030	1306848	rs774682374	NC_000010.11:121485512:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 11, 2021	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2070G>T (p.Gly690=)	FGFR2		not provided	VCV000498502	10	123245034	10	121485520	498502	489926	rs1281525856	NC_000010.11:121485519:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Dec 13, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2058-10T>C	FGFR2		not provided|FGFR2-related craniosynostosis	VCV000668208	10	123245056	10	121485542	668208	664073	rs756377540	NC_000010.11:121485541:A:G	single nucleotide variant	intron variant	Benign/Likely benign	Dec 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2057+256C>T	FGFR2		not provided	VCV000667900	10	123246612	10	121487098	667900	664919	rs2288336	NC_000010.11:121487097:G:A	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2057+220A>T	FGFR2		not provided	VCV001217512	10	123246648	10	121487134	1217512	1207496	rs3135805	NC_000010.11:121487133:T:A	single nucleotide variant	intron variant	Likely benign	Jul 15, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2057+114_2057+135del	FGFR2		not provided	VCV001294293	10	123246733 - 123246754	10	121487219 - 121487240	1294293	1284083	rs3214540	NC_000010.11:121487218:TTCTAAGGCCAGCTCCTGCACCTTCTA:TTCTA	Deletion	intron variant	Benign	Jun 26, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2057+17T>A	FGFR2		FGFR2-related craniosynostosis	VCV002896926	10	123246851	10	121487337	2896926	3059854		NC_000010.11:121487336:A:T	single nucleotide variant	intron variant	Likely benign	Nov 3, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2056G>A (p.Val686Ile)	FGFR2	V687I, V458I, V569I, V570I, V571I, V597I, V684I, V686I, V574I, V598I	FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Beare-Stevenson cutis gyrata syndrome|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Gastric cancer|LADD syndrome 1|Jackson-Weiss syndrome|Acrocephalosyndactyly type I|Saethre-Chotzen syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Acrocephalosyndactyly type I|Pfeiffer syndrome	VCV002725055	10	123246869	10	121487355	2725055	2885547		NC_000010.11:121487354:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2053G>T (p.Asp685Tyr)	FGFR2	D457Y, D568Y, D569Y, D570Y, D573Y, D596Y, D597Y, D683Y, D685Y, D686Y	Bilateral sensorineural hearing impairment	VCV001185580	10	123246872	10	121487358	1185580	1175553	rs2133823028	NC_000010.11:121487357:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic		criteria provided, single submitter							
NM_000141.5(FGFR2):c.2045A>G (p.His682Arg)	FGFR2	H594R, H565R, H570R, H683R, H680R, H454R, H566R, H567R, H593R, H682R	Craniosynostosis syndrome|Isolated Coronal Synostosis|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome	VCV000880311	10	123246880	10	121487366	880311	865495	rs1845557012	NC_000010.11:121487365:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2040C>T (p.Tyr680=)	FGFR2		FGFR2-related craniosynostosis|not provided	VCV000194457	10	123246885	10	121487371	194457	191620	rs751495618	NC_000010.11:121487370:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 7, 2022	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.2032A>G (p.Arg678Gly)	FGFR2	R562G, R676G, R679G, R450G, R566G, R589G, R590G, R561G, R563G, R678G	not provided|FGFR2-related craniosynostosis	VCV000834843	10	123246893	10	121487379	834843	836683	rs1845559552	NC_000010.11:121487378:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2028T>C (p.Phe676=)	FGFR2		FGFR2-related craniosynostosis	VCV001577056	10	123246897	10	121487383	1577056	1639913	rs766703071	NC_000010.11:121487382:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 4, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2021C>T (p.Ala674Val)	FGFR2	A674V, A675V, A446V, A557V, A562V, A585V, A558V, A559V, A586V, A672V	Levy-Hollister syndrome	VCV000547379	10	123246904	10	121487390	547379	537868	rs1554907337	NC_000010.11:121487389:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Nov 1, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2016A>T (p.Pro672=)	FGFR2		FGFR2-related craniosynostosis	VCV002183836	10	123246909	10	121487395	2183836	1910067		NC_000010.11:121487394:T:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 10, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2001C>G (p.Val667=)	FGFR2		Craniosynostosis syndrome|Saethre-Chotzen syndrome|not provided|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Isolated Coronal Synostosis|FGFR2-related craniosynostosis	VCV000298997	10	123246924	10	121487410	298997	314396	rs61731218	NC_000010.11:121487409:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Dec 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.2000T>C (p.Val667Ala)	FGFR2	V550A, V555A, V578A, V579A, V439A, V551A, V552A, V665A, V667A, V668A	FGFR2-related craniosynostosis	VCV002104711	10	123246925	10	121487411	2104711	2162474		NC_000010.11:121487410:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 28, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1991G>A (p.Arg664Gln)	FGFR2	R664Q, R665Q, R547Q, R549Q, R662Q, R436Q, R548Q, R552Q, R575Q, R576Q	Inborn genetic diseases	VCV000521431	10	123246934	10	121487420	521431	511857	rs1554907364	NC_000010.11:121487419:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Dec 23, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1988G>A (p.Gly663Glu)	FGFR2	G551E, G663E, G547E, G548E, G574E, G575E, G661E, G435E, G546E, G664E	Pfeiffer syndrome|FGFR2-related craniosynostosis	VCV002735492	10	123246937	10	121487423	2735492	2901515		NC_000010.11:121487422:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	May 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1987-5T>G	FGFR2		FGFR2-related craniosynostosis	VCV000747119	10	123246943	10	121487429	747119	759899	rs778413728	NC_000010.11:121487428:A:C	single nucleotide variant	intron variant	Likely benign	Aug 6, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1987-20A>T	FGFR2		FGFR2-related craniosynostosis|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Levy-Hollister syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Bent bone dysplasia syndrome 1|Gastric cancer	VCV001673614	10	123246958	10	121487444	1673614	1648914	rs772633227	NC_000010.11:121487443:T:A	single nucleotide variant	intron variant	Likely benign	Jun 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1987-20A>G	FGFR2		FGFR2-related craniosynostosis	VCV001653371	10	123246958	10	121487444	1653371	1547944	rs772633227	NC_000010.11:121487443:T:C	single nucleotide variant	intron variant	Benign	Jul 26, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1987-99G>A	FGFR2		not provided	VCV001221003	10	123247037	10	121487523	1221003	1211400	rs2981461	NC_000010.11:121487522:C:T	single nucleotide variant	intron variant	Benign	Jun 26, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1987-106A>G	FGFR2		not provided	VCV001250609	10	123247044	10	121487530	1250609	1239696	rs2981460	NC_000010.11:121487529:T:C	single nucleotide variant	intron variant	Benign	Jun 26, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1987-129T>C	FGFR2		not provided	VCV001208622	10	123247067	10	121487553	1208622	1198008	rs3135804	NC_000010.11:121487552:A:G	single nucleotide variant	intron variant	Likely benign	Jan 25, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1987-165T>G	FGFR2		not provided	VCV001203812	10	123247103	10	121487589	1203812	1194302	rs74500478	NC_000010.11:121487588:A:C	single nucleotide variant	intron variant	Likely benign	Dec 23, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1987-166A>C	FGFR2		not provided	VCV001205524	10	123247104	10	121487590	1205524	1194303	rs79305817	NC_000010.11:121487589:T:G	single nucleotide variant	intron variant	Likely benign	Dec 23, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1987-238G>A	FGFR2		not provided	VCV001232317	10	123247176	10	121487662	1232317	1224025	rs1649199	NC_000010.11:121487661:C:T	single nucleotide variant	intron variant	Benign	Jun 30, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1986+23G>C	FGFR2		Squamous cell lung carcinoma	VCV000873187	10	123247482	10	121487968	873187	861312	rs1845634185	NC_000010.11:121487967:C:G	single nucleotide variant	intron variant	Uncertain significance	May 5, 2020	no assertion criteria provided							
NM_000141.5(FGFR2):c.1986+19C>G	FGFR2		Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590765	10	123247486	10	121487972	3590765	3728070		NC_000010.11:121487971:G:C	single nucleotide variant	intron variant	Uncertain significance	Apr 22, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1986+15G>A	FGFR2		FGFR2-related craniosynostosis	VCV003625739	10	123247490	10	121487976	3625739	3752226		NC_000010.11:121487975:C:T	single nucleotide variant	intron variant	Likely benign	Nov 22, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1986+8G>A	FGFR2		FGFR2-related craniosynostosis	VCV002721639	10	123247497	10	121487983	2721639	2884728		NC_000010.11:121487982:C:T	single nucleotide variant	intron variant	Likely benign	Jan 31, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1986+7C>T	FGFR2		not specified|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1|Gastric cancer|Acrocephalosyndactyly type I|Levy-Hollister syndrome|Beare-Stevenson cutis gyrata syndrome|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|FGFR2-related craniosynostosis	VCV000383647	10	123247498	10	121487984	383647	371196	rs199697707	NC_000010.11:121487983:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Sep 13, 2021	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1985A>G (p.Asn662Ser)	FGFR2	N546S, N550S, N573S, N663S, N434S, N545S, N574S, N662S, N547S, N660S	not provided|FGFR2-related craniosynostosis|Inborn genetic diseases|Bent bone dysplasia syndrome 1|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Gastric cancer|Jackson-Weiss syndrome|Acrocephalosyndactyly type I|Saethre-Chotzen syndrome|LADD syndrome 1	VCV001412875	10	123247506	10	121487992	1412875	1356472	rs962103382	NC_000010.11:121487991:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1977G>T (p.Lys659Asn)	FGFR2	K431N, K542N, K543N, K544N, K547N, K570N, K571N, K657N, K659N, K660N	FGFR2-related craniosynostosis|not provided	VCV001698211	10	123247514	10	121488000	1698211	1690590	rs1589722765	NC_000010.11:121487999:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jul 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1977G>C (p.Lys659Asn)	FGFR2	K542N, K543N, K544N, K570N, K571N, K547N, K657N, K660N, K431N, K659N	FGFR2-related craniosynostosis|not provided|FGFR2-related disorder	VCV000661397	10	123247514	10	121488000	661397	638761	rs1589722765	NC_000010.11:121487999:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jan 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1961T>C (p.Ile654Thr)	FGFR2	I537T, I538T, I426T, I542T, I652T, I654T, I566T, I539T, I565T, I655T	FGFR2-related craniosynostosis	VCV002901886	10	123247530	10	121488016	2901886	3064590		NC_000010.11:121488015:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 19, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1960A>G (p.Ile654Val)	FGFR2	I426V, I537V, I538V, I539V, I542V, I565V, I566V, I652V, I654V, I655V	Acrocephalosyndactyly type I	VCV001285493	10	123247531	10	121488017	1285493	1275336	rs747718232	NC_000010.11:121488016:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 4, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1957A>C (p.Asn653His)	FGFR2	N425H, N536H, N538H, N651H, N537H, N541H, N565H, N653H, N654H, N564H	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590782	10	123247534	10	121488020	3590782	3728087		NC_000010.11:121488019:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 24, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1949A>G (p.Asp650Gly)	FGFR2	D422G, D533G, D534G, D535G, D538G, D561G, D562G, D648G, D650G, D651G	FGFR2-related disorder	VCV003054855	10	123247542	10	121488028	3054855	3219515		NC_000010.11:121488027:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 22, 2024	no assertion criteria provided							
NM_000141.5(FGFR2):c.1947_1949del (p.Arg649_Asp650delinsSer)	FGFR2		Levy-Hollister syndrome	VCV000013297	10	123247542 - 123247544	10	121488028 - 121488030	13297	28336	rs879253720	NC_000010.11:121488027:TCT:	Deletion	inframe_indel|non-coding transcript variant	Pathogenic	Apr 1, 2006	no assertion criteria provided							
NM_000141.5(FGFR2):c.1942G>A (p.Ala648Thr)	FGFR2	A648T, A649T, A531T, A533T, A532T, A559T, A420T, A536T, A560T, A646T	FGFR2-related craniosynostosis|not provided|Levy-Hollister syndrome	VCV000013296	10	123247549	10	121488035	13296	28335	rs121918508	NC_000010.11:121488034:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Sep 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1941C>T (p.Leu647=)	FGFR2		Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|FGFR2-related craniosynostosis|not specified|not provided|Isolated Coronal Synostosis|Craniosynostosis syndrome|Saethre-Chotzen syndrome	VCV000255316	10	123247550	10	121488036	255316	253700	rs35337478	NC_000010.11:121488035:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jan 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1925T>A (p.Ile642Lys)	FGFR2	I642K, I643K, I525K, I526K, I414K, I527K, I530K, I554K, I640K, I553K	not provided	VCV000423420	10	123247566	10	121488052	423420	407826	rs1064796413	NC_000010.11:121488051:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Feb 9, 2017	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1922A>G (p.Lys641Arg)	FGFR2	K641R, K642R, K413R, K526R, K553R, K552R, K524R, K639R, K525R, K529R	Pfeiffer syndrome|not provided	VCV000374824	10	123247569	10	121488055	374824	361706	rs1057519047	NC_000010.11:121488054:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Oct 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1915G>A (p.Val639Met)	FGFR2	V411M, V522M, V551M, V640M, V527M, V637M, V639M, V524M, V550M, V523M	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590790	10	123247576	10	121488062	3590790	3728094		NC_000010.11:121488061:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 14, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1911C>T (p.Asn637=)	FGFR2		FGFR2-related craniosynostosis|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Levy-Hollister syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Bent bone dysplasia syndrome 1|not provided	VCV000703147	10	123247580	10	121488066	703147	692792	rs149008039	NC_000010.11:121488065:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1907A>G (p.Glu636Gly)	FGFR2	E408G, E520G, E524G, E547G, E637G, E519G, E548G, E521G, E634G, E636G	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590798	10	123247584	10	121488070	3590798	3728099		NC_000010.11:121488069:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 19, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1891A>G (p.Asn631Asp)	FGFR2	N403D, N514D, N515D, N516D, N519D, N542D, N543D, N629D, N631D, N632D	not provided	VCV001329626	10	123247600	10	121488086	1329626	1320310	rs2133838683	NC_000010.11:121488085:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 24, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1886_1887delinsTT (p.Ala629Val)	FGFR2	A401V, A512V, A513V, A514V, A517V, A540V, A541V, A627V, A629V, A630V	not provided	VCV003343751	10	123247604 - 123247605	10	121488090 - 121488091	3343751	3502983		NC_000010.11:121488089:GG:AA	Indel	missense variant|non-coding transcript variant	Uncertain significance	May 17, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1882G>A (p.Ala628Thr)	FGFR2	A628T, A629T, A400T, A511T, A516T, A540T, A513T, A512T, A539T, A626T	not provided	VCV000013298	10	123247609	10	121488095	13298	28337	rs121918509	NC_000010.11:121488094:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Dec 7, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1866T>C (p.Cys622=)	FGFR2		FGFR2-related craniosynostosis	VCV001566114	10	123247625	10	121488111	1566114	1656052	rs369637667	NC_000010.11:121488110:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 26, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1864-6T>C	FGFR2		FGFR2-related craniosynostosis	VCV001557025	10	123247633	10	121488119	1557025	1561684	rs767324356	NC_000010.11:121488118:A:G	single nucleotide variant	intron variant	Likely benign	Jan 27, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1864-9T>G	FGFR2		FGFR2-related disorder	VCV002672124	10	123247636	10	121488122	2672124	2839652		NC_000010.11:121488121:A:C	single nucleotide variant	intron variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1864-17T>G	FGFR2		not specified|not provided|FGFR2-related craniosynostosis	VCV000255315	10	123247644	10	121488130	255315	253701	rs3135802	NC_000010.11:121488129:A:C	single nucleotide variant	intron variant	Benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1864-43del	FGFR2		not provided	VCV000873188	10	123247670	10	121488156	873188	861313	rs111564057	NC_000010.11:121488155:C:	Deletion	intron variant	Benign	Jun 30, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1864-125dup	FGFR2		not provided	VCV000670714	10	123247751 - 123247752	10	121488237 - 121488238	670714	664921	rs4647914	NC_000010.11:121488237:A:AA	Duplication	intron variant	Benign	Jun 14, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1863+246A>G	FGFR2		not provided	VCV001193796	10	123255800	10	121496286	1193796	1184326	rs41293767	NC_000010.11:121496285:T:C	single nucleotide variant	intron variant	Likely benign	Dec 10, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1863+199C>T	FGFR2		not provided	VCV001208456	10	123255847	10	121496333	1208456	1198009	rs17612814	NC_000010.11:121496332:G:A	single nucleotide variant	intron variant	Likely benign	Aug 20, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1863+19A>G	FGFR2		FGFR2-related craniosynostosis	VCV001626747	10	123256027	10	121496513	1626747	1636440	rs1164060462	NC_000010.11:121496512:T:C	single nucleotide variant	intron variant	Likely benign	Aug 16, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1863+14A>G	FGFR2		FGFR2-related craniosynostosis	VCV001943647	10	123256032	10	121496518	1943647	1995188		NC_000010.11:121496517:T:C	single nucleotide variant	intron variant	Likely benign	Mar 24, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1863+13C>T	FGFR2		FGFR2-related craniosynostosis	VCV002805632	10	123256033	10	121496519	2805632	2964158		NC_000010.11:121496518:G:A	single nucleotide variant	intron variant	Likely benign	Apr 9, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1854T>C (p.Ala618=)	FGFR2		not provided	VCV003388474	10	123256055	10	121496541	3388474	3547600		NC_000010.11:121496540:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 1, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1852G>A (p.Ala618Thr)	FGFR2	A390T, A506T, A530T, A616T, A619T, A501T, A502T, A503T, A529T, A618T	Inborn genetic diseases	VCV002228559	10	123256057	10	121496543	2228559	2219301		NC_000010.11:121496542:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 31, 2020	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1847A>G (p.Tyr616Cys)	FGFR2	Y388C, Y499C, Y500C, Y501C, Y504C, Y527C, Y528C, Y614C, Y616C, Y617C	not specified	VCV001684744	10	123256062	10	121496548	1684744	1676771	rs762545440	NC_000010.11:121496547:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 4, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1845G>A (p.Glu615=)	FGFR2		not provided	VCV002640892	10	123256064	10	121496550	2640892	2809678		NC_000010.11:121496549:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 1, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1840A>G (p.Met614Val)	FGFR2	M386V, M497V, M502V, M498V, M525V, M612V, M615V, M499V, M526V, M614V	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590809	10	123256069	10	121496555	3590809	3728107		NC_000010.11:121496554:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 29, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1830G>A (p.Leu610=)	FGFR2		FGFR2-related craniosynostosis	VCV001551023	10	123256079	10	121496565	1551023	1638060	rs2133934402	NC_000010.11:121496564:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 20, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1818C>T (p.Cys606=)	FGFR2		Beare-Stevenson cutis gyrata syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Acrocephalosyndactyly type I|LADD syndrome 1|Jackson-Weiss syndrome|Gastric cancer|Bent bone dysplasia syndrome 1|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|FGFR2-related craniosynostosis	VCV000544299	10	123256091	10	121496577	544299	525522	rs371395564	NC_000010.11:121496576:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1808T>A (p.Leu603Ter)	FGFR2	L375*, L486*, L487*, L488*, L491*, L514*, L515*, L601*, L603*, L604*	not provided	VCV002579608	10	123256101	10	121496587	2579608	2744644		NC_000010.11:121496586:A:T	single nucleotide variant	nonsense|non-coding transcript variant	Uncertain significance	Mar 9, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1802A>G (p.Lys601Arg)	FGFR2	K373R, K484R, K489R, K512R, K599R, K486R, K602R, K485R, K513R, K601R	not provided|FGFR2-related craniosynostosis	VCV002885269	10	123256107	10	121496593	2885269	3046729		NC_000010.11:121496592:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1800C>T (p.Phe600=)	FGFR2		Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590823	10	123256109	10	121496595	3590823	3728116		NC_000010.11:121496594:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Jun 7, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1788G>A (p.Glu596=)	FGFR2		not provided|FGFR2-related craniosynostosis|not specified	VCV000281582	10	123256121	10	121496607	281582	265819	rs56335660	NC_000010.11:121496606:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1774C>T (p.Arg592Cys)	FGFR2	R592C, R593C, R475C, R504C, R590C, R477C, R364C, R480C, R476C, R503C	Craniosynostosis syndrome|Crouzon syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Pfeiffer syndrome|Acrocephalosyndactyly type I|LADD syndrome 1|Bent bone dysplasia syndrome 1|Beare-Stevenson cutis gyrata syndrome|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Gastric cancer|Familial scaphocephaly syndrome, McGillivray type|Saethre-Chotzen syndrome|FGFR2-related craniosynostosis	VCV000298998	10	123256135	10	121496621	298998	320459	rs141929882	NC_000010.11:121496620:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 24, 2024	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.1772A>G (p.Asn591Ser)	FGFR2	N363S, N474S, N475S, N476S, N479S, N502S, N503S, N589S, N591S, N592S	FGFR2-related craniosynostosis	VCV001716388	10	123256137	10	121496623	1716388	1778069		NC_000010.11:121496622:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 12, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1761C>T (p.Ser587=)	FGFR2		FGFR2-related craniosynostosis|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Levy-Hollister syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Bent bone dysplasia syndrome 1|not provided	VCV000724975	10	123256148	10	121496634	724975	737380	rs147173572	NC_000010.11:121496633:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Oct 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1757_1758delinsGA (p.Tyr586Ter)	FGFR2	Y358*, Y469*, Y470*, Y474*, Y584*, Y586*, Y471*, Y587*, Y497*, Y498*	not provided	VCV000546064	10	123256151 - 123256152	10	121496637 - 121496638	546064	536363	rs1554914180	NC_000010.11:121496636:GT:TC	Indel	nonsense|non-coding transcript variant	Likely pathogenic	May 17, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1753G>C (p.Glu585Gln)	FGFR2	E585Q, E586Q, E470Q, E496Q, E497Q, E357Q, E468Q, E469Q, E473Q, E583Q	FGFR2-related craniosynostosis	VCV000570239	10	123256156	10	121496642	570239	563599	rs1564875398	NC_000010.11:121496641:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 5, 2017	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1750A>G (p.Met584Val)	FGFR2	M467V, M472V, M496V, M468V, M495V, M584V, M585V, M356V, M469V, M582V	FGFR2-related craniosynostosis	VCV002985463	10	123256159	10	121496645	2985463	3153525		NC_000010.11:121496644:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 28, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1748G>C (p.Gly583Ala)	FGFR2	G468A, G471A, G467A, G581A, G583A, G584A, G494A, G355A, G466A, G495A	Inborn genetic diseases|FGFR2-related craniosynostosis	VCV002196500	10	123256161	10	121496647	2196500	1933036		NC_000010.11:121496646:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1746C>T (p.Pro582=)	FGFR2		FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Saethre-Chotzen syndrome|Levy-Hollister syndrome|Gastric cancer|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Jackson-Weiss syndrome|Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	VCV001091719	10	123256163	10	121496649	1091719	1076929	rs369850306	NC_000010.11:121496648:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 19, 2021	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1735C>T (p.Arg579Trp)	FGFR2	R579W, R580W, R463W, R464W, R491W, R462W, R490W, R351W, R467W, R577W	Levy-Hollister syndrome|Acrocephalosyndactyly type I|Bent bone dysplasia syndrome 1|Beare-Stevenson cutis gyrata syndrome|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Pfeiffer syndrome|Gastric cancer	VCV000591392	10	123256174	10	121496660	591392	582384	rs1564875549	NC_000010.11:121496659:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 17, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1721_1732del (p.Glu574_Arg577del)	FGFR2		not provided	VCV001318913	10	123256177 - 123256188	10	121496663 - 121496674	1318913	1307425	rs2133941864	NC_000010.11:121496662:CTCGGAGGTATTCTCGGAGGT:CTCGGAGGT	Deletion	inframe_indel|inframe_deletion|non-coding transcript variant	Uncertain significance	Dec 30, 2020	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1723T>C (p.Tyr575His)	FGFR2	Y347H, Y458H, Y459H, Y460H, Y463H, Y486H, Y487H, Y573H, Y575H, Y576H	not provided	VCV001318740	10	123256186	10	121496672	1318740	1307252	rs2133942461	NC_000010.11:121496671:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 14, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1718G>A (p.Arg573Gln)	FGFR2	R345Q, R456Q, R457Q, R458Q, R461Q, R484Q, R485Q, R571Q, R573Q, R574Q	not provided	VCV001319052	10	123256191	10	121496677	1319052	1307563	rs2133942636	NC_000010.11:121496676:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 11, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1717C>T (p.Arg573Ter)	FGFR2	R573*, R574*, R456*, R461*, R484*, R571*, R345*, R457*, R458*, R485*	not provided	VCV000562281	10	123256192	10	121496678	562281	553465	rs1564875577	NC_000010.11:121496677:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Likely pathogenic	Sep 16, 2018	no assertion criteria provided							
NM_000141.5(FGFR2):c.1716C>T (p.Leu572=)	FGFR2		FGFR2-related craniosynostosis	VCV002717143	10	123256193	10	121496679	2717143	2872969		NC_000010.11:121496678:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 31, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1700C>T (p.Ala567Val)	FGFR2	A339V, A450V, A451V, A452V, A455V, A478V, A479V, A565V, A567V, A568V	Intellectual disability|Seizure|Craniosynostosis syndrome	VCV001683716	10	123256209	10	121496695	1683716	1675647	rs2133943742	NC_000010.11:121496694:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 15, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1699G>A (p.Ala567Thr)	FGFR2	A339T, A450T, A451T, A452T, A455T, A478T, A479T, A565T, A567T, A568T	FGFR2-related craniosynostosis|not provided	VCV001706429	10	123256210	10	121496696	1706429	1704743		NC_000010.11:121496695:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1695G>A (p.Glu565=)	FGFR2		FGFR2-related craniosynostosis	VCV002759993	10	123256214	10	121496700	2759993	2910805		NC_000010.11:121496699:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 27, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1694A>G (p.Glu565Gly)	FGFR2	E565G, E566G, E337G, E477G, E449G, E450G, E448G, E453G, E476G, E563G	not provided|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1|Gastric cancer|Acrocephalosyndactyly type I|Levy-Hollister syndrome|Beare-Stevenson cutis gyrata syndrome|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|FGFR2-related craniosynostosis|Pfeiffer syndrome	VCV000374823	10	123256215	10	121496701	374823	361707	rs121918506	NC_000010.11:121496700:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1694A>C (p.Glu565Ala)	FGFR2	E565A, E566A, E337A, E448A, E477A, E563A, E449A, E450A, E453A, E476A	not provided|Pfeiffer syndrome|FGFR2-related craniosynostosis	VCV000013294	10	123256215	10	121496701	13294	28333	rs121918506	NC_000010.11:121496700:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Oct 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1693G>A (p.Glu565Lys)	FGFR2	E453K, E477K, E565K, E449K, E563K, E337K, E566K, E448K, E450K, E476K	FGFR2-related craniosynostosis	VCV002807327	10	123256216	10	121496702	2807327	2964562		NC_000010.11:121496701:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Oct 6, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1690G>C (p.Val564Leu)	FGFR2	V447L, V562L, V564L, V448L, V476L, V336L, V475L, V449L, V452L, V565L	FGFR2-related craniosynostosis	VCV002772519	10	123256219	10	121496705	2772519	2933671		NC_000010.11:121496704:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 5, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1690G>A (p.Val564Ile)	FGFR2	V564I, V565I, V336I, V449I, V475I, V448I, V452I, V476I, V447I, V562I	not provided	VCV000376155	10	123256219	10	121496705	376155	363034	rs1057519797	NC_000010.11:121496704:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 14, 2020	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1687A>G (p.Ile563Val)	FGFR2	I335V, I446V, I447V, I448V, I451V, I474V, I475V, I561V, I563V, I564V	FGFR2-related craniosynostosis	VCV001713592	10	123256222	10	121496708	1713592	1777487		NC_000010.11:121496707:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1673-8C>T	FGFR2		FGFR2-related craniosynostosis	VCV002962540	10	123256244	10	121496730	2962540	3123744		NC_000010.11:121496729:G:A	single nucleotide variant	intron variant	Likely benign	Aug 11, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1673-12C>T	FGFR2		Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Crouzon syndrome|not provided|Isolated Coronal Synostosis|Craniosynostosis syndrome|FGFR2-related craniosynostosis	VCV000298999	10	123256248	10	121496734	298999	309587	rs41293763	NC_000010.11:121496733:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1673-171C>T	FGFR2		not provided	VCV001178291	10	123256407	10	121496893	1178291	1167490	rs148685299	NC_000010.11:121496892:G:A	single nucleotide variant	intron variant	Likely benign	Jul 27, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1673-273C>T	FGFR2		not provided	VCV001219618	10	123256509	10	121496995	1219618	1209596	rs181663041	NC_000010.11:121496994:G:A	single nucleotide variant	intron variant	Likely benign	Aug 17, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1672+336A>G	FGFR2		not provided	VCV001195665	10	123257673	10	121498159	1195665	1184327	rs527799074	NC_000010.11:121498158:T:C	single nucleotide variant	intron variant	Likely benign	Mar 17, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1672+181T>G	FGFR2		not provided	VCV001187393	10	123257828	10	121498314	1187393	1177260	rs41293747	NC_000010.11:121498313:A:C	single nucleotide variant	intron variant	Likely benign	Jan 2, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1672+20G>A	FGFR2		FGFR2-related craniosynostosis	VCV002019003	10	123257989	10	121498475	2019003	2069239		NC_000010.11:121498474:C:T	single nucleotide variant	intron variant	Likely benign	Sep 13, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1672+17dup	FGFR2		FGFR2-related craniosynostosis	VCV002880061	10	123257991 - 123257992	10	121498477 - 121498478	2880061	3036721		NC_000010.11:121498477:TTTTT:TTTTTT	Duplication	intron variant	Benign	Jul 10, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1672+1del	FGFR2		Colorectal cancer	VCV000998141	10	123258008	10	121498494	998141	985864	rs1847174277	NC_000010.11:121498493:CC:C	Deletion	splice donor variant	Pathogenic		no assertion criteria provided							
NM_000141.5(FGFR2):c.1661G>C (p.Cys554Ser)	FGFR2	C326S, C437S, C438S, C439S, C442S, C465S, C466S, C552S, C554S, C555S	FGFR2-related craniosynostosis	VCV001717833	10	123258020	10	121498506	1717833	1771809		NC_000010.11:121498505:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 1, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1646A>G (p.Asn549Ser)	FGFR2	N321S, N432S, N550S, N434S, N547S, N433S, N460S, N437S, N461S, N549S	Inborn genetic diseases	VCV003515003	10	123258035	10	121498521	3515003	3672738		NC_000010.11:121498520:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 26, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1646A>C (p.Asn549Thr)	FGFR2	N321T, N432T, N433T, N434T, N437T, N460T, N461T, N547T, N549T, N550T	not provided	VCV002446487	10	123258035	10	121498521	2446487	2421615		NC_000010.11:121498520:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Oct 3, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1645_1646delinsCT (p.Asn549Leu)	FGFR2	N432L, N461L, N321L, N434L, N460L, N550L, N437L, N547L, N433L, N549L	Craniosynostosis, nonspecific	VCV000374822	10	123258035 - 123258036	10	121498521 - 121498522	374822	361708	rs1057519046	NC_000010.11:121498520:TT:AG	Indel	missense variant|non-coding transcript variant	Likely pathogenic	Sep 17, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1645A>C (p.Asn549His)	FGFR2	N549H, N550H, N461H, N433H, N434H, N547H, N321H, N432H, N437H, N460H	Crouzon syndrome	VCV000374821	10	123258036	10	121498522	374821	361709	rs1057519045	NC_000010.11:121498521:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Sep 17, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1637A>C (p.Asn546Thr)	FGFR2	N318T, N429T, N430T, N431T, N434T, N457T, N458T, N544T, N546T, N547T	not provided|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|LADD syndrome 1|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Bent bone dysplasia syndrome 1|Gastric cancer	VCV001700436	10	123258044	10	121498530	1700436	1692829	rs765658636	NC_000010.11:121498529:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1632C>G (p.His544Gln)	FGFR2	H316Q, H427Q, H428Q, H544Q, H432Q, H456Q, H542Q, H545Q, H429Q, H455Q	FGFR2-related craniosynostosis	VCV002801080	10	123258049	10	121498535	2801080	2959608		NC_000010.11:121498534:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 23, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1623T>G (p.Ile541Met)	FGFR2	I541M, I542M, I426M, I452M, I453M, I313M, I425M, I424M, I429M, I539M	not provided	VCV000393138	10	123258058	10	121498544	393138	371199	rs1057524807	NC_000010.11:121498543:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1603A>T (p.Met535Leu)	FGFR2	M418L, M419L, M420L, M447L, M533L, M536L, M307L, M446L, M423L, M535L	FGFR2-related craniosynostosis	VCV001934605	10	123258078	10	121498564	1934605	1985730		NC_000010.11:121498563:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 27, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1600G>A (p.Glu534Lys)	FGFR2	E306K, E417K, E418K, E419K, E422K, E445K, E446K, E532K, E534K, E535K	Levy-Hollister syndrome	VCV001710242	10	123258081	10	121498567	1710242	1708636		NC_000010.11:121498566:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	May 2, 2022	no assertion criteria provided							
NM_000141.5(FGFR2):c.1576A>G (p.Lys526Glu)	FGFR2	K526E, K527E, K437E, K298E, K409E, K414E, K438E, K410E, K411E, K524E	not provided|Pfeiffer syndrome	VCV000013295	10	123258105	10	121498591	13295	28334	rs121918507	NC_000010.11:121498590:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1574A>T (p.Glu525Val)	FGFR2	E297V, E408V, E409V, E410V, E413V, E436V, E437V, E523V, E525V, E526V	not provided	VCV003368607	10	123258107	10	121498593	3368607	3527802		NC_000010.11:121498592:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 31, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1572A>G (p.Thr524=)	FGFR2		Craniosynostosis syndrome|not specified|Crouzon syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|not provided|Isolated Coronal Synostosis|FGFR2-related craniosynostosis	VCV000284342	10	123258109	10	121498595	284342	268579	rs74160613	NC_000010.11:121498594:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1570A>G (p.Thr524Ala)	FGFR2	T524A, T525A, T436A, T407A, T408A, T435A, T296A, T522A, T409A, T412A	FGFR2-related craniosynostosis	VCV000376749	10	123258111	10	121498597	376749	363628	rs1057520044	NC_000010.11:121498596:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1565A>T (p.Asp522Val)	FGFR2	D294V, D405V, D406V, D407V, D410V, D433V, D434V, D520V, D522V, D523V	not provided	VCV001679479	10	123258116	10	121498602	1679479	1671399	rs756076618	NC_000010.11:121498601:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 26, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1562A>G (p.Asp521Gly)	FGFR2	D293G, D405G, D433G, D522G, D404G, D409G, D519G, D406G, D521G, D432G	FGFR2-related craniosynostosis|Craniosynostosis syndrome|Isolated Coronal Synostosis|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome	VCV000880347	10	123258119	10	121498605	880347	865496	rs55689343	NC_000010.11:121498604:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 27, 2022	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.1562-8_1562-6dup	FGFR2		not provided	VCV003368397	10	123258124 - 123258125	10	121498610 - 121498611	3368397	3527594		NC_000010.11:121498610:AACA:AACAACA	Duplication	intron variant	Uncertain significance	Jan 25, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1562-6del	FGFR2		FGFR2-related craniosynostosis	VCV002063947	10	123258125	10	121498611	2063947	2117934		NC_000010.11:121498610:AA:A	Deletion	intron variant	Likely benign	May 17, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1562-9_1562-7delinsAA	FGFR2		not provided|Bent bone dysplasia syndrome 1|Pfeiffer syndrome|Levy-Hollister syndrome|Beare-Stevenson cutis gyrata syndrome|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Saethre-Chotzen syndrome|Jackson-Weiss syndrome	VCV001318925	10	123258126 - 123258128	10	121498612 - 121498614	1318925	1307436	rs2133978031	NC_000010.11:121498611:ACA:TT	Indel	intron variant	Uncertain significance	May 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1562-9_1562-8delinsAA	FGFR2		FGFR2-related craniosynostosis	VCV002063949	10	123258127 - 123258128	10	121498613 - 121498614	2063949	2117936		NC_000010.11:121498612:CA:TT	Indel	intron variant	Uncertain significance	May 14, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1562-11A>G	FGFR2		Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Crouzon syndrome|Isolated Coronal Synostosis	VCV000299000	10	123258130	10	121498616	299000	314414	rs41293744	NC_000010.11:121498615:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 13, 2018	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.1561+333G>A	FGFR2		not provided	VCV001285863	10	123260007	10	121500493	1285863	1275702	rs3135785	NC_000010.11:121500492:C:T	single nucleotide variant	intron variant	Benign	Aug 14, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1561+179T>C	FGFR2		not provided	VCV001187500	10	123260161	10	121500647	1187500	1177261	rs74160616	NC_000010.11:121500646:A:G	single nucleotide variant	intron variant	Likely benign	Jan 2, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1561+72A>G	FGFR2		not provided	VCV001186066	10	123260268	10	121500754	1186066	1177262	rs28702981	NC_000010.11:121500753:T:C	single nucleotide variant	intron variant	Likely benign	Dec 10, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1561+14C>T	FGFR2		FGFR2-related craniosynostosis	VCV002194433	10	123260326	10	121500812	2194433	1923215		NC_000010.11:121500811:G:A	single nucleotide variant	intron variant	Likely benign	Jun 15, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1561+10G>C	FGFR2		FGFR2-related craniosynostosis|Levy-Hollister syndrome	VCV001089475	10	123260330	10	121500816	1089475	1076930	rs758605716	NC_000010.11:121500815:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 8, 2024	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.1561+7G>A	FGFR2		FGFR2-related craniosynostosis	VCV000749454	10	123260333	10	121500819	749454	759872	rs757328995	NC_000010.11:121500818:C:T	single nucleotide variant	intron variant	Likely benign	Jun 28, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1561+6C>T	FGFR2		Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Crouzon syndrome|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|Levy-Hollister syndrome|Pfeiffer syndrome|Bent bone dysplasia syndrome 1|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|FGFR2-related craniosynostosis	VCV000964516	10	123260334	10	121500820	964516	959929	rs781352732	NC_000010.11:121500819:G:A	single nucleotide variant	intron variant	Uncertain significance	Apr 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1548G>A (p.Val516=)	FGFR2		Craniosynostosis syndrome|Crouzon syndrome|Saethre-Chotzen syndrome|not provided|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|FGFR2-related craniosynostosis	VCV000299001	10	123260353	10	121500839	299001	320884	rs200522893	NC_000010.11:121500838:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jan 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1545C>T (p.Ala515=)	FGFR2		Levy-Hollister syndrome|Bent bone dysplasia syndrome 1|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Gastric cancer|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Crouzon syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|not provided	VCV000767470	10	123260356	10	121500842	767470	701222	rs778789088	NC_000010.11:121500841:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 16, 2021	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1544C>T (p.Ala515Val)	FGFR2	A287V, A398V, A399V, A400V, A403V, A426V, A427V, A513V, A515V, A516V	Levy-Hollister syndrome	VCV000810729	10	123260357	10	121500843	810729	798979	rs1847510893	NC_000010.11:121500842:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic		no assertion criteria provided							
NM_000141.5(FGFR2):c.1539C>A (p.Thr513=)	FGFR2		Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Saethre-Chotzen syndrome|Isolated Coronal Synostosis	VCV000299002	10	123260362	10	121500848	299002	314416	rs74160617	NC_000010.11:121500847:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1539C>T (p.Thr513=)	FGFR2		Craniosynostosis syndrome|Saethre-Chotzen syndrome|not specified|Crouzon syndrome|not provided|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|FGFR2-related craniosynostosis	VCV000284354	10	123260362	10	121500848	284354	268591	rs74160617	NC_000010.11:121500847:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1537A>G (p.Thr513Ala)	FGFR2	T398A, T396A, T401A, T285A, T397A, T424A, T511A, T425A, T513A, T514A	Inborn genetic diseases	VCV002228032	10	123260364	10	121500850	2228032	2208864		NC_000010.11:121500849:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 15, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1536C>T (p.Val512=)	FGFR2		FGFR2-related craniosynostosis	VCV002022519	10	123260365	10	121500851	2022519	2076583		NC_000010.11:121500850:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 1, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1531G>T (p.Ala511Ser)	FGFR2	A394S, A399S, A509S, A511S, A395S, A422S, A423S, A512S, A283S, A396S	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590844	10	123260370	10	121500856	3590844	3728131		NC_000010.11:121500855:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 25, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1531G>A (p.Ala511Thr)	FGFR2	A509T, A512T, A396T, A399T, A422T, A423T, A511T, A283T, A394T, A395T	FGFR2-related craniosynostosis	VCV002071440	10	123260370	10	121500856	2071440	2126801		NC_000010.11:121500855:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 5, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1512C>G (p.Asp504Glu)	FGFR2	D388E, D416E, D389E, D387E, D392E, D502E, D504E, D276E, D415E, D505E	FGFR2-related craniosynostosis	VCV002700214	10	123260389	10	121500875	2700214	2859066		NC_000010.11:121500874:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 9, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1493C>T (p.Ala498Val)	FGFR2	A381V, A382V, A410V, A383V, A270V, A386V, A496V, A498V, A409V, A499V	FGFR2-related craniosynostosis	VCV002096486	10	123260408	10	121500894	2096486	2146637		NC_000010.11:121500893:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1486G>A (p.Val496Ile)	FGFR2	V381I, V384I, V268I, V380I, V496I, V379I, V407I, V408I, V494I, V497I	FGFR2-related craniosynostosis|Acrocephalosyndactyly type I|Beare-Stevenson cutis gyrata syndrome|Bent bone dysplasia syndrome 1|Gastric cancer|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Jackson-Weiss syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|LADD syndrome 1	VCV001971541	10	123260415	10	121500901	1971541	2032828		NC_000010.11:121500900:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1485G>A (p.Val495=)	FGFR2		FGFR2-related craniosynostosis	VCV001593931	10	123260416	10	121500902	1593931	1655350	rs1362401352	NC_000010.11:121500901:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 30, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1485G>T (p.Val495=)	FGFR2		Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Saethre-Chotzen syndrome|Crouzon syndrome	VCV000879194	10	123260416	10	121500902	879194	865497	rs1362401352	NC_000010.11:121500901:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Apr 27, 2017	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1482A>T (p.Gln494His)	FGFR2	Q266H, Q377H, Q378H, Q379H, Q382H, Q405H, Q406H, Q492H, Q494H, Q495H	FGFR2-related craniosynostosis	VCV001721294	10	123260419	10	121500905	1721294	1772628		NC_000010.11:121500904:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 8, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1481A>G (p.Gln494Arg)	FGFR2	Q266R, Q377R, Q378R, Q379R, Q382R, Q405R, Q406R, Q492R, Q494R, Q495R	FGFR2-related craniosynostosis	VCV003622004	10	123260420	10	121500906	3622004	3751099		NC_000010.11:121500905:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 28, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1477G>T (p.Gly493Trp)	FGFR2	G493W, G494W, G378W, G404W, G265W, G376W, G377W, G405W, G491W, G381W	Levy-Hollister syndrome	VCV000547378	10	123260424	10	121500910	547378	537869	rs1554917471	NC_000010.11:121500909:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Nov 1, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1455G>A (p.Lys485=)	FGFR2		FGFR2-related craniosynostosis	VCV002060136	10	123260446	10	121500932	2060136	2110249		NC_000010.11:121500931:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 27, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1448T>A (p.Leu483Gln)	FGFR2	L255Q, L366Q, L367Q, L368Q, L371Q, L394Q, L395Q, L481Q, L483Q, L484Q	not specified	VCV003629663	10	123260453	10	121500939	3629663	3762342		NC_000010.11:121500938:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 13, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1448T>C (p.Leu483Pro)	FGFR2	L255P, L366P, L367P, L368P, L371P, L394P, L395P, L481P, L483P, L484P	not provided|FGFR2-related craniosynostosis	VCV001181407	10	123260453	10	121500939	1181407	1172065	rs767430380	NC_000010.11:121500938:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1441C>T (p.Leu481=)	FGFR2		FGFR2-related craniosynostosis	VCV001645552	10	123260460	10	121500946	1645552	1652851	rs144116729	NC_000010.11:121500945:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jan 12, 2025	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1440-6A>G	FGFR2		FGFR2-related craniosynostosis	VCV001557308	10	123260467	10	121500953	1557308	1561967	rs2134013964	NC_000010.11:121500952:T:C	single nucleotide variant	intron variant	Likely benign	Nov 16, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1440-14A>G	FGFR2		not provided|FGFR2-related craniosynostosis	VCV000993886	10	123260475	10	121500961	993886	981686	rs1053077541	NC_000010.11:121500960:T:C	single nucleotide variant	intron variant	Likely benign	Aug 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1440-231C>T	FGFR2		not provided	VCV000673069	10	123260692	10	121501178	673069	664640	rs3135782	NC_000010.11:121501177:G:A	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1440-248C>T	FGFR2		not provided	VCV001207926	10	123260709	10	121501195	1207926	1198010	rs41295621	NC_000010.11:121501194:G:A	single nucleotide variant	intron variant	Likely benign	Dec 10, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1439+185dup	FGFR2		not provided	VCV001207256	10	123263118 - 123263119	10	121503604 - 121503605	1207256	1198011	rs11365153	NC_000010.11:121503604:TTTTTTTTTTT:TTTTTTTTTTTT	Duplication	intron variant	Likely benign	Aug 6, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1439+174T>A	FGFR2		not provided	VCV001193369	10	123263130	10	121503616	1193369	1184328	rs41295593	NC_000010.11:121503615:A:T	single nucleotide variant	intron variant	Likely benign	Aug 15, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1439+165A>G	FGFR2		not provided	VCV001190080	10	123263139	10	121503625	1190080	1180648	rs41295591	NC_000010.11:121503624:T:C	single nucleotide variant	intron variant	Likely benign	Sep 2, 2019	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1439+95A>G	FGFR2		not provided	VCV001219755	10	123263209	10	121503695	1219755	1209733	rs41295589	NC_000010.11:121503694:T:C	single nucleotide variant	intron variant	Likely benign	Apr 9, 2019	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1431A>G (p.Pro477=)	FGFR2		FGFR2-related disorder	VCV003048729	10	123263312	10	121503798	3048729	3216189		NC_000010.11:121503797:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 16, 2019	no assertion criteria provided							
NM_000141.5(FGFR2):c.1394A>G (p.Glu465Gly)	FGFR2	E237G, E348G, E353G, E376G, E463G, E466G, E349G, E350G, E377G, E465G	Inborn genetic diseases	VCV002243392	10	123263349	10	121503835	2243392	2230226		NC_000010.11:121503834:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 12, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1392C>T (p.Ser464=)	FGFR2		FGFR2-related craniosynostosis	VCV002142842	10	123263351	10	121503837	2142842	1872535		NC_000010.11:121503836:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 17, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1388T>A (p.Val463Asp)	FGFR2	V235D, V346D, V347D, V348D, V351D, V374D, V375D, V461D, V463D, V464D	FGFR2-related craniosynostosis	VCV001001445	10	123263355	10	121503841	1001445	993742	rs751433223	NC_000010.11:121503840:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 4, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1382C>T (p.Ala461Val)	FGFR2	A233V, A344V, A345V, A346V, A349V, A372V, A373V, A459V, A461V, A462V	FGFR2-related craniosynostosis|not provided	VCV001316124	10	123263361	10	121503847	1316124	1308526	rs376451171	NC_000010.11:121503846:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1372C>A (p.Pro458Thr)	FGFR2	P456T, P459T, P342T, P343T, P346T, P458T, P230T, P341T, P370T, P369T	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590850	10	123263371	10	121503857	3590850	3728142		NC_000010.11:121503856:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 8, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1370C>A (p.Thr457Asn)	FGFR2	T341N, T342N, T229N, T345N, T455N, T458N, T340N, T457N, T368N, T369N	FGFR2-related craniosynostosis	VCV001443032	10	123263373	10	121503859	1443032	1371919	rs1245946700	NC_000010.11:121503858:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 8, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1367A>G (p.Asp456Gly)	FGFR2	D339G, D367G, D456G, D341G, D228G, D340G, D344G, D368G, D454G, D457G	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590857	10	123263376	10	121503862	3590857	3728149		NC_000010.11:121503861:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 24, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1362G>A (p.Thr454=)	FGFR2		FGFR2-related craniosynostosis|not provided	VCV000514601	10	123263381	10	121503867	514601	503164	rs200183009	NC_000010.11:121503866:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1361C>T (p.Thr454Met)	FGFR2	T226M, T337M, T342M, T452M, T338M, T339M, T365M, T366M, T455M, T454M	FGFR2-related craniosynostosis	VCV000864431	10	123263382	10	121503868	864431	836684	rs148672240	NC_000010.11:121503867:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Oct 18, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1356T>A (p.Ser452=)	FGFR2		Levy-Hollister syndrome|Beare-Stevenson cutis gyrata syndrome|Gastric cancer|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1|FGFR2-related craniosynostosis	VCV001079179	10	123263387	10	121503873	1079179	1076931	rs2134060289	NC_000010.11:121503872:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1355C>T (p.Ser452Phe)	FGFR2	S335F, S337F, S340F, S363F, S364F, S450F, S453F, S336F, S452F, S224F	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590863	10	123263388	10	121503874	3590863	3728156		NC_000010.11:121503873:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 12, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1351C>G (p.Leu451Val)	FGFR2	L223V, L334V, L335V, L336V, L449V, L451V, L363V, L452V, L362V, L339V	FGFR2-related craniosynostosis|Inborn genetic diseases	VCV002479385	10	123263392	10	121503878	2479385	2450691		NC_000010.11:121503877:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1349G>A (p.Arg450His)	FGFR2	R222H, R333H, R334H, R335H, R338H, R361H, R362H, R448H, R450H, R451H	not provided	VCV002428568	10	123263394	10	121503880	2428568	2402010		NC_000010.11:121503879:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 10, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1348C>T (p.Arg450Cys)	FGFR2	R222C, R333C, R334C, R335C, R338C, R361C, R362C, R448C, R450C, R451C	FGFR2-related craniosynostosis|Inborn genetic diseases|Bent bone dysplasia syndrome 1|Saethre-Chotzen syndrome|LADD syndrome 1|Gastric cancer|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Jackson-Weiss syndrome|Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|not provided	VCV001052478	10	123263395	10	121503881	1052478	1046461	rs536181987	NC_000010.11:121503880:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 6, 2024	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.1342A>G (p.Thr448Ala)	FGFR2	T331A, T333A, T336A, T449A, T220A, T360A, T448A, T332A, T359A, T446A	not provided|Jackson-Weiss syndrome|Bent bone dysplasia syndrome 1|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Gastric cancer|Acrocephalosyndactyly type I|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|LADD syndrome 1|FGFR2-related craniosynostosis	VCV001903593	10	123263401	10	121503887	1903593	1957784		NC_000010.11:121503886:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1335G>T (p.Val445=)	FGFR2		FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Jackson-Weiss syndrome|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Levy-Hollister syndrome|Acrocephalosyndactyly type I|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer	VCV001584653	10	123263408	10	121503894	1584653	1560804	rs1460282965	NC_000010.11:121503893:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1328C>G (p.Pro443Arg)	FGFR2	P215R, P327R, P354R, P355R, P326R, P331R, P444R, P328R, P441R, P443R	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590880	10	123263415	10	121503901	3590880	3728169		NC_000010.11:121503900:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 3, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1328C>T (p.Pro443Leu)	FGFR2	P328L, P331L, P441L, P444L, P355L, P327L, P354L, P215L, P326L, P443L	FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Levy-Hollister syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Acrocephalosyndactyly type I|Jackson-Weiss syndrome	VCV001482755	10	123263415	10	121503901	1482755	1442120	rs757125418	NC_000010.11:121503900:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1327C>G (p.Pro443Ala)	FGFR2	P215A, P326A, P327A, P328A, P331A, P354A, P355A, P441A, P443A, P444A	not provided|FGFR2-related craniosynostosis	VCV000994609	10	123263416	10	121503902	994609	982735	rs7078073	NC_000010.11:121503901:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1326C>T (p.Thr442=)	FGFR2		FGFR2-related craniosynostosis	VCV002995548	10	123263417	10	121503903	2995548	3155902		NC_000010.11:121503902:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 9, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1325C>T (p.Thr442Ile)	FGFR2	T214I, T326I, T354I, T327I, T330I, T353I, T440I, T443I, T325I, T442I	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590886	10	123263418	10	121503904	3590886	3728178		NC_000010.11:121503903:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 1, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1313T>C (p.Met438Thr)	FGFR2	M321T, M349T, M439T, M210T, M322T, M436T, M323T, M350T, M326T, M438T	Inborn genetic diseases|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Acrocephalosyndactyly type I|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Jackson-Weiss syndrome|Saethre-Chotzen syndrome|LADD syndrome 1	VCV002310022	10	123263430	10	121503916	2310022	2301096		NC_000010.11:121503915:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1303A>G (p.Ser435Gly)	FGFR2	S207G, S318G, S323G, S433G, S435G, S319G, S346G, S436G, S320G, S347G	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590897	10	123263440	10	121503926	3590897	3728188		NC_000010.11:121503925:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 30, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1302C>T (p.Ser434=)	FGFR2		FGFR2-related craniosynostosis	VCV001146101	10	123263441	10	121503927	1146101	1141010	rs141297318	NC_000010.11:121503926:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 14, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1299G>C (p.Glu433Asp)	FGFR2	E344D, E433D, E431D, E205D, E316D, E318D, E434D, E317D, E321D, E345D	FGFR2-related craniosynostosis	VCV002980938	10	123263444	10	121503930	2980938	3138236		NC_000010.11:121503929:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 24, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1288-1G>A	FGFR2		Neoplasm	VCV003257946	10	123263456	10	121503942	3257946	3416705		NC_000010.11:121503941:C:T	single nucleotide variant	splice acceptor variant							Uncertain significance	Jul 31, 2024	criteria provided, single submitter	
NM_000141.5(FGFR2):c.1288-8G>A	FGFR2		FGFR2-related craniosynostosis	VCV002726714	10	123263463	10	121503949	2726714	2885904		NC_000010.11:121503948:C:T	single nucleotide variant	intron variant	Likely benign	Dec 10, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1288-15G>A	FGFR2		FGFR2-related craniosynostosis	VCV002725947	10	123263470	10	121503956	2725947	2892454		NC_000010.11:121503955:C:T	single nucleotide variant	intron variant	Likely benign	Oct 18, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1288-16_1288-15insTTG	FGFR2		FGFR2-related craniosynostosis	VCV001645271	10	123263470 - 123263471	10	121503956 - 121503957	1645271	1599169	rs778424804	NC_000010.11:121503956:A:ACAA	Insertion	intron variant	Likely benign	Dec 7, 2020	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1288-23G>C	FGFR2		not provided	VCV000675995	10	123263478	10	121503964	675995	664619	rs3135774	NC_000010.11:121503963:C:G	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1288-35A>G	FGFR2		not provided|not specified	VCV001686405	10	123263490	10	121503976	1686405	1678413	rs41295587	NC_000010.11:121503975:T:C	single nucleotide variant	intron variant	Likely benign	May 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1288-158G>A	FGFR2		not provided	VCV001214954	10	123263613	10	121504099	1214954	1204937	rs3135773	NC_000010.11:121504098:C:T	single nucleotide variant	intron variant	Likely benign	Jul 30, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1288-161G>A	FGFR2		not provided	VCV000671367	10	123263616	10	121504102	671367	664643	rs3135772	NC_000010.11:121504101:C:T	single nucleotide variant	intron variant	Benign	Jun 19, 2018	criteria provided, single submitter							
GRCh38/hg38 10q26.13(chr10:121507745-121870082)x3	ATE1|FGFR2|LOC124416921|LOC124416922|LOC126861065|LOC130004864|LOC130004865|LOC132089750		See cases	VCV000059729	10	123267259 - 123629597	10	121507745 - 121870082	59729	74324			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1287+287GT[5]	FGFR2		not provided	VCV001194112	10	123274336 - 123274337	10	121514822 - 121514823	1194112	1184329	rs576981699	NC_000010.11:121514822:ACACACACA:ACACACACACA	Microsatellite	intron variant	Likely benign	Feb 28, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1287+11A>G	FGFR2		FGFR2-related craniosynostosis	VCV001568032	10	123274620	10	121515106	1568032	1657540	rs758846086	NC_000010.11:121515105:T:C	single nucleotide variant	intron variant	Likely benign	Jun 23, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1287+1G>T	FGFR2		FGFR2-related craniosynostosis	VCV002025994	10	123274630	10	121515116	2025994	2077485		NC_000010.11:121515115:C:A	single nucleotide variant	splice donor variant|intron variant	Uncertain significance	Nov 22, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1278A>C (p.Arg426Ser)	FGFR2	R337S, R314S, R427S, R338S, R426S, R198S, R311S	FGFR2-related craniosynostosis	VCV001393582	10	123274640	10	121515126	1393582	1399434	rs2134219875	NC_000010.11:121515125:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 12, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1277G>A (p.Arg426Lys)	FGFR2	R198K, R311K, R314K, R337K, R338K, R426K, R427K	not provided	VCV003363738	10	123274641	10	121515127	3363738	3522947		NC_000010.11:121515126:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 14, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1274G>A (p.Arg425Gln)	FGFR2	R310Q, R336Q, R426Q, R313Q, R197Q, R337Q, R425Q	FGFR2-related craniosynostosis|Autosomal dominant syndrome including deafness	VCV002202644	10	123274644	10	121515130	2202644	1928295		NC_000010.11:121515129:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Feb 28, 2023	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.1267C>T (p.Pro423Ser)	FGFR2	P195S, P308S, P311S, P334S, P335S, P423S, P424S	not provided	VCV001320736	10	123274651	10	121515137	1320736	1310981	rs1207716999	NC_000010.11:121515136:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 19, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1262G>A (p.Arg421His)	FGFR2	R421H, R422H, R332H, R193H, R309H, R306H, R333H	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590904	10	123274656	10	121515142	3590904	3728191		NC_000010.11:121515141:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 11, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1254G>T (p.Leu418=)	FGFR2		FGFR2-related craniosynostosis	VCV002985863	10	123274664	10	121515150	2985863	3149999		NC_000010.11:121515149:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Dec 6, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1252C>G (p.Leu418Val)	FGFR2	L190V, L330V, L306V, L329V, L418V, L303V, L419V	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590914	10	123274666	10	121515152	3590914	3728195		NC_000010.11:121515151:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 4, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1242T>C (p.Ala414=)	FGFR2		FGFR2-related craniosynostosis	VCV002778649	10	123274676	10	121515162	2778649	2943686		NC_000010.11:121515161:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Aug 14, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1240G>A (p.Ala414Thr)	FGFR2	A302T, A414T, A299T, A186T, A415T, A325T, A326T	FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Levy-Hollister syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Acrocephalosyndactyly type I|Jackson-Weiss syndrome	VCV001464298	10	123274678	10	121515164	1464298	1435969	rs769880096	NC_000010.11:121515163:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1239G>A (p.Pro413=)	FGFR2		Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome|FGFR2-related craniosynostosis	VCV000299003	10	123274679	10	121515165	299003	320908	rs147674677	NC_000010.11:121515164:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Dec 12, 2021	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.1238C>T (p.Pro413Leu)	FGFR2	P298L, P185L, P301L, P324L, P325L, P414L, P413L	Acrocephalosyndactyly type I|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|Bent bone dysplasia syndrome 1|Jackson-Weiss syndrome|Levy-Hollister syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|FGFR2-related craniosynostosis	VCV001373931	10	123274680	10	121515166	1373931	1456749	rs372348666	NC_000010.11:121515165:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1225T>G (p.Phe409Val)	FGFR2	F181V, F294V, F297V, F320V, F321V, F409V, F410V	not provided	VCV002576791	10	123274693	10	121515179	2576791	2741688		NC_000010.11:121515178:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 15, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1213A>G (p.Lys405Glu)	FGFR2	K290E, K293E, K177E, K317E, K406E, K316E, K405E	Jackson-Weiss syndrome|Gastric cancer|Acrocephalosyndactyly type I|Bent bone dysplasia syndrome 1|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|LADD syndrome 1|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Craniosynostosis syndrome|Isolated Coronal Synostosis|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome	VCV000877638	10	123274705	10	121515191	877638	865498	rs772986332	NC_000010.11:121515190:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Mar 7, 2024	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.1212C>T (p.Thr404=)	FGFR2		FGFR2-related craniosynostosis	VCV003604511	10	123274706	10	121515192	3604511	3743262		NC_000010.11:121515191:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Nov 29, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1211C>T (p.Thr404Ile)	FGFR2	T315I, T404I, T405I, T316I, T176I, T289I, T292I	FGFR2-related craniosynostosis	VCV002131368	10	123274707	10	121515193	2131368	2191503		NC_000010.11:121515192:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 6, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1207A>G (p.Thr403Ala)	FGFR2	T175A, T288A, T291A, T314A, T315A, T403A, T404A	not provided	VCV002502025	10	123274711	10	121515197	2502025	2534237		NC_000010.11:121515196:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 10, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1205A>G (p.Asn402Ser)	FGFR2	N403S, N402S, N313S, N314S, N287S, N174S, N290S	FGFR2-related craniosynostosis|not provided	VCV000281555	10	123274713	10	121515199	281555	265792	rs764748528	NC_000010.11:121515198:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 27, 2021	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1200G>A (p.Met400Ile)	FGFR2	M172I, M312I, M285I, M311I, M288I, M400I, M401I	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590929	10	123274718	10	121515204	3590929	3728201		NC_000010.11:121515203:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 8, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1191G>A (p.Leu397=)	FGFR2		FGFR2-related craniosynostosis	VCV002072518	10	123274727	10	121515213	2072518	2130447		NC_000010.11:121515212:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	May 27, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1183G>A (p.Val395Ile)	FGFR2	V167I, V280I, V283I, V306I, V307I, V395I, V396I	not provided	VCV003390700	10	123274735	10	121515221	3390700	3549829		NC_000010.11:121515220:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 10, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1180A>G (p.Thr394Ala)	FGFR2	T395A, T282A, T394A, T166A, T305A, T306A, T279A	FGFR2-related craniosynostosis	VCV002742071	10	123274738	10	121515224	2742071	2906716		NC_000010.11:121515223:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 11, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1179A>G (p.Val393=)	FGFR2		FGFR2-related craniosynostosis	VCV002892098	10	123274739	10	121515225	2892098	3048356		NC_000010.11:121515224:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Dec 28, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1179A>T (p.Val393=)	FGFR2		Craniosynostosis syndrome|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Isolated Coronal Synostosis	VCV000299004	10	123274739	10	121515225	299004	314418	rs886046763	NC_000010.11:121515224:T:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1173G>A (p.Met391Ile)	FGFR2	M163I, M276I, M279I, M302I, M303I, M391I, M392I	not provided	VCV001703393	10	123274745	10	121515231	1703393	1695783		NC_000010.11:121515230:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 24, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1172T>G (p.Met391Arg)	FGFR2	M391R, M392R, M163R, M303R, M276R, M279R, M302R	not provided	VCV000029855	10	123274746	10	121515232	29855	38810	rs387906677	NC_000010.11:121515231:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Sep 14, 2015	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1167C>G (p.Ala389=)	FGFR2		Craniosynostosis syndrome|Isolated Coronal Synostosis|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome	VCV000877639	10	123274751	10	121515237	877639	865499	rs757648006	NC_000010.11:121515236:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1165G>A (p.Ala389Thr)	FGFR2	A161T, A389T, A301T, A390T, A274T, A277T, A300T	Neoplasm	VCV003257947	10	123274753	10	121515239	3257947	3416706		NC_000010.11:121515238:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant							Uncertain significance	Jul 31, 2024	criteria provided, single submitter	
NM_000141.5(FGFR2):c.1164C>T (p.Ile388=)	FGFR2		FGFR2-related craniosynostosis	VCV002177594	10	123274754	10	121515240	2177594	1919286		NC_000010.11:121515239:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Mar 4, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1155C>G (p.Val385=)	FGFR2		Beare-Stevenson cutis gyrata syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Bent bone dysplasia syndrome 1|Jackson-Weiss syndrome|Pfeiffer syndrome|Levy-Hollister syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Gastric cancer|Acrocephalosyndactyly type I|not provided|FGFR2-related craniosynostosis	VCV001328666	10	123274763	10	121515249	1328666	1319353	rs531426519	NC_000010.11:121515248:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Sep 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1152G>A (p.Gly384=)	FGFR2		FGFR2-related craniosynostosis	VCV000544303	10	123274766	10	121515252	544303	524995	rs772014466	NC_000010.11:121515251:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Oct 30, 2017	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1150G>A (p.Gly384Arg)	FGFR2	G384R, G385R, G156R, G295R, G269R, G296R, G272R	FGFR2-related craniosynostosis|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Levy-Hollister syndrome|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Neoplasm of stomach|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Bent bone dysplasia syndrome 1	VCV000478046	10	123274768	10	121515254	478046	459906	rs1554927408	NC_000010.11:121515253:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Oct 31, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1148T>C (p.Ile383Thr)	FGFR2	I268T, I155T, I271T, I294T, I295T, I383T, I384T	Inborn genetic diseases	VCV003278667	10	123274770	10	121515256	3278667	3439160		NC_000010.11:121515255:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely benign	May 13, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1144T>C (p.Cys382Arg)	FGFR2	C382R, C383R, C294R, C154R, C270R, C267R, C293R	not provided|Adenoid cystic carcinoma	VCV000376431	10	123274774	10	121515260	376431	363310	rs121913474	NC_000010.11:121515259:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Aug 16, 2023	criteria provided, single submitter				Uncertain significance	Nov 13, 2024	no assertion criteria provided	
NM_000141.5(FGFR2):c.1142A>G (p.Tyr381Cys)	FGFR2	Y381C, Y382C, Y266C, Y292C, Y293C, Y153C, Y269C	not provided	VCV000423481	10	123274776	10	121515262	423481	407827	rs1064796452	NC_000010.11:121515261:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Feb 22, 2017	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1141T>C (p.Tyr381His)	FGFR2	Y381H, Y382H, Y266H, Y292H, Y153H, Y269H, Y293H	not provided	VCV000376316	10	123274777	10	121515263	376316	363195	rs387906678	NC_000010.11:121515262:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Nov 28, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1141T>G (p.Tyr381Asp)	FGFR2	Y381D, Y382D, Y292D, Y266D, Y153D, Y293D, Y269D	Bent bone dysplasia syndrome 1|Inborn genetic diseases|FGFR2-related disorder|not provided	VCV000029856	10	123274777	10	121515263	29856	38811	rs387906678	NC_000010.11:121515262:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Apr 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1132A>G (p.Ile378Val)	FGFR2	I150V, I263V, I266V, I289V, I290V, I378V, I379V	Disorder of sexual differentiation	VCV001202602	10	123274786	10	121515272	1202602	1192604	rs2134229231	NC_000010.11:121515271:T:C	single nucleotide variant	intron variant|missense variant|non-coding transcript variant	Uncertain significance	Aug 15, 2021	no assertion criteria provided							
NM_000141.5(FGFR2):c.1124A>T (p.Tyr375Phe)	FGFR2	Y147F, Y260F, Y263F, Y286F, Y287F, Y375F, Y376F	Pfeiffer syndrome|Bent bone dysplasia syndrome 1|Crouzon syndrome|Familial scaphocephaly syndrome, McGillivray type|Beare-Stevenson cutis gyrata syndrome|Acrocephalosyndactyly type I|LADD syndrome 1|Saethre-Chotzen syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Jackson-Weiss syndrome	VCV003075688	10	123274794	10	121515280	3075688	3234984		NC_000010.11:121515279:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Mar 9, 2024	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.1124A>G (p.Tyr375Cys)	FGFR2	Y375C, Y376C, Y263C, Y147C, Y286C, Y287C, Y260C	Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Jackson-Weiss syndrome|Saethre-Chotzen syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|Neoplasm of stomach|Levy-Hollister syndrome|Acrocephalosyndactyly type I|not provided|FGFR2-related craniosynostosis|Beare-Stevenson cutis gyrata syndrome	VCV000013277	10	123274794	10	121515280	13277	28316	rs121913478	NC_000010.11:121515279:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Jan 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1120G>A (p.Asp374Asn)	FGFR2	D146N, D375N, D262N, D286N, D259N, D285N, D374N	FGFR2-related craniosynostosis	VCV002186170	10	123274798	10	121515284	2186170	1921382		NC_000010.11:121515283:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 7, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1117C>T (p.Pro373Ser)	FGFR2	P261S, P374S, P373S, P145S, P258S, P284S, P285S	Inborn genetic diseases|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Acrocephalosyndactyly type I|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Jackson-Weiss syndrome|Saethre-Chotzen syndrome|LADD syndrome 1	VCV002294474	10	123274801	10	121515287	2294474	2280385		NC_000010.11:121515286:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1116C>T (p.Ser372=)	FGFR2		FGFR2-related craniosynostosis	VCV003622360	10	123274802	10	121515288	3622360	3760258		NC_000010.11:121515287:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Sep 9, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1115C>G (p.Ser372Cys)	FGFR2	S372C, S373C, S257C, S260C, S283C, S284C, S144C	FGFR2-related craniosynostosis	VCV000013278	10	123274803	10	121515289	13278	28317	rs121913477	NC_000010.11:121515288:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jul 19, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1112C>T (p.Ala371Val)	FGFR2	A143V, A256V, A259V, A282V, A283V, A371V, A372V	FGFR2-related craniosynostosis	VCV003604588	10	123274806	10	121515292	3604588	3743339		NC_000010.11:121515291:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 12, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1095A>G (p.Arg365=)	FGFR2		FGFR2-related craniosynostosis	VCV002879360	10	123274823	10	121515309	2879360	3042262		NC_000010.11:121515308:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Apr 6, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1093A>C (p.Arg365=)	FGFR2		Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Crouzon syndrome|Saethre-Chotzen syndrome	VCV000878653	10	123274825	10	121515311	878653	865500	rs1849564914	NC_000010.11:121515310:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1086G>A (p.Ala362=)	FGFR2		Beare-Stevenson cutis gyrata syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Levy-Hollister syndrome|Gastric cancer|Bent bone dysplasia syndrome 1|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|FGFR2-related craniosynostosis|not provided	VCV000514591	10	123274832	10	121515318	514591	503289	rs151250769	NC_000010.11:121515317:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Nov 29, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1086G>C (p.Ala362=)	FGFR2		not provided|FGFR2-related craniosynostosis	VCV000498876	10	123274832	10	121515318	498876	490300	rs151250769	NC_000010.11:121515317:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Jul 26, 2022	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.1085C>A (p.Ala362Glu)	FGFR2	A247E, A250E, A274E, A134E, A363E, A273E, A362E	Inborn genetic diseases	VCV002252250	10	123274833	10	121515319	2252250	2235620		NC_000010.11:121515318:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 27, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1085C>T (p.Ala362Val)	FGFR2	A134V, A363V, A274V, A362V, A247V, A250V, A273V	Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|FGFR2-related craniosynostosis	VCV001506367	10	123274833	10	121515319	1506367	1430292	rs757846343	NC_000010.11:121515318:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1085-3T>C	FGFR2		FGFR2-related craniosynostosis	VCV002783780	10	123274836	10	121515322	2783780	2944924		NC_000010.11:121515321:A:G	single nucleotide variant	intron variant	Uncertain significance	Nov 18, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1085-6A>G	FGFR2		Saethre-Chotzen syndrome	VCV001065423	10	123274839	10	121515325	1065423	1053766	rs2134232051	NC_000010.11:121515324:T:C	single nucleotide variant	intron variant	Uncertain significance	Mar 12, 2020	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1085-8C>T	FGFR2		FGFR2-related craniosynostosis	VCV002817339	10	123274841	10	121515327	2817339	2977150		NC_000010.11:121515326:G:A	single nucleotide variant	intron variant	Likely benign	Nov 7, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1085-9G>A	FGFR2		FGFR2-related craniosynostosis	VCV001986971	10	123274842	10	121515328	1986971	2047417		NC_000010.11:121515327:C:T	single nucleotide variant	intron variant	Likely benign	Jan 6, 2025	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1085-13A>G	FGFR2		FGFR2-related craniosynostosis	VCV001952450	10	123274846	10	121515332	1952450	2007862		NC_000010.11:121515331:T:C	single nucleotide variant	intron variant	Likely benign	Jul 30, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1085-13A>T	FGFR2		FGFR2-related craniosynostosis|Craniosynostosis syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Isolated Coronal Synostosis|not provided	VCV000299005	10	123274846	10	121515332	299005	320461	rs41295573	NC_000010.11:121515331:T:A	single nucleotide variant	intron variant	Benign/Likely benign	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1085-15T>C	FGFR2		FGFR2-related craniosynostosis	VCV002886906	10	123274848	10	121515334	2886906	3047065		NC_000010.11:121515333:A:G	single nucleotide variant	intron variant	Likely benign	Mar 30, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1085-19C>T	FGFR2		not specified	VCV003233694	10	123274852	10	121515338	3233694	3392818		NC_000010.11:121515337:G:A	single nucleotide variant	intron variant	Likely benign	Mar 1, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1085-222G>A	FGFR2		not provided	VCV001241526	10	123275055	10	121515541	1241526	1233583	rs41295565	NC_000010.11:121515540:C:T	single nucleotide variant	intron variant	Benign	Aug 14, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1085-256C>A	FGFR2		not provided	VCV001186807	10	123275089	10	121515575	1186807	1177263	rs4647918	NC_000010.11:121515574:G:T	single nucleotide variant	intron variant	Likely benign	Apr 12, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1084+20T>C	FGFR2		FGFR2-related craniosynostosis|not specified	VCV000511076	10	123276813	10	121517299	511076	503588	rs1554928776	NC_000010.11:121517298:A:G	single nucleotide variant	intron variant	Likely benign	Jun 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1084+8C>T	FGFR2		FGFR2-related craniosynostosis	VCV000747152	10	123276825	10	121517311	747152	759874	rs1589827584	NC_000010.11:121517310:G:A	single nucleotide variant	intron variant	Likely benign	Jan 28, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1084+4T>C	FGFR2		FGFR2-related craniosynostosis	VCV002969432	10	123276829	10	121517315	2969432	3131973		NC_000010.11:121517314:A:G	single nucleotide variant	intron variant	Uncertain significance	Jan 15, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1084+3A>G	FGFR2		Pfeiffer syndrome|FGFR2-related craniosynostosis|not provided	VCV000013299	10	123276830	10	121517316	13299	28338	rs879253721	NC_000010.11:121517315:T:C	single nucleotide variant	intron variant	Pathogenic	Apr 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1084+2T>C	FGFR2		Pfeiffer syndrome|FGFR2-related craniosynostosis	VCV002136935	10	123276831	10	121517317	2136935	1877937		NC_000010.11:121517316:A:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Nov 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1084+1G>A	FGFR2		FGFR2-related disorder|FGFR2-related craniosynostosis	VCV002136936	10	123276832	10	121517318	2136936	1877938		NC_000010.11:121517317:C:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Aug 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1084+1G>T	FGFR2		not provided	VCV001335051	10	123276832	10	121517318	1335051	1326025	rs2134253609	NC_000010.11:121517317:C:A	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Dec 1, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1084_1085insTCAACA (p.Ala362delinsValAsnThr)	FGFR2		FGFR2-related craniosynostosis	VCV000544300	10	123276832 - 123276833	10	121517318 - 121517319	544300	525525	rs1554928786	NC_000010.11:121517318::TGTTGA	Insertion	inframe_indel|non-coding transcript variant|intron variant	Uncertain significance	Oct 17, 2017	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1084G>T (p.Ala362Ser)	FGFR2	A134S, A273S, A362S, A247S	FGFR2-related craniosynostosis	VCV002735493	10	123276833	10	121517319	2735493	2901516		NC_000010.11:121517318:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Nov 10, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1084G>A (p.Ala362Thr)	FGFR2	A247T, A362T, A273T, A134T	FGFR2-related craniosynostosis	VCV001381082	10	123276833	10	121517319	1381082	1499924	rs2134253669	NC_000010.11:121517318:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 7, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1083A>T (p.Pro361=)	FGFR2		FGFR2-related craniosynostosis	VCV002735494	10	123276834	10	121517320	2735494	2901517		NC_000010.11:121517319:T:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Pathogenic	Jun 3, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1078C>G (p.Leu360Val)	FGFR2	L132V, L245V, L271V, L360V	not provided	VCV003369828	10	123276839	10	121517325	3369828	3529019		NC_000010.11:121517324:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 26, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1075G>A (p.Val359Ile)	FGFR2	V131I, V359I, V244I, V270I	FGFR2-related craniosynostosis	VCV001433705	10	123276842	10	121517328	1433705	1419378	rs1274989878	NC_000010.11:121517327:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Sep 10, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1075G>T (p.Val359Phe)	FGFR2	V244F, V270F, V131F, V359F	FGFR2-related craniosynostosis	VCV000952522	10	123276842	10	121517328	952522	925760	rs1274989878	NC_000010.11:121517327:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	May 5, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1070T>C (p.Leu357Ser)	FGFR2	L129S, L242S, L357S, L268S	FGFR2-related craniosynostosis	VCV001406374	10	123276847	10	121517333	1406374	1408395	rs2134254345	NC_000010.11:121517332:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jul 13, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1066T>G (p.Trp356Gly)	FGFR2	W356G, W241G, W128G, W267G	not provided|FGFR2-related craniosynostosis	VCV002103395	10	123276851	10	121517337	2103395	2158699		NC_000010.11:121517336:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Dec 9, 2023	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.1064C>T (p.Ala355Val)	FGFR2	A127V, A266V, A240V, A355V	FGFR2-related craniosynostosis	VCV001963742	10	123276853	10	121517339	1963742	2013538		NC_000010.11:121517338:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 5, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1062T>A (p.Ser354=)	FGFR2		Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590949	10	123276855	10	121517341	3590949	3728221		NC_000010.11:121517340:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 1, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1061C>T (p.Ser354Phe)	FGFR2	S126F, S239F, S265F, S354F	FGFR2-related craniosynostosis|Acrocephalosyndactyly type I	VCV001066784	10	123276856	10	121517342	1066784	1055894	rs121918490	NC_000010.11:121517341:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Mar 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1061C>G (p.Ser354Cys)	FGFR2	S354C, S126C, S239C, S265C	Crouzon syndrome|FGFR2-related craniosynostosis|Inborn genetic diseases|See cases|not provided	VCV000013265	10	123276856	10	121517342	13265	28304	rs121918490	NC_000010.11:121517341:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1058A>T (p.His353Leu)	FGFR2	H353L, H238L, H125L, H264L	FGFR2-related craniosynostosis	VCV002849960	10	123276859	10	121517345	2849960	3005915		NC_000010.11:121517344:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 27, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1052C>G (p.Ser351Cys)	FGFR2	S351C, S123C, S262C, S236C	Pfeiffer syndrome|Crouzon syndrome|FGFR2-related craniosynostosis|not provided	VCV000013286	10	123276865	10	121517351	13286	28325	rs121918502	NC_000010.11:121517350:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Sep 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1042A>G (p.Ile348Val)	FGFR2	I259V, I233V, I120V, I348V	FGFR2-related craniosynostosis	VCV002780568	10	123276875	10	121517361	2780568	2944307		NC_000010.11:121517360:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 2, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1040C>G (p.Ser347Cys)	FGFR2	S347C, S258C, S232C, S119C	Hydrocephalus|Abnormal posterior cranial fossa morphology|High forehead|Choanal stenosis|Deviated nasal septum|High palate|Cranial asymmetry|Shallow orbits|Brachyturricephaly|Wide anterior fontanel|Facial asymmetry|Short neck|Abnormal pinna morphology|Mild fetal ventriculomegaly|Lateral ventricle dilatation|Hypertelorism|Downslanted palpebral fissures|Flat occiput|Narrow forehead|Hypointensity of cerebral white matter on MRI|Low-set ears|Abnormal zygomatic bone morphology|FGFR2-related craniosynostosis|not provided|Pfeiffer syndrome|Crouzon syndrome|Meier-Gorlin syndrome 1	VCV000013271	10	123276877	10	121517363	13271	28310	rs121918494	NC_000010.11:121517362:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1038T>C (p.Asn346=)	FGFR2		FGFR2-related craniosynostosis	VCV002846424	10	123276879	10	121517365	2846424	3004950		NC_000010.11:121517364:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 12, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1038T>G (p.Asn346Lys)	FGFR2	N118K, N231K, N257K, N346K	FGFR2-related craniosynostosis	VCV002844464	10	123276879	10	121517365	2844464	3008105		NC_000010.11:121517364:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 27, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1034G>A (p.Gly345Asp)	FGFR2	G345D, G230D, G256D, G117D	FGFR2-related craniosynostosis	VCV000478045	10	123276883	10	121517369	478045	459911	rs1554928838	NC_000010.11:121517368:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 29, 2017	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1032G>A (p.Ala344=)	FGFR2		Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Jackson-Weiss syndrome|Saethre-Chotzen syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|Neoplasm of stomach|Levy-Hollister syndrome|Acrocephalosyndactyly type I|Craniosynostosis syndrome|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Jackson-Weiss syndrome|Saethre-Chotzen syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|Gastric cancer|Levy-Hollister syndrome|Acrocephalosyndactyly type I|FGFR2-related disorder|Pfeiffer syndrome|Crouzon syndrome|FGFR2-related craniosynostosis|not provided|Acrocephalosyndactyly type I	VCV000013268	10	123276885	10	121517371	13268	28307	rs121918491	NC_000010.11:121517370:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Pathogenic	Jan 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1031C>G (p.Ala344Gly)	FGFR2	A344G, A229G, A255G, A116G	Pfeiffer syndrome|FGFR2-related craniosynostosis	VCV000013269	10	123276886	10	121517372	13269	28308	rs121918492	NC_000010.11:121517371:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Mar 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1030G>C (p.Ala344Pro)	FGFR2	A116P, A229P, A255P, A344P	FGFR2-related craniosynostosis	VCV001076383	10	123276887	10	121517373	1076383	1061868	rs2134256250	NC_000010.11:121517372:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Mar 10, 2020	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1029G>A (p.Leu343=)	FGFR2		FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Pfeiffer syndrome|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Saethre-Chotzen syndrome|LADD syndrome 1|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer	VCV002891853	10	123276888	10	121517374	2891853	3051995		NC_000010.11:121517373:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1025_1027del (p.Cys342del)	FGFR2	C253del, C342del, C227del, C114del	Crouzon syndrome|FGFR2-related craniosynostosis	VCV002093701	10	123276890 - 123276892	10	121517376 - 121517378	2093701	2152904		NC_000010.11:121517375:AGCA:A	Deletion	inframe_deletion|inframe_indel|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Nov 6, 2024	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.1026C>G (p.Cys342Trp)	FGFR2	C342W, C253W, C114W, C227W	not provided|FGFR2-related craniosynostosis	VCV000013275	10	123276891	10	121517377	13275	28314	rs121918496	NC_000010.11:121517376:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Mar 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1025G>C (p.Cys342Ser)	FGFR2	C342S, C227S, C253S, C114S	not provided|Crouzon syndrome|Pfeiffer syndrome|FGFR2-related craniosynostosis|Jackson-Weiss syndrome	VCV000374820	10	123276892	10	121517378	374820	361711	rs121918487	NC_000010.11:121517377:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1025G>T (p.Cys342Phe)	FGFR2	C342F, C227F, C114F, C253F	Jackson-Weiss syndrome|FGFR2-related craniosynostosis|not provided	VCV000374819	10	123276892	10	121517378	374819	361710	rs121918487	NC_000010.11:121517377:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Sep 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1025G>A (p.Cys342Tyr)	FGFR2	C342Y, C253Y, C227Y, C114Y	Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Jackson-Weiss syndrome|Saethre-Chotzen syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|Neoplasm of stomach|Levy-Hollister syndrome|Acrocephalosyndactyly type I|Craniosynostosis syndrome|Crouzon syndrome|not provided|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Jackson-Weiss syndrome|Saethre-Chotzen syndrome|LADD syndrome 1|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|Gastric cancer|Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|FGFR2-related craniosynostosis	VCV000013263	10	123276892	10	121517378	13263	28302	rs121918487	NC_000010.11:121517377:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Nov 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1023_1024delinsAG (p.Cys342Gly)	FGFR2	C114G, C342G, C227G, C253G	FGFR2-related craniosynostosis	VCV002131381	10	123276893 - 123276894	10	121517379 - 121517380	2131381	2191516		NC_000010.11:121517378:AC:CT	Indel	missense variant|non-coding transcript variant|intron variant	Pathogenic	Apr 28, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1024T>G (p.Cys342Gly)	FGFR2	C342G, C114G, C253G, C227G	FGFR2-related craniosynostosis|FGFR2-related syndromic and non-syndromic craniosynostoses|Pfeiffer syndrome|not provided	VCV000374818	10	123276893	10	121517379	374818	361712	rs121918488	NC_000010.11:121517378:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jan 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1024T>A (p.Cys342Ser)	FGFR2	C342S, C227S, C253S, C114S	Pfeiffer syndrome|not provided|Crouzon syndrome|FGFR2-related craniosynostosis	VCV000013267	10	123276893	10	121517379	13267	28306	rs121918488	NC_000010.11:121517378:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jan 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1024T>C (p.Cys342Arg)	FGFR2	C342R, C114R, C253R, C227R	Pfeiffer syndrome|Crouzon syndrome|not provided|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|FGFR2-related craniosynostosis	VCV000013266	10	123276893	10	121517379	13266	28305	rs121918488	NC_000010.11:121517378:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jan 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1023G>A (p.Thr341=)	FGFR2		FGFR2-related craniosynostosis	VCV002177428	10	123276894	10	121517380	2177428	1919120		NC_000010.11:121517379:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Oct 18, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1023G>T (p.Thr341=)	FGFR2		FGFR2-related craniosynostosis	VCV001578672	10	123276894	10	121517380	1578672	1652354	rs201648220	NC_000010.11:121517379:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Aug 4, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1021_1022insATT (p.Thr341delinsAsnSer)	FGFR2		not provided	VCV001677695	10	123276895 - 123276896	10	121517381 - 121517382	1677695	1669385	rs2134256765	NC_000010.11:121517381::AAT	Insertion	inframe_indel|non-coding transcript variant|intron variant	Likely pathogenic	Jul 9, 2020	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1021A>C (p.Thr341Pro)	FGFR2	T341P, T113P, T226P, T252P	not provided|FGFR2-related craniosynostosis|Pfeiffer syndrome	VCV000013274	10	123276896	10	121517382	13274	28313	rs121918495	NC_000010.11:121517381:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Oct 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1019A>G (p.Tyr340Cys)	FGFR2	Y340C, Y112C, Y225C, Y251C	Pfeiffer syndrome|FGFR2-related craniosynostosis|not provided	VCV000449398	10	123276898	10	121517384	449398	444565	rs1554928884	NC_000010.11:121517383:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Nov 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1018T>C (p.Tyr340His)	FGFR2	Y340H, Y251H, Y112H, Y225H	Crouzon syndrome|not provided|FGFR2-related craniosynostosis	VCV000013264	10	123276899	10	121517385	13264	28303	rs121918489	NC_000010.11:121517384:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	May 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1014_1015insATT (p.Gly338_Glu339insIle)	FGFR2		FGFR2-related craniosynostosis	VCV002105788	10	123276902 - 123276903	10	121517388 - 121517389	2105788	2166249		NC_000010.11:121517388::AAT	Insertion	inframe_insertion|non-coding transcript variant|intron variant	Uncertain significance	Mar 4, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1012_1013delinsAA (p.Gly338Lys)	FGFR2	G110K, G249K, G223K, G338K	FGFR2-related craniosynostosis	VCV000478044	10	123276904 - 123276905	10	121517390 - 121517391	478044	460155	rs1554928905	NC_000010.11:121517389:CC:TT	Indel	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 31, 2017	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1013G>A (p.Gly338Glu)	FGFR2	G338E, G249E, G110E, G223E	Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1|Acrocephalosyndactyly type I|Levy-Hollister syndrome|Beare-Stevenson cutis gyrata syndrome|Jackson-Weiss syndrome|Neoplasm of stomach|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|FGFR2-related craniosynostosis	VCV000374817	10	123276904	10	121517390	374817	361713	rs1057519044	NC_000010.11:121517389:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Oct 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1010_1012del (p.Ala337del)	FGFR2	A109del, A222del, A248del, A337del	not provided	VCV001176274	10	123276905 - 123276907	10	121517391 - 121517393	1176274	1165938	rs2134257361	NC_000010.11:121517390:CAGC:C	Deletion	inframe_deletion|non-coding transcript variant|intron variant	Uncertain significance	Apr 1, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1012G>A (p.Gly338Arg)	FGFR2	G338R, G223R, G249R, G110R	FGFR2-related craniosynostosis	VCV000574062	10	123276905	10	121517391	574062	566187	rs1057519043	NC_000010.11:121517390:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jul 5, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1012G>T (p.Gly338Trp)	FGFR2	G338W, G223W, G110W, G249W	FGFR2-related craniosynostosis	VCV000544301	10	123276905	10	121517391	544301	525006	rs1057519043	NC_000010.11:121517390:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Jul 25, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1012G>C (p.Gly338Arg)	FGFR2	G338R, G110R, G249R, G223R	FGFR2-related craniosynostosis|Crouzon syndrome	VCV000374816	10	123276905	10	121517391	374816	361714	rs1057519043	NC_000010.11:121517390:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Feb 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1011T>C (p.Ala337=)	FGFR2		not specified	VCV000255313	10	123276906	10	121517392	255313	253702	rs886038254	NC_000010.11:121517391:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign		criteria provided, single submitter							
NM_000141.5(FGFR2):c.1009G>A (p.Ala337Thr)	FGFR2	A337T, A222T, A109T, A248T	Variant of unknown significance	VCV000029854	10	123276908	10	121517394	29854	38809	rs387906676	NC_000010.11:121517393:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 1, 1995	no assertion criteria provided							
NM_000141.5(FGFR2):c.1009G>C (p.Ala337Pro)	FGFR2	A337P, A222P, A248P, A109P	Crouzon syndrome|FGFR2-related craniosynostosis	VCV000029853	10	123276908	10	121517394	29853	38808	rs387906676	NC_000010.11:121517393:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Mar 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1007A>G (p.Asp336Gly)	FGFR2	D336G, D221G, D108G, D247G	Crouzon syndrome	VCV000374815	10	123276910	10	121517396	374815	361715	rs1057519042	NC_000010.11:121517395:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	May 28, 2019	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1002T>C (p.Phe334=)	FGFR2		FGFR2-related craniosynostosis	VCV002894826	10	123276915	10	121517401	2894826	3052366		NC_000010.11:121517400:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Oct 22, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1001T>A (p.Phe334Tyr)	FGFR2	F245Y, F334Y, F106Y, F219Y	not provided	VCV001810425	10	123276916	10	121517402	1810425	1867440		NC_000010.11:121517401:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 7, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.996A>G (p.Val332=)	FGFR2		FGFR2-related craniosynostosis	VCV001577071	10	123276921	10	121517407	1577071	1639928	rs1420060403	NC_000010.11:121517406:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Dec 2, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.992A>G (p.Asn331Ser)	FGFR2	N103S, N216S, N242S, N331S	FGFR2-related craniosynostosis	VCV001509054	10	123276925	10	121517411	1509054	1452171	rs2134258264	NC_000010.11:121517410:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 12, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.990G>T (p.Arg330=)	FGFR2		FGFR2-related craniosynostosis	VCV002050648	10	123276927	10	121517413	2050648	2114993		NC_000010.11:121517412:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Mar 13, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.989G>A (p.Arg330Gln)	FGFR2	R330Q, R102Q, R241Q, R215Q	Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|LADD syndrome 1|Acrocephalosyndactyly type I|Bent bone dysplasia syndrome 1|Beare-Stevenson cutis gyrata syndrome|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Pfeiffer syndrome|Gastric cancer|Levy-Hollister syndrome|Acrocephalosyndactyly type I|Bent bone dysplasia syndrome 1|Neoplasm of stomach|Beare-Stevenson cutis gyrata syndrome|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Pfeiffer syndrome|FGFR2-related craniosynostosis|not provided|Isolated Coronal Synostosis|Craniosynostosis syndrome	VCV000577711	10	123276928	10	121517414	577711	569547	rs199757302	NC_000010.11:121517413:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Jun 3, 2024	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.988C>T (p.Arg330Trp)	FGFR2	R102W, R215W, R241W, R330W	Craniosynostosis syndrome|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Acrocephalosyndactyly type I|Gastric cancer|Jackson-Weiss syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Saethre-Chotzen syndrome|LADD syndrome 1	VCV003376743	10	123276929	10	121517415	3376743	3535927		NC_000010.11:121517414:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.984T>C (p.Tyr328=)	FGFR2		FGFR2-related craniosynostosis	VCV002053692	10	123276933	10	121517419	2053692	2105107		NC_000010.11:121517418:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Jul 6, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.983A>G (p.Tyr328Cys)	FGFR2	Y328C, Y100C, Y213C, Y239C	Crouzon syndrome|not provided|FGFR2-related craniosynostosis	VCV000013270	10	123276934	10	121517420	13270	28309	rs121918493	NC_000010.11:121517419:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Feb 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.940-165_978del	FGFR2		Inborn genetic diseases	VCV000520630	10	123276939 - 123277142	10	121517425 - 121517628	520630	511858	rs1554928978		Deletion	splice acceptor variant|intron variant	Likely pathogenic	Mar 3, 2015	criteria provided, single submitter							
NM_000141.5(FGFR2):c.976G>A (p.Val326Ile)	FGFR2	V326I, V98I, V211I, V237I	FGFR2-related craniosynostosis	VCV002005278	10	123276941	10	121517427	2005278	2055906		NC_000010.11:121517426:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 12, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.974A>T (p.Glu325Val)	FGFR2	E210V, E236V, E325V, E97V	not provided	VCV003383781	10	123276943	10	121517429	3383781	3542946		NC_000010.11:121517428:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	May 29, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.970A>G (p.Ile324Val)	FGFR2	I324V, I209V, I96V, I235V	FGFR2-related craniosynostosis	VCV000544304	10	123276947	10	121517433	544304	525008	rs1443966407	NC_000010.11:121517432:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Benign	Sep 15, 2017	criteria provided, single submitter							
NM_000141.5(FGFR2):c.963C>A (p.Asp321Glu)	FGFR2	D321E, D206E, D232E, D93E	FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Acrocephalosyndactyly type I|Gastric cancer|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Saethre-Chotzen syndrome|LADD syndrome 1	VCV002977031	10	123276954	10	121517440	2977031	3130931		NC_000010.11:121517439:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Jun 18, 2024	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.962A>T (p.Asp321Val)	FGFR2	D206V, D232V, D321V, D93V	FGFR2-related craniosynostosis	VCV001060632	10	123276955	10	121517441	1060632	1046462	rs121918510	NC_000010.11:121517440:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Nov 7, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.962A>C (p.Asp321Ala)	FGFR2	D321A, D232A, D206A, D93A	FGFR2-related craniosynostosis|Pfeiffer syndrome	VCV000013300	10	123276955	10	121517441	13300	28339	rs121918510	NC_000010.11:121517440:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	May 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.959C>T (p.Thr320Met)	FGFR2	T205M, T231M, T320M, T92M	not provided	VCV001326810	10	123276958	10	121517444	1326810	1317169	rs2134259953	NC_000010.11:121517443:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 25, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.958A>G (p.Thr320Ala)	FGFR2	T320A, T205A, T231A, T92A	FGFR2-related craniosynostosis|not provided	VCV001358709	10	123276959	10	121517445	1358709	1360870	rs2134260022	NC_000010.11:121517444:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.949G>A (p.Val317Ile)	FGFR2	V89I, V202I, V228I, V317I	FGFR2-related craniosynostosis	VCV002743403	10	123276968	10	121517454	2743403	2896859		NC_000010.11:121517453:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 14, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.940-3_946delinsACC	FGFR2		Pfeiffer syndrome	VCV000013292	10	123276971 - 123276980	10	121517457 - 121517466	13292	28331	rs1589828632	NC_000010.11:121517456:CGGCGGCCTA:GGT	Indel	splice acceptor variant|intron variant	Pathogenic	Apr 1, 2005	no assertion criteria provided							
NM_000141.5(FGFR2):c.945C>T (p.Ala315=)	FGFR2		FGFR2-related craniosynostosis	VCV002777342	10	123276972	10	121517458	2777342	2939792		NC_000010.11:121517457:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Jan 20, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.943G>A (p.Ala315Thr)	FGFR2	A200T, A226T, A315T, A87T	Pfeiffer syndrome|not provided|Bent bone dysplasia syndrome 1|Crouzon syndrome|Familial scaphocephaly syndrome, McGillivray type|Beare-Stevenson cutis gyrata syndrome|Acrocephalosyndactyly type I|LADD syndrome 1|Saethre-Chotzen syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Jackson-Weiss syndrome	VCV003064171	10	123276974	10	121517460	3064171	3224377		NC_000010.11:121517459:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Jun 21, 2024	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.943G>T (p.Ala315Ser)	FGFR2	A315S, A226S, A87S, A200S	Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Jackson-Weiss syndrome|Saethre-Chotzen syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|Gastric cancer|Levy-Hollister syndrome|Acrocephalosyndactyly type I|Crouzon syndrome|not provided|FGFR2-related craniosynostosis	VCV000013289	10	123276974	10	121517460	13289	28328	rs121918504	NC_000010.11:121517459:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jun 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.942C>T (p.Ala314=)	FGFR2		FGFR2-related craniosynostosis|not provided	VCV000134393	10	123276975	10	121517461	134393	138132	rs201717227	NC_000010.11:121517460:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Nov 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.940G>T (p.Ala314Ser)	FGFR2	A314S, A199S, A225S, A86S	not provided|FGFR2-related craniosynostosis	VCV000478049	10	123276977	10	121517463	478049	460158	rs1358919643	NC_000010.11:121517462:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Aug 24, 2021	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.940-1G>T	FGFR2		not provided|FGFR2-related craniosynostosis	VCV001322899	10	123276978	10	121517464	1322899	1313196	rs879253719	NC_000010.11:121517463:C:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Nov 13, 2020	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.940-1G>A	FGFR2		FGFR2-related craniosynostosis	VCV000013291	10	123276978	10	121517464	13291	28330	rs879253719	NC_000010.11:121517463:C:T	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Oct 5, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.940-2A>C	FGFR2		FGFR2-related craniosynostosis|Acrocephalosyndactyly type I	VCV001685821	10	123276979	10	121517465	1685821	1677835	rs1057519041	NC_000010.11:121517464:T:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Oct 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.940-2A>G	FGFR2		not provided|Gastric cancer|LADD syndrome 1|Pfeiffer syndrome|Crouzon syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Acrocephalosyndactyly type I|Bent bone dysplasia syndrome 1|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Familial scaphocephaly syndrome, McGillivray type|Pfeiffer syndrome|FGFR2-related craniosynostosis	VCV000374814	10	123276979	10	121517465	374814	361716	rs1057519041	NC_000010.11:121517464:T:C	single nucleotide variant	splice acceptor variant|intron variant	Conflicting classifications of pathogenicity	Apr 8, 2024	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.940-4C>G	FGFR2		FGFR2-related craniosynostosis	VCV001961223	10	123276981	10	121517467	1961223	2020069		NC_000010.11:121517466:G:C	single nucleotide variant	intron variant	Likely benign	Aug 12, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.940-9G>A	FGFR2		FGFR2-related craniosynostosis	VCV001648919	10	123276986	10	121517472	1648919	1662571	rs752752282	NC_000010.11:121517471:C:T	single nucleotide variant	intron variant	Likely benign	Aug 22, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.940-36C>T	FGFR2		not provided	VCV001178079	10	123277013	10	121517499	1178079	1167491	rs112692991	NC_000010.11:121517498:G:A	single nucleotide variant	intron variant	Likely benign	Aug 15, 2019	criteria provided, single submitter							
NM_022970.4(FGFR2):c.1067C>G (p.Thr356Ser)	FGFR2	T267S, T356S	FGFR2-related disorder	VCV003046133	10	123278216	10	121518702	3046133	3209007		NC_000010.11:121518701:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 8, 2024	no assertion criteria provided							
NM_022970.4(FGFR2):c.1049A>G (p.Asn350Ser)	FGFR2	N261S, N350S	Acrocephalosyndactyly type I	VCV003237417	10	123278234	10	121518720	3237417	3396538		NC_000010.11:121518719:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 14, 2023	criteria provided, single submitter							
NM_022970.4(FGFR2):c.1035T>C (p.Tyr345=)	FGFR2		not provided	VCV003025350	10	123278248	10	121518734	3025350	3185662		NC_000010.11:121518733:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Feb 1, 2024	criteria provided, single submitter							
NM_022970.4(FGFR2):c.1017A>G (p.Ile339Met)	FGFR2	I250M, I339M	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590985	10	123278266	10	121518752	3590985	3728227		NC_000010.11:121518751:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 4, 2024	criteria provided, single submitter							
NM_022970.4(FGFR2):c.1008G>C (p.Gly336=)	FGFR2		FGFR2-related disorder	VCV003029645	10	123278275	10	121518761	3029645	3189511		NC_000010.11:121518760:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Feb 8, 2022	no assertion criteria provided							
NM_022970.4(FGFR2):c.993C>T (p.Thr331=)	FGFR2		FGFR2-related disorder	VCV003042515	10	123278290	10	121518776	3042515	3207992		NC_000010.11:121518775:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Jul 1, 2019	no assertion criteria provided							
NM_022970.4(FGFR2):c.984C>A (p.Phe328Leu)	FGFR2	F239L, F328L	not provided	VCV002575832	10	123278299	10	121518785	2575832	2740728		NC_000010.11:121518784:G:T	single nucleotide variant	intron variant|missense variant|non-coding transcript variant	Uncertain significance	Feb 11, 2023	criteria provided, single submitter							
NM_022970.4(FGFR2):c.942C>T (p.His314=)	FGFR2		FGFR2-related disorder	VCV003030519	10	123278341	10	121518827	3030519	3197752		NC_000010.11:121518826:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Mar 26, 2021	no assertion criteria provided							
NM_000141.5(FGFR2):c.939+982C>T	FGFR2		not provided	VCV001186145	10	123278511	10	121518997	1186145	1177264	rs41295555	NC_000010.11:121518996:G:A	single nucleotide variant	intron variant	Likely benign	Jan 2, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.939+923C>G	FGFR2		not provided	VCV001180291	10	123278570	10	121519056	1180291	1169376	rs41295553	NC_000010.11:121519055:G:C	single nucleotide variant	intron variant	Benign	Aug 14, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.939+11T>A	FGFR2		FGFR2-related craniosynostosis	VCV002073852	10	123279482	10	121519968	2073852	2120500		NC_000010.11:121519967:A:T	single nucleotide variant	intron variant	Likely benign	May 26, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.939+11T>C	FGFR2		not provided|Isolated Coronal Synostosis|Saethre-Chotzen syndrome|FGFR2-related craniosynostosis|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Craniosynostosis syndrome	VCV000135547	10	123279482	10	121519968	135547	139286	rs145303463	NC_000010.11:121519967:A:G	single nucleotide variant	intron variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.924C>T (p.Tyr308=)	FGFR2		FGFR2-related craniosynostosis	VCV001646088	10	123279508	10	121519994	1646088	1565692	rs775459922	NC_000010.11:121519993:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Jul 21, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.923A>G (p.Tyr308Cys)	FGFR2	Y308C, Y193C, Y219C, Y80C	Crouzon syndrome	VCV000374813	10	123279509	10	121519995	374813	361717	rs1057519040	NC_000010.11:121519994:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Sep 17, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.859_921del (p.His287_Pro307del)	FGFR2		Beare-Stevenson cutis gyrata syndrome	VCV000029852	10	123279511 - 123279573	10	121519997 - 121520059	29852	38807	rs1554930637		Deletion	inframe_deletion|inframe_indel|non-coding transcript variant|intron variant	Pathogenic	Aug 1, 2009	no assertion criteria provided							
NM_000141.5(FGFR2):c.918del (p.Tyr308fs)	FGFR2	Y308fs, Y219fs, Y80fs, Y193fs	FGFR2-related craniosynostosis	VCV001440549	10	123279514	10	121520000	1440549	1461834	rs2134308426	NC_000010.11:121519999:C:	Deletion	frameshift variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 25, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.914G>T (p.Gly305Val)	FGFR2	G190V, G216V, G305V, G77V	not provided	VCV001700926	10	123279518	10	121520004	1700926	1693319	rs2134308697	NC_000010.11:121520003:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 15, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.913G>A (p.Gly305Arg)	FGFR2	G190R, G216R, G305R, G77R	not provided	VCV003392693	10	123279519	10	121520005	3392693	3551772		NC_000010.11:121520004:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 25, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.910G>A (p.Asp304Asn)	FGFR2	D304N, D76N, D189N, D215N	Levy-Hollister syndrome|Acrocephalosyndactyly type I|Bent bone dysplasia syndrome 1|Beare-Stevenson cutis gyrata syndrome|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Pfeiffer syndrome|Gastric cancer|FGFR2-related craniosynostosis	VCV000566306	10	123279522	10	121520008	566306	566190	rs370877537	NC_000010.11:121520007:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.908C>G (p.Pro303Arg)	FGFR2	P214R, P75R, P188R, P303R	FGFR2-related craniosynostosis	VCV002852948	10	123279524	10	121520010	2852948	3006766		NC_000010.11:121520009:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 24, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.904G>A (p.Gly302Arg)	FGFR2	G74R, G187R, G213R, G302R	FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Jackson-Weiss syndrome|Acrocephalosyndactyly type I|Saethre-Chotzen syndrome|LADD syndrome 1	VCV002905267	10	123279528	10	121520014	2905267	3065372		NC_000010.11:121520013:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.903C>T (p.Tyr301=)	FGFR2		FGFR2-related craniosynostosis	VCV002086012	10	123279529	10	121520015	2086012	2133601		NC_000010.11:121520014:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Jun 11, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.902A>G (p.Tyr301Cys)	FGFR2	Y301C, Y212C, Y73C, Y186C	FGFR2-related craniosynostosis	VCV000478048	10	123279530	10	121520016	478048	459913	rs1554930684	NC_000010.11:121520015:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 3, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.864_881del (p.Ile288_Val294delinsMet)	FGFR2		Pfeiffer syndrome	VCV000254237	10	123279551 - 123279568	10	121520037 - 121520054	254237	248739	rs886037837	NC_000010.11:121520036:ACGTGCTTGATCCACTGGA:A	Deletion	inframe_indel|non-coding transcript variant|intron variant	Pathogenic		no assertion criteria provided							
NM_000141.5(FGFR2):c.879C>T (p.His293=)	FGFR2		Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Crouzon syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome|FGFR2-related craniosynostosis	VCV000299006	10	123279553	10	121520039	299006	314419	rs55745510	NC_000010.11:121520038:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Jul 10, 2021	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.857_877del (p.Pro286_Lys292del)	FGFR2		FGFR2-related disorder	VCV003061415	10	123279555 - 123279575	10	121520041 - 121520061	3061415	3193920		NC_000010.11:121520040:GCTTGATCCACTGGATGTGGGGCT:GCT	Deletion	inframe_indel|non-coding transcript variant|intron variant	Likely pathogenic	May 2, 2024	no assertion criteria provided							
NM_000141.5(FGFR2):c.877C>T (p.His293Tyr)	FGFR2	H204Y, H65Y, H178Y, H293Y	FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Gastric cancer|Jackson-Weiss syndrome|Acrocephalosyndactyly type I|Saethre-Chotzen syndrome|LADD syndrome 1	VCV001372714	10	123279555	10	121520041	1372714	1440092	rs748526473	NC_000010.11:121520040:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.874A>G (p.Lys292Glu)	FGFR2	K292E, K177E, K203E, K64E	FGFR2-related craniosynostosis	VCV000013282	10	123279558	10	121520044	13282	28321	rs121918500	NC_000010.11:121520043:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	May 4, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.870G>T (p.Trp290Cys)	FGFR2	W290C, W175C, W62C, W201C	Gastric cancer|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome|Bent bone dysplasia syndrome 1|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|Acrocephalosyndactyly type I|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Levy-Hollister syndrome|not provided|FGFR2-related craniosynostosis|Pfeiffer syndrome	VCV000013293	10	123279562	10	121520048	13293	28332	rs121918499	NC_000010.11:121520047:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jul 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.870G>C (p.Trp290Cys)	FGFR2	W290C, W201C, W62C, W175C	not provided|Aural atresia, congenital|Pfeiffer syndrome|FGFR2-related disorder	VCV000013281	10	123279562	10	121520048	13281	28320	rs121918499	NC_000010.11:121520047:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.869G>T (p.Trp290Leu)	FGFR2	W290L, W201L, W62L, W175L	FGFR2-related craniosynostosis	VCV001358710	10	123279563	10	121520049	1358710	1360871	rs1057519039	NC_000010.11:121520048:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Nov 25, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.869G>C (p.Trp290Ser)	FGFR2	W290S, W62S, W201S, W175S	Crouzon syndrome	VCV000374812	10	123279563	10	121520049	374812	361718	rs1057519039	NC_000010.11:121520048:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Sep 17, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.868T>A (p.Trp290Arg)	FGFR2	W175R, W62R, W201R, W290R	FGFR2-related craniosynostosis	VCV001995111	10	123279564	10	121520050	1995111	2049611		NC_000010.11:121520049:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	May 16, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.868T>G (p.Trp290Gly)	FGFR2	W290G, W201G, W175G, W62G	Crouzon syndrome	VCV000013284	10	123279564	10	121520050	13284	28323	rs121918501	NC_000010.11:121520049:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Sep 17, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.868T>C (p.Trp290Arg)	FGFR2	W290R, W201R, W175R, W62R	Crouzon syndrome|not provided|FGFR2-related craniosynostosis	VCV000013283	10	123279564	10	121520050	13283	28322	rs121918501	NC_000010.11:121520049:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jun 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.866A>C (p.Gln289Pro)	FGFR2	Q289P, Q174P, Q200P, Q61P	Pfeiffer syndrome|not provided|FGFR2-related craniosynostosis	VCV000013276	10	123279566	10	121520052	13276	28315	rs121918497	NC_000010.11:121520051:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Mar 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.863T>A (p.Ile288Asn)	FGFR2	I173N, I288N, I60N, I199N	FGFR2-related craniosynostosis	VCV000846218	10	123279569	10	121520055	846218	836685	rs1850289942	NC_000010.11:121520054:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 31, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.855G>A (p.Gln285=)	FGFR2		FGFR2-related disorder	VCV003029741	10	123279577	10	121520063	3029741	3189607		NC_000010.11:121520062:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Sep 3, 2021	no assertion criteria provided							
NM_000141.5(FGFR2):c.842A>G (p.Tyr281Cys)	FGFR2	Y281C, Y166C, Y53C, Y192C	Crouzon syndrome|not provided|FGFR2-related craniosynostosis	VCV000374811	10	123279590	10	121520076	374811	361719	rs1057519038	NC_000010.11:121520075:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Jun 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.840T>G (p.Val280=)	FGFR2		FGFR2-related craniosynostosis	VCV002828898	10	123279592	10	121520078	2828898	2983564		NC_000010.11:121520077:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Jan 15, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.837G>A (p.Lys279=)	FGFR2		FGFR2-related craniosynostosis	VCV002101034	10	123279595	10	121520081	2101034	2151054		NC_000010.11:121520080:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Aug 4, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.833_834delinsTT (p.Cys278Phe)	FGFR2	C189F, C278F, C50F, C163F	FGFR2-related craniosynostosis	VCV000578389	10	123279598 - 123279599	10	121520084 - 121520085	578389	566194	rs1057519037	NC_000010.11:121520083:GC:AA	Indel	missense variant|non-coding transcript variant|intron variant	Pathogenic	Apr 10, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.834C>G (p.Cys278Trp)	FGFR2	C278W, C163W, C189W, C50W	FGFR2-related craniosynostosis	VCV000544302	10	123279598	10	121520084	544302	525009	rs1554930790	NC_000010.11:121520083:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 4, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.833_834delinsTA (p.Cys278Leu)	FGFR2	C50L, C163L, C189L, C278L	Pfeiffer syndrome	VCV000374810	10	123279598 - 123279599	10	121520084 - 121520085	374810	361720	rs1057519037	NC_000010.11:121520083:GC:TA	Indel	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Sep 17, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.833G>A (p.Cys278Tyr)	FGFR2	C163Y, C189Y, C50Y, C278Y	not provided	VCV000871445	10	123279599	10	121520085	871445	859785	rs776587763	NC_000010.11:121520084:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	May 1, 2017	criteria provided, single submitter							
NM_000141.5(FGFR2):c.833G>T (p.Cys278Phe)	FGFR2	C278F, C50F, C163F, C189F	Pfeiffer syndrome|Crouzon syndrome|not provided|FGFR2-related craniosynostosis	VCV000265431	10	123279599	10	121520085	265431	259933	rs776587763	NC_000010.11:121520084:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.831C>T (p.Val277=)	FGFR2		not specified	VCV000255320	10	123279601	10	121520087	255320	253703	rs886038255	NC_000010.11:121520086:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign		criteria provided, single submitter							
NM_000141.5(FGFR2):c.824_829dup (p.Phe276_Val277insGluPhe)	FGFR2		Crouzon syndrome	VCV000981191	10	123279602 - 123279603	10	121520088 - 121520089	981191	969285	rs1850299732	NC_000010.11:121520088:CAAACTC:CAAACTCAAACTC	Duplication	inframe_indel|inframe_insertion|non-coding transcript variant|intron variant	Likely pathogenic	Oct 7, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.827T>G (p.Phe276Cys)	FGFR2	F187C, F276C, F48C, F161C	Neoplasm	VCV003257948	10	123279605	10	121520091	3257948	3416707		NC_000010.11:121520090:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant							Oncogenic	Jul 31, 2024	criteria provided, single submitter	
NM_000141.5(FGFR2):c.826T>G (p.Phe276Val)	FGFR2	F276V, F161V, F187V, F48V	Crouzon syndrome|FGFR2-related craniosynostosis|not provided	VCV000374809	10	123279606	10	121520092	374809	361721	rs1057519036	NC_000010.11:121520091:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Nov 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.823G>C (p.Glu275Gln)	FGFR2	E275Q, E47Q, E160Q, E186Q	FGFR2-related craniosynostosis	VCV000478047	10	123279609	10	121520095	478047	460619	rs1258584689	NC_000010.11:121520094:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 17, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.820G>A (p.Val274Ile)	FGFR2	V159I, V185I, V274I, V46I	FGFR2-related craniosynostosis	VCV003031460	10	123279612	10	121520098	3031460	3190012		NC_000010.11:121520097:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 2, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.818_820del (p.Asp273del)	FGFR2	D273del, D158del, D45del, D184del	Pfeiffer syndrome	VCV000013288	10	123279612 - 123279614	10	121520098 - 121520100	13288	28327	rs121918503	NC_000010.11:121520097:CGTC:C	Deletion	inframe_deletion|inframe_indel|non-coding transcript variant|intron variant	Pathogenic	Jul 1, 2000	no assertion criteria provided							
NM_000141.5(FGFR2):c.812GAG[1] (p.Gly272del)	FGFR2	G157del, G44del, G272del, G183del	FGFR2-related craniosynostosis	VCV002780194	10	123279615 - 123279617	10	121520101 - 121520103	2780194	2947389		NC_000010.11:121520100:CTCCTCC:CTCC	Microsatellite	inframe_deletion|inframe_indel|non-coding transcript variant|intron variant	Likely pathogenic	May 20, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.811_812inv (p.Gly271Pro)	FGFR2	G156P, G182P, G271P, G43P	Crouzon syndrome	VCV001048584	10	123279620 - 123279621	10	121520106 - 121520107	1048584	1036629		NC_000010.11:121520105:CC:GG	Inversion	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Mar 29, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.812G>T (p.Gly271Val)	FGFR2	G271V, G156V, G43V, G182V	Crouzon syndrome|FGFR2-related craniosynostosis	VCV000573667	10	123279620	10	121520106	573667	563601	rs1564919048	NC_000010.11:121520105:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Jan 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.810C>T (p.Val270=)	FGFR2		FGFR2-related craniosynostosis	VCV001938824	10	123279622	10	121520108	1938824	2004151		NC_000010.11:121520107:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Jan 12, 2025	criteria provided, single submitter							
NM_000141.5(FGFR2):c.804_809del (p.Val269_Val270del)	FGFR2		Saethre-Chotzen syndrome	VCV000013285	10	123279623 - 123279628	10	121520109 - 121520114	13285	28324	rs879253718	NC_000010.11:121520108:ACCACT:	Deletion	inframe_indel|inframe_deletion|non-coding transcript variant|intron variant	Pathogenic	Jun 1, 1998	no assertion criteria provided							
NM_000141.5(FGFR2):c.807G>A (p.Val269=)	FGFR2		FGFR2-related craniosynostosis	VCV001143361	10	123279625	10	121520111	1143361	1141011	rs2134316233	NC_000010.11:121520110:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Dec 2, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.803C>T (p.Thr268Ile)	FGFR2	T153I, T179I, T40I, T268I	Inborn genetic diseases	VCV002271423	10	123279629	10	121520115	2271423	2257796		NC_000010.11:121520114:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 10, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.799T>A (p.Ser267Thr)	FGFR2	S152T, S178T, S267T, S39T	not provided	VCV003372370	10	123279633	10	121520119	3372370	3531560		NC_000010.11:121520118:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 17, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.799T>C (p.Ser267Pro)	FGFR2	S267P, S152P, S178P, S39P	Pfeiffer syndrome|Crouzon syndrome|FGFR2-related craniosynostosis|not provided	VCV000013290	10	123279633	10	121520119	13290	28329	rs121918505	NC_000010.11:121520118:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Oct 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.796G>C (p.Ala266Pro)	FGFR2	A151P, A177P, A266P, A38P	FGFR2-related craniosynostosis|not provided	VCV000853635	10	123279636	10	121520122	853635	836686	rs1375799439	NC_000010.11:121520121:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.789G>A (p.Pro263=)	FGFR2		FGFR2-related craniosynostosis|not provided	VCV000706415	10	123279643	10	121520129	706415	692793	rs138315382	NC_000010.11:121520128:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.788C>T (p.Pro263Leu)	FGFR2	P148L, P174L, P263L, P35L	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Bent bone dysplasia syndrome 1|Acrocephalosyndactyly type I|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Jackson-Weiss syndrome|Levy-Hollister syndrome|FGFR2-related craniosynostosis	VCV001000825	10	123279644	10	121520130	1000825	993743	rs779326224	NC_000010.11:121520129:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.781G>A (p.Gly261Arg)	FGFR2	G146R, G172R, G261R, G33R	not provided|Bent bone dysplasia syndrome 1|Pfeiffer syndrome|Levy-Hollister syndrome|Beare-Stevenson cutis gyrata syndrome|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Saethre-Chotzen syndrome|Jackson-Weiss syndrome	VCV001316322	10	123279651	10	121520137	1316322	1308724	rs2134317947	NC_000010.11:121520136:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.780C>T (p.Ala260=)	FGFR2		FGFR2-related craniosynostosis|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Craniosynostosis syndrome|Isolated Coronal Synostosis	VCV000772255	10	123279652	10	121520138	772255	701223	rs778288494	NC_000010.11:121520137:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Aug 8, 2023	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.772C>T (p.Leu258Phe)	FGFR2	L143F, L169F, L258F, L30F	Jackson-Weiss syndrome|Levy-Hollister syndrome|Gastric cancer|Acrocephalosyndactyly type I|Bent bone dysplasia syndrome 1|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|FGFR2-related craniosynostosis|Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Saethre-Chotzen syndrome|Crouzon syndrome	VCV000878704	10	123279660	10	121520146	878704	865501	rs747171741	NC_000010.11:121520145:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.764G>A (p.Arg255Gln)	FGFR2	R140Q, R255Q, R27Q, R166Q	Ectrodactyly	VCV000869459	10	123279668	10	121520154	869459	857675	rs1850314485	NC_000010.11:121520153:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	May 31, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.763C>T (p.Arg255Trp)	FGFR2	R140W, R166W, R255W, R27W	Pfeiffer syndrome	VCV002500735	10	123279669	10	121520155	2500735	2523633		NC_000010.11:121520154:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 2, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.759T>G (p.Pro253=)	FGFR2		FGFR2-related craniosynostosis|not provided	VCV000500287	10	123279673	10	121520159	500287	491711	rs3135755	NC_000010.11:121520158:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Jun 1, 2024	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.758C>T (p.Pro253Leu)	FGFR2	P138L, P253L, P164L, P25L	FGFR2-related craniosynostosis|Acrocephalosyndactyly type I|Inborn genetic diseases	VCV000829801	10	123279674	10	121520160	829801	818138	rs77543610	NC_000010.11:121520159:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Sep 1, 2021	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.756_758delinsCTT (p.Pro253Phe)	FGFR2	P138F, P164F, P253F, P25F	Acrocephalosyndactyly type I	VCV000055867	10	123279674 - 123279676	10	121520160 - 121520162	55867	70518	rs387907372	NC_000010.11:121520159:GGC:AAG	Indel	missense variant|non-coding transcript variant|intron variant	Pathogenic		no assertion criteria provided							
NM_000141.5(FGFR2):c.758C>G (p.Pro253Arg)	FGFR2	P253R, P138R, P164R, P25R	not provided|Neoplasm of stomach|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome|Bent bone dysplasia syndrome 1|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|Acrocephalosyndactyly type I|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Levy-Hollister syndrome|FGFR2-related craniosynostosis|Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	VCV000013273	10	123279674	10	121520160	13273	28312	rs77543610	NC_000010.11:121520159:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Oct 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.755_757delinsTCT (p.Ser252_Pro253delinsPheSer)	FGFR2		Pfeiffer syndrome variant	VCV000013280	10	123279675 - 123279677	10	121520161 - 121520163	13280	28319	rs281865420	NC_000010.11:121520160:GCG:AGA	Indel	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jan 1, 1997	no assertion criteria provided							
NM_000141.5(FGFR2):c.756G>A (p.Ser252=)	FGFR2		FGFR2-related craniosynostosis	VCV001113095	10	123279676	10	121520162	1113095	1098593	rs138769323	NC_000010.11:121520161:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Sep 22, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.755_756delinsTT (p.Ser252Phe)	FGFR2	S252F, S137F, S163F, S24F	Acrocephalosyndactyly type I	VCV000013279	10	123279676 - 123279677	10	121520162 - 121520163	13279	28318	rs121918498	NC_000010.11:121520161:CG:AA	Indel	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Sep 17, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.755C>T (p.Ser252Leu)	FGFR2	S252L, S24L, S137L, S163L	Crouzon syndrome|FGFR2-related disorder|not specified|FGFR2-related craniosynostosis|not provided	VCV000549484	10	123279677	10	121520163	549484	539974	rs79184941	NC_000010.11:121520162:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Jan 8, 2024	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.755C>G (p.Ser252Trp)	FGFR2	S252W, S137W, S163W, S24W	not provided|FGFR2-related disorder|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Jackson-Weiss syndrome|Saethre-Chotzen syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|Gastric cancer|Levy-Hollister syndrome|Acrocephalosyndactyly type I|Pfeiffer syndrome|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Jackson-Weiss syndrome|Saethre-Chotzen syndrome|LADD syndrome 1|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|Gastric cancer|Acrocephalosyndactyly type I|FGFR2-related craniosynostosis|Acrocephalosyndactyly type I	VCV000013272	10	123279677	10	121520163	13272	28311	rs79184941	NC_000010.11:121520162:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jun 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.749A>G (p.Glu250Gly)	FGFR2	E135G, E161G, E22G, E250G	FGFR2-related craniosynostosis	VCV001416087	10	123279683	10	121520169	1416087	1371715	rs2134320317	NC_000010.11:121520168:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 10, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.749-12TC[2]	FGFR2		FGFR2-related craniosynostosis	VCV001132516	10	123279690 - 123279691	10	121520176 - 121520177	1132516	1120167	rs760498153	NC_000010.11:121520175:GAGAGAG:GAGAG	Microsatellite	intron variant	Likely benign	Feb 5, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.749-11C>G	FGFR2		FGFR2-related craniosynostosis	VCV001454911	10	123279694	10	121520180	1454911	1441397	rs2134320757	NC_000010.11:121520179:G:C	single nucleotide variant	intron variant	Likely benign	Oct 10, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.749-19dup	FGFR2		FGFR2-related craniosynostosis	VCV002801820	10	123279701 - 123279702	10	121520187 - 121520188	2801820	2952583		NC_000010.11:121520187:AAA:AAAA	Duplication	intron variant	Likely benign	May 30, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.749-27T>C	FGFR2		not provided	VCV001180004	10	123279710	10	121520196	1180004	1169377	rs41295547	NC_000010.11:121520195:A:G	single nucleotide variant	intron variant	Likely benign	Apr 4, 2019	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.749-62G>A	FGFR2		not provided	VCV001244122	10	123279745	10	121520231	1244122	1232374	rs2981448	NC_000010.11:121520230:C:T	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.749-112G>A	FGFR2		not provided	VCV001262737	10	123279795	10	121520281	1262737	1252646	rs2071616	NC_000010.11:121520280:C:T	single nucleotide variant	intron variant	Benign	Jun 26, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.749-183G>A	FGFR2		not provided	VCV000667899	10	123279866	10	121520352	667899	664927	rs2981447	NC_000010.11:121520351:C:T	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.749-6576T>G	FGFR2	L3*	FGFR2-related disorder	VCV002634723	10	123286259	10	121526745	2634723	2804246		NC_000010.11:121526744:A:C	single nucleotide variant	nonsense|intron variant	Uncertain significance	Jun 23, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.749-6590C>T	FGFR2		FGFR2-related disorder	VCV003045175	10	123286273	10	121526759	3045175	3215237		NC_000010.11:121526758:G:A	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Apr 14, 2022	no assertion criteria provided							
NM_000141.5(FGFR2):c.748+182G>A	FGFR2		not provided	VCV002640893	10	123297924	10	121538410	2640893	2809679		NC_000010.11:121538409:C:T	single nucleotide variant	intron variant	Likely benign	Apr 1, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.748+19G>A	FGFR2		not provided|FGFR2-related craniosynostosis	VCV000993816	10	123298087	10	121538573	993816	981687	rs372837794	NC_000010.11:121538572:C:T	single nucleotide variant	intron variant	Likely benign	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.748+18C>T	FGFR2		FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Acrocephalosyndactyly type I|Pfeiffer syndrome|Jackson-Weiss syndrome|Gastric cancer|Levy-Hollister syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome	VCV000135548	10	123298088	10	121538574	135548	139287	rs377269009	NC_000010.11:121538573:G:A	single nucleotide variant	intron variant	Likely benign	Dec 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.748+15C>T	FGFR2		FGFR2-related craniosynostosis	VCV001959003	10	123298091	10	121538577	1959003	2009238		NC_000010.11:121538576:G:A	single nucleotide variant	intron variant	Likely benign	Feb 8, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.748+14T>A	FGFR2		FGFR2-related craniosynostosis	VCV002087640	10	123298092	10	121538578	2087640	2133931		NC_000010.11:121538577:A:T	single nucleotide variant	intron variant	Likely benign	Jul 2, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.748+10C>T	FGFR2		FGFR2-related craniosynostosis	VCV002707316	10	123298096	10	121538582	2707316	2867007		NC_000010.11:121538581:G:A	single nucleotide variant	intron variant	Likely benign	Jan 4, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.748+7T>C	FGFR2		FGFR2-related craniosynostosis	VCV002800523	10	123298099	10	121538585	2800523	2962503		NC_000010.11:121538584:A:G	single nucleotide variant	intron variant	Likely benign	May 24, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.729G>A (p.Thr243=)	FGFR2		FGFR2-related craniosynostosis|not provided	VCV001574060	10	123298125	10	121538611	1574060	1539263	rs199890227	NC_000010.11:121538610:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.728C>T (p.Thr243Met)	FGFR2	T154M, T128M, T243M	FGFR2-related craniosynostosis	VCV002188506	10	123298126	10	121538612	2188506	1918550		NC_000010.11:121538611:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 8, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.722A>G (p.Asn241Ser)	FGFR2	N126S, N152S, N241S	FGFR2-related craniosynostosis	VCV003621720	10	123298132	10	121538618	3621720	3754270		NC_000010.11:121538617:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 3, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.720C>T (p.Ile240=)	FGFR2		FGFR2-related craniosynostosis	VCV002131468	10	123298134	10	121538620	2131468	2189456		NC_000010.11:121538619:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 28, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.717C>T (p.Ser239=)	FGFR2		FGFR2-related craniosynostosis	VCV003625801	10	123298137	10	121538623	3625801	3761095		NC_000010.11:121538622:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 20, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.716C>T (p.Ser239Phe)	FGFR2	S124F, S150F, S239F	not provided	VCV003383904	10	123298138	10	121538624	3383904	3543069		NC_000010.11:121538623:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 1, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.715T>A (p.Ser239Thr)	FGFR2	S124T, S150T, S239T	not provided	VCV002576935	10	123298139	10	121538625	2576935	2741832		NC_000010.11:121538624:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 10, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.714G>A (p.Gly238=)	FGFR2		Saethre-Chotzen syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome|not provided|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome	VCV000728535	10	123298140	10	121538626	728535	737381	rs1276387170	NC_000010.11:121538625:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 12, 2018	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.711C>T (p.Tyr237=)	FGFR2		FGFR2-related craniosynostosis	VCV002037662	10	123298143	10	121538629	2037662	2094284		NC_000010.11:121538628:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 22, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.696A>T (p.Val232=)	FGFR2		FGFR2-related craniosynostosis	VCV002916218	10	123298158	10	121538644	2916218	3071727		NC_000010.11:121538643:T:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 7, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.696A>G (p.Val232=)	FGFR2		Crouzon syndrome|FGFR2-related craniosynostosis|not specified|not provided|Isolated Coronal Synostosis|Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome	VCV000255319	10	123298158	10	121538644	255319	253704	rs1047100	NC_000010.11:121538643:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.671C>G (p.Ser224Cys)	FGFR2	S109C, S135C, S224C	not provided	VCV001318689	10	123298183	10	121538669	1318689	1307201	rs2134606046	NC_000010.11:121538668:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 14, 2020	criteria provided, single submitter							
NM_000141.5(FGFR2):c.664G>A (p.Val222Ile)	FGFR2	V107I, V133I, V222I	FGFR2-related craniosynostosis	VCV001721506	10	123298190	10	121538676	1721506	1772840		NC_000010.11:121538675:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 28, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.657A>G (p.Glu219=)	FGFR2		FGFR2-related craniosynostosis	VCV002162562	10	123298197	10	121538683	2162562	1894858		NC_000010.11:121538682:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 7, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.644G>A (p.Ser215Asn)	FGFR2	S100N, S126N, S215N	not provided	VCV003343441	10	123298210	10	121538696	3343441	3502673		NC_000010.11:121538695:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 11, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.628C>T (p.Arg210Ter)	FGFR2	R95*, R121*, R210*	FGFR2-related craniosynostosis	VCV002694990	10	123298226	10	121538712	2694990	2857697		NC_000010.11:121538711:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Uncertain significance	Nov 10, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.625-8C>A	FGFR2		FGFR2-related craniosynostosis	VCV001556176	10	123298237	10	121538723	1556176	1529560	rs1853240523	NC_000010.11:121538722:G:T	single nucleotide variant	intron variant	Likely benign	May 19, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.625-8C>T	FGFR2		Craniosynostosis syndrome|Isolated Coronal Synostosis|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome	VCV000877715	10	123298237	10	121538723	877715	868452	rs1853240523	NC_000010.11:121538722:G:A	single nucleotide variant	intron variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.625-10A>G	FGFR2		Craniosynostosis syndrome|not specified|Crouzon syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|FGFR2-related craniosynostosis	VCV000299007	10	123298239	10	121538725	299007	314420	rs201512833	NC_000010.11:121538724:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 29, 2023	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.624+140T>C	FGFR2		not provided	VCV000670711	10	123310664	10	121551150	670711	664928	rs3135746	NC_000010.11:121551149:A:G	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.624+139A>G	FGFR2		not provided	VCV000670041	10	123310665	10	121551151	670041	664621	rs3135745	NC_000010.11:121551150:T:C	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.624+70dup	FGFR2		not provided	VCV001181298	10	123310733 - 123310734	10	121551219 - 121551220	1181298	1172066	rs199542453	NC_000010.11:121551219:AAAAAAAAAA:AAAAAAAAAAA	Duplication	intron variant	Likely benign	Aug 5, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.610A>G (p.Ile204Val)	FGFR2	I115V, I89V, I204V	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003590999	10	123310818	10	121551304	3590999	3728229		NC_000010.11:121551303:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 4, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.608G>A (p.Arg203His)	FGFR2	R203H, R88H, R114H	FGFR2-related craniosynostosis|not provided	VCV000426670	10	123310820	10	121551306	426670	415215	rs747502397	NC_000010.11:121551305:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.591G>A (p.Glu197=)	FGFR2		FGFR2-related craniosynostosis	VCV002768102	10	123310837	10	121551323	2768102	2929270		NC_000010.11:121551322:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Jan 11, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.589G>C (p.Glu197Gln)	FGFR2	E108Q, E197Q, E82Q	not provided	VCV002442551	10	123310839	10	121551325	2442551	2416262		NC_000010.11:121551324:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 29, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.583G>A (p.Gly195Arg)	FGFR2	G106R, G80R, G195R	FGFR2-related craniosynostosis	VCV002738839	10	123310845	10	121551331	2738839	2902204		NC_000010.11:121551330:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 28, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.569G>A (p.Arg190Gln)	FGFR2	R101Q, R75Q, R190Q	not specified|FGFR2-related craniosynostosis	VCV001351197	10	123310859	10	121551345	1351197	1407547	rs759750319	NC_000010.11:121551344:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.568C>T (p.Arg190Trp)	FGFR2	R190W, R75W, R101W	not provided|FGFR2-related craniosynostosis	VCV000286840	10	123310860	10	121551346	286840	271077	rs147987917	NC_000010.11:121551345:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 29, 2023	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.564C>G (p.Thr188=)	FGFR2		FGFR2-related craniosynostosis	VCV002005680	10	123310864	10	121551350	2005680	2052444		NC_000010.11:121551349:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Apr 28, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.563C>A (p.Thr188Asn)	FGFR2	T188N, T73N, T99N	not provided	VCV003603108	10	123310865	10	121551351	3603108	3735822		NC_000010.11:121551350:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 6, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.562A>G (p.Thr188Ala)	FGFR2	T73A, T188A, T99A	Inborn genetic diseases	VCV002230393	10	123310866	10	121551352	2230393	2219847		NC_000010.11:121551351:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 29, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.560C>G (p.Pro187Arg)	FGFR2	P187R, P72R, P98R	not specified	VCV003233841	10	123310868	10	121551354	3233841	3392964		NC_000010.11:121551353:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 21, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.560C>T (p.Pro187Leu)	FGFR2	P187L, P98L, P72L	not provided	VCV000591363	10	123310868	10	121551354	591363	582355	rs1564972481	NC_000010.11:121551353:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 16, 2018	no assertion criteria provided							
NM_000141.5(FGFR2):c.557T>C (p.Met186Thr)	FGFR2	M186T, M71T, M97T	Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|FGFR2-related craniosynostosis|Craniosynostosis syndrome|not provided|not specified|Isolated Coronal Synostosis|Saethre-Chotzen syndrome	VCV000134392	10	123310871	10	121551357	134392	138131	rs755793	NC_000010.11:121551356:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.556A>G (p.Met186Val)	FGFR2	M186V, M71V, M97V	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003591007	10	123310872	10	121551358	3591007	3724758		NC_000010.11:121551357:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 19, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.554C>T (p.Pro185Leu)	FGFR2	P185L, P70L, P96L	Inborn genetic diseases	VCV002279125	10	123310874	10	121551360	2279125	2270239		NC_000010.11:121551359:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 21, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.544G>T (p.Gly182Trp)	FGFR2	G182W, G93W, G67W	not provided|FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Acrocephalosyndactyly type I|Gastric cancer|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|LADD syndrome 1|Saethre-Chotzen syndrome	VCV002172927	10	123310884	10	121551370	2172927	1904289		NC_000010.11:121551369:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.544G>A (p.Gly182Arg)	FGFR2	G182R, G67R, G93R	not provided	VCV001703932	10	123310884	10	121551370	1703932	1696409		NC_000010.11:121551369:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 2, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.543C>T (p.Ala181=)	FGFR2		FGFR2-related craniosynostosis	VCV001096635	10	123310885	10	121551371	1096635	1076932	rs150598483	NC_000010.11:121551370:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 12, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.543C>G (p.Ala181=)	FGFR2		not provided	VCV000993893	10	123310885	10	121551371	993893	981688	rs150598483	NC_000010.11:121551370:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 17, 2020	criteria provided, single submitter							
NM_000141.5(FGFR2):c.533G>A (p.Arg178His)	FGFR2	R89H, R63H, R178H	FGFR2-related craniosynostosis	VCV001391701	10	123310895	10	121551381	1391701	1386499	rs141796960	NC_000010.11:121551380:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 25, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.532C>T (p.Arg178Cys)	FGFR2	R89C, R178C, R63C	Inborn genetic diseases|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Acrocephalosyndactyly type I|Gastric cancer|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|LADD syndrome 1|Saethre-Chotzen syndrome	VCV002226118	10	123310896	10	121551382	2226118	2212125		NC_000010.11:121551381:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.525C>T (p.Val175=)	FGFR2		FGFR2-related craniosynostosis	VCV003618550	10	123310903	10	121551389	3618550	3750225		NC_000010.11:121551388:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 20, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.514_515delinsTT (p.Ala172Phe)	FGFR2	A172F, A57F, A83F	not provided	VCV002578102	10	123310913 - 123310914	10	121551399 - 121551400	2578102	2742993		NC_000010.11:121551398:GC:AA	Indel	missense variant|non-coding transcript variant	Likely pathogenic	Mar 3, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.501T>C (p.His167=)	FGFR2		not provided|FGFR2-related craniosynostosis	VCV001618304	10	123310927	10	121551413	1618304	1527626	rs766869457	NC_000010.11:121551412:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.494G>A (p.Arg165Gln)	FGFR2	R165Q, R50Q, R76Q	FGFR2-related craniosynostosis|not provided	VCV001316479	10	123310934	10	121551420	1316479	1307573	rs146244307	NC_000010.11:121551419:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.469A>G (p.Thr157Ala)	FGFR2	T68A, T157A, T42A	Inborn genetic diseases|not provided|FGFR2-related craniosynostosis	VCV001431541	10	123310959	10	121551445	1431541	1490838	rs770169545	NC_000010.11:121551444:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.455_456delinsTT (p.Arg152Ile)	FGFR2	G37V, R152I, R63I	not provided	VCV003364700	10	123310972 - 123310973	10	121551458 - 121551459	3364700	3523907		NC_000010.11:121551457:TC:AA	Indel	missense variant|non-coding transcript variant	Uncertain significance	Nov 20, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.455G>T (p.Arg152Ile)	FGFR2	G37V, R152I, R63I	not specified	VCV003233840	10	123310973	10	121551459	3233840	3392963		NC_000010.11:121551458:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 21, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.455-9C>T	FGFR2		FGFR2-related craniosynostosis	VCV002186086	10	123310982	10	121551468	2186086	1921298		NC_000010.11:121551467:G:A	single nucleotide variant	intron variant	Likely benign	Jul 12, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.455-20_455-15del	FGFR2		FGFR2-related craniosynostosis	VCV001665348	10	123310988 - 123310993	10	121551474 - 121551479	1665348	1589732	rs754925091	NC_000010.11:121551473:AGTATTAG:AG	Deletion	intron variant	Likely benign	Feb 10, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.455-219C>T	FGFR2		not provided	VCV001265133	10	123311192	10	121551678	1265133	1255459	rs184026051	NC_000010.11:121551677:G:A	single nucleotide variant	intron variant	Benign	Aug 8, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.455-242G>A	FGFR2		not provided	VCV001201788	10	123311215	10	121551701	1201788	1191036	rs147906363	NC_000010.11:121551700:C:T	single nucleotide variant	intron variant	Likely benign	Mar 31, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.455-315T>A	FGFR2		not provided	VCV000670039	10	123311288	10	121551774	670039	664930	rs3135743	NC_000010.11:121551773:A:T	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.454+107G>A	FGFR2		not provided	VCV001189444	10	123323909	10	121564395	1189444	1180649	rs41302307	NC_000010.11:121564394:C:T	single nucleotide variant	intron variant	Likely benign	Jul 15, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.454+54T>C	FGFR2		not provided	VCV001221381	10	123323962	10	121564448	1221381	1211776	rs2303568	NC_000010.11:121564447:A:G	single nucleotide variant	intron variant	Benign	Jun 25, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.454+20C>T	FGFR2		FGFR2-related craniosynostosis	VCV002745684	10	123323996	10	121564482	2745684	2903877		NC_000010.11:121564481:G:A	single nucleotide variant	intron variant	Likely benign	Jun 20, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.454+15G>A	FGFR2		FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Jackson-Weiss syndrome|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Levy-Hollister syndrome|Acrocephalosyndactyly type I|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer	VCV001555692	10	123324001	10	121564487	1555692	1626566	rs200275522	NC_000010.11:121564486:C:T	single nucleotide variant	intron variant	Likely benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.454+14C>T	FGFR2		FGFR2-related craniosynostosis|Craniosynostosis syndrome|not provided|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Crouzon syndrome|Saethre-Chotzen syndrome	VCV000878757	10	123324002	10	121564488	878757	868453	rs112142377	NC_000010.11:121564487:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.454+3A>G	FGFR2		not provided|Inborn genetic diseases	VCV001803498	10	123324013	10	121564499	1803498	1860526		NC_000010.11:121564498:T:C	single nucleotide variant	intron variant	Uncertain significance	Dec 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.420G>A (p.Ala140=)	FGFR2		FGFR2-related craniosynostosis|not provided|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Levy-Hollister syndrome|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Gastric cancer|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Bent bone dysplasia syndrome 1	VCV000511482	10	123324050	10	121564536	511482	502758	rs765024365	NC_000010.11:121564535:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.419C>T (p.Ala140Val)	FGFR2	A51V, A140V	Bent bone dysplasia syndrome 1|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Gastric cancer|Jackson-Weiss syndrome|Acrocephalosyndactyly type I|Saethre-Chotzen syndrome|LADD syndrome 1|FGFR2-related craniosynostosis	VCV001388509	10	123324051	10	121564537	1388509	1371250	rs752501698	NC_000010.11:121564536:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.418G>A (p.Ala140Thr)	FGFR2	A140T, A51T	FGFR2-related craniosynostosis|not provided	VCV000806578	10	123324052	10	121564538	806578	796372	rs762636391	NC_000010.11:121564537:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 22, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.415G>A (p.Gly139Ser)	FGFR2	G139S, G50S	FGFR2-related craniosynostosis|not provided	VCV002203088	10	123324055	10	121564541	2203088	1925316		NC_000010.11:121564540:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.399T>C (p.Asp133=)	FGFR2		not provided|FGFR2-related craniosynostosis	VCV002044336	10	123324071	10	121564557	2044336	2099626		NC_000010.11:121564556:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jul 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.394G>C (p.Asp132His)	FGFR2	D132H, D43H	not provided	VCV001704076	10	123324076	10	121564562	1704076	1696553		NC_000010.11:121564561:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 2, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.390C>T (p.Ser130=)	FGFR2		FGFR2-related craniosynostosis	VCV001584607	10	123324080	10	121564566	1584607	1560758	rs1029635273	NC_000010.11:121564565:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 23, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.390C>G (p.Ser130=)	FGFR2		FGFR2-related craniosynostosis|Beare-Stevenson cutis gyrata syndrome|Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Jackson-Weiss syndrome|Levy-Hollister syndrome|Pfeiffer syndrome|Bent bone dysplasia syndrome 1|Gastric cancer|Crouzon syndrome	VCV000707001	10	123324080	10	121564566	707001	692794	rs1029635273	NC_000010.11:121564565:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.389C>G (p.Ser130Cys)	FGFR2	S130C, S41C	not provided	VCV003373212	10	123324081	10	121564567	3373212	3532402		NC_000010.11:121564566:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.377-6A>T	FGFR2		not provided	VCV000750784	10	123324099	10	121564585	750784	759935	rs1447764550	NC_000010.11:121564584:T:A	single nucleotide variant	intron variant	Likely benign	Jun 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.377-10T>C	FGFR2		not provided	VCV000682369	10	123324103	10	121564589	682369	664651	rs1253602922	NC_000010.11:121564588:A:G	single nucleotide variant	intron variant	Likely benign	May 3, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.376+261dup	FGFR2		not provided	VCV001229911	10	123324690 - 123324691	10	121565176 - 121565177	1229911	1219878	rs71865754	NC_000010.11:121565176:AAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAA	Duplication	intron variant	Benign	Aug 15, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.376+259_376+261dup	FGFR2		not provided	VCV001191156	10	123324690 - 123324691	10	121565176 - 121565177	1191156	1180651	rs71865754	NC_000010.11:121565176:AAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAA	Duplication	intron variant	Likely benign	Aug 13, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.376+260_376+261dup	FGFR2		not provided	VCV001181724	10	123324690 - 123324691	10	121565176 - 121565177	1181724	1172067	rs71865754	NC_000010.11:121565176:AAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAA	Duplication	intron variant	Benign	Aug 15, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.376+261del	FGFR2		not provided	VCV001190951	10	123324691	10	121565177	1190951	1180650	rs71865754	NC_000010.11:121565176:AAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAA	Deletion	intron variant	Likely benign	Aug 8, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.376+213A>T	FGFR2		not provided	VCV001284239	10	123324739	10	121565225	1284239	1274095	rs7895493	NC_000010.11:121565224:T:A	single nucleotide variant	intron variant	Benign	Jun 25, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.376+63G>A	FGFR2		not provided	VCV001263322	10	123324889	10	121565375	1263322	1251940	rs3135734	NC_000010.11:121565374:C:T	single nucleotide variant	intron variant	Benign	Jun 30, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.376+20C>A	FGFR2		FGFR2-related craniosynostosis	VCV002198048	10	123324932	10	121565418	2198048	1924209		NC_000010.11:121565417:G:T	single nucleotide variant	intron variant	Likely benign	Sep 12, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.376+15C>T	FGFR2		FGFR2-related craniosynostosis	VCV001933865	10	123324937	10	121565423	1933865	1992746		NC_000010.11:121565422:G:A	single nucleotide variant	intron variant	Likely benign	Jun 23, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.376G>A (p.Asp126Asn)	FGFR2	D126N	not provided|FGFR2-related craniosynostosis	VCV000388241	10	123324952	10	121565438	388241	370647	rs1057523040	NC_000010.11:121565437:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.362T>C (p.Met121Thr)	FGFR2	M121T	not provided|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Acrocephalosyndactyly type I|Gastric cancer|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Jackson-Weiss syndrome|Levy-Hollister syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome	VCV001193382	10	123324966	10	121565452	1193382	1184330	rs748322657	NC_000010.11:121565451:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.361A>G (p.Met121Val)	FGFR2	M121V	FGFR2-related craniosynostosis	VCV002064139	10	123324967	10	121565453	2064139	2118125		NC_000010.11:121565452:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 28, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.351T>C (p.Thr117=)	FGFR2		Crouzon syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome	VCV000299008	10	123324977	10	121565463	299008	314421	rs886046764	NC_000010.11:121565462:A:G	single nucleotide variant	intron variant|synonymous variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.344G>A (p.Ser115Asn)	FGFR2	S115N	not provided	VCV000994367	10	123324984	10	121565470	994367	981689	rs867109770	NC_000010.11:121565469:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 2, 2020	criteria provided, single submitter							
NM_000141.5(FGFR2):c.343A>G (p.Ser115Gly)	FGFR2	S115G	Inborn genetic diseases	VCV003278666	10	123324985	10	121565471	3278666	3439159		NC_000010.11:121565470:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 22, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.326C>A (p.Ala109Asp)	FGFR2	A109D	not provided	VCV001801065	10	123325002	10	121565488	1801065	1858353		NC_000010.11:121565487:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 26, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.318T>A (p.Ala106=)	FGFR2		not provided	VCV002501475	10	123325010	10	121565496	2501475	2524378		NC_000010.11:121565495:A:T	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Nov 3, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.314A>G (p.Tyr105Cys)	FGFR2	Y105C	Jackson-Weiss syndrome|Levy-Hollister syndrome|Pfeiffer syndrome|Neoplasm of stomach|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Bent bone dysplasia syndrome 1|Acrocephalosyndactyly type I|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1|not provided|Inborn genetic diseases|Crouzon syndrome|FGFR2-related craniosynostosis	VCV000449024	10	123325014	10	121565500	449024	444566	rs1434545235	NC_000010.11:121565499:T:C	single nucleotide variant	missense variant|intron variant	Pathogenic/Likely pathogenic	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.309C>A (p.Gly103=)	FGFR2		not specified	VCV000255318	10	123325019	10	121565505	255318	253705	rs749255726	NC_000010.11:121565504:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign		criteria provided, single submitter							
NM_000141.5(FGFR2):c.306C>T (p.Ser102=)	FGFR2		FGFR2-related craniosynostosis|not provided	VCV001191304	10	123325022	10	121565508	1191304	1180652	rs368662264	NC_000010.11:121565507:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.299G>A (p.Arg100Lys)	FGFR2	R100K	FGFR2-related craniosynostosis	VCV002747251	10	123325029	10	121565515	2747251	2908011		NC_000010.11:121565514:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 20, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.298A>G (p.Arg100Gly)	FGFR2	R100G	FGFR2-related craniosynostosis	VCV002843882	10	123325030	10	121565516	2843882	3011355		NC_000010.11:121565515:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.294G>A (p.Thr98=)	FGFR2		not specified|not provided|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Craniosynostosis syndrome|Isolated Coronal Synostosis|FGFR2-related craniosynostosis	VCV000196217	10	123325034	10	121565520	196217	193378	rs1047101	NC_000010.11:121565519:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Oct 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.293C>T (p.Thr98Met)	FGFR2	T98M	not provided|FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|LADD syndrome 1|Saethre-Chotzen syndrome	VCV002072601	10	123325035	10	121565521	2072601	2130530		NC_000010.11:121565520:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.291C>A (p.Ala97=)	FGFR2		FGFR2-related craniosynostosis	VCV001084022	10	123325037	10	121565523	1084022	1076933	rs2135114699	NC_000010.11:121565522:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 20, 2020	criteria provided, single submitter							
NM_000141.5(FGFR2):c.289G>A (p.Ala97Thr)	FGFR2	A97T	FGFR2-related craniosynostosis|FGFR2-realated disorder|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Levy-Hollister syndrome|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Gastric cancer|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Bent bone dysplasia syndrome 1|not provided	VCV000497484	10	123325039	10	121565525	497484	488908	rs372430349	NC_000010.11:121565524:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 8, 2023	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.288C>T (p.Gly96=)	FGFR2		FGFR2-related craniosynostosis	VCV002194098	10	123325040	10	121565526	2194098	1926298		NC_000010.11:121565525:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 12, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.287G>T (p.Gly96Val)	FGFR2	G96V	FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Acrocephalosyndactyly type I|Jackson-Weiss syndrome	VCV001503438	10	123325041	10	121565527	1503438	1401155	rs1277734487	NC_000010.11:121565526:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 4, 2024	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.287G>A (p.Gly96Asp)	FGFR2	G96D	not provided|FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Pfeiffer syndrome|Levy-Hollister syndrome|Beare-Stevenson cutis gyrata syndrome|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Saethre-Chotzen syndrome|Jackson-Weiss syndrome	VCV001316125	10	123325041	10	121565527	1316125	1308527	rs1277734487	NC_000010.11:121565526:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.263T>C (p.Ile88Thr)	FGFR2	I88T	FGFR2-related craniosynostosis|Inborn genetic diseases|not provided	VCV001115796	10	123325065	10	121565551	1115796	1098594	rs200369248	NC_000010.11:121565550:A:G	single nucleotide variant	missense variant|intron variant	Likely benign	Oct 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.257T>G (p.Val86Gly)	FGFR2	V86G	FGFR2-related craniosynostosis|Acrocephalosyndactyly type I|Beare-Stevenson cutis gyrata syndrome|Bent bone dysplasia syndrome 1|Gastric cancer|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Jackson-Weiss syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|LADD syndrome 1	VCV001966091	10	123325071	10	121565557	1966091	2021482		NC_000010.11:121565556:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.256G>A (p.Val86Met)	FGFR2	V86M	not provided	VCV001317096	10	123325072	10	121565558	1317096	1306914	rs1396687223	NC_000010.11:121565557:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 26, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.252G>A (p.Arg84=)	FGFR2		FGFR2-related craniosynostosis	VCV000788701	10	123325076	10	121565562	788701	712202	rs779848635	NC_000010.11:121565561:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 11, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.248A>T (p.Asn83Ile)	FGFR2	N83I	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003591056	10	123325080	10	121565566	3591056	3724795		NC_000010.11:121565565:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 4, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.247A>G (p.Asn83Asp)	FGFR2	N83D	not provided	VCV002664534	10	123325081	10	121565567	2664534	2831984		NC_000010.11:121565566:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 21, 2021	no assertion criteria provided							
NM_000141.5(FGFR2):c.242C>T (p.Pro81Leu)	FGFR2	P81L	FGFR2-related craniosynostosis	VCV002046920	10	123325086	10	121565572	2046920	2093195		NC_000010.11:121565571:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 31, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.236T>G (p.Leu79Trp)	FGFR2	L79W	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003591064	10	123325092	10	121565578	3591064	3724800		NC_000010.11:121565577:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 14, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.234C>T (p.His78=)	FGFR2		not provided|FGFR2-related craniosynostosis	VCV000681595	10	123325094	10	121565580	681595	655986	rs778093907	NC_000010.11:121565579:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.231G>A (p.Val77=)	FGFR2		FGFR2-related craniosynostosis	VCV003624091	10	123325097	10	121565583	3624091	3760693		NC_000010.11:121565582:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 14, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.222G>A (p.Lys74=)	FGFR2		FGFR2-related craniosynostosis	VCV002163136	10	123325106	10	121565592	2163136	1887621		NC_000010.11:121565591:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 1, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.212G>T (p.Ser71Ile)	FGFR2	S71I	FGFR2-related craniosynostosis	VCV001431550	10	123325116	10	121565602	1431550	1490847	rs2135119186	NC_000010.11:121565601:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 26, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.204C>T (p.Ala68=)	FGFR2		Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome	VCV000299009	10	123325124	10	121565610	299009	320909	rs747982371	NC_000010.11:121565609:G:A	single nucleotide variant	intron variant|synonymous variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.203C>T (p.Ala68Val)	FGFR2	A68V	FGFR2-related craniosynostosis	VCV001421264	10	123325125	10	121565611	1421264	1399991	rs537841180	NC_000010.11:121565610:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.202G>A (p.Ala68Thr)	FGFR2	A68T	not specified|FGFR2-related craniosynostosis	VCV002682300	10	123325126	10	121565612	2682300	2843331		NC_000010.11:121565611:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.201C>T (p.Ala67=)	FGFR2		FGFR2-related craniosynostosis|Craniosynostosis syndrome|Isolated Coronal Synostosis|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome	VCV000877763	10	123325127	10	121565613	877763	865502	rs200386134	NC_000010.11:121565612:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jan 1, 2024	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.195A>G (p.Lys65=)	FGFR2		Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003591071	10	123325133	10	121565619	3591071	3724805		NC_000010.11:121565618:T:C	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Jan 2, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.186C>T (p.Cys62=)	FGFR2		FGFR2-related craniosynostosis	VCV002822168	10	123325142	10	121565628	2822168	2981971		NC_000010.11:121565627:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 23, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.185G>T (p.Cys62Phe)	FGFR2	C62F	FGFR2-related craniosynostosis	VCV002765919	10	123325143	10	121565629	2765919	2922793		NC_000010.11:121565628:C:A	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Oct 5, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.182G>A (p.Arg61His)	FGFR2	R61H	FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Jackson-Weiss syndrome|LADD syndrome 1|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Acrocephalosyndactyly type I|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer	VCV001525168	10	123325146	10	121565632	1525168	1363507	rs199575491	NC_000010.11:121565631:C:T	single nucleotide variant	missense variant|intron variant	Likely benign	Apr 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.181C>T (p.Arg61Cys)	FGFR2	R61C	not specified	VCV002501045	10	123325147	10	121565633	2501045	2523939		NC_000010.11:121565632:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 29, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.170C>T (p.Ser57Leu)	FGFR2	S57L	Beare-Stevenson cutis gyrata syndrome|FGFR2-related craniosynostosis|not specified|Craniosynostosis syndrome|Crouzon syndrome|not provided|Isolated Coronal Synostosis|Saethre-Chotzen syndrome	VCV000134390	10	123325158	10	121565644	134390	138129	rs56226109	NC_000010.11:121565643:G:A	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Jan 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.168G>A (p.Glu56=)	FGFR2		FGFR2-related craniosynostosis	VCV002793454	10	123325160	10	121565646	2793454	2950701		NC_000010.11:121565645:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 5, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.160C>T (p.Pro54Ser)	FGFR2	P54S	Inborn genetic diseases|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Acrocephalosyndactyly type I|Gastric cancer|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|LADD syndrome 1|Saethre-Chotzen syndrome	VCV002208075	10	123325168	10	121565654	2208075	2204057		NC_000010.11:121565653:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.159G>T (p.Ala53=)	FGFR2		not provided	VCV000736990	10	123325169	10	121565655	736990	752003	rs1047102	NC_000010.11:121565654:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 9, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.159G>A (p.Ala53=)	FGFR2		not provided|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Saethre-Chotzen syndrome|Craniosynostosis syndrome|not specified|Isolated Coronal Synostosis|FGFR2-related craniosynostosis	VCV000196218	10	123325169	10	121565655	196218	193379	rs1047102	NC_000010.11:121565654:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.158C>T (p.Ala53Val)	FGFR2	A53V	not provided	VCV003342652	10	123325170	10	121565656	3342652	3501884		NC_000010.11:121565655:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 20, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.151G>A (p.Val51Met)	FGFR2	V51M	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003591089	10	123325177	10	121565663	3591089	3724826		NC_000010.11:121565662:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.150C>T (p.Tyr50=)	FGFR2		FGFR2-related craniosynostosis	VCV001577039	10	123325178	10	121565664	1577039	1639896	rs376622125	NC_000010.11:121565663:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 18, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.149A>T (p.Tyr50Phe)	FGFR2	Y50F	not provided|FGFR2-related craniosynostosis	VCV000432678	10	123325179	10	121565665	432678	425868	rs1398842143	NC_000010.11:121565664:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 28, 2021	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.143A>C (p.Glu48Ala)	FGFR2	E48A	FGFR2-related craniosynostosis|Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|LADD syndrome 1|Saethre-Chotzen syndrome	VCV002076324	10	123325185	10	121565671	2076324	2138127		NC_000010.11:121565670:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.141A>G (p.Pro47=)	FGFR2		FGFR2-related craniosynostosis	VCV001961307	10	123325187	10	121565673	1961307	2020153		NC_000010.11:121565672:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 24, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.138A>G (p.Gln46=)	FGFR2		FGFR2-related craniosynostosis	VCV002801281	10	123325190	10	121565676	2801281	2959809		NC_000010.11:121565675:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 19, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.138A>C (p.Gln46His)	FGFR2	Q46H	Craniosynostosis, nonspecific|Beare-Stevenson cutis gyrata syndrome|Bent bone dysplasia syndrome 1|Jackson-Weiss syndrome|Levy-Hollister syndrome|Familial scaphocephaly syndrome, McGillivray type|Gastric cancer|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|Crouzon syndrome|Saethre-Chotzen syndrome|Acrocephalosyndactyly type I|FGFR2-related craniosynostosis	VCV000374808	10	123325190	10	121565676	374808	361722	rs748117555	NC_000010.11:121565675:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 25, 2023	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.122A>G (p.Lys41Arg)	FGFR2	K41R	not provided	VCV001342613	10	123325206	10	121565692	1342613	1334190	rs2135124493	NC_000010.11:121565691:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.119C>T (p.Thr40Ile)	FGFR2	T40I	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003591104	10	123325209	10	121565695	3591104	3724841		NC_000010.11:121565694:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 27, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.116C>G (p.Pro39Arg)	FGFR2	P39R	not provided	VCV003381654	10	123325212	10	121565698	3381654	3540835		NC_000010.11:121565697:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.114A>T (p.Pro38=)	FGFR2		FGFR2-related craniosynostosis	VCV001659728	10	123325214	10	121565700	1659728	1606099	rs370046872	NC_000010.11:121565699:T:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 17, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.110-22TC[3]	FGFR2		Craniosynostosis syndrome|Pfeiffer syndrome|Jackson-Weiss syndrome|Levy-Hollister syndrome|Saethre-Chotzen syndrome|Crouzon syndrome|Isolated Coronal Synostosis|Beare-Stevenson cutis gyrata syndrome|FGFR2-related craniosynostosis|Acrocephalosyndactyly type I	VCV000299010	10	123325233 - 123325234	10	121565719 - 121565720	299010	320916	rs773932794	NC_000010.11:121565718:GAGAGAGA:GAGAGA	Microsatellite	intron variant	Conflicting classifications of pathogenicity	Nov 1, 2023	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.110-26G>A	FGFR2		not provided	VCV001259590	10	123325244	10	121565730	1259590	1250353	rs3135733	NC_000010.11:121565729:C:T	single nucleotide variant	intron variant	Benign	Jun 30, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.110-54C>T	FGFR2		not specified|not provided	VCV000675994	10	123325272	10	121565758	675994	664655	rs3135732	NC_000010.11:121565757:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jul 24, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.110-179C>G	FGFR2		not provided	VCV001281787	10	123325397	10	121565883	1281787	1273014	rs2981452	NC_000010.11:121565882:G:C	single nucleotide variant	intron variant	Benign	Jun 25, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.110-195G>C	FGFR2		not provided	VCV001211591	10	123325413	10	121565899	1211591	1201588	rs529146683	NC_000010.11:121565898:C:G	single nucleotide variant	intron variant	Likely benign	Oct 26, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.110-320A>G	FGFR2		not provided	VCV001281077	10	123325538	10	121566024	1281077	1271795	rs2912787	NC_000010.11:121566023:T:C	single nucleotide variant	intron variant	Benign	Jun 25, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.110-12117T>C	FGFR2		FGFR2-related craniosynostosis	VCV000225807	10	123337335	10	121577821	225807	227622	rs2981579	NC_000010.11:121577820:A:G	single nucleotide variant	intron variant	Benign	Jan 29, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.109+13116T>C	FGFR2|LOC124416922		FGFR2-related craniosynostosis	VCV001659826	10	123340107	10	121580593	1659826	1606197	rs45631580	NC_000010.11:121580592:A:G	single nucleotide variant	intron variant	Benign	Jan 29, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.109+12912G>T	FGFR2|LOC124416922		FGFR2-related craniosynostosis	VCV001663380	10	123340311	10	121580797	1663380	1619689	rs2981578	NC_000010.11:121580796:C:A	single nucleotide variant	intron variant	Benign	Oct 24, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.109+12912G>A	FGFR2|LOC124416922		FGFR2-related craniosynostosis	VCV001598913	10	123340311	10	121580797	1598913	1544350	rs2981578	NC_000010.11:121580796:C:T	single nucleotide variant	intron variant	Benign	Jan 29, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.109+12791del	FGFR2|LOC124416922		FGFR2-related craniosynostosis	VCV001659816	10	123340432	10	121580918	1659816	1606187	rs35054928	NC_000010.11:121580917:CC:C	Deletion	intron variant	Benign	Jan 29, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.109+12790G>A	FGFR2|LOC124416922		FGFR2-related craniosynostosis	VCV001672748	10	123340433	10	121580919	1672748	1531195	rs1043544122	NC_000010.11:121580918:C:T	single nucleotide variant	intron variant	Likely benign	Nov 8, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.109+7107C>T	FGFR2		FGFR2-related craniosynostosis	VCV001543852	10	123346116	10	121586602	1543852	1558007	rs2981575	NC_000010.11:121586601:G:A	single nucleotide variant	intron variant	Benign	Jan 29, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.109+7033T>C	FGFR2		FGFR2-related craniosynostosis	VCV001663397	10	123346190	10	121586676	1663397	1619706	rs1219648	NC_000010.11:121586675:A:G	single nucleotide variant	intron variant	Benign	Jan 29, 2024	criteria provided, single submitter							
GRCh38/hg38 10q26.13-26.3(chr10:121588992-133620674)x1	FUOM|GLRX3|GPR26|HMX2|HMX3|HTRA1|IKZF5|INPP5A|INSYN2A|JAKMIP3|JAKMIP3-AS1|KNDC1|LHPP|LINC00601|LINC01163|LINC01164|LINC01165|LINC01166|LINC01167|LINC01168|LINC02641|LINC02667|LINC02870|LINC03068|LOC102724883|LOC105378552|LOC107984281|LOC107984282|LOC110120846|LOC110120851|LOC110120852|LOC110120892|LOC110120898|LOC110120916|LOC110120924|LOC110120928|LOC110121344|LOC110121444|LOC110599579|LOC110599585|LOC111818958|LOC111818962|LOC111818963|LOC111875832|LOC111875833|LOC111875834|LOC111875835|LOC111946221|LOC113939915|LOC121366088|LOC121366089|LOC121366090|LOC121366091|LOC121366092|LOC121366093|LOC121815973|LOC121815974|LOC121815975|LOC121815976|LOC121815977|LOC124416923|LOC124416924|LOC124416925|LOC124416926|LOC124416927|LOC124416928|LOC124416929|LOC124416930|LOC124416931|LOC124416932|LOC124416933|LOC124416934|LOC124416935|LOC124416936|LOC126861065|LOC126861066|LOC126861067|LOC126861068|LOC126861069|LOC126861070|LOC126861071|LOC126861072|LOC126861073|LOC126861074|LOC126861075|LOC126861076|LOC126861077|LOC126861078|LOC126861079|LOC126861080|LOC126861081|LOC126861082|LOC126861083|LOC126861084|LOC126861085|LOC126861086|LOC126861087|LOC126861088|LOC126861089|LOC126861090|LOC126861091|LOC126861092|LOC126861093|LOC126861094|LOC126861095|LOC126861096|LOC126861097|LOC126861098|LOC126861099|LOC126861100|LOC126861101|LOC126861102|LOC126861103|LOC126861104|LOC126861105|LOC126861106|LOC126861107|LOC128598885|LOC129390237|LOC129390238|LOC129390239|LOC129390240|LOC129390241|LOC129390242|LOC130004864|LOC130004865|LOC130004866|LOC130004867|LOC130004868|LOC130004869|LOC130004870|LOC130004871|LOC130004872|LOC130004873|LOC130004874|LOC130004875|LOC130004876|LOC130004877|LOC130004878|LOC130004879|LOC130004880|LOC130004881|LOC130004882|LOC130004883|LOC130004884|LOC130004885|LOC130004886|LOC130004887|LOC130004888|LOC130004889|LOC130004890|LOC130004891|LOC130004892|LOC130004893|LOC130004894|LOC130004895|LOC130004896|LOC130004897|LOC130004898|LOC130004899|LOC130004900|LOC130004901|LOC130004902|LOC130004903|LOC130004904|LOC130004905|LOC130004906|LOC130004907|LOC130004908|LOC130004909|LOC130004910|LOC130004911|LOC130004912|LOC130004913|LOC130004914|LOC130004915|LOC130004916|LOC130004917|LOC130004918|LOC130004919|LOC130004920|LOC130004921|LOC130004922|LOC130004923|LOC130004924|LOC130004925|LOC130004926|LOC130004927|LOC130004928|LOC130004929|LOC130004930|LOC130004931|LOC130004932|LOC130004933|LOC130004934|LOC130004935|LOC130004936|LOC130004937|LOC130004938|LOC130004939|LOC130004940|LOC130004941|LOC130004942|LOC130004943|LOC130004944|LOC130004945|LOC130004946|LOC130004947|LOC130004948|LOC130004949|LOC130004950|LOC130004951|LOC130004952|LOC130004953|LOC130004954|LOC130004955|LOC130004956|LOC130004957|LOC130004958|LOC130004959|LOC130004960|LOC130004961|LOC130004962|LOC130004963|LOC130004964|LOC130004965|LOC130004966|LOC130004967|LOC130004968|LOC130004969|LOC130004970|LOC130004971|LOC130004972|LOC130004973|LOC130004974|LOC130004975|LOC130004976|LOC130004977|LOC130004978|LOC130004979|LOC130004980|LOC130004981|LOC130004982|LOC130004983|LOC130004984|LOC130004985|LOC130004986|LOC130004987|LOC130004988|LOC130004989|LOC130004990|LOC130004991|LOC130004992|LOC130004993|LOC130004994|LOC130004995|LOC130004996|LOC130004997|LOC130004998|LOC130004999|LOC130005000|LOC130005001|LOC130005002|LOC130005003|LOC130005004|LOC130005005|LOC130005006|LOC130005007|LOC130005008|LOC130005009|LOC130005010|LOC130005011|LOC130005012|LOC130005013|LOC130005014|LOC130005015|LOC130005016|LOC130005017|LOC130005018|LOC130005019|LOC130005020|LOC130005021|LOC130005022|LOC130005023|LOC130005024|LOC130005025|LOC130005026|LOC130005027|LOC130005028|LOC130005029|LOC130005030|LOC130005031|LOC130005032|LOC130005033|LOC130005034|LOC130005035|LOC130005036|LOC132089751|LOC132089752|LOC132089753|LOC132089754|LOC132089755|LOC132089756|LOC132089757|LOC132089758|LOC132089759|LOC132089760|LOC132089761|LOC132090829|LOC132090830|LOC132211103|LOC132211104|LOC283038|LOC728158|LRRC27|MGMT|MIR202|MIR202HG|MIR378C|MIR3941|MIR3944|MIR4296|MIR4297|MIR4484|MKI67|MMP21|MTG1|NKX1-2|NKX6-2|NPS|NSMCE4A|OAT|PAOX|PLEKHA1|PPP2R2D|PRAP1|PSTK|PTPRE|PWWP2B|SCART1|SPADH|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TEX36|TEX36-AS1|TUBGCP2|UROS|UTF1|VENTX|ZNF511|ZNF511-PRAP1|ZRANB1|ABRAXAS2|ACADSB|ADAM12|ADAM8|ADGRA1|ADGRA1-AS1|ARMS2|AS-PTPRE|ATE1|ATE1-AS1|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf143|C10orf88|C10orf90|CALY|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DHX32|DMBT1|DOCK1|DPYSL4|EBF3|ECHS1|EDRF1|EDRF1-AS1|EDRF1-DT|EEF1AKMT2|FAM24A|FAM24B|FAM24B-CUZD1|FAM53B|FAM53B-AS1|FANK1|FANK1-AS1|FGFR2|FOXI2		See cases	VCV000154374	10	123348506 - 135434178	10	121588992 - 133620674	154374	164128			copy number loss		Pathogenic	Aug 18, 2010	no assertion criteria provided							
NM_000141.5(FGFR2):c.109+4561_109+4562delinsCA	FGFR2		FGFR2-related craniosynostosis	VCV001668481	10	123348661 - 123348662	10	121589147 - 121589148	1668481	1633855	rs2135437452	NC_000010.11:121589146:CT:TG	Indel	intron variant	Likely benign	Aug 23, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.109+4561A>C	FGFR2		FGFR2-related craniosynostosis	VCV001663438	10	123348662	10	121589148	1663438	1619747	rs2912774	NC_000010.11:121589147:T:G	single nucleotide variant	intron variant	Benign	Jan 29, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.109+4561A>T	FGFR2		FGFR2-related craniosynostosis	VCV001663418	10	123348662	10	121589148	1663418	1619727	rs2912774	NC_000010.11:121589147:T:A	single nucleotide variant	intron variant	Benign	Oct 13, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.109+3899T>A	FGFR2		FGFR2-related craniosynostosis	VCV001168306	10	123349324	10	121589810	1168306	1156375	rs45631563	NC_000010.11:121589809:A:T	single nucleotide variant	intron variant	Benign	Jan 29, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.109+906_109+907inv	FGFR2		FGFR2-related craniosynostosis	VCV001375251	10	123352316 - 123352317	10	121592802 - 121592803	1375251	1392026		NC_000010.11:121592801:CA:TG	Inversion	intron variant	Uncertain significance	Jun 30, 2021	criteria provided, single submitter							
NM_000141.5(FGFR2):c.109+906T>C	FGFR2		FGFR2-related craniosynostosis	VCV000036931	10	123352317	10	121592803	36931	45591	rs2981582	NC_000010.11:121592802:A:G	single nucleotide variant	intron variant	Benign	Jan 29, 2024	criteria provided, single submitter							
NC_000010.11:g.(?_121593689)_(121593837_?)del	FGFR2		FGFR2-related craniosynostosis	VCV000644821	10	123353203 - 123353351	10	121593689 - 121593837	644821	652256			Deletion		Uncertain significance	Apr 25, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.109+17C>G	FGFR2		FGFR2-related craniosynostosis	VCV001568941	10	123353206	10	121593692	1568941	1634542	rs200633640	NC_000010.11:121593691:G:C	single nucleotide variant	intron variant	Likely benign	Nov 25, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.109+14T>C	FGFR2		FGFR2-related craniosynostosis	VCV002961584	10	123353209	10	121593695	2961584	3116747		NC_000010.11:121593694:A:G	single nucleotide variant	intron variant	Likely benign	Jul 29, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.109+10T>G	FGFR2		Crouzon syndrome|FGFR2-related craniosynostosis|not provided|Isolated Coronal Synostosis|Craniosynostosis syndrome|not specified|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome	VCV000255314	10	123353213	10	121593699	255314	253706	rs3135722	NC_000010.11:121593698:A:C	single nucleotide variant	intron variant	Benign/Likely benign	Jan 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.109G>C (p.Glu37Gln)	FGFR2	D37H, E37Q, G37R	not provided	VCV002430583	10	123353223	10	121593709	2430583	2404090		NC_000010.11:121593708:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.108A>G (p.Glu36=)	FGFR2		FGFR2-related craniosynostosis	VCV003011366	10	123353224	10	121593710	3011366	3180752		NC_000010.11:121593709:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Oct 30, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.101A>T (p.Glu34Val)	FGFR2	E34V	not provided	VCV001174938	10	123353231	10	121593717	1174938	1164350	rs1863014865	NC_000010.11:121593716:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance		no assertion criteria provided							
NM_000141.5(FGFR2):c.96A>G (p.Thr32=)	FGFR2		FGFR2-related craniosynostosis	VCV002778477	10	123353236	10	121593722	2778477	2943515		NC_000010.11:121593721:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 27, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.94A>G (p.Thr32Ala)	FGFR2	T32A	FGFR2-related craniosynostosis	VCV002732934	10	123353238	10	121593724	2732934	2894262		NC_000010.11:121593723:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 27, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.91A>T (p.Thr31Ser)	FGFR2	T31S	Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Saethre-Chotzen syndrome|Crouzon syndrome	VCV000879382	10	123353241	10	121593727	879382	865503	rs1863017903	NC_000010.11:121593726:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 27, 2017	criteria provided, single submitter							
NM_000141.5(FGFR2):c.82G>A (p.Val28Ile)	FGFR2	V28I	FGFR2-related craniosynostosis	VCV001914366	10	123353250	10	121593736	1914366	1967246		NC_000010.11:121593735:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 12, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.68C>A (p.Pro23His)	FGFR2	P23H	Bent bone dysplasia syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Acrocephalosyndactyly type I|Gastric cancer|Jackson-Weiss syndrome|Saethre-Chotzen syndrome|LADD syndrome 1	VCV003354631	10	123353264	10	121593750	3354631	3513852		NC_000010.11:121593749:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 22, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.67C>G (p.Pro23Ala)	FGFR2	P23A	not provided	VCV002578144	10	123353265	10	121593751	2578144	2743035		NC_000010.11:121593750:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 28, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.67C>A (p.Pro23Thr)	FGFR2	P23T	not provided|Bent bone dysplasia syndrome 1|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Saethre-Chotzen syndrome|Jackson-Weiss syndrome	VCV001317487	10	123353265	10	121593751	1317487	1306431	rs1309596973	NC_000010.11:121593750:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.64C>T (p.Arg22Trp)	FGFR2	R22W	FGFR2-related craniosynostosis|Levy-Hollister syndrome|Bent bone dysplasia syndrome 1|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Gastric cancer|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Crouzon syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	VCV000767266	10	123353268	10	121593754	767266	701224	rs377570596	NC_000010.11:121593753:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign/Likely benign	Jan 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.56C>T (p.Ser19Phe)	FGFR2	S19F	not provided	VCV002429691	10	123353276	10	121593762	2429691	2403189		NC_000010.11:121593761:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 11, 2022	criteria provided, single submitter							
NM_000141.5(FGFR2):c.43A>C (p.Met15Leu)	FGFR2	M15L	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|LADD syndrome 1|Crouzon syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1	VCV003591126	10	123353289	10	121593775	3591126	3724851		NC_000010.11:121593774:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 22, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.43A>G (p.Met15Val)	FGFR2	M15V	Pfeiffer syndrome|FGFR2-related craniosynostosis	VCV002986411	10	123353289	10	121593775	2986411	3146727		NC_000010.11:121593774:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.34G>A (p.Val12Met)	FGFR2	V12M	FGFR2-related craniosynostosis|not provided	VCV000134387	10	123353298	10	121593784	134387	138126	rs143978938	NC_000010.11:121593783:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.33C>T (p.Val11=)	FGFR2		FGFR2-related craniosynostosis|Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Saethre-Chotzen syndrome|Crouzon syndrome	VCV000879767	10	123353299	10	121593785	879767	865504	rs200562301	NC_000010.11:121593784:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 6, 2023	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.27C>T (p.Cys9=)	FGFR2		FGFR2-related craniosynostosis	VCV002730617	10	123353305	10	121593791	2730617	2883353		NC_000010.11:121593790:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 30, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.23T>G (p.Ile8Ser)	FGFR2	I8S	Beare-Stevenson cutis gyrata syndrome|FGFR2-related craniosynostosis|Craniosynostosis syndrome|Crouzon syndrome|not provided|Isolated Coronal Synostosis|Saethre-Chotzen syndrome|not specified	VCV000134388	10	123353309	10	121593795	134388	138127	rs147307031	NC_000010.11:121593794:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 22, 2024	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.17G>A (p.Arg6His)	FGFR2	R6H	not provided	VCV001316348	10	123353315	10	121593801	1316348	1308750	rs3750819	NC_000010.11:121593800:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.17G>C (p.Arg6Pro)	FGFR2	R6P	Beare-Stevenson cutis gyrata syndrome|FGFR2-related craniosynostosis|Craniosynostosis syndrome|Crouzon syndrome|Saethre-Chotzen syndrome|Isolated Coronal Synostosis|not specified|not provided|Bent bone dysplasia syndrome 1|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Acrocephalosyndactyly type I|Pfeiffer syndrome|Jackson-Weiss syndrome|Gastric cancer|Levy-Hollister syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome	VCV000134386	10	123353315	10	121593801	134386	138125	rs3750819	NC_000010.11:121593800:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jan 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.16C>T (p.Arg6Cys)	FGFR2	R6C	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Bent bone dysplasia syndrome 1|Acrocephalosyndactyly type I|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Jackson-Weiss syndrome|Levy-Hollister syndrome|Inborn genetic diseases|FGFR2-related craniosynostosis	VCV001000813	10	123353316	10	121593802	1000813	993744	rs141724446	NC_000010.11:121593801:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 7, 2023	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.9C>T (p.Ser3=)	FGFR2		not provided	VCV003369195	10	123353323	10	121593809	3369195	3528387		NC_000010.11:121593808:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Feb 15, 2024	criteria provided, single submitter							
NM_000141.5(FGFR2):c.1A>G (p.Met1Val)	FGFR2	M1V	not provided	VCV001317061	10	123353331	10	121593817	1317061	1306879	rs774885289	NC_000010.11:121593816:T:C	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Uncertain significance	Dec 23, 2019	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-6G>A	FGFR2		not provided	VCV001215039	10	123353337	10	121593823	1215039	1205022	rs772427122	NC_000010.11:121593822:C:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Likely benign	Oct 1, 2020	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-7C>T	FGFR2		FGFR2-related disorder	VCV003044916	10	123353338	10	121593824	3044916	3203895		NC_000010.11:121593823:G:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Likely benign	May 24, 2019	no assertion criteria provided							
NM_000141.5(FGFR2):c.-17G>C	FGFR2		Jackson-Weiss syndrome|Levy-Hollister syndrome|Gastric cancer|Acrocephalosyndactyly type I|Bent bone dysplasia syndrome 1|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Crouzon syndrome|Saethre-Chotzen syndrome	VCV000877977	10	123353348	10	121593834	877977	865505	rs766629665	NC_000010.11:121593833:C:G	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 22, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.-46G>A	FGFR2		not provided|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Saethre-Chotzen syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome	VCV000299011	10	123353377	10	121593863	299011	320920	rs201606812	NC_000010.11:121593862:C:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	Mar 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.-61G>T	FGFR2		Craniosynostosis syndrome|not provided|Isolated Coronal Synostosis|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome	VCV000879439	10	123353392	10	121593878	879439	865506	rs3135721	NC_000010.11:121593877:C:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 26, 2019	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.-74G>A	FGFR2		Crouzon syndrome|not provided|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome	VCV000299012	10	123353405	10	121593891	299012	320462	rs4647922	NC_000010.11:121593890:C:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	Jan 13, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.-108C>T	FGFR2		Craniosynostosis syndrome|not provided|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Crouzon syndrome|Saethre-Chotzen syndrome	VCV000877867	10	123353439	10	121593925	877867	865507	rs540720034	NC_000010.11:121593924:G:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 13, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.-128G>A	FGFR2		Saethre-Chotzen syndrome|Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Isolated Coronal Synostosis	VCV000299013	10	123353459	10	121593945	299013	309588	rs547739869	NC_000010.11:121593944:C:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-129C>T	FGFR2		Craniosynostosis syndrome|Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Isolated Coronal Synostosis	VCV000299014	10	123353460	10	121593946	299014	320934	rs886046765	NC_000010.11:121593945:G:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-135C>T	FGFR2		Crouzon syndrome|Saethre-Chotzen syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome	VCV000299015	10	123353466	10	121593952	299015	309600	rs554557891	NC_000010.11:121593951:G:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 12, 2018	criteria provided, conflicting classifications							
NM_000141.5(FGFR2):c.-150-132G>A	FGFR2		not provided	VCV001216156	10	123353613	10	121594099	1216156	1206137	rs41301563	NC_000010.11:121594098:C:T	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Aug 17, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-150-388G>A	FGFR2		not provided	VCV001257485	10	123353869	10	121594355	1257485	1246980	rs3135718	NC_000010.11:121594354:C:T	single nucleotide variant	intron variant	Benign	Jun 25, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-150-522C>T	FGFR2		not provided	VCV000670026	10	123354003	10	121594489	670026	664623	rs3135717	NC_000010.11:121594488:G:A	single nucleotide variant	intron variant	Benign	Jun 19, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-151+19G>T	FGFR2		not specified	VCV000515199	10	123357457	10	121597943	515199	503601	rs974988741	NC_000010.11:121597942:C:A	single nucleotide variant	intron variant	Likely benign	Jan 25, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-157A>G	FGFR2		Beare-Stevenson cutis gyrata syndrome|not specified|Saethre-Chotzen syndrome|Crouzon syndrome|Craniosynostosis syndrome|Isolated Coronal Synostosis|not provided	VCV000299016	10	123357482	10	121597968	299016	320936	rs41258305	NC_000010.11:121597967:T:C	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Benign	Feb 26, 2020	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.-165G>A	FGFR2		Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Craniosynostosis syndrome|Isolated Coronal Synostosis	VCV000299017	10	123357490	10	121597976	299017	320467	rs886046766	NC_000010.11:121597975:C:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-173G>A	FGFR2		Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Saethre-Chotzen syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome	VCV000879853	10	123357498	10	121597984	879853	865508	rs540975865	NC_000010.11:121597983:C:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-196G>A	FGFR2		Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome	VCV000877914	10	123357521	10	121598007	877914	865509	rs1457119353	NC_000010.11:121598006:C:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-206C>A	FGFR2		Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome	VCV000877915	10	123357531	10	121598017	877915	865510	rs1238787517	NC_000010.11:121598016:G:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-236G>A	FGFR2		Beare-Stevenson cutis gyrata syndrome|Craniosynostosis syndrome|Saethre-Chotzen syndrome|not provided|Crouzon syndrome|Isolated Coronal Synostosis	VCV000299019	10	123357561	10	121598047	299019	320469	rs1047111	NC_000010.11:121598046:C:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Benign	Jan 13, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.-236G>C	FGFR2		Saethre-Chotzen syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Craniosynostosis syndrome|Isolated Coronal Synostosis|not provided	VCV000299018	10	123357561	10	121598047	299018	309606	rs1047111	NC_000010.11:121598046:C:G	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Benign	Jan 13, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.-237C>A	FGFR2		Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Isolated Coronal Synostosis|Saethre-Chotzen syndrome|Craniosynostosis syndrome	VCV000879901	10	123357562	10	121598048	879901	865511	rs1013618217	NC_000010.11:121598047:G:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-298_-297dup	FGFR2		Saethre-Chotzen syndrome|Jackson-Weiss syndrome|Acrocephalosyndactyly type I|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Crouzon syndrome|Craniosynostosis syndrome|Isolated Coronal Synostosis|Levy-Hollister syndrome	VCV000299020	10	123357621 - 123357622	10	121598107 - 121598108	299020	320937	rs41301549	NC_000010.11:121598107:GGG:GGGGG	Duplication	5 prime UTR variant|non-coding transcript variant	Likely benign	Jun 14, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-318G>C	FGFR2		Beare-Stevenson cutis gyrata syndrome|Craniosynostosis syndrome|Saethre-Chotzen syndrome|Crouzon syndrome|Isolated Coronal Synostosis	VCV000299021	10	123357643	10	121598129	299021	309607	rs41301547	NC_000010.11:121598128:C:G	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Benign	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-358C>T	FGFR2		Beare-Stevenson cutis gyrata syndrome|Craniosynostosis syndrome|Saethre-Chotzen syndrome|Crouzon syndrome|Isolated Coronal Synostosis	VCV000299022	10	123357683	10	121598169	299022	314431	rs41301545	NC_000010.11:121598168:G:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-371C>T	FGFR2		Beare-Stevenson cutis gyrata syndrome|Craniosynostosis syndrome|Saethre-Chotzen syndrome|Crouzon syndrome|Isolated Coronal Synostosis	VCV000299023	10	123357696	10	121598182	299023	320942	rs527570655	NC_000010.11:121598181:G:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-458C>A	FGFR2		Saethre-Chotzen syndrome|not provided|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Craniosynostosis syndrome|Isolated Coronal Synostosis	VCV000299024	10	123357783	10	121598269	299024	320947	rs41301043	NC_000010.11:121598268:G:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Benign	May 12, 2021	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.-535G>C	FGFR2		Beare-Stevenson cutis gyrata syndrome|Saethre-Chotzen syndrome|Crouzon syndrome|Craniosynostosis syndrome|Isolated Coronal Synostosis	VCV000299025	10	123357860	10	121598346	299025	309608	rs886046767	NC_000010.11:121598345:C:G	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-590G>C	FGFR2		Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Saethre-Chotzen syndrome|Isolated Coronal Synostosis|Craniosynostosis syndrome	VCV000879590	10	123357915	10	121598401	879590	865512	rs1221108798	NC_000010.11:121598400:C:G	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-603C>T	FGFR2		Craniosynostosis syndrome|Beare-Stevenson cutis gyrata syndrome|Isolated Coronal Synostosis|Saethre-Chotzen syndrome|Crouzon syndrome	VCV000879946	10	123357928	10	121598414	879946	865513	rs1863754113	NC_000010.11:121598413:G:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-622G>A	FGFR2		Craniosynostosis syndrome|Saethre-Chotzen syndrome|Crouzon syndrome|Isolated Coronal Synostosis|Beare-Stevenson cutis gyrata syndrome	VCV000299026	10	123357947	10	121598433	299026	320470	rs886046768	NC_000010.11:121598432:C:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000141.5(FGFR2):c.-626C>A	FGFR2		Craniosynostosis syndrome|Isolated Coronal Synostosis|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Saethre-Chotzen syndrome	VCV000877152	10	123357951	10	121598437	877152	865514	rs549524538	NC_000010.11:121598436:G:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 13, 2018	criteria provided, conflicting classifications							
NC_000010.11:g.121598531C>T	FGFR2		not provided	VCV001344944	10	123358045	10	121598531	1344944	1336764	rs753202350	NC_000010.11:121598530:C:T	single nucleotide variant		Likely benign	Sep 17, 2021	criteria provided, single submitter							
NC_000010.11:g.121598582C>G	FGFR2		not provided	VCV001272277	10	123358096	10	121598582	1272277	1263033	rs41301039	NC_000010.11:121598581:C:G	single nucleotide variant		Benign	May 13, 2021	criteria provided, single submitter							
NC_000010.11:g.121598656C>T	FGFR2		not provided	VCV001227396	10	123358170	10	121598656	1227396	1216080	rs4478918	NC_000010.11:121598655:C:T	single nucleotide variant		Benign	May 11, 2021	criteria provided, single submitter							
NC_000010.10:g.(?_123237845)_(123357959_?)dup	FGFR2		not specified	VCV003375379	10	123237845 - 123357959			3375379	3534567			Duplication		Uncertain significance	Sep 30, 2024	criteria provided, single submitter							
NC_000010.10:g.(?_123310784)_(123325238_?)dup	FGFR2		FGFR2-related craniosynostosis	VCV003244924	10	123310784 - 123325238			3244924	3402286			Duplication		Uncertain significance	Nov 3, 2023	criteria provided, single submitter							
NC_000010.10:g.(?_123323996)_(123325238_?)dup	FGFR2		FGFR2-related craniosynostosis	VCV003244923	10	123323996 - 123325238			3244923	3402285			Duplication		Uncertain significance	Sep 17, 2023	criteria provided, single submitter							
NC_000010.10:g.(?_122610933)_(124813281_?)dup	ACADSB|ARMS2|ATE1|BTBD16|C10orf120|C10orf88|CUZD1|DMBT1|FAM24A|FAM24B|FGFR2|HTRA1|IKZF5|NSMCE4A|PLEKHA1|PSTK|TACC2|WDR11		FGFR2-related craniosynostosis	VCV003244922	10	122610933 - 124813281			3244922	3402284			Duplication		Uncertain significance	Jul 10, 2023	criteria provided, single submitter							
NC_000010.10:g.(?_122842033)_(124813281_?)del	ACADSB|ARMS2|ATE1|BTBD16|C10orf120|C10orf88|CUZD1|DMBT1|FAM24A|FAM24B|FGFR2|HTRA1|IKZF5|NSMCE4A|PLEKHA1|PSTK|TACC2		Deficiency of 2-methylbutyryl-CoA dehydrogenase	VCV003244863	10	122842033 - 124813281			3244863	3402226			Deletion		Pathogenic	Oct 23, 2023	criteria provided, single submitter							
GRCh37/hg19 10q26.12-26.3(chr10:122331280-135426386)x1	ABRAXAS2|ACADSB|ADAM12|ADAM8|ADGRA1|ARMS2|ATE1|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf88|C10orf90|CALY|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DHX32|DMBT1|DOCK1|DPYSL4|EBF3|ECHS1|EDRF1|EEF1AKMT2|FAM24A|FAM24B|FAM53B|FANK1|FGFR2|FOXI2|FUOM|GLRX3|GPR26|HMX2|HMX3|HTRA1|IKZF5|INPP5A|INSYN2A|JAKMIP3|KNDC1|LHPP|LINC01166|LINC02870|LRRC27|MGMT|MKI67|MMP21|MTG1|NKX1-2|NKX6-2|NPS|NSMCE4A|OAT|PAOX|PLEKHA1|PLPP4|PPP2R2D|PRAP1|PSTK|PTPRE|PWWP2B|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TEX36|TUBGCP2|UROS|UTF1|VENTX|WDR11|ZNF511|ZRANB1		not provided	VCV003148924	10	122331280 - 135426386			3148924	3308172			copy number loss		Pathogenic		criteria provided, single submitter							
GRCh37/hg19 10q23.33-26.3(chr10:95078198-135427143)x3	ABCC2|ABLIM1|ABRAXAS2|ACADSB|ACSL5|ACSM6|ACTR1A|ADAM12|ADAM8|ADD3|ADGRA1|ADRA2A|ADRB1|AFAP1L2|ALDH18A1|ANKRD2|ARHGAP19|ARL3|ARMH3|ARMS2|AS3MT|ATE1|ATP5MK|ATRNL1|AVPI1|BAG3|BBIP1|BCCIP|BLNK|BLOC1S2|BNIP3|BORCS7|BTBD16|BTRC|BUB3|C10orf12|C10orf120|C10orf131|C10orf62|C10orf88|C10orf90|C10orf95|CACUL1|CALHM1|CALHM2|CALHM3|CALY|CASC2|CASP7|CC2D2B|CCDC172|CCDC186|CCNJ|CEP55|CFAP43|CFAP46|CFAP58|CHST15|CHUK|CLRN3|CNNM1|CNNM2|COL17A1|COX15|CPN1|CPXM2|CRTAC1|CTBP2|CUEDC2|CUTC|CUZD1|CWF19L1|CYP17A1|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2E1|DCLRE1A|DENND10|DHX32|DMBT1|DNMBP|DNTT|DOCK1|DPCD|DPYSL4|DUSP5|EBF3|ECHS1|EDRF1|EEF1AKMT2|EIF3A|ELOVL3|EMX2|EMX2OS|ENO4|ENTPD1|ENTPD7|ERLIN1|EXOSC1|FAM204A|FAM24A|FAM24B|FAM53B|FANK1|FBXL15|FBXW4|FFAR4|FGF8|FGFR2|FHIP2A|FOXI2|FRA10AC1|FRAT1|FRAT2|FUOM|GBF1|GFRA1|GLRX3|GOLGA7B|GOT1|GPAM|GPR26|GRK5|GSTO1|GSTO2|HABP2|HELLS|HIF1AN|HMX2|HMX3|HOGA1|HPS1|HPS6|HPSE2|HSPA12A|HTRA1|IKZF5|INA|INPP5A|INPP5F|INSYN2A|ITPRIP|JAKMIP3|KAZALD1|KCNIP2|KCNK18|KNDC1|LBX1|LCOR|LDB1|LGI1|LHPP|LINC01166|LINC02870|LOXL4|LRRC27|LZTS2|MARVELD1|MCMBP|MFSD13A|MGMT|MIR146B|MKI67|MMP21|MMS19|MORN4|MRPL43|MTG1|MXI1|MYOF|NANOS1|NDUFB8|NEURL1|NFKB2|NHLRC2|NKX1-2|NKX2-3|NKX6-2|NOC3L|NOLC1|NPM3|NPS|NRAP|NSMCE4A|NT5C2|OAT|OGA|OPALIN|PAOX|PAX2|PCGF6|PDCD11|PDCD4|PDE6C|PDLIM1|PDZD7|PDZD8|PGAM1|PI4K2A|PIK3AP1|PITX3|PKD2L1|PLCE1|PLEKHA1|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|POLL|PPP2R2D|PPRC1|PRAP1|PRDX3|PRLHR|PSD|PSTK|PTPRE|PWWP2B|PYROXD2|R3HCC1L|RAB11FIP2|RBM20|RBP4|RGS10|RRP12|SCD|SEC23IP|SEC31B|SEMA4G|SFR1|SFRP5|SFXN2|SFXN3|SFXN4|SH3PXD2A|SHOC2|SHTN1|SLC18A2|SLC25A28|SLC35G1|SLF2|SLIT1|SLK|SMC3|SMNDC1|SNORA12|SORBS1|SORCS1|SORCS3|SPMIP5|SPRN|STK32C|STN1|SUFU|SYCE1|TACC2|TAF5|TBC1D12|TCERG1L|TCERG1L-AS1|TCF7L2|TCTN3|TDRD1|TECTB|TEX36|TIAL1|TLL2|TLX1|TLX1NB|TM9SF3|TRIM8|TRUB1|TUBGCP2|TWNK|UBTD1|UROS|UTF1|VAX1|VENTX|VTI1A|VWA2|WBP1L|WDR11|WNT8B|XPNPEP1|ZDHHC16|ZDHHC6|ZFYVE27|ZNF511|ZNF518A|ZRANB1		not specified	VCV003063164	10	95078198 - 135427143			3063164	3223380			copy number gain		Pathogenic		criteria provided, single submitter							
GRCh37/hg19 10q25.1-26.13(chr10:107129993-123817654)x3	ABLIM1|ACSL5|ADD3|ADRA2A|ADRB1|AFAP1L2|ATE1|ATRNL1|BAG3|BBIP1|CACUL1|CASC2|CASP7|CCDC172|CCDC186|DCLRE1A|DENND10|DUSP5|EIF3A|EMX2|EMX2OS|ENO4|FAM204A|FGFR2|FHIP2A|GFRA1|GPAM|GRK5|HABP2|HSPA12A|INPP5F|KCNK18|MCMBP|MXI1|NANOS1|NHLRC2|NRAP|NSMCE4A|PDCD4|PDZD8|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PRDX3|PRLHR|RAB11FIP2|RBM20|RGS10|SEC23IP|SFXN4|SHOC2|SHTN1|SLC18A2|SMC3|SMNDC1|SORCS1|SPMIP5|TACC2|TCF7L2|TDRD1|TECTB|TIAL1|TRUB1|VAX1|VTI1A|VWA2|WDR11|XPNPEP1|ZDHHC6		not specified	VCV003063162	10	107129993 - 123817654			3063162	3223378			copy number gain		Likely pathogenic		criteria provided, single submitter							
GRCh37/hg19 10q25.1-26.3(chr10:111447991-133435388)x3	ABLIM1|ABRAXAS2|ACADSB|ACSL5|ADAM12|ADD3|ADRA2A|ADRB1|AFAP1L2|ARMS2|ATE1|ATRNL1|BAG3|BBIP1|BCCIP|BTBD16|BUB3|C10orf120|C10orf88|C10orf90|CACUL1|CASC2|CASP7|CCDC172|CCDC186|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|DCLRE1A|DENND10|DHX32|DMBT1|DOCK1|DUSP5|EBF3|EDRF1|EEF1AKMT2|EIF3A|EMX2|EMX2OS|ENO4|FAM204A|FAM24A|FAM24B|FAM53B|FANK1|FGFR2|FHIP2A|FOXI2|GFRA1|GLRX3|GPAM|GPR26|GRK5|HABP2|HMX2|HMX3|HSPA12A|HTRA1|IKZF5|INPP5F|INSYN2A|KCNK18|LHPP|MCMBP|MGMT|MKI67|MMP21|MXI1|NANOS1|NHLRC2|NKX1-2|NPS|NRAP|NSMCE4A|OAT|PDCD4|PDZD8|PLEKHA1|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PRDX3|PRLHR|PSTK|PTPRE|RAB11FIP2|RBM20|RGS10|SEC23IP|SFXN4|SHOC2|SHTN1|SLC18A2|SMC3|SMNDC1|SPMIP5|TACC2|TCERG1L|TCERG1L-AS1|TCF7L2|TDRD1|TECTB|TEX36|TIAL1|TRUB1|UROS|VAX1|VTI1A|VWA2|WDR11|XPNPEP1|ZDHHC6|ZRANB1		not provided	VCV002684621	10	111447991 - 133435388			2684621	2845656			copy number gain		Pathogenic	May 24, 2023	criteria provided, single submitter							
GRCh37/hg19 10q25.1-26.3(chr10:111378692-135427143)x3	ABLIM1|ABRAXAS2|ACADSB|ACSL5|ADAM12|ADAM8|ADD3|ADGRA1|ADRA2A|ADRB1|AFAP1L2|ARMS2|ATE1|ATRNL1|BAG3|BBIP1|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf88|C10orf90|CACUL1|CALY|CASC2|CASP7|CCDC172|CCDC186|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DCLRE1A|DENND10|DHX32|DMBT1|DOCK1|DPYSL4|DUSP5|EBF3|ECHS1|EDRF1|EEF1AKMT2|EIF3A|EMX2|EMX2OS|ENO4|FAM204A|FAM24A|FAM24B|FAM53B|FANK1|FGFR2|FHIP2A|FOXI2|FUOM|GFRA1|GLRX3|GPAM|GPR26|GRK5|HABP2|HMX2|HMX3|HSPA12A|HTRA1|IKZF5|INPP5A|INPP5F|INSYN2A|JAKMIP3|KCNK18|KNDC1|LHPP|LINC01166|LINC02870|LRRC27|MCMBP|MGMT|MKI67|MMP21|MTG1|MXI1|NANOS1|NHLRC2|NKX1-2|NKX6-2|NPS|NRAP|NSMCE4A|OAT|PAOX|PDCD4|PDZD8|PLEKHA1|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PPP2R2D|PRAP1|PRDX3|PRLHR|PSTK|PTPRE|PWWP2B|RAB11FIP2|RBM20|RGS10|SEC23IP|SFXN4|SHOC2|SHTN1|SLC18A2|SMC3|SMNDC1|SPMIP5|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TCF7L2|TDRD1|TECTB|TEX36|TIAL1|TRUB1|TUBGCP2|UROS|UTF1|VAX1|VENTX|VTI1A|VWA2|WDR11|XPNPEP1|ZDHHC6|ZNF511|ZRANB1		Distal trisomy 10q	VCV002671974	10	111378692 - 135427143			2671974	2839502			copy number gain		Pathogenic		no assertion criteria provided							
GRCh37/hg19 10p14-q26.3(chr10:11138692-135427143)	AGAP5|CRTAC1|CSGALNACT2|CYP2C18|AGAP6|ANKRD1|AGAP9|AIFM2|ALDH18A1|ALOX5|ANAPC16|ANK3|CSTF2T|CTBP2|CWF19L1|CXCL12|CYP17A1|CYP26A1|CYP26C1|A1CF|ABCC2|ABI1|ABLIM1|ABRAXAS2|ACADSB|ACBD5|ACBD7|ACSL5|ACSM6|ACTA2|ACTR1A|ADAM12|ADAM8|ADAMTS14|ADD3|ADGRA1|ADIRF|ADIRF-AS1|ADK|ADO|ADRA2A|ADRB1|AFAP1L2|AGAP10|AGAP11|AGAP4|ANKRD2|ANKRD22|ANKRD26|ANKRD30A|ANXA11|ANXA7|ANXA8|ANXA8L1|AP3M1|APBB1IP|ARHGAP12|ARHGAP19|ARHGAP21|ARHGAP22|ARID5B|ARL3|ARL5B|ARMC3|ARMH3|ARMS2|AS3MT|ASAH2|ASAH2B|ASCC1|ATAD1|ATE1|ATOH7|ATP5MK|ATRNL1|AVPI1|BAG3|BAMBI|BBIP1|BCCIP|BEND7|BICC1|BLNK|BLOC1S2|BMI1|BMPR1A|BMS1|BNIP3|BORCS7|BTAF1|BTBD16|BTRC|BUB3|C10orf105|C10orf113|C10orf12|C10orf120|C10orf126|C10orf131|C10orf53|C10orf55|C10orf62|C10orf67|C10orf71|C10orf88|C10orf90|C10orf95|C1QL3|CABCOCO1|CACNB2|CACUL1|CALHM1|CALHM2|CALHM3|CALY|CAMK1D|CAMK2G|CASC2|CASP7|CC2D2B|CCAR1|CCDC172|CCDC186|CCDC3|CCDC6|CCDC7|CCNJ|CCNY|CCSER2|CDC123|CDH23|CDHR1|CDK1|CDNF|CELF2|CEP55|CFAP43|CFAP46|CFAP58|CFAP70|CH25H|CHAT|CHCHD1|CHST15|CHST3|CHUK|CISD1|CLRN3|CNNM1|CNNM2|COL13A1|COL17A1|COMMD3|COMMD3-BMI1|COMTD1|COX15|CPEB3|CPN1|CPXM2|CREM|CTNNA3|CUBN|CUEDC2|CUL2|CUTC|CUZD1|CYP2C19|CYP2C8|CYP2C9|CYP2E1|DCLRE1A|DCLRE1C|DDIT4|DDX21|DDX50|DENND10|DEPP1|DHTKD1|DHX32|DKK1|DLG5|DMBT1|DNA2|DNAJB12|DNAJC1|DNAJC12|DNAJC9|DNMBP|DNTT|DOCK1|DPCD|DPYSL4|DRGX|DUSP13B|DUSP29|DUSP5|DYDC1|DYDC2|EBF3|EBLN1|ECD|ECHDC3|ECHS1|EDRF1|EEF1AKMT2|EGR2|EIF3A|EIF4EBP2|EIF5AL1|ELOVL3|EMX2|EMX2OS|ENKUR|ENO4|ENTPD1|ENTPD7|EPC1|ERCC6|ERLIN1|EXOC6|EXOSC1|FAM107B|FAM13C|FAM149B1|FAM170B|FAM171A1|FAM204A|FAM241B|FAM24A|FAM24B|FAM25A|FAM25C|FAM25E|FAM25G|FAM53B|FANK1|FAS|FAS-AS1|FBXL15|FBXW4|FFAR4|FGF8|FGFBP3|FGFR2|FHIP2A|FOXI2|FRA10AC1|FRAT1|FRAT2|FRMD4A|FRMPD2|FUOM|FUT11|FXYD4|FZD8|GAD2|GBF1|GDF10|GDF2|GFRA1|GHITM|GJD4|GLRX3|GLUD1|GOLGA7B|GOT1|GPAM|GPR158|GPR15LG|GPR26|GPRIN2|GRID1|GRK5|GSTO1|GSTO2|HABP2|HACD1|HECTD2|HELLS|HERC4|HHEX|HIF1AN|HK1|HKDC1|HMX2|HMX3|HNRNPF|HNRNPH3|HOGA1|HPS1|HPS6|HPSE2|HSPA12A|HSPA14|HTR7|HTRA1|IDE|IFIT1|IFIT1B|IFIT2|IFIT3|IFIT5|IKZF5|INA|INPP5A|INPP5F|INSYN2A|IPMK|ITGA8|ITGB1|ITPRIP|JAKMIP3|JCAD|JMJD1C|KAT6B|KAZALD1|KCNIP2|KCNK18|KCNMA1|KIAA1217|KIF11|KIF20B|KIF5B|KIFBP|KLLN|KNDC1|LBX1|LCOR|LDB1|LDB3|LGI1|LHPP|LINC01166|LINC01520|LINC02870|LIPA|LIPF|LIPJ|LIPK|LIPM|LIPN|LOC101929662|LOXL4|LRIT1|LRIT2|LRMDA|LRRC18|LRRC20|LRRC27|LRRTM3|LYZL1|LYZL2|LZTS2|MACROH2A2|MAP3K8|MAPK8|MARCHF5|MARCHF8|MARVELD1|MASTL|MAT1A|MBL2|MCM10|MCMBP|MCU|MEIG1|MFSD13A|MGMT|MICU1|MINDY3|MINPP1|MIR107|MIR146B|MIR1915|MIR1915HG|MIR346|MKI67|MKX|MLLT10|MMP21|MMRN2|MMS19|MORN4|MPP7|MRPL43|MRPS16|MSMB|MSRB2|MSS51|MTG1|MTPAP|MTRNR2L5|MTRNR2L7|MXI1|MYO3A|MYOF|MYOZ1|MYPN|NANOS1|NCOA4|NDST2|NDUFB8|NEBL|NEURL1|NEUROG3|NFKB2|NHLRC2|NKX1-2|NKX2-3|NKX6-2|NMT2|NOC3L|NODAL|NOLC1|NPFFR1|NPM3|NPS|NPY4R|NRAP|NRBF2|NRG3|NRP1|NSMCE4A|NSUN6|NT5C2|NUDT13|NUDT5|NUTM2A|NUTM2B|OAT|ODAD2|OGA|OGDHL|OIT3|OLAH|OPALIN|OPN4|OPTN|OR13A1|OTUD1|P4HA1|PALD1|PANK1|PAOX|PAPSS2|PARD3|PARG|PAX2|PBLD|PCBD1|PCDH15|PCGF5|PCGF6|PDCD11|PDCD4|PDE6C|PDLIM1|PDSS1|PDZD7|PDZD8|PGAM1|PGBD3|PHYH|PHYHIPL|PI4K2A|PIK3AP1|PIP4K2A|PITX3|PKD2L1|PLA2G12B|PLAC9|PLAU|PLCE1|PLEKHA1|PLEKHS1|PLPP4|PLXDC2|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|POLL|POLR3A|PPA1|PPIF|PPP1R3C|PPP2R2D|PPP3CB|PPRC1|PRAP1|PRDX3|PRF1|PRINS|PRKG1|PRLHR|PROSER2|PRPF18|PRTFDC1|PRXL2A|PSAP|PSD|PSTK|PTCHD3|PTEN|PTER|PTF1A|PTPN20|PTPRE|PWWP2B|PYROXD2|R3HCC1L|RAB11FIP2|RAB18|RASGEF1A|RASSF4|RBM20|RBP3|RBP4|REEP3|RET|RGR|RGS10|RHOBTB1|RNLS|RPP30|RPP38|RPP38-DT|RPS24|RRP12|RSU1|RTKN2|RUFY2|SAMD8|SAR1A|SCD|SEC23IP|SEC24C|SEC31B|SEC61A2|SEMA4G|SEPHS1|SFR1|SFRP5|SFTPA1|SFTPA2|SFTPD|SFXN2|SFXN3|SFXN4|SGMS1|SGPL1|SH2D4B|SH3PXD2A|SHLD2|SHOC2|SHTN1|SIRT1|SKIDA1|SLC16A12|SLC16A9|SLC18A2|SLC18A3|SLC25A16|SLC25A28|SLC29A3|SLC35G1|SLC39A12|SLF2|SLIT1|SLK|SMC3|SMNDC1|SNCG|SNORA12|SORBS1|SORCS1|SORCS3|SPAG6|SPMIP5|SPOCK2|SPRN|SRGN|ST8SIA6|STAM|STAMBPL1|STK32C|STN1|STOX1|SUFU|SUPV3L1|SUV39H2|SVIL|SYCE1|SYNPO2L|SYT15|TACC2|TACR2|TAF5|TBATA|TBC1D12|TCERG1L|TCERG1L-AS1|TCF7L2|TCTN3|TDRD1|TECTB|TET1|TEX36|TFAM|THNSL1|TIAL1|TIMM23|TLL2|TLX1|TLX1NB|TM9SF3|TMEM254|TMEM26|TMEM273|TMEM72|TNKS2|TRDMT1|TRIM8|TRUB1|TSPAN14|TSPAN15|TUBGCP2|TWNK|TYSND1|UBE2D1|UBTD1|UCMA|UNC5B|UPF2|UROS|USP54|USP6NL|UTF1|VAX1|VCL|VDAC2|VENTX|VIM|VPS26A|VSIR|VSTM4|VTI1A|VWA2|WAC|WAPL|WASHC2A|WASHC2C|WBP1L|WDFY4|WDR11|WNT8B|XPNPEP1|YME1L1|ZCCHC24|ZDHHC16|ZDHHC6|ZEB1|ZFAND4|ZFYVE27|ZMIZ1|ZNF22|ZNF22-AS1|ZNF239|ZNF248|ZNF25|ZNF32|ZNF33A|ZNF33B|ZNF365|ZNF37A|ZNF438|ZNF485|ZNF488|ZNF503|ZNF511|ZNF518A|ZRANB1|ZSWIM8|ZWINT		Distal trisomy 10q	VCV002574696	10	11138692 - 135427143			2574696	2739632			copy number gain		Pathogenic		no assertion criteria provided							
GRCh37/hg19 10p13-q26.3(chr10:12829206-135427143)	ABRAXAS2|CHCHD1|CLRN3|CHST3|CHST15|CHUK|CISD1|ADRA2A|PHYH|PHYHIPL|SYCE1|ACADSB|ACBD5|ACBD7|ACSL5|ACSM6|ADIRF-AS1|ADGRA1|ADIRF|ADK|ADO|A1CF|ABCC2|ABI1|ABLIM1|ACTA2|ACTR1A|ADAM12|ADAM8|ADAMTS14|ADD3|ADRB1|AFAP1L2|AGAP10|AGAP11|AGAP4|AGAP5|AGAP6|AGAP9|AIFM2|ALDH18A1|ALOX5|ANAPC16|ANK3|ANKRD1|ANKRD2|ANKRD22|ANKRD26|ANKRD30A|ANXA11|ANXA7|ANXA8|ANXA8L1|AP3M1|APBB1IP|ARHGAP12|ARHGAP19|ARHGAP21|ARHGAP22|ARID5B|ARL3|ARL5B|ARMC3|ARMH3|ARMS2|AS3MT|ASAH2|ASAH2B|ASCC1|ATAD1|ATE1|ATOH7|ATP5MK|ATRNL1|AVPI1|BAG3|BAMBI|BBIP1|BCCIP|BEND7|BICC1|BLNK|BLOC1S2|BMI1|BMPR1A|BMS1|BNIP3|BORCS7|BTAF1|BTBD16|BTRC|BUB3|C10orf105|C10orf113|C10orf12|C10orf120|C10orf126|C10orf131|C10orf53|C10orf55|C10orf62|C10orf67|C10orf71|C10orf88|C10orf90|C10orf95|C1QL3|CABCOCO1|CACNB2|CACUL1|CALHM1|CALHM2|CALHM3|CALY|CAMK1D|CAMK2G|CASC2|CASP7|CC2D2B|CCAR1|CCDC172|CCDC186|CCDC3|CCDC6|CCDC7|CCNJ|CCNY|CCSER2|CDH23|CDHR1|CDK1|CDNF|CEP55|CFAP43|CFAP46|CFAP58|CFAP70|CH25H|CHAT|CNNM1|CNNM2|COL13A1|COL17A1|COMMD3|COMMD3-BMI1|COMTD1|COX15|CPEB3|CPN1|CPXM2|CREM|CRTAC1|CSGALNACT2|CSTF2T|CTBP2|CTNNA3|CUBN|CUEDC2|CUL2|CUTC|CUZD1|CWF19L1|CXCL12|CYP17A1|CYP26A1|CYP26C1|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2E1|DCLRE1A|DCLRE1C|DDIT4|DDX21|DDX50|DENND10|DEPP1|DHX32|DKK1|DLG5|DMBT1|DNA2|DNAJB12|DNAJC1|DNAJC12|DNAJC9|DNMBP|DNTT|DOCK1|DPCD|DPYSL4|DRGX|DUSP13B|DUSP29|DUSP5|DYDC1|DYDC2|EBF3|EBLN1|ECD|ECHS1|EDRF1|EEF1AKMT2|EGR2|EIF3A|EIF4EBP2|EIF5AL1|ELOVL3|EMX2|EMX2OS|ENKUR|ENO4|ENTPD1|ENTPD7|EPC1|ERCC6|ERLIN1|EXOC6|EXOSC1|FAM107B|FAM13C|FAM149B1|FAM170B|FAM171A1|FAM204A|FAM241B|FAM24A|FAM24B|FAM25A|FAM25C|FAM25E|FAM25G|FAM53B|FANK1|FAS|FAS-AS1|FBXL15|FBXW4|FFAR4|FGF8|FGFBP3|FGFR2|FHIP2A|FOXI2|FRA10AC1|FRAT1|FRAT2|FRMD4A|FRMPD2|FUOM|FUT11|FXYD4|FZD8|GAD2|GBF1|GDF10|GDF2|GFRA1|GHITM|GJD4|GLRX3|GLUD1|GOLGA7B|GOT1|GPAM|GPR158|GPR15LG|GPR26|GPRIN2|GRID1|GRK5|GSTO1|GSTO2|HABP2|HACD1|HECTD2|HELLS|HERC4|HHEX|HIF1AN|HK1|HKDC1|HMX2|HMX3|HNRNPF|HNRNPH3|HOGA1|HPS1|HPS6|HPSE2|HSPA12A|HSPA14|HTR7|HTRA1|IDE|IFIT1|IFIT1B|IFIT2|IFIT3|IFIT5|IKZF5|INA|INPP5A|INPP5F|INSYN2A|IPMK|ITGA8|ITGB1|ITPRIP|JAKMIP3|JCAD|JMJD1C|KAT6B|KAZALD1|KCNIP2|KCNK18|KCNMA1|SYNPO2L|PLEKHA1|PLPP4|PLXDC2|PNLIP|PLEKHS1|PIK3AP1|SYT15|TACC2|LIPA|LINC01166|LINC01520|LINC02870|KLLN|TACR2|TAF5|TBATA|TBC1D12|TCERG1L|KIFBP|PI4K2A|PIP4K2A|KNDC1|KIAA1217|KIF11|KIF20B|KIF5B|LBX1|LCOR|LDB1|LDB3|LGI1|LHPP|LIPF|LIPJ|LIPK|LIPM|LIPN|LOC101929662|LOXL4|LRIT1|LRIT2|LRMDA|LRRC18|LRRC20|LRRC27|LRRTM3|LYZL1|LYZL2|LZTS2|MACROH2A2|MAP3K8|MAPK8|MARCHF5|MARCHF8|MARVELD1|MASTL|MAT1A|MBL2|MCM10|MCMBP|MCU|MEIG1|MFSD13A|MGMT|MICU1|MINDY3|MINPP1|MIR107|MIR146B|MIR1915|MIR1915HG|MIR346|MKI67|MKX|MLLT10|MMP21|MMRN2|MMS19|MORN4|MPP7|MRPL43|MRPS16|MSMB|MSRB2|MSS51|MTG1|MTPAP|MTRNR2L5|MTRNR2L7|MXI1|MYO3A|MYOF|MYOZ1|MYPN|NANOS1|NCOA4|NDST2|NDUFB8|NEBL|NEURL1|NEUROG3|NFKB2|NHLRC2|NKX1-2|NKX2-3|NKX6-2|NMT2|NOC3L|NODAL|NOLC1|NPFFR1|NPM3|NPS|NPY4R|NRAP|NRBF2|NRG3|NRP1|NSMCE4A|NSUN6|NT5C2|NUDT13|NUTM2A|NUTM2B|OAT|ODAD2|OGA|OGDHL|OIT3|OLAH|OPALIN|OPN4|OPTN|OR13A1|OTUD1|P4HA1|PALD1|PANK1|PAOX|PAPSS2|PARD3|PARG|PAX2|PBLD|PCBD1|PCDH15|PCGF5|PCGF6|PDCD11|PDCD4|PDE6C|PDLIM1|PDSS1|PDZD7|PDZD8|PGAM1|PGBD3|PITX3|PKD2L1|PLA2G12B|PLAC9|PLAU|PLCE1|PNLIPRP1|PNLIPRP2|PNLIPRP3|POLL|POLR3A|PPA1|PPIF|PPP1R3C|PPP2R2D|PPP3CB|PPRC1|PRAP1|PRDX3|PRF1|PRINS|PRKG1|PRLHR|PRPF18|PRTFDC1|PRXL2A|PSAP|PSD|PSTK|PTCHD3|PTEN|PTER|PTF1A|PTPN20|PTPRE|PWWP2B|PYROXD2|R3HCC1L|RAB11FIP2|RAB18|RASGEF1A|RASSF4|RBM20|RBP3|RBP4|REEP3|RET|RGR|RGS10|RHOBTB1|RNLS|RPP30|RPP38|RPP38-DT|RPS24|RRP12|RSU1|RTKN2|RUFY2|SAMD8|SAR1A|SCD|SEC23IP|SEC24C|SEC31B|SEMA4G|SEPHS1|SFR1|SFRP5|SFTPA1|SFTPA2|SFTPD|SFXN2|SFXN3|SFXN4|SGMS1|SGPL1|SH2D4B|SH3PXD2A|SHLD2|SHOC2|SHTN1|SIRT1|SKIDA1|SLC16A12|SLC16A9|SLC18A2|SLC18A3|SLC25A16|SLC25A28|SLC29A3|SLC35G1|SLC39A12|SLF2|SLIT1|SLK|SMC3|SMNDC1|SNCG|SNORA12|SORBS1|SORCS1|SORCS3|SPAG6|SPMIP5|SPOCK2|SPRN|SRGN|ST8SIA6|STAM|STAMBPL1|STK32C|STN1|STOX1|SUFU|SUPV3L1|SUV39H2|SVIL|TCERG1L-AS1|TCF7L2|TCTN3|TDRD1|TECTB|TET1|TEX36|TFAM|THNSL1|TIAL1|TIMM23|TLL2|TLX1|TLX1NB|TM9SF3|TMEM254|TMEM26|TMEM273|TMEM72|TNKS2|TRDMT1|TRIM8|TRUB1|TSPAN14|TSPAN15|TUBGCP2|TWNK|TYSND1|UBE2D1|UBTD1|UCMA|UNC5B|UROS|USP54|UTF1|VAX1|VCL|VDAC2|VENTX|VIM|VPS26A|VSIR|VSTM4|VTI1A|VWA2|WAC|WAPL|WASHC2A|WASHC2C|WBP1L|WDFY4|WDR11|WNT8B|XPNPEP1|YME1L1|ZCCHC24|ZDHHC16|ZDHHC6|ZEB1|ZFAND4|ZFYVE27|ZMIZ1|ZNF22|ZNF22-AS1|ZNF239|ZNF248|ZNF25|ZNF32|ZNF33A|ZNF33B|ZNF365|ZNF37A|ZNF438|ZNF485|ZNF488|ZNF503|ZNF511|ZNF518A|ZRANB1|ZSWIM8|ZWINT		Distal 10q deletion syndrome	VCV002574686	10	12829206 - 135427143			2574686	2739622			copy number loss		Pathogenic		no assertion criteria provided							
GRCh37/hg19 10q26.12-26.3(chr10:122610933-135439810)x1	ABRAXAS2|ACADSB|ADAM12|ADAM8|ADGRA1|ARMS2|ATE1|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf88|C10orf90|CALY|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DHX32|DMBT1|DOCK1|DPYSL4|EBF3|ECHS1|EDRF1|EEF1AKMT2|FAM24A|FAM24B|FAM53B|FANK1|FGFR2|FOXI2|FRG2B|FUOM|GLRX3|GPR26|HMX2|HMX3|HTRA1|IKZF5|INPP5A|INSYN2A|JAKMIP3|KNDC1|LHPP|LINC01166|LINC02870|LRRC27|MGMT|MKI67|MMP21|MTG1|NKX1-2|NKX6-2|NPS|NSMCE4A|OAT|PAOX|PLEKHA1|PPP2R2D|PRAP1|PSTK|PTPRE|PWWP2B|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TEX36|TUBGCP2|UROS|UTF1|VENTX|WDR11|ZNF511|ZRANB1		not provided	VCV002498475	10	122610933 - 135439810			2498475	2476452			copy number loss		Pathogenic	Jan 1, 2023	criteria provided, single submitter							
NC_000010.10:g.(?_123239371)_(124813281_?)del	ACADSB|ARMS2|ATE1|BTBD16|C10orf120|C10orf88|CUZD1|DMBT1|FAM24A|FAM24B|FGFR2|HTRA1|IKZF5|NSMCE4A|PLEKHA1|PSTK|TACC2		FGFR2-related craniosynostosis	VCV002422456	10	123239371 - 124813281			2422456	1942491			Deletion		Uncertain significance	Sep 2, 2022	criteria provided, single submitter							
GRCh37/hg19 10q26.13(chr10:123346115-123425406)	FGFR2		not specified	VCV001527610	10	123346115 - 123425406			1527610	1519099			copy number loss		Pathogenic	Mar 1, 2022	criteria provided, single submitter							
GRCh37/hg19 10q26.12-26.3(chr10:122343861-135427143)	FAM24A|FAM24B|FAM53B|FANK1|FGFR2|FOXI2|FUOM|GLRX3|GPR26|HMX2|HMX3|HTRA1|IKZF5|INPP5A|INSYN2A|JAKMIP3|KNDC1|LHPP|LINC01166|LINC02870|LRRC27|MGMT|MKI67|MMP21|MTG1|NKX1-2|NKX6-2|NPS|NSMCE4A|OAT|PAOX|PLEKHA1|PLPP4|PPP2R2D|PRAP1|PSTK|PTPRE|PWWP2B|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TEX36|TUBGCP2|UROS|UTF1|VENTX|WDR11|ZNF511|ZRANB1|ABRAXAS2|ACADSB|ADAM12|ADAM8|ADGRA1|ARMS2|ATE1|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf88|C10orf90|CALY|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DHX32|DMBT1|DOCK1|DPYSL4|EBF3|ECHS1|EDRF1|EEF1AKMT2		not specified	VCV001527609	10	122343861 - 135427143			1527609	1519098			copy number loss		Pathogenic	Mar 1, 2022	criteria provided, single submitter							
GRCh37/hg19 10q26.12-26.3(chr10:122125760-135062972)	ABRAXAS2|ACADSB|ADAM12|ADGRA1|ARMS2|ATE1|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf88|C10orf90|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|DHX32|DMBT1|DOCK1|DPYSL4|EBF3|EDRF1|EEF1AKMT2|FAM24A|FAM24B|FAM53B|FANK1|FGFR2|FOXI2|GLRX3|GPR26|HMX2|HMX3|HTRA1|IKZF5|INPP5A|INSYN2A|JAKMIP3|KNDC1|LHPP|LINC01166|LINC02870|LRRC27|MGMT|MKI67|MMP21|NKX1-2|NKX6-2|NPS|NSMCE4A|OAT|PLEKHA1|PLPP4|PPP2R2D|PSTK|PTPRE|PWWP2B|STK32C|TACC2|TCERG1L|TCERG1L-AS1|TEX36|UROS|UTF1|VENTX|WDR11|ZRANB1		not specified	VCV001527608	10	122125760 - 135062972			1527608	1519097			copy number gain		Likely pathogenic	Mar 1, 2022	criteria provided, single submitter							
GRCh37/hg19 10q25.3-26.13(chr10:117019650-125217066)	ACADSB|ARMS2|ATE1|ATRNL1|BAG3|BTBD16|BUB3|C10orf120|C10orf82|C10orf88|CACUL1|CASC2|CCDC172|CUZD1|DENND10|DMBT1|EIF3A|EMX2|EMX2OS|ENO4|FAM204A|FAM24A|FAM24B|FGFR2|GFRA1|GRK5|HMX2|HMX3|HSPA12A|HTRA1|IKZF5|INPP5F|KCNK18|MCMBP|NANOS1|NSMCE4A|PDZD8|PLEKHA1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PRDX3|PRLHR|PSTK|RAB11FIP2|RGS10|SEC23IP|SFXN4|SHTN1|SLC18A2|TACC2|TIAL1|VAX1|WDR11		not specified	VCV001527606	10	117019650 - 125217066			1527606	1519095			copy number loss		Pathogenic	Mar 1, 2022	criteria provided, single submitter							
GRCh37/hg19 10q25.1-26.3(chr10:108455687-135427143)	ABLIM1|ABRAXAS2|ACADSB|ACSL5|ADAM12|ADAM8|ADD3|ADGRA1|ADRA2A|ADRB1|AFAP1L2|ARMS2|ATE1|ATRNL1|BAG3|BBIP1|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf82|C10orf88|C10orf90|CACUL1|CALY|CASC2|CASP7|CCDC172|CCDC186|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DCLRE1A|DENND10|DHX32|DMBT1|DOCK1|DPYSL4|DUSP5|EBF3|ECHS1|EDRF1|EEF1AKMT2|EIF3A|EMX2|EMX2OS|ENO4|FAM204A|FAM24A|FAM24B|FAM53B|FANK1|FGFR2|FHIP2A|FOXI2|FUOM|GFRA1|GLRX3|GPAM|GPR26|GRK5|HABP2|HMX2|HMX3|HSPA12A|HTRA1|IKZF5|INPP5A|INPP5F|INSYN2A|JAKMIP3|KCNK18|KNDC1|LHPP|LINC01166|LINC02870|LRRC27|MCMBP|MGMT|MKI67|MMP21|MTG1|MXI1|NANOS1|NHLRC2|NKX1-2|NKX6-2|NPS|NRAP|NSMCE4A|OAT|PAOX|PDCD4|PDZD8|PLEKHA1|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PPP2R2D|PRAP1|PRDX3|PRLHR|PSTK|PTPRE|PWWP2B|RAB11FIP2|RBM20|RGS10|SEC23IP|SFXN4|SHOC2|SHTN1|SLC18A2|SMC3|SMNDC1|SORCS1|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TCF7L2|TDRD1|TECTB|TEX36|TIAL1|TRUB1|TUBGCP2|UROS|UTF1|VAX1|VENTX|VTI1A|VWA2|WDR11|XPNPEP1|ZDHHC6|ZNF511|ZRANB1		not specified	VCV001527605	10	108455687 - 135427143			1527605	1519094			copy number gain		Pathogenic	Mar 1, 2022	criteria provided, single submitter							
GRCh37/hg19 10q25.3-26.3(chr10:118247181-135435319)x3	ECHS1|EDRF1|EEF1AKMT2|TCERG1L|TCERG1L-AS1|TEX36|TIAL1|TUBGCP2|FAM53B|FANK1|FUOM|EIF3A|EMX2|FGFR2|FOXI2|EMX2OS|ENO4|FAM204A|FAM24A|FAM24B|ABRAXAS2|ACADSB|ADAM12|ADAM8|ADGRA1|ARMS2|ATE1|BAG3|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf82|C10orf88|C10orf90|CACUL1|CALY|CASC2|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DENND10|DHX32|DMBT1|DOCK1|DPYSL4|EBF3|GLRX3|GPR26|GRK5|HMX2|HMX3|HSPA12A|HTRA1|IKZF5|INPP5A|INPP5F|INSYN2A|JAKMIP3|KCNK18|KNDC1|LHPP|LINC01166|LINC02870|LRRC27|MCMBP|MGMT|MKI67|MMP21|MTG1|NANOS1|NKX1-2|NKX6-2|NPS|NSMCE4A|OAT|PAOX|PDZD8|PLEKHA1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PPP2R2D|PRAP1|PRDX3|PRLHR|PSTK|PTPRE|PWWP2B|RAB11FIP2|RGS10|SEC23IP|SFXN4|SHTN1|SLC18A2|SPRN|STK32C|SYCE1|TACC2|UROS|UTF1|VAX1|VENTX|WDR11|ZNF511|ZRANB1		not provided	VCV001180521	10	118247181 - 135435319			1180521	1170049			copy number gain		Pathogenic	Feb 20, 2019	criteria provided, single submitter							
GRCh37/hg19 10q26.12-26.3(chr10:122785023-135457222)x1	FANK1|FGFR2|FOXI2|FRG2B|GPR26|HMX2|LHPP|LINC01166|JAKMIP3|KNDC1|GLRX3|IKZF5|INPP5A|HMX3|HTRA1|FUOM|INSYN2A|ABRAXAS2|ACADSB|ADAM12|ADAM8|ADGRA1|ARMS2|ATE1|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf88|C10orf90|CALY|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DHX32|DMBT1|DOCK1|DPYSL4|EBF3|ECHS1|EDRF1|EEF1AKMT2|FAM24A|FAM24B|FAM53B|LINC02870|LRRC27|MGMT|MKI67|MMP21|MTG1|NKX1-2|NKX6-2|NPS|NSMCE4A|OAT|PAOX|PLEKHA1|PPP2R2D|PRAP1|PSTK|PTPRE|PWWP2B|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TEX36|TUBGCP2|UROS|UTF1|VENTX|ZNF511|ZRANB1		See cases	VCV001172570	10	122785023 - 135457222			1172570	1161741			copy number loss		Pathogenic	May 13, 2021	no assertion criteria provided							
Single allele	BTBD16|C10orf120|C10orf88|GRK5|HTRA1|INPP5F|IKZF5|CACUL1|DENND10|MCMBP|CASC2|CUZD1|DMBT1|EIF3A|ACADSB|ARMS2|ATE1|BAG3|EMX2|EMX2OS|FAM204A|FAM24A|FAM24B|FGFR2|NANOS1|NSMCE4A|PLEKHA1|PLPP4|PRDX3|PRLHR|PSTK|RAB11FIP2|RGS10|SEC23IP|SFXN4|TACC2|TIAL1|WDR11		not provided	VCV001077193	10	119302758 - 124813305			1077193	1065884			Deletion		Likely pathogenic	May 13, 2021	criteria provided, single submitter							
NC_000010.10:g.(?_123276813)_(123276997_?)del	FGFR2		FGFR2-related craniosynostosis	VCV001073828	10	123276813 - 123276997			1073828	1057453			Deletion		Pathogenic	Nov 8, 2022	criteria provided, single submitter							
t(10;16)(q26;q11)	FGFR2|VPS35		Glioma	VCV000930214	10	123241693 - 123243211			930214	918533			Translocation		Likely pathogenic	Mar 14, 2020	no assertion criteria provided							
GRCh37/hg19 10q26.13(chr10:123232922-124638514)x3	HTRA1|ARMS2|TACC2|ATE1|BTBD16|FGFR2|DMBT1|PLEKHA1|FAM24B|C10orf120|CUZD1|NSMCE4A		not provided	VCV000815380	10	123232922 - 124638514			815380	803589			copy number gain		Uncertain significance	Nov 7, 2018	no assertion criteria provided							
GRCh37/hg19 10q26.11-26.3(chr10:119996339-135427143)x3	FGFR2|FOXI2|FUOM|GLRX3|GPR26|ABRAXAS2|ACADSB|ADAM12|ADAM8|ADGRA1|ARMS2|ATE1|BAG3|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf88|C10orf90|CACUL1|CALY|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DENND10|DHX32|DMBT1|DOCK1|DPYSL4|EBF3|ECHS1|EDRF1|EEF1AKMT2|EIF3A|FAM204A|FAM24A|FAM24B|FAM53B|FANK1|GRK5|HMX2|HMX3|HTRA1|IKZF5|INPP5A|INPP5F|INSYN2A|JAKMIP3|KNDC1|LHPP|LINC01166|LINC02870|LRRC27|MCMBP|MGMT|MKI67|MMP21|MTG1|NANOS1|NKX1-2|NKX6-2|NPS|NSMCE4A|OAT|PAOX|PLEKHA1|PLPP4|PPP2R2D|PRAP1|PRDX3|PRLHR|PSTK|PTPRE|PWWP2B|RGS10|SEC23IP|SFXN4|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TEX36|TIAL1|TUBGCP2|UROS|UTF1|VENTX|WDR11|ZNF511|ZRANB1		not provided	VCV000815379	10	119996339 - 135427143			815379	803588			copy number gain		Pathogenic	Oct 16, 2018	no assertion criteria provided							
GRCh37/hg19 10q25.2-26.3(chr10:114544537-135427143)x3	ABLIM1|ABRAXAS2|ACADSB|ADAM12|ADAM8|ADGRA1|ADRB1|AFAP1L2|ARMS2|ATE1|ATRNL1|BAG3|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf82|C10orf88|C10orf90|CACUL1|CALY|CASC2|CASP7|CCDC172|CCDC186|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DCLRE1A|DENND10|DHX32|DMBT1|DOCK1|DPYSL4|EBF3|ECHS1|EDRF1|EEF1AKMT2|EIF3A|EMX2|EMX2OS|ENO4|FAM204A|FAM24A|FAM24B|FAM53B|FANK1|FGFR2|FHIP2A|FOXI2|FUOM|GFRA1|GLRX3|GPR26|GRK5|HABP2|HMX2|HMX3|HSPA12A|HTRA1|IKZF5|INPP5A|INPP5F|INSYN2A|JAKMIP3|KCNK18|KNDC1|LHPP|LINC01166|LINC02870|LRRC27|MCMBP|MGMT|MKI67|MMP21|MTG1|NANOS1|NHLRC2|NKX1-2|NKX6-2|NPS|NRAP|NSMCE4A|OAT|PAOX|PDZD8|PLEKHA1|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PPP2R2D|PRAP1|PRDX3|PRLHR|PSTK|PTPRE|PWWP2B|RAB11FIP2|RGS10|SEC23IP|SFXN4|SHTN1|SLC18A2|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TCF7L2|TDRD1|TEX36|TIAL1|TRUB1|TUBGCP2|UROS|UTF1|VAX1|VENTX|VTI1A|VWA2|WDR11|ZNF511|ZRANB1		not provided	VCV000687114	10	114544537 - 135427143			687114	674706			copy number gain		Pathogenic	May 31, 2017	no assertion criteria provided							
GRCh37/hg19 10q25.1-26.3(chr10:110022170-135439095)	ABLIM1|ABRAXAS2|ACADSB|ACSL5|ADAM12|ADAM8|ADD3|ADGRA1|ADRA2A|ADRB1|AFAP1L2|ARMS2|ATE1|ATRNL1|BAG3|BBIP1|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf82|C10orf88|C10orf90|CACUL1|CALY|CASC2|CASP7|CCDC172|CCDC186|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DCLRE1A|DENND10|DHX32|DMBT1|DOCK1|DPYSL4|DUSP5|EBF3|ECHS1|EDRF1|EEF1AKMT2|EIF3A|EMX2|EMX2OS|ENO4|FAM204A|FAM24A|FAM24B|FAM53B|FANK1|FGFR2|FHIP2A|FOXI2|FRG2B|FUOM|GFRA1|GLRX3|GPAM|GPR26|GRK5|HABP2|HMX2|HMX3|HSPA12A|HTRA1|IKZF5|INPP5A|INPP5F|INSYN2A|JAKMIP3|KCNK18|KNDC1|LHPP|LINC01166|LINC02870|LRRC27|MCMBP|MGMT|MKI67|MMP21|MTG1|MXI1|NANOS1|NHLRC2|NKX1-2|NKX6-2|NPS|NRAP|NSMCE4A|OAT|PAOX|PDCD4|PDZD8|PLEKHA1|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PPP2R2D|PRAP1|PRDX3|PRLHR|PSTK|PTPRE|PWWP2B|RAB11FIP2|RBM20|RGS10|SEC23IP|SFXN4|SHOC2|SHTN1|SLC18A2|SMC3|SMNDC1|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TCF7L2|TDRD1|TECTB|TEX36|TIAL1|TRUB1|TUBGCP2|UROS|UTF1|VAX1|VENTX|VTI1A|VWA2|WDR11|XPNPEP1|ZDHHC6|ZNF511|ZRANB1		not provided	VCV000625657	10	110022170 - 135439095			625657	613961			copy number gain		Pathogenic	Nov 1, 2018	criteria provided, single submitter							
GRCh37/hg19 10q25.3-26.13(chr10:117024753-124942806)	ACADSB|ARMS2|ATE1|ATRNL1|BAG3|BTBD16|BUB3|C10orf120|C10orf82|C10orf88|CACUL1|CASC2|CCDC172|CUZD1|DENND10|DMBT1|EIF3A|EMX2|EMX2OS|ENO4|FAM204A|FAM24A|FAM24B|FGFR2|GFRA1|GRK5|HMX2|HMX3|HSPA12A|HTRA1|IKZF5|INPP5F|KCNK18|MCMBP|NANOS1|NSMCE4A|PDZD8|PLEKHA1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PRDX3|PRLHR|PSTK|RAB11FIP2|RGS10|SEC23IP|SFXN4|SHTN1|SLC18A2|TACC2|TIAL1|VAX1|WDR11		Distal 10q deletion syndrome	VCV000625556	10	117024753 - 124942806			625556	613860			copy number loss		Pathogenic	Nov 1, 2018	criteria provided, single submitter							
GRCh37/hg19 10q23.33-26.3(chr10:94346520-135427143)x3	ABCC2|ABLIM1|ABRAXAS2|ACADSB|ACSL5|ACSM6|ACTR1A|ADAM12|ADAM8|ADD3|ADGRA1|ADRA2A|ADRB1|AFAP1L2|ALDH18A1|ANKRD2|ARHGAP19|ARL3|ARMH3|ARMS2|AS3MT|ATE1|ATP5MK|ATRNL1|AVPI1|BAG3|BBIP1|BCCIP|BLNK|BLOC1S2|BNIP3|BORCS7|BTBD16|BTRC|BUB3|C10orf12|C10orf120|C10orf131|C10orf62|C10orf82|C10orf88|C10orf90|C10orf95|CACUL1|CALHM1|CALHM2|CALHM3|CALY|CASC2|CASP7|CC2D2B|CCDC172|CCDC186|CCNJ|CEP55|CFAP43|CFAP46|CFAP58|CHST15|CHUK|CLRN3|CNNM1|CNNM2|COL17A1|COX15|CPN1|CPXM2|CRTAC1|CTBP2|CUEDC2|CUTC|CUZD1|CWF19L1|CYP17A1|CYP26A1|CYP26C1|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2E1|DCLRE1A|DENND10|DHX32|DMBT1|DNMBP|DNTT|DOCK1|DPCD|DPYSL4|DUSP5|EBF3|ECHS1|EDRF1|EEF1AKMT2|EIF3A|ELOVL3|EMX2|EMX2OS|ENO4|ENTPD1|ENTPD7|ERLIN1|EXOC6|EXOSC1|FAM204A|FAM24A|FAM24B|FAM53B|FANK1|FBXL15|FBXW4|FFAR4|FGF8|FGFR2|FHIP2A|FOXI2|FRA10AC1|FRAT1|FRAT2|FUOM|GBF1|GFRA1|GLRX3|GOLGA7B|GOT1|GPAM|GPR26|GRK5|GSTO1|GSTO2|HABP2|HELLS|HHEX|HIF1AN|HMX2|HMX3|HOGA1|HPS1|HPS6|HPSE2|HSPA12A|HTRA1|IKZF5|INA|INPP5A|INPP5F|INSYN2A|ITPRIP|JAKMIP3|KAZALD1|KCNIP2|KCNK18|KIF11|KNDC1|LBX1|LCOR|LDB1|LGI1|LHPP|LINC01166|LINC02870|LOXL4|LRRC27|LZTS2|MARVELD1|MCMBP|MFSD13A|MGMT|MIR146B|MKI67|MMP21|MMS19|MORN4|MRPL43|MTG1|MXI1|MYOF|NANOS1|NDUFB8|NEURL1|NFKB2|NHLRC2|NKX1-2|NKX2-3|NKX6-2|NOC3L|NOLC1|NPM3|NPS|NRAP|NSMCE4A|NT5C2|OAT|OGA|OPALIN|PAOX|PAX2|PCGF6|PDCD11|PDCD4|PDE6C|PDLIM1|PDZD7|PDZD8|PGAM1|PI4K2A|PIK3AP1|PITX3|PKD2L1|PLCE1|PLEKHA1|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|POLL|PPP2R2D|PPRC1|PRAP1|PRDX3|PRLHR|PSD|PSTK|PTPRE|PWWP2B|PYROXD2|R3HCC1L|RAB11FIP2|RBM20|RBP4|RGS10|RRP12|SCD|SEC23IP|SEC31B|SEMA4G|SFR1|SFRP5|SFXN2|SFXN3|SFXN4|SH3PXD2A|SHOC2|SHTN1|SLC18A2|SLC25A28|SLC35G1|SLF2|SLIT1|SLK|SMC3|SMNDC1|SNORA12|SORBS1|SORCS1|SORCS3|SPRN|STK32C|STN1|SUFU|SYCE1|TACC2|TAF5|TBC1D12|TCERG1L|TCERG1L-AS1|TCF7L2|TCTN3|TDRD1|TECTB|TEX36|TIAL1|TLL2|TLX1|TLX1NB|TM9SF3|TRIM8|TRUB1|TUBGCP2|TWNK|UBTD1|UROS|UTF1|VAX1|VENTX|VTI1A|VWA2|WBP1L|WDR11|WNT8B|XPNPEP1|ZDHHC16|ZDHHC6|ZFYVE27|ZNF511|ZNF518A|ZRANB1		not provided	VCV000563802	10	94346520 - 135427143			563802	554986			copy number gain		Pathogenic	Jul 8, 2017	no assertion criteria provided							
GRCh37/hg19 10q24.33-26.3(chr10:105613040-135427143)x3	ABLIM1|ABRAXAS2|ACADSB|ACSL5|ADAM12|ADAM8|ADD3|ADGRA1|ADRA2A|ADRB1|AFAP1L2|ARMS2|ATE1|ATRNL1|BAG3|BBIP1|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf82|C10orf88|C10orf90|CACUL1|CALY|CASC2|CASP7|CCDC172|CCDC186|CFAP43|CFAP46|CFAP58|CHST15|CLRN3|COL17A1|CPXM2|CTBP2|CUZD1|CYP2E1|DCLRE1A|DENND10|DHX32|DMBT1|DOCK1|DPYSL4|DUSP5|EBF3|ECHS1|EDRF1|EEF1AKMT2|EIF3A|EMX2|EMX2OS|ENO4|FAM204A|FAM24A|FAM24B|FAM53B|FANK1|FGFR2|FHIP2A|FOXI2|FUOM|GFRA1|GLRX3|GPAM|GPR26|GRK5|GSTO1|GSTO2|HABP2|HMX2|HMX3|HSPA12A|HTRA1|IKZF5|INPP5A|INPP5F|INSYN2A|ITPRIP|JAKMIP3|KCNK18|KNDC1|LHPP|LINC01166|LINC02870|LRRC27|MCMBP|MGMT|MKI67|MMP21|MTG1|MXI1|NANOS1|NHLRC2|NKX1-2|NKX6-2|NPS|NRAP|NSMCE4A|OAT|PAOX|PDCD4|PDZD8|PLEKHA1|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PPP2R2D|PRAP1|PRDX3|PRLHR|PSTK|PTPRE|PWWP2B|RAB11FIP2|RBM20|RGS10|SEC23IP|SFR1|SFXN4|SH3PXD2A|SHOC2|SHTN1|SLC18A2|SLK|SMC3|SMNDC1|SORCS1|SORCS3|SPRN|STK32C|STN1|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TCF7L2|TDRD1|TECTB|TEX36|TIAL1|TRUB1|TUBGCP2|UROS|UTF1|VAX1|VENTX|VTI1A|VWA2|WDR11|XPNPEP1|ZDHHC6|ZNF511|ZRANB1		not provided	VCV000563801	10	105613040 - 135427143			563801	554985			copy number gain		Pathogenic	Apr 12, 2018	no assertion criteria provided							
GRCh37/hg19 10q26.11-26.3(chr10:121269222-135427143)x3	ABRAXAS2|ACADSB|ADAM12|ADAM8|ADGRA1|ARMS2|ATE1|BAG3|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf88|C10orf90|CALY|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DHX32|DMBT1|DOCK1|DPYSL4|EBF3|ECHS1|EDRF1|EEF1AKMT2|FAM24A|FAM24B|FAM53B|FANK1|FGFR2|FOXI2|FUOM|GLRX3|GPR26|HMX2|HMX3|HTRA1|IKZF5|INPP5A|INPP5F|INSYN2A|JAKMIP3|KNDC1|LHPP|LINC01166|LINC02870|LRRC27|MCMBP|MGMT|MKI67|MMP21|MTG1|NKX1-2|NKX6-2|NPS|NSMCE4A|OAT|PAOX|PLEKHA1|PLPP4|PPP2R2D|PRAP1|PSTK|PTPRE|PWWP2B|RGS10|SEC23IP|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TEX36|TIAL1|TUBGCP2|UROS|UTF1|VENTX|WDR11|ZNF511|ZRANB1		not provided	VCV000563799	10	121269222 - 135427143			563799	554983			copy number gain		Pathogenic	Dec 28, 2017	no assertion criteria provided							
GRCh37/hg19 10q26.12-26.3(chr10:122509781-135427143)x1	ABRAXAS2|ACADSB|ADAM12|ADAM8|ADGRA1|ARMS2|ATE1|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf88|C10orf90|CALY|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DHX32|DMBT1|DOCK1|DPYSL4|EBF3|ECHS1|EDRF1|EEF1AKMT2|FAM24A|FAM24B|FAM53B|FANK1|FGFR2|FOXI2|FUOM|GLRX3|GPR26|HMX2|HMX3|HTRA1|IKZF5|INPP5A|INSYN2A|JAKMIP3|KNDC1|LHPP|LINC01166|LINC02870|LRRC27|MGMT|MKI67|MMP21|MTG1|NKX1-2|NKX6-2|NPS|NSMCE4A|OAT|PAOX|PLEKHA1|PPP2R2D|PRAP1|PSTK|PTPRE|PWWP2B|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TEX36|TUBGCP2|UROS|UTF1|VENTX|WDR11|ZNF511|ZRANB1		not provided	VCV000563798	10	122509781 - 135427143			563798	554982			copy number loss		Pathogenic	Aug 4, 2023	criteria provided, single submitter							
GRCh37/hg19 10q26.12-26.3(chr10:123019239-135427143)x1	ABRAXAS2|ACADSB|ADAM12|ADAM8|ADGRA1|ARMS2|ATE1|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf88|C10orf90|CALY|CFAP46|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DHX32|DMBT1|DOCK1|DPYSL4|EBF3|ECHS1|EDRF1|EEF1AKMT2|FAM24A|FAM24B|FAM53B|FANK1|FGFR2|FOXI2|FUOM|GLRX3|GPR26|HMX2|HMX3|HTRA1|IKZF5|INPP5A|INSYN2A|JAKMIP3|KNDC1|LHPP|LINC01166|LINC02870|LRRC27|MGMT|MKI67|MMP21|MTG1|NKX1-2|NKX6-2|NPS|NSMCE4A|OAT|PAOX|PLEKHA1|PPP2R2D|PRAP1|PSTK|PTPRE|PWWP2B|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TEX36|TUBGCP2|UROS|UTF1|VENTX|ZNF511|ZRANB1		not provided	VCV000563797	10	123019239 - 135427143			563797	554981			copy number loss		Pathogenic	Dec 18, 2017	no assertion criteria provided							
GRCh37/hg19 10q11.21-26.3(chr10:42347406-135534747)x1	COX15|CPEB3|FAM204A|FAM241B|HOGA1|HPS1|CPN1|FAM24A|FAM24B|HPS6|HPSE2|MAPK8|OPN4|OR13A1|RASGEF1A|TCERG1L-AS1|TCF7L2|ZNF485|ZNF488|ZSWIM8|ZRANB1|ZNF503|ZWINT|ZNF511|ZNF518A|TECTB|TET1|TEX36|TFAM|TIAL1|TIMM23|TLL2|TCTN3|TDRD1|TMEM273|TMEM72|TNKS2|TLX1|TLX1NB|TM9SF3|TMEM254|TMEM26|SFR1|SFRP5|SFTPA1|REEP3|SCD|RASSF4|RBM20|RBP3|SEC23IP|SEC24C|SFTPA2|RBP4|SEC31B|SEMA4G|PDLIM1|PDZD7|PDZD8|PGAM1|P4HA1|PALD1|PGBD3|PANK1|PAOX|PAPSS2|PARG|PDCD11|PDCD4|PDE6C|MIR146B|MARCHF5|MFSD13A|MGMT|MICU1|MINPP1|MIR107|MARCHF8|MARVELD1|MAT1A|MBL2|MCMBP|MCU|HSPA12A|IFIT1|IFIT1B|IFIT2|IFIT3|INA|INPP5A|IFIT5|IKZF5|INPP5F|INSYN2A|HTR7|HTRA1|IDE|FGFR2|FHIP2A|FAM25C|FAM25E|FAM25G|FAM53B|FANK1|FGF8|FGFBP3|FOXI2|FRA10AC1|FAM25A|CYP2C8|CYP2C9|CTBP2|CYP17A1|CYP26A1|CYP26C1|CYP2C18|CYP2C19|CYP2E1|CPXM2|CRTAC1|CSGALNACT2|CSTF2T|C10orf55|C10orf62|C10orf12|C10orf120|C10orf105|C10orf131|C10orf53|BTAF1|BTBD16|BTRC|BUB3|C10orf71|C10orf82|C10orf88|C10orf90|C10orf95|CABCOCO1|CACUL1|CALHM1|CALHM2|CALHM3|CALY|CAMK2G|CASC2|CASP7|CC2D2B|CCAR1|CCDC172|CCDC186|CCDC6|CCNJ|CCSER2|CDH23|CDHR1|CDK1|CEP55|CFAP43|CFAP46|CFAP58|CFAP70|CH25H|CHAT|CHCHD1|CHST15|CHST3|CHUK|CISD1|CLRN3|CNNM1|CNNM2|COL13A1|COL17A1|COMTD1|CTNNA3|CUEDC2|CUTC|CUZD1|CWF19L1|CXCL12|DCLRE1A|DDIT4|DDX21|DDX50|DENND10|DEPP1|DHX32|DKK1|DLG5|DMBT1|DNA2|DNAJB12|DNAJC12|DNAJC9|DNMBP|DNTT|DOCK1|DPCD|DPYSL4|DRGX|DUSP13B|DUSP29|DUSP5|DYDC1|DYDC2|EBF3|ECD|ECHS1|EDRF1|EEF1AKMT2|EGR2|EIF3A|EIF4EBP2|EIF5AL1|ELOVL3|EMX2|EMX2OS|ENO4|ENTPD1|ENTPD7|ERCC6|ERLIN1|EXOC6|EXOSC1|FAM13C|FAM149B1|FAM170B|FAS|FAS-AS1|FBXL15|FBXW4|FFAR4|FRAT1|FRAT2|FRG2B|FRMPD2|FUOM|FUT11|FXYD4|GBF1|GDF10|GDF2|GFRA1|GHITM|GLRX3|GLUD1|GOLGA7B|GOT1|GPAM|GPR15LG|GPR26|GPRIN2|GRID1|GRK5|GSTO1|GSTO2|HABP2|HECTD2|HELLS|HERC4|HHEX|HIF1AN|HK1|HKDC1|HMX2|HMX3|HNRNPF|HNRNPH3|IPMK|ITPRIP|JAKMIP3|JMJD1C|KAT6B|KAZALD1|KCNIP2|KCNK18|KCNMA1|KIF11|KIF20B|KIFBP|KLLN|KNDC1|LBX1|LCOR|LDB1|LDB3|LGI1|LHPP|LINC01166|LINC01520|LINC02870|LIPA|LIPF|LIPJ|LIPK|LIPM|LIPN|LOC100131132|LOC101929662|LOXL4|LRIT1|LRIT2|LRMDA|LRRC18|LRRC20|LRRC27|LRRTM3|LZTS2|MACROH2A2|MIR346|MKI67|MMP21|MMRN2|MMS19|MORN4|MRPL43|MRPS16|MSMB|MSS51|MTG1|MTRNR2L5|MXI1|MYOF|MYOZ1|MYPN|NANOS1|NCOA4|NDST2|NDUFB8|NEURL1|NEUROG3|NFKB2|NHLRC2|NKX1-2|NKX2-3|NKX6-2|NOC3L|NODAL|NOLC1|NPFFR1|NPM3|NPS|NPY4R|NRAP|NRBF2|NRG3|NSMCE4A|NT5C2|NUDT13|NUTM2A|NUTM2B|OAT|OGA|OGDHL|OIT3|OPALIN|PAX2|PBLD|PCBD1|PCDH15|PCGF5|PCGF6|PHYHIPL|PI4K2A|PIK3AP1|PITX3|PKD2L1|PLA2G12B|PLAC9|PLAU|PLCE1|PLEKHA1|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|POLL|POLR3A|PPA1|PPIF|PPP1R3C|PPP2R2D|PPP3CB|PPRC1|PRAP1|PRDX3|PRF1|PRKG1|PRLHR|PRXL2A|PSAP|PSD|PSTK|PTEN|PTPN20|PTPRE|PWWP2B|PYROXD2|R3HCC1L|RAB11FIP2|RET|RGR|RGS10|RHOBTB1|RNLS|RPP30|RPS24|RRP12|RTKN2|RUFY2|SAMD8|SAR1A|SFTPD|SFXN2|SFXN3|SFXN4|SGMS1|SGPL1|SH2D4B|SH3PXD2A|SHLD2|SHOC2|SHTN1|SIRT1|SLC16A12|SLC16A9|SLC18A2|SLC18A3|SLC25A16|SLC25A28|SLC29A3|SLC35G1|SLF2|SLIT1|SLK|SMC3|SMNDC1|SNCG|SNORA12|SORBS1|SORCS1|SORCS3|SPOCK2|SPRN|SRGN|STAMBPL1|STK32C|STN1|STOX1|SUFU|SUPV3L1|SYCE1|SYNPO2L|SYT15|TACC2|TACR2|TAF5|TBATA|TBC1D12|TCERG1L|TRIM8|TRUB1|TSPAN14|TSPAN15|TUBGCP2|TWNK|TYSND1|UBE2D1|UBTD1|UNC5B|UROS|USP54|UTF1|VAX1|VCL|VDAC2|VENTX|VPS26A|VSIR|VSTM4|VTI1A|VWA2|WAPL|WASHC2A|WASHC2C|WBP1L|WDFY4|WDR11|WNT8B|XPNPEP1|ZCCHC24|ZDHHC16|ZDHHC6|ZFAND4|ZFYVE27|ZMIZ1|ZNF22|ZNF22-AS1|ZNF239|ZNF32|ZNF33B|ZNF365|A1CF|ABCC2|ABLIM1|ABRAXAS2|ACADSB|ACSL5|ACSM6|ACTA2|ACTR1A|ADAM12|ADAM8|ADAMTS14|ADD3|ADGRA1|ADIRF|ADIRF-AS1|ADK|ADO|ADRA2A|ADRB1|AFAP1L2|AGAP10|AGAP11|AGAP4|AGAP5|AGAP6|AGAP9|AIFM2|ALDH18A1|ALOX5|ANAPC16|ANK3|ANKRD1|ANKRD2|ANKRD22|ANXA11|ANXA7|ANXA8|ANXA8L1|AP3M1|ARHGAP19|ARHGAP22|ARID5B|ARL3|ARMH3|ARMS2|AS3MT|ASAH2|ASAH2B|ASCC1|ATAD1|ATE1|ATOH7|ATP5MK|ATRNL1|AVPI1|BAG3|BBIP1|BCCIP|BICC1|BLNK|BLOC1S2|BMPR1A|BMS1|BNIP3|BORCS7		Poly (ADP-Ribose) polymerase inhibitor response	VCV000523165	10	42347406 - 135534747			523165	513797			copy number loss		drug response	Nov 27, 2017	no assertion criteria provided							
GRCh37/hg19 10q25.1-26.3(chr10:106003533-135427143)x3	ABLIM1|ABRAXAS2|ACADSB|ACSL5|ADAM12|ADAM8|ADD3|ADGRA1|ADRA2A|ADRB1|AFAP1L2|ARMS2|ATE1|ATRNL1|BAG3|BBIP1|BCCIP|BNIP3|BTBD16|BUB3|C10orf120|C10orf88|C10orf90|CACUL1|CALY|CASC2|CASP7|CCDC172|CCDC186|CFAP46|CFAP58|CHST15|CLRN3|CPXM2|CTBP2|CUZD1|CYP2E1|DCLRE1A|DENND10|DHX32|DMBT1|DOCK1|DPYSL4|DUSP5|EBF3|ECHS1|EDRF1|EEF1AKMT2|EIF3A|EMX2|EMX2OS|ENO4|FAM204A|FAM24A|FAM24B|FAM53B|FANK1|FGFR2|FHIP2A|FOXI2|FUOM|GFRA1|GLRX3|GPAM|GPR26|GRK5|GSTO1|GSTO2|HABP2|HMX2|HMX3|HSPA12A|HTRA1|IKZF5|INPP5A|INPP5F|INSYN2A|ITPRIP|JAKMIP3|KCNK18|KNDC1|LHPP|LINC01166|LINC02870|LRRC27|MCMBP|MGMT|MKI67|MMP21|MTG1|MXI1|NANOS1|NHLRC2|NKX1-2|NKX6-2|NPS|NRAP|NSMCE4A|OAT|PAOX|PDCD4|PDZD8|PLEKHA1|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PPP2R2D|PRAP1|PRDX3|PRLHR|PSTK|PTPRE|PWWP2B|RAB11FIP2|RBM20|RGS10|SEC23IP|SFXN4|SHOC2|SHTN1|SLC18A2|SMC3|SMNDC1|SORCS1|SORCS3|SPMIP5|SPRN|STK32C|SYCE1|TACC2|TCERG1L|TCERG1L-AS1|TCF7L2|TDRD1|TECTB|TEX36|TIAL1|TRUB1|TUBGCP2|UROS|UTF1|VAX1|VENTX|VTI1A|VWA2|WDR11|XPNPEP1|ZDHHC6|ZNF511|ZRANB1		See cases	VCV000443838	10	106003533 - 135427143			443838	437500			copy number gain		Pathogenic	Aug 15, 2014	no assertion criteria provided							
GRCh37/hg19 10q23.32-26.3(chr10:93283493-135427143)x3	ABCC2|ABLIM1|ABRAXAS2|ACADSB|ACSL5|ACSM6|ACTR1A|ADAM12|ADAM8|ADD3|ADGRA1|ADRA2A|ADRB1|AFAP1L2|ALDH18A1|ANKRD2|ARHGAP19|ARL3|ARMH3|ARMS2|AS3MT|ATE1|ATP5MK|ATRNL1|AVPI1|BAG3|BBIP1|BCCIP|BLNK|BLOC1S2|BNIP3|BORCS7|BTAF1|BTBD16|BTRC|BUB3|C10orf12|C10orf120|C10orf131|C10orf62|C10orf88|C10orf90|C10orf95|CACUL1|CALHM1|CALHM2|CALHM3|CALY|CASC2|CASP7|CC2D2B|CCDC172|CCDC186|CCNJ|CEP55|CFAP43|CFAP46|CFAP58|CHST15|CHUK|CLRN3|CNNM1|CNNM2|COL17A1|COX15|CPEB3|CPN1|CPXM2|CRTAC1|CTBP2|CUEDC2|CUTC|CUZD1|CWF19L1|CYP17A1|CYP26A1|CYP26C1|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2E1|DCLRE1A|DENND10|DHX32|DMBT1|DNMBP|DNTT|DOCK1|DPCD|DPYSL4|DUSP5|EBF3|ECHS1|EDRF1|EEF1AKMT2|EIF3A|ELOVL3|EMX2|EMX2OS|ENO4|ENTPD1|ENTPD7|ERLIN1|EXOC6|EXOSC1|FAM204A|FAM24A|FAM24B|FAM53B|FANK1|FBXL15|FBXW4|FFAR4|FGF8|FGFBP3|FGFR2|FHIP2A|FOXI2|FRA10AC1|FRAT1|FRAT2|FUOM|GBF1|GFRA1|GLRX3|GOLGA7B|GOT1|GPAM|GPR26|GRK5|GSTO1|GSTO2|HABP2|HELLS|HHEX|HIF1AN|HMX2|HMX3|HOGA1|HPS1|HPS6|HPSE2|HSPA12A|HTRA1|IDE|IKZF5|INA|INPP5A|INPP5F|INSYN2A|ITPRIP|JAKMIP3|KAZALD1|KCNIP2|KCNK18|KIF11|KNDC1|LBX1|LCOR|LDB1|LGI1|LHPP|LINC01166|LINC02870|LOXL4|LRRC27|LZTS2|MARCHF5|MARVELD1|MCMBP|MFSD13A|MGMT|MIR146B|MKI67|MMP21|MMS19|MORN4|MRPL43|MTG1|MXI1|MYOF|NANOS1|NDUFB8|NEURL1|NFKB2|NHLRC2|NKX1-2|NKX2-3|NKX6-2|NOC3L|NOLC1|NPM3|NPS|NRAP|NSMCE4A|NT5C2|OAT|OGA|OPALIN|PAOX|PAX2|PCGF6|PDCD11|PDCD4|PDE6C|PDLIM1|PDZD7|PDZD8|PGAM1|PI4K2A|PIK3AP1|PITX3|PKD2L1|PLCE1|PLEKHA1|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PRLHR|POLL|PPP1R3C|PPP2R2D|PPRC1|PRAP1|PRDX3|PSD|PSTK|PTPRE|PWWP2B|PYROXD2|R3HCC1L|RAB11FIP2|RBM20|RBP4|RGS10|RRP12|SCD|SEC23IP|SEC31B|SEMA4G|SFR1|SFRP5|SFXN2|SFXN3|SFXN4|SH3PXD2A|SHOC2|SHTN1|SLC18A2|SLC25A28|SLC35G1|SLF2|SLIT1|SLK|SMC3|SMNDC1|SNORA12|SORBS1|SORCS1|SORCS3|SPMIP5|SPRN|STK32C|STN1|SUFU|SYCE1|TACC2|TAF5|TBC1D12|TCERG1L|TCERG1L-AS1|TCF7L2|TCTN3|TDRD1|TECTB|TEX36|TIAL1|TLL2|TLX1|TLX1NB|TM9SF3|TNKS2|TRIM8|TRUB1|TUBGCP2|TWNK|UBTD1|UROS|UTF1|VAX1|VENTX|VTI1A|VWA2|WBP1L|WDR11|WNT8B|XPNPEP1|ZDHHC16|ZDHHC6|ZFYVE27|ZNF511|ZNF518A|ZRANB1		See cases	VCV000443323	10	93283493 - 135427143			443323	436985			copy number gain		Pathogenic	Jun 23, 2014	no assertion criteria provided							
GRCh37/hg19 10p15.3-q26.3(chr10:100027-135427143)	INA|INPP5A|INPP5F|INSYN2A|IPMK|ITGA8|ITGB1|ITIH2|ITIH5|ITPRIP|JAKMIP3|JCAD|JMJD1C|KAT6B|KAZALD1|KCNIP2|KCNK18|KCNMA1|KIAA1217|KIF11|KIF20B|KIF5B|KIFBP|KIN|KLF6|KLLN|KNDC1|LARP4B|LBX1|LCOR|LDB1|LDB3|LGI1|LHPP|LINC01166|LINC01520|LINC02870|LIPA|LIPF|LIPJ|LIPK|LIPM|LIPN|LOC101929662|LOXL4|LRIT1|LRIT2|LRMDA|LRRC18|LRRC20|LRRC27|LRRTM3|LYZL1|LYZL2|LZTS2|MACROH2A2|MAP3K8|MAPK8|MARCHF5|MARCHF8|MARVELD1|MASTL|MAT1A|MBL2|MCM10|MCMBP|MCU|MEIG1|MFSD13A|MGMT|MICU1|MINDY3|MINPP1|MIR107|MIR146B|MIR1915|MIR1915HG|MIR346|MKI67|MKX|MLLT10|MMP21|MMRN2|MMS19|MORN4|MPP7|MRPL43|MRPS16|MSMB|MSRB2|MSS51|MTG1|MTPAP|MTRNR2L5|MTRNR2L7|MXI1|MYO3A|MYOF|MYOZ1|MYPN|NANOS1|NCOA4|NDST2|NDUFB8|NEBL|NET1|NEURL1|NEUROG3|NFKB2|NHLRC2|NKX1-2|NKX2-3|NKX6-2|NMT2|NOC3L|NODAL|NOLC1|NPFFR1|NPM3|NPS|NPY4R|NRAP|NRBF2|NRG3|NRP1|NSMCE4A|NSUN6|NT5C2|NUDT13|NUDT5|NUTM2A|NUTM2B|OAT|ODAD2|OGA|OGDHL|OIT3|OLAH|OPALIN|OPN4|OPTN|OR13A1|OTUD1|P4HA1|PALD1|PANK1|PAOX|PAPSS2|PARD3|PARG|PAX2|PBLD|PCBD1|PCDH15|PCGF5|PCGF6|PDCD11|PDCD4|PDE6C|PDLIM1|PDSS1|PDZD7|PDZD8|PFKFB3|PFKP|PGAM1|PGBD3|PHYH|PHYHIPL|PI4K2A|PIK3AP1|PIP4K2A|PITRM1|PITX3|PKD2L1|PLA2G12B|PLAC9|PLAU|PLCE1|PLEKHA1|PLEKHS1|PLPP4|PLXDC2|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|POLL|POLR3A|PPA1|PPIF|PPP1R3C|PPP2R2D|PPP3CB|PPRC1|PRAP1|PRDX3|PRF1|PRINS|PRKCQ|PRKG1|PRLHR|PROSER2|PRPF18|PRTFDC1|PRXL2A|PSAP|PSD|PSTK|PTCHD3|PTEN|PTER|PTF1A|PTPN20|PTPRE|PWWP2B|PYROXD2|R3HCC1L|RAB11FIP2|RAB18|RASGEF1A|RASSF4|RBM17|RBM20|RBP3|RBP4|REEP3|RET|RGR|RGS10|RHOBTB1|RNLS|RPP30|RPP38|RPP38-DT|RPS24|RRP12|RSU1|RTKN2|RUFY2|SAMD8|SAR1A|SCD|SEC23IP|SEC24C|SEC31B|SEC61A2|SEMA4G|SEPHS1|SFMBT2|SFR1|SFRP5|SFTPA1|SFTPA2|SFTPD|SFXN2|SFXN3|SFXN4|SGMS1|SGPL1|SH2D4B|SH3PXD2A|SHLD2|SHOC2|SHTN1|SIRT1|SKIDA1|SLC16A12|SLC16A9|SLC18A2|SLC18A3|SLC25A16|SLC25A28|SLC29A3|SLC35G1|SLC39A12|SLF2|SLIT1|SLK|SMC3|SMNDC1|SNCG|SNORA12|SORBS1|SORCS1|SORCS3|SPAG6|SPMIP5|SPOCK2|SPRN|SRGN|ST8SIA6|STAM|STAMBPL1|STK32C|STN1|STOX1|SUFU|SUPV3L1|SUV39H2|SVIL|SYCE1|SYNPO2L|SYT15|TACC2|TACR2|TAF3|TAF5|TASOR2|TBATA|TBC1D12|TCERG1L|TCERG1L-AS1|TCF7L2|TCTN3|TDRD1|TECTB|TET1|TEX36|TFAM|THNSL1|TIAL1|TIMM23|TLL2|TLX1|TLX1NB|TM9SF3|TMEM254|TMEM26|TMEM273|TMEM72|TNKS2|TRDMT1|TRIM8|TRUB1|TSPAN14|TSPAN15|TUBAL3|TUBGCP2|TWNK|TYSND1|UBE2D1|UBTD1|UCMA|UCN3|UNC5B|UPF2|UROS|USP54|USP6NL|UTF1|VAX1|VCL|VDAC2|VENTX|VIM|VPS26A|VSIR|VSTM4|VTI1A|VWA2|WAC|WAPL|WASHC2A|WASHC2C|WBP1L|WDFY4|WDR11|WDR37|WNT8B|XPNPEP1|YME1L1|ZCCHC24|ZDHHC16|ZDHHC6|ZEB1|ZFAND4|ZFYVE27|ZMIZ1|ZMYND11|ZNF22|ZNF22-AS1|ZNF239|ZNF248|ZNF25|ZNF32|ZNF33A|ZNF33B|ZNF365|ZNF37A|ZNF438|ZNF485|ZNF488|ZNF503|ZNF511|ZNF518A|ZRANB1|ZSWIM8|ZWINT|A1CF|ABCC2|ABI1|ABLIM1|ABRAXAS2|ACADSB|ACBD5|ACBD7|ACSL5|ACSM6|ACTA2|ACTR1A|ADAM12|ADAM8|ADAMTS14|ADARB2|ADD3|ADGRA1|ADIRF|ADIRF-AS1|ADK|ADO|ADRA2A|ADRB1|AFAP1L2|AGAP10|AGAP11|AGAP4|AGAP5|AGAP6|AGAP9|AIFM2|AKR1C1|AKR1C2|AKR1C3|AKR1C4|AKR1E2|ALDH18A1|ALOX5|ANAPC16|ANK3|ANKRD1|ANKRD16|ANKRD2|ANKRD22|ANKRD26|ANKRD30A|ANXA11|ANXA7|ANXA8|ANXA8L1|AP3M1|APBB1IP|ARHGAP12|ARHGAP19|ARHGAP21|ARHGAP22|ARID5B|ARL3|ARL5B|ARMC3|ARMH3|ARMS2|AS3MT|ASAH2|ASAH2B|ASB13|ASCC1|ATAD1|ATE1|ATOH7|ATP5F1C|ATP5MK|ATRNL1|AVPI1|BAG3|BAMBI|BBIP1|BCCIP|BEND7|BICC1|BLNK|BLOC1S2|BMI1|BMPR1A|BMS1|BNIP3|BORCS7|BTAF1|BTBD16|BTRC|BUB3|C10orf105|C10orf113|C10orf12|C10orf120|C10orf126|C10orf131|C10orf53|C10orf55|C10orf62|C10orf67|C10orf71|C10orf88|C10orf90|C10orf95|C1QL3|CABCOCO1|CACNB2|CACUL1|CALHM1|CALHM2|CALHM3|CALML3|CALML3-AS1|CALML5|CALY|CAMK1D|CAMK2G|CASC2|CASP7|CC2D2B|CCAR1|CCDC172|CCDC186|CCDC3|CCDC6|CCDC7|CCNJ|CCNY|CCSER2|CDC123|CDH23|CDHR1|CDK1|CDNF|CELF2|CEP55|CFAP43|CFAP46|CFAP58|CFAP70|CH25H|CHAT|CHCHD1|CHST15|CHST3|CHUK|CISD1|CLRN3|CNNM1|CNNM2|COL13A1|COL17A1|COMMD3|COMMD3-BMI1|COMTD1|COX15|CPEB3|CPN1|CPXM2|CREM|CRTAC1|CSGALNACT2|CSTF2T|CTBP2|CTNNA3|CUBN|CUEDC2|CUL2|CUTC|CUZD1|CWF19L1|CXCL12|CYP17A1|CYP26A1|CYP26C1|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2E1|DCLRE1A|DCLRE1C|DDIT4|DDX21|DDX50|DENND10|DEPP1|DHTKD1|DHX32|DIP2C|DKK1|DLG5|DMBT1|DNA2|DNAJB12|DNAJC1|DNAJC12|DNAJC9|DNMBP|DNTT|DOCK1|DPCD|DPYSL4|DRGX|DUSP13B|DUSP29|DUSP5|DYDC1|DYDC2|EBF3|EBLN1|ECD|ECHDC3|ECHS1|EDRF1|EEF1AKMT2|EGR2|EIF3A|EIF4EBP2|EIF5AL1|ELOVL3|EMX2|EMX2OS|ENKUR|ENO4|ENTPD1|ENTPD7|EPC1|ERCC6|ERLIN1|EXOC6|EXOSC1|FAM107B|FAM13C|FAM149B1|FAM170B|FAM171A1|FAM204A|FAM241B|FAM24A|FAM24B|FAM25A|FAM25C|FAM25E|FAM25G|FAM53B|FANK1|FAS|FAS-AS1|FBH1|FBXL15|FBXW4|FFAR4|FGF8|FGFBP3|FGFR2|FHIP2A|FOXI2|FRA10AC1|FRAT1|FRAT2|FRMD4A|FRMPD2|FUOM|FUT11|FXYD4|FZD8|GAD2|GATA3|GBF1|GDF10|GDF2|GDI2|GFRA1|GHITM|GJD4|GLRX3|GLUD1|GOLGA7B|GOT1|GPAM|GPR158|GPR15LG|GPR26|GPRIN2|GRID1|GRK5|GSTO1|GSTO2|GTPBP4|HABP2|HACD1|HECTD2|HELLS|HERC4|HHEX|HIF1AN|HK1|HKDC1|HMX2|HMX3|HNRNPF|HNRNPH3|HOGA1|HPS1|HPS6|HPSE2|HSPA12A|HSPA14|HTR7|HTRA1|IDE|IDI1|IDI2|IFIT1|IFIT1B|IFIT2|IFIT3|IFIT5|IKZF5|IL15RA|IL2RA		See cases	VCV000441987	10	100027 - 135427143			441987	435649			copy number gain		Pathogenic	Jul 14, 2015	no assertion criteria provided							
GRCh37/hg19 10p15.3-q26.3(chr10:100027-135427143)x3	A1CF|ABCC2|ABI1|ABLIM1|ABRAXAS2|ACADSB|ACBD5|ACBD7|ACSL5|ACSM6|ACTA2|ACTR1A|ADAM12|ADAM8|ADAMTS14|ADARB2|ADD3|ADGRA1|ADIRF|ADIRF-AS1|ADK|ADO|ADRA2A|ADRB1|AFAP1L2|AGAP10|AGAP11|AGAP4|AGAP5|AGAP6|AGAP9|AIFM2|AKR1C1|AKR1C2|AKR1C3|AKR1C4|AKR1E2|ALDH18A1|ALOX5|ANAPC16|ANK3|ANKRD1|ANKRD16|ANKRD2|ANKRD22|ANKRD26|ANKRD30A|ANXA11|ANXA7|ANXA8|ANXA8L1|AP3M1|APBB1IP|ARHGAP12|ARHGAP19|ARHGAP21|ARHGAP22|ARID5B|ARL3|ARL5B|ARMC3|ARMH3|ARMS2|AS3MT|ASAH2|ASAH2B|ASB13|ASCC1|ATAD1|ATE1|ATOH7|ATP5F1C|ATP5MK|ATRNL1|AVPI1|BAG3|BAMBI|BBIP1|BCCIP|BEND7|BICC1|BLNK|BLOC1S2|BMI1|BMPR1A|BMS1|BNIP3|BORCS7|BTAF1|BTBD16|BTRC|BUB3|C10orf105|C10orf113|C10orf12|C10orf120|C10orf126|C10orf131|C10orf53|C10orf55|C10orf62|C10orf67|C10orf71|C10orf88|C10orf90|C10orf95|C1QL3|CABCOCO1|CACNB2|CACUL1|CALHM1|CALHM2|CALHM3|CALML3|CALML3-AS1|CALML5|CALY|CAMK1D|CAMK2G|CASC2|CASP7|CC2D2B|CCAR1|CCDC172|CCDC186|CCDC3|CCDC6|CCDC7|CCNJ|CCNY|CCSER2|CDC123|CDH23|CDHR1|CDK1|CDNF|CELF2|CEP55|CFAP43|CFAP46|CFAP58|CFAP70|CH25H|CHAT|CHCHD1|CHST15|CHST3|CHUK|CISD1|CLRN3|CNNM1|CNNM2|COL13A1|COL17A1|COMMD3|COMMD3-BMI1|COMTD1|COX15|CPEB3|CPN1|CPXM2|CREM|CRTAC1|CSGALNACT2|CSTF2T|CTBP2|CTNNA3|CUBN|CUEDC2|CUL2|CUTC|CUZD1|CWF19L1|CXCL12|CYP17A1|CYP26A1|CYP26C1|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2E1|DCLRE1A|DCLRE1C|DDIT4|DDX21|DDX50|DENND10|DEPP1|DHTKD1|DHX32|DIP2C|DKK1|DLG5|DMBT1|DNA2|DNAJB12|DNAJC1|DNAJC12|DNAJC9|DNMBP|DNTT|DOCK1|DPCD|DPYSL4|DRGX|DUSP13B|DUSP29|DUSP5|DYDC1|DYDC2|EBF3|EBLN1|ECD|ECHDC3|ECHS1|EDRF1|EEF1AKMT2|EGR2|EIF3A|EIF4EBP2|EIF5AL1|ELOVL3|EMX2|EMX2OS|ENKUR|ENO4|ENTPD1|ENTPD7|EPC1|ERCC6|ERLIN1|EXOC6|EXOSC1|FAM107B|FAM13C|FAM149B1|FAM170B|FAM171A1|FAM204A|FAM241B|FAM24A|FAM24B|FAM25A|FAM25C|FAM25E|FAM25G|FAM53B|FANK1|FAS|FAS-AS1|FBH1|FBXL15|FBXW4|FFAR4|FGF8|FGFBP3|FGFR2|FHIP2A|FOXI2|FRA10AC1|FRAT1|FRAT2|FRMD4A|FRMPD2|FUOM|FUT11|FXYD4|FZD8|GAD2|GATA3|GBF1|GDF10|GDF2|GDI2|GFRA1|GHITM|GJD4|GLRX3|GLUD1|GOLGA7B|GOT1|GPAM|GPR158|GPR15LG|GPR26|GPRIN2|GRID1|GRK5|GSTO1|GSTO2|GTPBP4|HABP2|HACD1|HECTD2|HELLS|HERC4|HHEX|HIF1AN|HK1|HKDC1|HMX2|HMX3|HNRNPF|HNRNPH3|HOGA1|HPS1|HPS6|HPSE2|HSPA12A|HSPA14|HTR7|HTRA1|IDE|IDI1|IDI2|IFIT1|IFIT1B|IFIT2|IFIT3|IFIT5|IKZF5|IL15RA|IL2RA|INA|INPP5A|INPP5F|INSYN2A|IPMK|ITGA8|ITGB1|ITIH2|ITIH5|ITPRIP|JAKMIP3|JCAD|JMJD1C|KAT6B|KAZALD1|KCNIP2|KCNK18|KCNMA1|KIAA1217|KIF11|KIF20B|KIF5B|KIFBP|KIN|KLF6|KLLN|KNDC1|LARP4B|LBX1|LCOR|LDB1|LDB3|LGI1|LHPP|LINC01166|LINC01520|LINC02870|LIPA|LIPF|LIPJ|LIPK|LIPM|LIPN|LOC101929662|LOXL4|LRIT1|LRIT2|LRMDA|LRRC18|LRRC20|LRRC27|LRRTM3|LYZL1|LYZL2|LZTS2|MACROH2A2|MAP3K8|MAPK8|MARCHF5|MARCHF8|MARVELD1|MASTL|MAT1A|MBL2|MCM10|MCMBP|MCU|MEIG1|MFSD13A|MGMT|MICU1|MINDY3|MINPP1|MIR107|MIR146B|MIR1915|MIR1915HG|MIR346|MKI67|MKX|MLLT10|MMP21|MMRN2|MMS19|MORN4|MPP7|MRPL43|MRPS16|MSMB|MSRB2|MSS51|MTG1|MTPAP|MTRNR2L5|MTRNR2L7|MXI1|MYO3A|MYOF|MYOZ1|MYPN|NANOS1|NCOA4|NDST2|NDUFB8|NEBL|NET1|NEURL1|NEUROG3|NFKB2|NHLRC2|NKX1-2|NKX2-3|NKX6-2|NMT2|NOC3L|NODAL|NOLC1|NPFFR1|NPM3|NPS|NPY4R|NRAP|NRBF2|NRG3|NRP1|NSMCE4A|NSUN6|NT5C2|NUDT13|NUDT5|NUTM2A|NUTM2B|OAT|ODAD2|OGA|OGDHL|OIT3|OLAH|OPALIN|OPN4|OPTN|OR13A1|OTUD1|P4HA1|PALD1|PANK1|PAOX|PAPSS2|PARD3|PARG|PAX2|PBLD|PCBD1|PCDH15|PCGF5|PCGF6|PDCD11|PDCD4|PDE6C|PDLIM1|PDSS1|PDZD7|PDZD8|PFKFB3|PFKP|PGAM1|PGBD3|PHYH|PHYHIPL|PI4K2A|PIK3AP1|PIP4K2A|PITRM1|PITX3|PKD2L1|PLA2G12B|PLAC9|PLAU|PLCE1|PLEKHA1|PLEKHS1|PLPP4|PLXDC2|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PPP3CB|POLL|POLR3A|PPA1|PPIF|PPP1R3C|PPP2R2D|PPRC1|PRAP1|PRDX3|PRF1|PRINS|PRKCQ|PRKG1|PRLHR|PROSER2|PRPF18|PRTFDC1|PRXL2A|PSAP|PSD|PSTK|PTCHD3|PTEN|PTER|PTF1A|PTPN20|PTPRE|PWWP2B|PYROXD2|R3HCC1L|RAB11FIP2|RAB18|RASGEF1A|RASSF4|RBM17|RBM20|RBP3|RBP4|REEP3|RET|RGR|RGS10|RHOBTB1|RNLS|RPP30|RPP38|RPP38-DT|RPS24|RRP12|RSU1|RTKN2|RUFY2|SAMD8|SAR1A|SCD|SEC23IP|SEC24C|SEC31B|SEC61A2|SEMA4G|SEPHS1|SFMBT2|SFR1|SFRP5|SFTPA1|SFTPA2|SFTPD|SFXN2|SFXN3|SFXN4|SGMS1|SGPL1|SH2D4B|SH3PXD2A|SHLD2|SHOC2|SHTN1|SIRT1|SKIDA1|SLC16A12|SLC16A9|SLC18A2|SLC18A3|SLC25A16|SLC25A28|SLC29A3|SLC35G1|SLC39A12|SLF2|SLIT1|SLK|SMC3|SMNDC1|SNCG|SNORA12|SORBS1|SORCS1|SORCS3|SPAG6|SPMIP5|SPOCK2|SPRN|SRGN|ST8SIA6|STAM|STAMBPL1|STK32C|STN1|STOX1|SUFU|SUPV3L1|SUV39H2|SVIL|SYCE1|SYNPO2L|SYT15|TACC2|TACR2|TAF3|TAF5|TASOR2|TBATA|TBC1D12|TCERG1L|TCERG1L-AS1|TCF7L2|TCTN3|TDRD1|TECTB|TET1|TEX36|TFAM|THNSL1|TIAL1|TIMM23|TLL2|TLX1|TLX1NB|TM9SF3|TMEM254|TMEM26|TMEM273|TMEM72|TNKS2|TRDMT1|TRIM8|TRUB1|TSPAN14|TSPAN15|TUBAL3|TUBGCP2|TWNK|TYSND1|UBE2D1|UBTD1|UCMA|UCN3|UNC5B|UPF2|UROS|USP54|USP6NL|UTF1|VAX1|VCL|VDAC2|VENTX|VIM|VPS26A|VSIR|VSTM4|VTI1A|VWA2|WAC|WAPL|WASHC2A|WASHC2C|WBP1L|WDFY4|WDR11|WDR37|WNT8B|XPNPEP1|YME1L1|ZCCHC24|ZDHHC16|ZDHHC6|ZEB1|ZFAND4|ZFYVE27|ZMIZ1|ZMYND11|ZNF22|ZNF22-AS1|ZNF239|ZNF248|ZNF25|ZNF32|ZNF33A|ZNF33B|ZNF365|ZNF37A|ZNF438|ZNF485|ZNF488|ZNF503|ZNF511|ZNF518A|ZRANB1|ZSWIM8|ZWINT		See cases	VCV000441986	10	100027 - 135427143			441986	435648			copy number gain		Pathogenic	Dec 2, 2014	no assertion criteria provided							
GRCh37/hg19 10p15.3-q26.3(chr10:93297-135378918)x3	A1CF|ABCC2|ABI1|ABLIM1|ABRAXAS2|ACADSB|ACBD5|ACBD7|ACSL5|ACSM6|ACTA2|ACTR1A|ADAM12|ADAM8|ADAMTS14|ADARB2|ADD3|ADGRA1|ADIRF|ADIRF-AS1|ADK|ADO|ADRA2A|ADRB1|AFAP1L2|AGAP10|AGAP11|AGAP4|AGAP5|AGAP6|AGAP9|AIFM2|AKR1C1|AKR1C2|AKR1C3|AKR1C4|AKR1E2|ALDH18A1|ALOX5|ANAPC16|ANK3|ANKRD1|ANKRD16|ANKRD2|ANKRD22|ANKRD26|ANKRD30A|ANXA11|ANXA7|ANXA8|ANXA8L1|AP3M1|APBB1IP|ARHGAP12|ARHGAP19|ARHGAP21|ARHGAP22|ARID5B|ARL3|ARL5B|ARMC3|ARMH3|ARMS2|AS3MT|ASAH2|ASAH2B|ASB13|ASCC1|ATAD1|ATE1|ATOH7|ATP5F1C|ATP5MK|ATRNL1|AVPI1|BAG3|BAMBI|BBIP1|BCCIP|BEND7|BICC1|BLNK|BLOC1S2|BMI1|BMPR1A|BMS1|BNIP3|BORCS7|BTAF1|BTBD16|BTRC|BUB3|C10orf105|C10orf113|C10orf12|C10orf120|C10orf126|C10orf131|C10orf53|C10orf55|C10orf62|C10orf67|C10orf71|C10orf88|C10orf90|C10orf95|C1QL3|CABCOCO1|CACNB2|CACUL1|CALHM1|CALHM2|CALHM3|CALML3|CALML3-AS1|CALML5|CALY|CAMK1D|CAMK2G|CASC2|CASP7|CC2D2B|CCAR1|CCDC172|CCDC186|CCDC3|CCDC6|CCDC7|CCNJ|CCNY|CCSER2|CDC123|CDH23|CDHR1|CDK1|CDNF|CELF2|CEP55|CFAP43|CFAP46|CFAP58|CFAP70|CH25H|CHAT|CHCHD1|CHST15|CHST3|CHUK|CISD1|CLRN3|CNNM1|CNNM2|COL13A1|COL17A1|COMMD3|COMMD3-BMI1|COMTD1|COX15|CPEB3|CPN1|CPXM2|CREM|CRTAC1|CSGALNACT2|CSTF2T|CTBP2|CTNNA3|CUBN|CUEDC2|CUL2|CUTC|CUZD1|CWF19L1|CXCL12|CYP17A1|CYP26A1|CYP26C1|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2E1|DCLRE1A|DCLRE1C|DDIT4|DDX21|DDX50|DENND10|DEPP1|DHTKD1|DHX32|DIP2C|DKK1|DLG5|DMBT1|DNA2|DNAJB12|DNAJC1|DNAJC12|DNAJC9|DNMBP|DNTT|DOCK1|DPCD|DPYSL4|DRGX|DUSP13B|DUSP29|DUSP5|DYDC1|DYDC2|EBF3|EBLN1|ECD|ECHDC3|ECHS1|EDRF1|EEF1AKMT2|EGR2|EIF3A|EIF4EBP2|EIF5AL1|ELOVL3|EMX2|EMX2OS|ENKUR|ENO4|ENTPD1|ENTPD7|EPC1|ERCC6|ERLIN1|EXOC6|EXOSC1|FAM107B|FAM13C|FAM149B1|FAM170B|FAM171A1|FAM204A|FAM241B|FAM24A|FAM24B|FAM25A|FAM25C|FAM25E|FAM25G|FAM53B|FANK1|FAS|FAS-AS1|FBH1|FBXL15|FBXW4|FFAR4|FGF8|FGFBP3|FGFR2|FHIP2A|FOXI2|FRA10AC1|FRAT1|FRAT2|FRMD4A|FRMPD2|FUOM|FUT11|FXYD4|FZD8|GAD2|GATA3|GBF1|GDF10|GDF2|GDI2|GFRA1|GHITM|GJD4|GLRX3|GLUD1|GOLGA7B|GOT1|GPAM|GPR158|GPR15LG|GPR26|GPRIN2|GRID1|GRK5|GSTO1|GSTO2|GTPBP4|HABP2|HACD1|HECTD2|HELLS|HERC4|HHEX|HIF1AN|HK1|HKDC1|HMX2|HMX3|HNRNPF|HNRNPH3|HOGA1|HPS1|HPS6|HPSE2|HSPA12A|HSPA14|HTR7|HTRA1|IDE|IDI1|IDI2|IFIT1|IFIT1B|IFIT2|IFIT3|IFIT5|IKZF5|IL15RA|IL2RA|INA|INPP5A|INPP5F|INSYN2A|IPMK|ITGA8|ITGB1|ITIH2|ITIH5|ITPRIP|JAKMIP3|JCAD|JMJD1C|KAT6B|KAZALD1|KCNIP2|KCNK18|KCNMA1|KIAA1217|KIF11|KIF20B|KIF5B|KIFBP|KIN|KLF6|KLLN|KNDC1|LARP4B|LBX1|LCOR|LDB1|LDB3|LGI1|LHPP|LINC01166|LINC01520|LINC02870|LIPA|LIPF|LIPJ|LIPK|LIPM|LIPN|LOC101929662|LOXL4|LRIT1|LRIT2|LRMDA|LRRC18|LRRC20|LRRC27|LRRTM3|LYZL1|LYZL2|LZTS2|MACROH2A2|MAP3K8|MAPK8|MARCHF5|MARCHF8|MARVELD1|MASTL|MAT1A|MBL2|MCM10|MCMBP|MCU|MEIG1|MFSD13A|MGMT|MICU1|MINDY3|MINPP1|MIR107|MIR146B|MIR1915|MIR1915HG|MIR346|MKI67|MKX|MLLT10|MMP21|MMRN2|MMS19|MORN4|MPP7|MRPL43|MRPS16|MSMB|MSRB2|MSS51|MTG1|MTPAP|MTRNR2L5|MTRNR2L7|MXI1|MYO3A|MYOF|MYOZ1|MYPN|NANOS1|NCOA4|NDST2|NDUFB8|NEBL|NET1|NEURL1|NEUROG3|NFKB2|NHLRC2|NKX1-2|NKX2-3|NKX6-2|NMT2|NOC3L|NODAL|NOLC1|NPFFR1|NPM3|NPS|NPY4R|NRAP|NRBF2|NRG3|NRP1|NSMCE4A|NSUN6|NT5C2|NUDT13|NUDT5|NUTM2A|NUTM2B|OAT|ODAD2|OGA|OGDHL|OIT3|OLAH|OPALIN|OPN4|OPTN|OR13A1|OTUD1|P4HA1|PALD1|PANK1|PAOX|PAPSS2|PARD3|PARG|PAX2|PBLD|PCBD1|PCDH15|PCGF5|PCGF6|PDCD11|PDCD4|PDE6C|PDLIM1|PDSS1|PDZD7|PDZD8|PFKFB3|PFKP|PGAM1|PGBD3|PHYH|PHYHIPL|PI4K2A|PIK3AP1|PIP4K2A|PITRM1|PITX3|PKD2L1|PLA2G12B|PLAC9|PLAU|PLCE1|PLEKHA1|PLEKHS1|PLPP4|PLXDC2|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PPP3CB|POLL|POLR3A|PPA1|PPIF|PPP1R3C|PPP2R2D|PPRC1|PRAP1|PRDX3|PRF1|PRINS|PRKCQ|PRKG1|PRLHR|PROSER2|PRPF18|PRTFDC1|PRXL2A|PSAP|PSD|PSTK|PTCHD3|PTEN|PTER|PTF1A|PTPN20|PTPRE|PWWP2B|PYROXD2|R3HCC1L|RAB11FIP2|RAB18|RASGEF1A|RASSF4|RBM17|RBM20|RBP3|RBP4|REEP3|RET|RGR|RGS10|RHOBTB1|RNLS|RPP30|RPP38|RPP38-DT|RPS24|RRP12|RSU1|RTKN2|RUFY2|SAMD8|SAR1A|SCD|SEC23IP|SEC24C|SEC31B|SEC61A2|SEMA4G|SEPHS1|SFMBT2|SFR1|SFRP5|SFTPA1|SFTPA2|SFTPD|SFXN2|SFXN3|SFXN4|SGMS1|SGPL1|SH2D4B|SH3PXD2A|SHLD2|SHOC2|SHTN1|SIRT1|SKIDA1|SLC16A12|SLC16A9|SLC18A2|SLC18A3|SLC25A16|SLC25A28|SLC29A3|SLC35G1|SLC39A12|SLF2|SLIT1|SLK|SMC3|SMNDC1|SNCG|SNORA12|SORBS1|SORCS1|SORCS3|SPAG6|SPMIP5|SPOCK2|SPRN|SRGN|ST8SIA6|STAM|STAMBPL1|STK32C|STN1|STOX1|SUFU|SUPV3L1|SUV39H2|SVIL|SYCE1|SYNPO2L|SYT15|TACC2|TACR2|TAF3|TAF5|TASOR2|TBATA|TBC1D12|TCERG1L|TCERG1L-AS1|TCF7L2|TCTN3|TDRD1|TECTB|TET1|TEX36|TFAM|THNSL1|TIAL1|TIMM23|TLL2|TLX1|TLX1NB|TM9SF3|TMEM254|TMEM26|TMEM273|TMEM72|TNKS2|TRDMT1|TRIM8|TRUB1|TSPAN14|TSPAN15|TUBAL3|TUBB8|TUBGCP2|TWNK|TYSND1|UBE2D1|UBTD1|UCMA|UCN3|UNC5B|UPF2|UROS|USP54|USP6NL|UTF1|VAX1|VCL|VDAC2|VENTX|VIM|VPS26A|VSIR|VSTM4|VTI1A|VWA2|WAC|WAPL|WASHC2A|WASHC2C|WBP1L|WDFY4|WDR11|WDR37|WNT8B|XPNPEP1|YME1L1|ZCCHC24|ZDHHC16|ZDHHC6|ZEB1|ZFAND4|ZFYVE27|ZMIZ1|ZMYND11|ZNF22|ZNF22-AS1|ZNF239|ZNF248|ZNF25|ZNF32|ZNF33A|ZNF33B|ZNF365|ZNF37A|ZNF438|ZNF485|ZNF488|ZNF503|ZNF511|ZNF518A|ZRANB1|ZSWIM8|ZWINT		See cases	VCV000393995	10	93297 - 135378918			393995	380888			copy number gain		Pathogenic		no assertion criteria provided							
GRCh37/hg19 10q24.32-26.3(chr10:103288313-135512075)x3	ABLIM1|ABRAXAS2|ACADSB|ACSL5|ACTR1A|ADAM12|ADAM8|ADD3|ADGRA1|ADRA2A|ADRB1|AFAP1L2|ARL3|ARMH3|ARMS2|AS3MT|ATE1|ATP5MK|ATRNL1|BAG3|BBIP1|BCCIP|BNIP3|BORCS7|BTBD16|BTRC|BUB3|C10orf120|C10orf82|C10orf88|C10orf90|C10orf95|CACUL1|CALHM1|CALHM2|CALHM3|CALY|CASC2|CASP7|CCDC172|CCDC186|CFAP43|CFAP46|CFAP58|CHST15|CLRN3|CNNM2|COL17A1|CPXM2|CTBP2|CUEDC2|CUZD1|CYP17A1|CYP2E1|DCLRE1A|DENND10|DHX32|DMBT1|DOCK1|DPCD|DPYSL4|DUSP5|EBF3|ECHS1|EDRF1|EEF1AKMT2|EIF3A|ELOVL3|EMX2|EMX2OS|ENO4|FAM204A|FAM24A|FAM24B|FAM53B|FANK1|FBXL15|FBXW4|FGF8|FGFR2|FHIP2A|FOXI2|FRG2B|FUOM|GBF1|GFRA1|GLRX3|GPAM|GPR26|GRK5|GSTO1|GSTO2|HABP2|HMX2|HMX3|HPS6|HSPA12A|HTRA1|IKZF5|INA|INPP5A|INPP5F|INSYN2A|ITPRIP|JAKMIP3|KCNIP2|KCNK18|KNDC1|LDB1|LHPP|LINC01166|LINC02870|LRRC27|MCMBP|MFSD13A|MGMT|MIR146B|MKI67|MMP21|MTG1|MXI1|NANOS1|NEURL1|NFKB2|NHLRC2|NKX1-2|NKX6-2|NOLC1|NPM3|NPS|NRAP|NSMCE4A|NT5C2|OAT|OGA|PAOX|PCGF6|PDCD11|PDCD4|PDZD8|PITX3|PLEKHA1|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|POLL|PPP2R2D|PPRC1|PRAP1|PRDX3|PRLHR|PSD|PSTK|PTPRE|PWWP2B|RAB11FIP2|RBM20|RGS10|SEC23IP|SFR1|SFXN2|SFXN4|SH3PXD2A|SHOC2|SHTN1|SLC18A2|SLK|SMC3|SMNDC1|SORCS1|SORCS3|SPRN|STK32C|STN1|SUFU|SYCE1|TACC2|TAF5|TCERG1L|TCERG1L-AS1|TCF7L2|TDRD1|TECTB|TEX36|TIAL1|TRIM8|TRUB1|TUBGCP2|UROS|UTF1|VAX1|VENTX|VTI1A|VWA2|WBP1L|WDR11|XPNPEP1|ZDHHC6|ZNF511|ZRANB1		See cases	VCV000253479	10	103288313 - 135512075			253479	247927			copy number gain		Pathogenic	Jan 20, 2016	criteria provided, single submitter							
GRCh37/hg19 10q26.12-26.2(chr10:122239239-128203032)x1	C10orf90|CHST15|CPXM2|CTBP2|DMBT1|EDRF1|EEF1AKMT2|FAM24A|FAM24B|FAM53B|FANK1|FGFR2|GPR26|CUZD1|DHX32|ABRAXAS2|ACADSB|ADAM12|ARMS2|ATE1|BCCIP|BTBD16|BUB3|C10orf120|C10orf88|HMX2|HMX3|HTRA1|IKZF5|LHPP|MMP21|NKX1-2|NSMCE4A|OAT|PLEKHA1|PLPP4|PSTK|TACC2|TEX36|UROS|WDR11|ZRANB1		See cases	VCV000253439	10	122239239 - 128203032			253439	247887			copy number loss		Pathogenic	Jan 20, 2016	criteria provided, single submitter							
NM_000141.5(FGFR2):c.2422T>C (p.Cys808Arg)	FGFR2	C580R, C691R, C692R, C693R, C696R, C719R, C806R, C808R, C809R	not provided	VCV003360340					3360340	3519551			single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 26, 2023	criteria provided, single submitter							
NM_022970.4(FGFR2):c.947G>A (p.Gly316Glu)	FGFR2	G227E, G316E	not provided	VCV003360126					3360126	3519337			single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 20, 2023	criteria provided, single submitter							
NM_000141.5(FGFR2):c.223G>T (p.Asp75Tyr)	FGFR2	D75Y	not provided	VCV003359764					3359764	3518976			single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 15, 2023	criteria provided, single submitter							
NM_000141.5:c.940-19_940-18insAlu	FGFR2		Acrocephalosyndactyly type I	VCV002664499					2664499	2831950			Insertion		Likely pathogenic	Nov 9, 2023	criteria provided, single submitter							
t(10;19)(q26.13;q13.43)	FGFR2|ZNF135		Glioblastoma	VCV001177145					1177145	1166554			Translocation		Uncertain significance		no assertion criteria provided							
NM_000141.5:c.1040_1041ins[N[360];1026_1040]	FGFR2		Acrocephalosyndactyly type I	VCV000013287					13287	28326			Insertion		Pathogenic	Feb 1, 1999	no assertion criteria provided							
